|
OMIM |
Link |
Information gain |
01 |
|
RA
|
[NCBI]
|
0.0250059
|
|
|
SLE
|
[NCBI]
|
0.014596
|
|
|
VRNI
|
[NCBI]
|
0.00348479
|
|
|
MDD
|
[NCBI]
|
0.00297274
|
|
|
TNF
|
[NCBI]
|
0.00226604
|
|
|
VEGF
|
[NCBI]
|
0.00221807
|
|
|
MG
|
[NCBI]
|
0.00220051
|
|
|
CFTR
|
[NCBI]
|
0.00212231
|
|
|
stiff skin syndrome
|
[NCBI]
|
0.00211335
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.00189219
|
|
|
ALS3
|
[NCBI]
|
0.00167751
|
|
|
AD
|
[NCBI]
|
0.00166885
|
|
|
NPY
|
[NCBI]
|
0.00161819
|
|
|
PRL
|
[NCBI]
|
0.00154317
|
|
|
RTT
|
[NCBI]
|
0.00140536
|
|
|
leber optic atrophy
|
[NCBI]
|
0.00139084
|
|
|
MODY
|
[NCBI]
|
0.0013589
|
|
|
renal cell carcinoma, papillary, 3
|
[NCBI]
|
0.00135457
|
|
|
EGF
|
[NCBI]
|
0.00133433
|
|
|
KLK3
|
[NCBI]
|
0.00126787
|
|
|
AF8T
|
[NCBI]
|
0.00125772
|
|
|
methylmalonic aciduria and homocystinuria, cbld type
|
[NCBI]
|
0.00125772
|
|
|
ARVD5
|
[NCBI]
|
0.00125772
|
|
|
arrhythmogenic right ventricular dysplasia, familial, 6
|
[NCBI]
|
0.00125772
|
|
|
NGFB
|
[NCBI]
|
0.0012042
|
|
|
CD
|
[NCBI]
|
0.00118564
|
|
|
mannose 6-phosphate receptor recognition defect, lebanese type
|
[NCBI]
|
0.00111789
|
|
|
familial wilms tumor 2
|
[NCBI]
|
0.00111789
|
|
|
alport syndrome, autosomal dominant
|
[NCBI]
|
0.00111255
|
|
|
MFS
|
[NCBI]
|
0.00110154
|
|
|
SRS
|
[NCBI]
|
0.00106528
|
|
|
CCK
|
[NCBI]
|
0.00105691
|
|
|
DYT7
|
[NCBI]
|
0.00105481
|
|
|
CRH
|
[NCBI]
|
0.00100535
|
|
|
TSD
|
[NCBI]
|
0.000966538
|
|
|
PTH
|
[NCBI]
|
0.000913365
|
|
|
CEACAM5
|
[NCBI]
|
0.000897162
|
|
|
TH
|
[NCBI]
|
0.000892162
|
|
|
PWS
|
[NCBI]
|
0.000882866
|
|
|
VIP
|
[NCBI]
|
0.000879276
|
|
|
IS1
|
[NCBI]
|
0.00087594
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
0.000867599
|
|
|
MPO
|
[NCBI]
|
0.000836011
|
|
|
FSHMD1A
|
[NCBI]
|
0.000816275
|
|
|
duane retraction syndrome 2
|
[NCBI]
|
0.000805128
|
|
|
SHFM2
|
[NCBI]
|
0.000805128
|
|
|
TP53
|
[NCBI]
|
0.000800618
|
|
|
CBBM
|
[NCBI]
|
0.000797122
|
|
|
AVP
|
[NCBI]
|
0.000790709
|
|
|
GFAP
|
[NCBI]
|
0.000789003
|
|
|
HSCR9
|
[NCBI]
|
0.000763136
|
|
|
CSE
|
[NCBI]
|
0.000763136
|
|
|
ACHE
|
[NCBI]
|
0.000762258
|
|
|
APC
|
[NCBI]
|
0.000732624
|
|
|
temporal arteritis
|
[NCBI]
|
0.000721312
|
|
|
SOD1
|
[NCBI]
|
0.000720841
|
|
|
PSACH
|
[NCBI]
|
0.000719853
|
|
|
HBB
|
[NCBI]
|
0.000700496
|
|
|
FMF
|
[NCBI]
|
0.000695684
|
|
|
HSCR1
|
[NCBI]
|
0.000652303
|
|
|
CDB2
|
[NCBI]
|
0.000644802
|
|
|
CAT
|
[NCBI]
|
0.000622479
|
|
|
HPS
|
[NCBI]
|
0.000613399
|
|
|
cholesterol level quantitative trait locus 1
|
[NCBI]
|
0.00060859
|
|
|
EXT3
|
[NCBI]
|
0.00060859
|
|
|
RP6
|
[NCBI]
|
0.00060859
|
|
|
RIEG2
|
[NCBI]
|
0.00060859
|
|
|
RP24
|
[NCBI]
|
0.00060859
|
|
|
hypobetalipoproteinemia, familial, 2
|
[NCBI]
|
0.00060859
|
|
|
PARK11
|
[NCBI]
|
0.00060859
|
|
|
ARVD3
|
[NCBI]
|
0.00060859
|
|
|
oligosynaptic infertility
|
[NCBI]
|
0.00060859
|
|
|
ARVD4
|
[NCBI]
|
0.00060859
|
|
|
CMT2B2
|
[NCBI]
|
0.00060859
|
|
|
parkinson disease 12
|
[NCBI]
|
0.00060859
|
|
|
SCA19
|
[NCBI]
|
0.00060859
|
|
|
EVR3
|
[NCBI]
|
0.00060859
|
|
|
BRCA3
|
[NCBI]
|
0.00060859
|
|
|
GJB2
|
[NCBI]
|
0.000602175
|
|
|
NPPA
|
[NCBI]
|
0.000593489
|
|
|
phenylketonuria
|
[NCBI]
|
0.000583799
|
|
|
AIS
|
[NCBI]
|
0.000564986
|
|
|
SHFM3
|
[NCBI]
|
0.000560778
|
|
|
AFP
|
[NCBI]
|
0.000559799
|
|
|
knobloch syndrome, type ii
|
[NCBI]
|
0.000558723
|
|
|
HSCR5
|
[NCBI]
|
0.000558723
|
|
|
temperature sensitivity complementation, cell cycle specific, k12
|
[NCBI]
|
0.000558723
|
|
|
STHAG5
|
[NCBI]
|
0.000558723
|
|
|
hypotrichosis-osteolysis-periodontitis-palmoplantar keratoderma syndrome
|
[NCBI]
|
0.000558723
|
|
|
epiphyseal dysplasia, multiple, with severe proximal femoral dysplasia
|
[NCBI]
|
0.000558723
|
|
|
arrhythmogenic right ventricular dysplasia, familial, 7
|
[NCBI]
|
0.000558723
|
|
|
hypertensive nephropathy
|
[NCBI]
|
0.000558723
|
|
|
graying of hair, precocious
|
[NCBI]
|
0.000558723
|
|
|
polydactyly, postaxial, type a3
|
[NCBI]
|
0.000558723
|
|
|
SCA28
|
[NCBI]
|
0.000558723
|
|
|
intelligence quantitative trait locus 3
|
[NCBI]
|
0.000558723
|
|
|
ovarian cancer, epithelial, susceptibility to
|
[NCBI]
|
0.000558723
|
|
|
vasculitis, lymphocytic, cutaneous small vessel
|
[NCBI]
|
0.000558723
|
|
|
SPAX3
|
[NCBI]
|
0.000558723
|
|
|
intelligence quantitative trait locus 2
|
[NCBI]
|
0.000558723
|
|
|
FMTLE
|
[NCBI]
|
0.000558723
|
|
|
OPA6
|
[NCBI]
|
0.000558723
|
|
|
nephropathy, progressive, with deafness
|
[NCBI]
|
0.000558723
|
|
|
GLC1K
|
[NCBI]
|
0.000558723
|
|
|
OPA5
|
[NCBI]
|
0.000558723
|
|
|
DYTCA
|
[NCBI]
|
0.000558723
|
|
|
acropectoral syndrome
|
[NCBI]
|
0.000558723
|
|
|
DFNB40
|
[NCBI]
|
0.000558723
|
|
|
GLC1J
|
[NCBI]
|
0.000558723
|
|
|
camptosynpolydactyly, complex
|
[NCBI]
|
0.000558723
|
|
|
noncompaction of left ventricular myocardium, familial isolated, autosomal dominant 2
|
[NCBI]
|
0.000558723
|
|
|
SPG32
|
[NCBI]
|
0.000558723
|
|
|
waardenburg syndrome, type iic
|
[NCBI]
|
0.000558723
|
|
|
epiphyseal dysplasia, multiple, with miniepiphyses
|
[NCBI]
|
0.000558723
|
|
|
bleeding disorder, east texas type
|
[NCBI]
|
0.000558723
|
|
|
GOA1
|
[NCBI]
|
0.000558723
|
|
|
EPO
|
[NCBI]
|
0.000557665
|
|
|
BDNF
|
[NCBI]
|
0.000548529
|
|
|
SHFM1
|
[NCBI]
|
0.000523716
|
|
|
MECP2
|
[NCBI]
|
0.000519929
|
|
|
acromegaloid facial appearance syndrome
|
[NCBI]
|
0.00050581
|
|
|
OPA4
|
[NCBI]
|
0.00050581
|
|
|
spondyloepiphyseal dysplasia tarda, autosomal dominant
|
[NCBI]
|
0.00050581
|
|
|
malignant hyperthermia, susceptibility to, 2
|
[NCBI]
|
0.00050581
|
|
|
CORD7
|
[NCBI]
|
0.00050581
|
|
|
CHAT
|
[NCBI]
|
0.000505043
|
|
|
holoprosencephaly
|
[NCBI]
|
0.000499786
|
|
|
COL1A1
|
[NCBI]
|
0.000481217
|
|
|
ALPS
|
[NCBI]
|
0.000471831
|
|
|
PSEN1
|
[NCBI]
|
0.000467112
|
|
|
HEMB
|
[NCBI]
|
0.000461537
|
|
|
FGFR3
|
[NCBI]
|
0.000454983
|
|
|
apc gene
|
[NCBI]
|
0.000453132
|
|
|
GBA
|
[NCBI]
|
0.000452585
|
|
|
HPRT1
|
[NCBI]
|
0.000451278
|
|
|
LMNA
|
[NCBI]
|
0.000433017
|
|
|
HEXA
|
[NCBI]
|
0.000431703
|
|
|
CCA1
|
[NCBI]
|
0.000429517
|
|
|
LRRK2
|
[NCBI]
|
0.000428831
|
|
|
SMEI
|
[NCBI]
|
0.000423449
|
|
|
GTS
|
[NCBI]
|
0.000419492
|
|
|
RP
|
[NCBI]
|
0.000416256
|
|
|
CF
|
[NCBI]
|
0.000407699
|
|
|
hemophagocytic lymphohistiocytosis, familial, 1
|
[NCBI]
|
0.000407061
|
|
|
hemophilia a
|
[NCBI]
|
0.000405702
|
|
|
TTR
|
[NCBI]
|
0.000404351
|
|
|
leber optic atrophy, susceptibility to
|
[NCBI]
|
0.000401882
|
|
|
HGF
|
[NCBI]
|
0.000398163
|
|
|
PMD
|
[NCBI]
|
0.000391278
|
|
|
MAS
|
[NCBI]
|
0.000390083
|
|
|
PCNA
|
[NCBI]
|
0.000389966
|
|
|
MBP
|
[NCBI]
|
0.000384211
|
|
|
BBS
|
[NCBI]
|
0.000382504
|
|
|
BRCA1
|
[NCBI]
|
0.000370565
|
|
|
hypotrichosis, marie unna type
|
[NCBI]
|
0.000369531
|
|
|
BRCD1
|
[NCBI]
|
0.000369531
|
|
|
MEAX
|
[NCBI]
|
0.000369531
|
|
|
acrodysostosis
|
[NCBI]
|
0.000369531
|
|
|
neuropathy, hereditary motor and sensory, russe type
|
[NCBI]
|
0.000369531
|
|
|
CFEOM3
|
[NCBI]
|
0.000369531
|
|
|
DA5
|
[NCBI]
|
0.000369531
|
|
|
DURS1
|
[NCBI]
|
0.000368068
|
|
|
FGFR2
|
[NCBI]
|
0.000362466
|
|
|
MM
|
[NCBI]
|
0.000359643
|
|
|
CPI
|
[NCBI]
|
0.000356954
|
|
|
BRCA2
|
[NCBI]
|
0.00035274
|
|
|
HGPS
|
[NCBI]
|
0.00034575
|
|
|
LDLR
|
[NCBI]
|
0.000338754
|
|
|
SHBG
|
[NCBI]
|
0.000334149
|
|
|
APRT
|
[NCBI]
|
0.000333504
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
0.000324592
|
|
|
MELAS
|
[NCBI]
|
0.000321633
|
|
|
DFN2
|
[NCBI]
|
0.000320643
|
|
|
adrenoleukodystrophy, autosomal neonatal form
|
[NCBI]
|
0.000318606
|
|
|
TBS
|
[NCBI]
|
0.000317751
|
|
|
LS
|
[NCBI]
|
0.000313044
|
|
|
FBN1
|
[NCBI]
|
0.000310874
|
|
|
COL1A2
|
[NCBI]
|
0.000310607
|
|
|
SGM1
|
[NCBI]
|
0.000304097
|
|
|
CMD1H
|
[NCBI]
|
0.000304097
|
|
|
malaria, mild, susceptibility to
|
[NCBI]
|
0.000304097
|
|
|
WS2B
|
[NCBI]
|
0.000304097
|
|
|
glucocorticoid deficiency 3
|
[NCBI]
|
0.000304097
|
|
|
SPG14
|
[NCBI]
|
0.000304097
|
|
|
myopathy, hyaline body, autosomal recessive
|
[NCBI]
|
0.000304097
|
|
|
spondyloepiphyseal dysplasia tarda, toledo type
|
[NCBI]
|
0.000304097
|
|
|
sabinas brittle hair syndrome
|
[NCBI]
|
0.000304097
|
|
|
CCAL1
|
[NCBI]
|
0.000304097
|
|
|
breast cancer, 11-22 translocation associated
|
[NCBI]
|
0.000304097
|
|
|
multiple mitochondrial dysfunctions syndrome
|
[NCBI]
|
0.000304097
|
|
|
alacrima, congenital
|
[NCBI]
|
0.000304097
|
|
|
CHR
|
[NCBI]
|
0.000304097
|
|
|
HHG
|
[NCBI]
|
0.000304097
|
|
|
aase-smith syndrome i
|
[NCBI]
|
0.000304097
|
|
|
leber congenital amaurosis, type ix
|
[NCBI]
|
0.000304097
|
|
|
atresia of external auditory canal and conduction deafness
|
[NCBI]
|
0.000304097
|
|
|
primary lateral sclerosis, adult
|
[NCBI]
|
0.000304097
|
|
|
saccharopinuria
|
[NCBI]
|
0.000304097
|
|
|
EA3
|
[NCBI]
|
0.000304097
|
|
|
HRPT3
|
[NCBI]
|
0.000304097
|
|
|
DFNB33
|
[NCBI]
|
0.000304097
|
|
|
CMD1K
|
[NCBI]
|
0.000304097
|
|
|
rosselli-gulienetti syndrome
|
[NCBI]
|
0.000304097
|
|
|
LGMD2L
|
[NCBI]
|
0.000304097
|
|
|
spondyloepiphyseal dysplasia tarda, autosomal recessive
|
[NCBI]
|
0.000304097
|
|
|
DFNA7
|
[NCBI]
|
0.000304097
|
|
|
PDB4
|
[NCBI]
|
0.000304097
|
|
|
cdags syndrome
|
[NCBI]
|
0.000304097
|
|
|
ataxia, sensory, autosomal dominant
|
[NCBI]
|
0.000304097
|
|
|
distichiasis
|
[NCBI]
|
0.000304097
|
|
|
ichthyosis prematurity syndrome
|
[NCBI]
|
0.000304097
|
|
|
dermatoglyphics--fingerprint pattern
|
[NCBI]
|
0.000304097
|
|
|
vitamin d-dependent rickets, type ii, with normal vitamin d receptor
|
[NCBI]
|
0.000304097
|
|
|
lynch syndrome i
|
[NCBI]
|
0.000301805
|
|
|
andersen cardiodysrhythmic periodic paralysis
|
[NCBI]
|
0.000289951
|
|
|
PRNP
|
[NCBI]
|
0.000287488
|
|
|
PJS
|
[NCBI]
|
0.000285348
|
|
|
CDAN2
|
[NCBI]
|
0.000284176
|
|
|
IBD2
|
[NCBI]
|
0.000279815
|
|
|
PARK6
|
[NCBI]
|
0.000277865
|
|
|
RNASE3
|
[NCBI]
|
0.000275015
|
|
|
RET
|
[NCBI]
|
0.000272523
|
|
|
osteogenesis imperfecta, type iia
|
[NCBI]
|
0.000271697
|
|
|
HD
|
[NCBI]
|
0.000270744
|
|
|
GNRH1
|
[NCBI]
|
0.000267166
|
|
|
PXE
|
[NCBI]
|
0.000265574
|
|
|
CCD
|
[NCBI]
|
0.00026058
|
|
|
RHO
|
[NCBI]
|
0.000255124
|
|
|
porphyria variegata
|
[NCBI]
|
0.000252537
|
|
|
F3
|
[NCBI]
|
0.000251842
|
|
|
SPG4
|
[NCBI]
|
0.00025074
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
0.000250097
|
|
|
HYPX
|
[NCBI]
|
0.000245112
|
|
|
gonadal dysgenesis, xy type
|
[NCBI]
|
0.000245112
|
|
|
MUC1
|
[NCBI]
|
0.000244809
|
|
|
RYR1
|
[NCBI]
|
0.000244688
|
|
|
TNFSF6
|
[NCBI]
|
0.000244267
|
|
|
CHNG1
|
[NCBI]
|
0.000243485
|
|
|
ACADM
|
[NCBI]
|
0.000242471
|
|
|
ACH
|
[NCBI]
|
0.000241764
|
|
|
VUR1
|
[NCBI]
|
0.000239472
|
|
|
PYY
|
[NCBI]
|
0.000239165
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
0.000238634
|
|
|
MYOC
|
[NCBI]
|
0.000236797
|
|
|
CRC
|
[NCBI]
|
0.000234758
|
|
|
periodic fever, familial, autosomal dominant
|
[NCBI]
|
0.000233795
|
|
|
PBD
|
[NCBI]
|
0.000232767
|
|
|
PPARA
|
[NCBI]
|
0.000231493
|
|
|
ATM
|
[NCBI]
|
0.000230496
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
0.000228306
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
0.00022828
|
|
|
MTND4
|
[NCBI]
|
0.000227467
|
|
|
leiomyomatosis and renal cell cancer, hereditary
|
[NCBI]
|
0.000227156
|
|
|
HMBS
|
[NCBI]
|
0.000226835
|
|
|
CBAVD
|
[NCBI]
|
0.000225673
|
|
|
NF1
|
[NCBI]
|
0.000224297
|
|
|
LGMD2A
|
[NCBI]
|
0.000223991
|
|
|
RB1
|
[NCBI]
|
0.000220689
|
|
|
ATP7B
|
[NCBI]
|
0.000220042
|
|
|
THRB
|
[NCBI]
|
0.000216397
|
|
|
MTTK
|
[NCBI]
|
0.000216231
|
|
|
IBD5
|
[NCBI]
|
0.000215224
|
|
|
MEFV
|
[NCBI]
|
0.000215166
|
|
|
EVA
|
[NCBI]
|
0.000214694
|
|
|
SPG16
|
[NCBI]
|
0.000214584
|
|
|
pyle disease
|
[NCBI]
|
0.000214584
|
|
|
ATFB1
|
[NCBI]
|
0.000214584
|
|
|
erythrokeratodermia variabilis 3
|
[NCBI]
|
0.000214584
|
|
|
osteogenesis imperfecta, type v
|
[NCBI]
|
0.000214584
|
|
|
macular dystrophy, butterfly-shaped pigmentary, 2
|
[NCBI]
|
0.000214584
|
|
|
SCAR6
|
[NCBI]
|
0.000214584
|
|
|
koilonychia, hereditary
|
[NCBI]
|
0.000214584
|
|
|
gangliosidosis, gm2, type iii, or juvenile type
|
[NCBI]
|
0.000214584
|
|
|
transient erythroblastopenia of childhood
|
[NCBI]
|
0.000214584
|
|
|
SPG9
|
[NCBI]
|
0.000214584
|
|
|
dianzani autoimmune lymphoproliferative disease
|
[NCBI]
|
0.000214584
|
|
|
malignant hyperthermia, susceptibility to, 3
|
[NCBI]
|
0.000214584
|
|
|
CVD1
|
[NCBI]
|
0.000214584
|
|
|
GLC1M
|
[NCBI]
|
0.000214584
|
|
|
testicular microlithiasis
|
[NCBI]
|
0.000214584
|
|
|
CMD1F
|
[NCBI]
|
0.000214584
|
|
|
DIP
|
[NCBI]
|
0.000214584
|
|
|
USH1E
|
[NCBI]
|
0.000214584
|
|
|
metatropic dwarfism
|
[NCBI]
|
0.000214584
|
|
|
vitreoretinal degeneration, snowflake type
|
[NCBI]
|
0.000214584
|
|
|
b-cell malignancy, low-grade
|
[NCBI]
|
0.000214584
|
|
|
klippel-feil syndrome, autosomal recessive
|
[NCBI]
|
0.000214584
|
|
|
MCOPS4
|
[NCBI]
|
0.000214584
|
|
|
bruck syndrome 1
|
[NCBI]
|
0.000214584
|
|
|
frontofacionasal dysostosis
|
[NCBI]
|
0.000214584
|
|
|
pterygium, antecubital
|
[NCBI]
|
0.000214584
|
|
|
HHC2
|
[NCBI]
|
0.000214584
|
|
|
myasthenia, limb-girdle, with tubular aggregates
|
[NCBI]
|
0.000214584
|
|
|
IBD6
|
[NCBI]
|
0.000214584
|
|
|
DYT15
|
[NCBI]
|
0.000214584
|
|
|
SPG19
|
[NCBI]
|
0.000214584
|
|
|
patent ductus arteriosus
|
[NCBI]
|
0.000214584
|
|
|
MS
|
[NCBI]
|
0.000214521
|
|
|
cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency
|
[NCBI]
|
0.000210857
|
|
|
renal tubular acidosis, distal, with hemolytic anemia
|
[NCBI]
|
0.000210857
|
|
|
PNDM
|
[NCBI]
|
0.000209779
|
|
|
mitochondrial complex i deficiency
|
[NCBI]
|
0.000205863
|
|
|
MYO7A
|
[NCBI]
|
0.000205617
|
|
|
HFE3
|
[NCBI]
|
0.000204905
|
|
|
SBS
|
[NCBI]
|
0.000204905
|
|
|
TYR
|
[NCBI]
|
0.000201709
|
|
|
MAPT
|
[NCBI]
|
0.000200554
|
|
|
KCNH2
|
[NCBI]
|
0.000200354
|
|
|
MPZ
|
[NCBI]
|
0.000198917
|
|
|
COMT
|
[NCBI]
|
0.000198572
|
|
|
gaucher disease, type iiic
|
[NCBI]
|
0.000198121
|
|
|
STL2
|
[NCBI]
|
0.000198121
|
|
|
wilson disease
|
[NCBI]
|
0.000197374
|
|
|
ABCA4
|
[NCBI]
|
0.000194529
|
|
|
LGMD2B
|
[NCBI]
|
0.000192935
|
|
|
ornithine transcarbamylase deficiency, hyperammonemia due to
|
[NCBI]
|
0.000191698
|
|
|
pyruvate decarboxylase deficiency
|
[NCBI]
|
0.000190337
|
|
|
ALS1
|
[NCBI]
|
0.000190087
|
|
|
DYT2
|
[NCBI]
|
0.000189222
|
|
|
PINK1
|
[NCBI]
|
0.000189129
|
|
|
TCOF
|
[NCBI]
|
0.000188167
|
|
|
TNFRSF11B
|
[NCBI]
|
0.000188044
|
|
|
GCK
|
[NCBI]
|
0.000187341
|
|
|
SCN5A
|
[NCBI]
|
0.000186711
|
|
|
ARSA
|
[NCBI]
|
0.000185141
|
|
|
FGF7
|
[NCBI]
|
0.000184697
|
|
|
SPP1
|
[NCBI]
|
0.000183372
|
|
|
PARK2
|
[NCBI]
|
0.000182581
|
|
|
NF2
|
[NCBI]
|
0.000182518
|
|
|
HIDS
|
[NCBI]
|
0.000181852
|
|
|
VWM
|
[NCBI]
|
0.000181852
|
|
|
PPOX
|
[NCBI]
|
0.000181358
|
|
|
HFE4
|
[NCBI]
|
0.000180635
|
|
|
LGMD2E
|
[NCBI]
|
0.000180635
|
|
|
USH1D
|
[NCBI]
|
0.000180635
|
|
|
HBA2
|
[NCBI]
|
0.00017945
|
|
|
CAPN3
|
[NCBI]
|
0.000179009
|
|
|
EDM1
|
[NCBI]
|
0.000176872
|
|
|
FTNS
|
[NCBI]
|
0.000176872
|
|
|
OTC
|
[NCBI]
|
0.000176863
|
|
|
MLC
|
[NCBI]
|
0.000176202
|
|
|
methylmalonic aciduria due to methylmalonyl-coa mutase deficiency
|
[NCBI]
|
0.000176202
|
|
|
myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency
|
[NCBI]
|
0.000176202
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
0.000176033
|
|
|
BRAF
|
[NCBI]
|
0.000175123
|
|
|
GJB1
|
[NCBI]
|
0.000175061
|
|
|
DFSP
|
[NCBI]
|
0.000174908
|
|
|
DFNB1
|
[NCBI]
|
0.000173554
|
|
|
TD1
|
[NCBI]
|
0.000171837
|
|
|
gaucher disease, type i
|
[NCBI]
|
0.000171837
|
|
|
WHS
|
[NCBI]
|
0.000171145
|
|
|
hypogonadotropic hypogonadism
|
[NCBI]
|
0.000170813
|
|
|
VHL
|
[NCBI]
|
0.000170767
|
|
|
refsum disease, infantile form
|
[NCBI]
|
0.000170039
|
|
|
PARK8
|
[NCBI]
|
0.000170039
|
|
|
ORW2
|
[NCBI]
|
0.000170039
|
|
|
citrullinemia, type ii, neonatal-onset
|
[NCBI]
|
0.000168109
|
|
|
HOS
|
[NCBI]
|
0.000167985
|
|
|
RPGR
|
[NCBI]
|
0.000167805
|
|
|
TWIST1
|
[NCBI]
|
0.000166826
|
|
|
FEB1
|
[NCBI]
|
0.000166423
|
|
|
SPG4
|
[NCBI]
|
0.00016495
|
|
|
SPG2
|
[NCBI]
|
0.000164903
|
|
|
molybdenum cofactor deficiency
|
[NCBI]
|
0.000164903
|
|
|
GNAS
|
[NCBI]
|
0.000164894
|
|
|
CTGF
|
[NCBI]
|
0.000164755
|
|
|
BL
|
[NCBI]
|
0.000164722
|
|
|
PPSH
|
[NCBI]
|
0.000164666
|
|
|
APP
|
[NCBI]
|
0.000164304
|
|
|
ZS
|
[NCBI]
|
0.000162284
|
|
|
KCNQ1
|
[NCBI]
|
0.000162152
|
|
|
GCH1
|
[NCBI]
|
0.000162077
|
|
|
INSR
|
[NCBI]
|
0.000161602
|
|
|
LQT3
|
[NCBI]
|
0.000161461
|
|
|
LGMD2I
|
[NCBI]
|
0.000161461
|
|
|
disorganization, mouse, homolog of
|
[NCBI]
|
0.000161461
|
|
|
LGMD1B
|
[NCBI]
|
0.000161461
|
|
|
gm1-gangliosidosis, type iii
|
[NCBI]
|
0.000161461
|
|
|
MODY3
|
[NCBI]
|
0.000161166
|
|
|
L1CAM
|
[NCBI]
|
0.000161025
|
|
|
HHF2
|
[NCBI]
|
0.000160771
|
|
|
keratolytic winter erythema
|
[NCBI]
|
0.000160168
|
|
|
sprengel deformity
|
[NCBI]
|
0.000160168
|
|
|
CCV
|
[NCBI]
|
0.000160168
|
|
|
PPPP
|
[NCBI]
|
0.000160168
|
|
|
ALS5
|
[NCBI]
|
0.000160168
|
|
|
epilepsy, nocturnal frontal lobe, type 2
|
[NCBI]
|
0.000160168
|
|
|
dyschromatosis universalis hereditaria
|
[NCBI]
|
0.000160168
|
|
|
muscular dystrophy, congenital, merosin-positive
|
[NCBI]
|
0.000160168
|
|
|
CORD5
|
[NCBI]
|
0.000160168
|
|
|
amyotrophy, neurogenic scapuloperoneal, new england type
|
[NCBI]
|
0.000160168
|
|
|
noonan syndrome 2
|
[NCBI]
|
0.000160168
|
|
|
CARASIL
|
[NCBI]
|
0.000160168
|
|
|
HMPS1
|
[NCBI]
|
0.000160168
|
|
|
CNA1
|
[NCBI]
|
0.000160168
|
|
|
DYT6
|
[NCBI]
|
0.000160168
|
|
|
CORD8
|
[NCBI]
|
0.000160168
|
|
|
heterotaxy, visceral, 3, autosomal
|
[NCBI]
|
0.000160168
|
|
|
eosinophilia, familial
|
[NCBI]
|
0.000160168
|
|
|
psoriasis susceptibility 8
|
[NCBI]
|
0.000160168
|
|
|
DFNB15
|
[NCBI]
|
0.000160168
|
|
|
EA4
|
[NCBI]
|
0.000160168
|
|
|
trichorrhexis nodosa syndrome
|
[NCBI]
|
0.000160168
|
|
|
SLEB3
|
[NCBI]
|
0.000160168
|
|
|
CTAA2
|
[NCBI]
|
0.000160168
|
|
|
PN
|
[NCBI]
|
0.000160168
|
|
|
OB10P
|
[NCBI]
|
0.000160168
|
|
|
charcot-marie-tooth disease, axonal, type 2b1
|
[NCBI]
|
0.000159298
|
|
|
DFNB18
|
[NCBI]
|
0.000159298
|
|
|
gm1-gangliosidosis, type i
|
[NCBI]
|
0.000159231
|
|
|
UCMD
|
[NCBI]
|
0.000159231
|
|
|
APOE
|
[NCBI]
|
0.00015792
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
0.000157869
|
|
|
mitochondrial complex iv deficiency
|
[NCBI]
|
0.000157067
|
|
|
factor v deficiency
|
[NCBI]
|
0.000156818
|
|
|
ABCC6
|
[NCBI]
|
0.000156649
|
|
|
CLS
|
[NCBI]
|
0.000155148
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
0.000155085
|
|
|
SLC26A4
|
[NCBI]
|
0.000152767
|
|
|
PTHLH
|
[NCBI]
|
0.000152659
|
|
|
CASR
|
[NCBI]
|
0.000152545
|
|
|
TG
|
[NCBI]
|
0.000152311
|
|
|
MTTL1
|
[NCBI]
|
0.000152019
|
|
|
PDS
|
[NCBI]
|
0.000151911
|
|
|
PD
|
[NCBI]
|
0.000151767
|
|
|
HCH
|
[NCBI]
|
0.000149827
|
|
|
ADCYAP1
|
[NCBI]
|
0.000148845
|
|
|
COMP
|
[NCBI]
|
0.000148714
|
|
|
RTS
|
[NCBI]
|
0.000148387
|
|
|
LCA1
|
[NCBI]
|
0.000148099
|
|
|
PLP1
|
[NCBI]
|
0.000147576
|
|
|
MUT
|
[NCBI]
|
0.000147483
|
|
|
WAS
|
[NCBI]
|
0.00014724
|
|
|
FFI
|
[NCBI]
|
0.000146936
|
|
|
MYP2
|
[NCBI]
|
0.000146312
|
|
|
fundus albipunctatus
|
[NCBI]
|
0.00014607
|
|
|
MTRNR1
|
[NCBI]
|
0.000145883
|
|
|
NOD2
|
[NCBI]
|
0.000145475
|
|
|
BTHS
|
[NCBI]
|
0.000145455
|
|
|
mitochondrial dna depletion syndrome, myopathic form
|
[NCBI]
|
0.000144936
|
|
|
PSEN2
|
[NCBI]
|
0.000144914
|
|
|
SCN9A
|
[NCBI]
|
0.000144592
|
|
|
CMM
|
[NCBI]
|
0.000143471
|
|
|
ENG
|
[NCBI]
|
0.000142959
|
|
|
CYP17A1
|
[NCBI]
|
0.000142959
|
|
|
HFE
|
[NCBI]
|
0.000142439
|
|
|
ACP5
|
[NCBI]
|
0.00014232
|
|
|
IBM2
|
[NCBI]
|
0.000142271
|
|
|
GEFS+
|
[NCBI]
|
0.000142271
|
|
|
DYSF
|
[NCBI]
|
0.000141777
|
|
|
HBFQTL2
|
[NCBI]
|
0.000141383
|
|
|
TFPI
|
[NCBI]
|
0.000141149
|
|
|
FPLD2
|
[NCBI]
|
0.000141037
|
|
|
PEE1
|
[NCBI]
|
0.000139129
|
|
|
protoporphyria, erythropoietic
|
[NCBI]
|
0.000138736
|
|
|
GAA
|
[NCBI]
|
0.000138736
|
|
|
DLL3
|
[NCBI]
|
0.00013698
|
|
|
CCM
|
[NCBI]
|
0.000135372
|
|
|
KRAS
|
[NCBI]
|
0.000134925
|
|
|
GIP
|
[NCBI]
|
0.000134462
|
|
|
pyruvate kinase deficiency of red cells
|
[NCBI]
|
0.000133391
|
|
|
IL2
|
[NCBI]
|
0.000133365
|
|
|
MC4R
|
[NCBI]
|
0.000133351
|
|
|
EGFR
|
[NCBI]
|
0.000133317
|
|
|
GNRHR
|
[NCBI]
|
0.000132624
|
|
|
GLA
|
[NCBI]
|
0.00013248
|
|
|
AR
|
[NCBI]
|
0.000132435
|
|
|
OSM
|
[NCBI]
|
0.00013222
|
|
|
cardiomyopathy, familial hypertrophic, with wolff-parkinson-white syndrome
|
[NCBI]
|
0.000132159
|
|
|
CORD3
|
[NCBI]
|
0.000132159
|
|
|
biotinidase deficiency
|
[NCBI]
|
0.000131608
|
|
|
EV
|
[NCBI]
|
0.000131569
|
|
|
COL7A1
|
[NCBI]
|
0.000131169
|
|
|
bartter syndrome, antenatal, type 2
|
[NCBI]
|
0.000131068
|
|
|
MCDS
|
[NCBI]
|
0.000131068
|
|
|
PSORS1
|
[NCBI]
|
0.000130894
|
|
|
WS1
|
[NCBI]
|
0.000130339
|
|
|
POLG
|
[NCBI]
|
0.000129514
|
|
|
alzheimer disease 4
|
[NCBI]
|
0.000128608
|
|
|
LISX1
|
[NCBI]
|
0.000128608
|
|
|
HCHWAD
|
[NCBI]
|
0.000128608
|
|
|
renal tubular acidosis, distal, with progressive nerve deafness
|
[NCBI]
|
0.000128608
|
|
|
corneal dystrophy, gelatinous drop-like
|
[NCBI]
|
0.000128608
|
|
|
CTLN2
|
[NCBI]
|
0.000128608
|
|
|
CLN8
|
[NCBI]
|
0.000128608
|
|
|
WAS
|
[NCBI]
|
0.00012845
|
|
|
CDKN2A
|
[NCBI]
|
0.000127791
|
|
|
MITF
|
[NCBI]
|
0.000127791
|
|
|
PARK2
|
[NCBI]
|
0.000127397
|
|
|
CMD1J
|
[NCBI]
|
0.000126508
|
|
|
CMD1L
|
[NCBI]
|
0.000126508
|
|
|
methylmalonic aciduria, cblb type
|
[NCBI]
|
0.000126508
|
|
|
SMC
|
[NCBI]
|
0.000126508
|
|
|
LIMM
|
[NCBI]
|
0.000126508
|
|
|
MODY4
|
[NCBI]
|
0.000126508
|
|
|
LCA10
|
[NCBI]
|
0.000126508
|
|
|
meniere disease
|
[NCBI]
|
0.000126508
|
|
|
immunodeficiency without anhidrotic ectodermal dysplasia
|
[NCBI]
|
0.000126508
|
|
|
HANAC
|
[NCBI]
|
0.000126508
|
|
|
alzheimer disease 3
|
[NCBI]
|
0.000125148
|
|
|
osteogenesis imperfecta, type iii
|
[NCBI]
|
0.000123482
|
|
|
PKD2
|
[NCBI]
|
0.000123271
|
|
|
WBS
|
[NCBI]
|
0.000122968
|
|
|
FECD2
|
[NCBI]
|
0.000122423
|
|
|
SPG12
|
[NCBI]
|
0.000122423
|
|
|
ETM2
|
[NCBI]
|
0.000122423
|
|
|
IBD3
|
[NCBI]
|
0.000122423
|
|
|
nevi flammei, familial multiple
|
[NCBI]
|
0.000122423
|
|
|
splenic hypoplasia
|
[NCBI]
|
0.000122423
|
|
|
pelizaeus-merzbacher-like disease, autosomal recessive, 2
|
[NCBI]
|
0.000122423
|
|
|
HBD
|
[NCBI]
|
0.000122423
|
|
|
x inactivation, familial skewed, 2
|
[NCBI]
|
0.000122423
|
|
|
glomerulopathy with fibronectin deposits
|
[NCBI]
|
0.000122423
|
|
|
MRX3
|
[NCBI]
|
0.000122423
|
|
|
USH2B
|
[NCBI]
|
0.000122423
|
|
|
HTC2
|
[NCBI]
|
0.000122423
|
|
|
larsen syndrome, recessive
|
[NCBI]
|
0.000122423
|
|
|
CMD1B
|
[NCBI]
|
0.000122423
|
|
|
scheuermann disease
|
[NCBI]
|
0.000122423
|
|
|
CMDR
|
[NCBI]
|
0.000122423
|
|
|
anosmia, congenital
|
[NCBI]
|
0.000122423
|
|
|
VMD
|
[NCBI]
|
0.000122342
|
|
|
hypertrophic neuropathy of dejerine-sottas
|
[NCBI]
|
0.000121263
|
|
|
DFNB2
|
[NCBI]
|
0.000121157
|
|
|
DFNB12
|
[NCBI]
|
0.000121157
|
|
|
niemann-pick disease, type c2
|
[NCBI]
|
0.000121157
|
|
|
myoclonic dystonia
|
[NCBI]
|
0.000121112
|
|
|
cortisol 11-beta-ketoreductase deficiency
|
[NCBI]
|
0.000121074
|
|
|
WFS1
|
[NCBI]
|
0.000120892
|
|
|
JAG1
|
[NCBI]
|
0.000120752
|
|
|
TSHR
|
[NCBI]
|
0.000119667
|
|
|
SCN4A
|
[NCBI]
|
0.000119333
|
|
|
PMCH
|
[NCBI]
|
0.000119268
|
|
|
JLNS1
|
[NCBI]
|
0.000119012
|
|
|
HHF1
|
[NCBI]
|
0.000118616
|
|
|
SALL1
|
[NCBI]
|
0.000117579
|
|
|
HBA1
|
[NCBI]
|
0.000117578
|
|
|
COL2A1
|
[NCBI]
|
0.000117226
|
|
|
CDH23
|
[NCBI]
|
0.000116329
|
|
|
CHM
|
[NCBI]
|
0.000116286
|
|
|
PROP1
|
[NCBI]
|
0.000115523
|
|
|
PRKAR1A
|
[NCBI]
|
0.000115523
|
|
|
AHO
|
[NCBI]
|
0.000115325
|
|
|
CDPX2
|
[NCBI]
|
0.000115149
|
|
|
STK11
|
[NCBI]
|
0.000114829
|
|
|
BDA1
|
[NCBI]
|
0.000114202
|
|
|
ASMD
|
[NCBI]
|
0.000114202
|
|
|
HNPCC2
|
[NCBI]
|
0.000114202
|
|
|
HTX1
|
[NCBI]
|
0.000114202
|
|
|
MYH7
|
[NCBI]
|
0.000113715
|
|
|
RASA1
|
[NCBI]
|
0.000113649
|
|
|
AVPR2
|
[NCBI]
|
0.00011336
|
|
|
GATA1
|
[NCBI]
|
0.00011336
|
|
|
creatine deficiency syndrome, x-linked
|
[NCBI]
|
0.000112631
|
|
|
JBTS3
|
[NCBI]
|
0.000112631
|
|
|
IGAD1
|
[NCBI]
|
0.000112628
|
|
|
MRX1
|
[NCBI]
|
0.000112628
|
|
|
COL10A1
|
[NCBI]
|
0.000112291
|
|
|
asthma, susceptibility to
|
[NCBI]
|
0.000112286
|
|
|
PF4
|
[NCBI]
|
0.000112258
|
|
|
exostoses, multiple, type i
|
[NCBI]
|
0.000112038
|
|
|
PDHA1
|
[NCBI]
|
0.000112031
|
|
|
NPC1
|
[NCBI]
|
0.000111924
|
|
|
maple syrup urine disease
|
[NCBI]
|
0.000111818
|
|
|
ARX
|
[NCBI]
|
0.000111776
|
|
|
AHR
|
[NCBI]
|
0.000111535
|
|
|
ATRX
|
[NCBI]
|
0.00011139
|
|
|
PTEN
|
[NCBI]
|
0.000110703
|
|
|
SGSH
|
[NCBI]
|
0.000110689
|
|
|
PKD1
|
[NCBI]
|
0.000109932
|
|
|
RCDP1
|
[NCBI]
|
0.000109432
|
|
|
mucopolysaccharidosis type vii
|
[NCBI]
|
0.000109432
|
|
|
CTNNB1
|
[NCBI]
|
0.000108924
|
|
|
PMP22
|
[NCBI]
|
0.000108565
|
|
|
mowat-wilson syndrome
|
[NCBI]
|
0.000108396
|
|
|
waardenburg-shah syndrome
|
[NCBI]
|
0.000108396
|
|
|
danon disease
|
[NCBI]
|
0.000108396
|
|
|
EXT1
|
[NCBI]
|
0.000108077
|
|
|
SPTA1
|
[NCBI]
|
0.00010797
|
|
|
IDUA
|
[NCBI]
|
0.000107849
|
|
|
SNCA
|
[NCBI]
|
0.000107849
|
|
|
MSD
|
[NCBI]
|
0.00010758
|
|
|
USH2A
|
[NCBI]
|
0.00010758
|
|
|
IDDM
|
[NCBI]
|
0.000107538
|
|
|
SCA6
|
[NCBI]
|
0.000107428
|
|
|
ADHD
|
[NCBI]
|
0.00010726
|
|
|
PEX1
|
[NCBI]
|
0.000106902
|
|
|
PCDH15
|
[NCBI]
|
0.00010639
|
|
|
PCCB
|
[NCBI]
|
0.00010639
|
|
|
cystinuria
|
[NCBI]
|
0.000106033
|
|
|
AIRE
|
[NCBI]
|
0.000105032
|
|
|
ACVRL1
|
[NCBI]
|
0.000104859
|
|
|
NPC1
|
[NCBI]
|
0.000104859
|
|
|
COL4A5
|
[NCBI]
|
0.000104859
|
|
|
EDNRB
|
[NCBI]
|
0.000104745
|
|
|
LAMB3
|
[NCBI]
|
0.000104654
|
|
|
MVK
|
[NCBI]
|
0.000104322
|
|
|
CEP290
|
[NCBI]
|
0.000104279
|
|
|
LFS1
|
[NCBI]
|
0.000104099
|
|
|
OCA1A
|
[NCBI]
|
0.000104099
|
|
|
LQT1
|
[NCBI]
|
0.000103642
|
|
|
PIGA
|
[NCBI]
|
0.000103023
|
|
|
DAR
|
[NCBI]
|
0.000102977
|
|
|
HP
|
[NCBI]
|
0.000102839
|
|
|
MRXS13
|
[NCBI]
|
0.000102006
|
|
|
gaucher disease, type ii
|
[NCBI]
|
0.000102006
|
|
|
leiomyoma, hereditary multiple, of skin
|
[NCBI]
|
0.000102006
|
|
|
SMDP1
|
[NCBI]
|
0.000102006
|
|
|
MERRF
|
[NCBI]
|
0.000102006
|
|
|
SHH
|
[NCBI]
|
0.000101822
|
|
|
PMM2
|
[NCBI]
|
0.000100633
|
|
|
RMD
|
[NCBI]
|
0.000100506
|
|
|
PRPH2
|
[NCBI]
|
0.000100193
|
|
|
ACPP
|
[NCBI]
|
9.95962e-05
|
|
|
HYPP
|
[NCBI]
|
9.89738e-05
|
|
|
pseudoxanthoma elasticum, forme fruste
|
[NCBI]
|
9.89537e-05
|
|
|
IVA
|
[NCBI]
|
9.89537e-05
|
|
|
exostoses, multiple, type ii
|
[NCBI]
|
9.89537e-05
|
|
|
hurler-scheie syndrome
|
[NCBI]
|
9.89537e-05
|
|
|
alexander disease
|
[NCBI]
|
9.89537e-05
|
|
|
LI1
|
[NCBI]
|
9.84231e-05
|
|
|
FANCA
|
[NCBI]
|
9.74762e-05
|
|
|
C1NH
|
[NCBI]
|
9.74305e-05
|
|
|
CMT4B2
|
[NCBI]
|
9.74005e-05
|
|
|
morquio syndrome b
|
[NCBI]
|
9.74005e-05
|
|
|
DFNA9
|
[NCBI]
|
9.74005e-05
|
|
|
ehlers-danlos syndrome, type vii, autosomal dominant
|
[NCBI]
|
9.74005e-05
|
|
|
DFNA3
|
[NCBI]
|
9.74005e-05
|
|
|
RP12
|
[NCBI]
|
9.74005e-05
|
|
|
MODY2
|
[NCBI]
|
9.74005e-05
|
|
|
XPB
|
[NCBI]
|
9.74005e-05
|
|
|
FPLD3
|
[NCBI]
|
9.73733e-05
|
|
|
ceroid lipofuscinosis, neuronal, 8, northern epilepsy variant
|
[NCBI]
|
9.73733e-05
|
|
|
DFNA11
|
[NCBI]
|
9.73733e-05
|
|
|
l-2-hydroxyglutaric aciduria
|
[NCBI]
|
9.73733e-05
|
|
|
FANCD1
|
[NCBI]
|
9.73733e-05
|
|
|
methylmalonic aciduria, cbla type
|
[NCBI]
|
9.73733e-05
|
|
|
OCA4
|
[NCBI]
|
9.73733e-05
|
|
|
adenylosuccinase deficiency
|
[NCBI]
|
9.73733e-05
|
|
|
stickler syndrome, type i, nonsyndromic ocular
|
[NCBI]
|
9.73733e-05
|
|
|
SPG13
|
[NCBI]
|
9.73733e-05
|
|
|
ectodermal dysplasia, hypohidrotic, with immune deficiency
|
[NCBI]
|
9.73733e-05
|
|
|
DMD
|
[NCBI]
|
9.72429e-05
|
|
|
TSC1
|
[NCBI]
|
9.7143e-05
|
|
|
apert syndrome
|
[NCBI]
|
9.69201e-05
|
|
|
RPS19
|
[NCBI]
|
9.68692e-05
|
|
|
FKRP
|
[NCBI]
|
9.68692e-05
|
|
|
PAX6
|
[NCBI]
|
9.66307e-05
|
|
|
GIST
|
[NCBI]
|
9.60751e-05
|
|
|
CLCN1
|
[NCBI]
|
9.56858e-05
|
|
|
CYP1A1
|
[NCBI]
|
9.53419e-05
|
|
|
PAX3
|
[NCBI]
|
9.51709e-05
|
|
|
CMD1A
|
[NCBI]
|
9.49821e-05
|
|
|
precocious puberty
|
[NCBI]
|
9.44969e-05
|
|
|
MKS2
|
[NCBI]
|
9.44969e-05
|
|
|
branchial clefts with characteristic facies, growth retardation, imperforate nasolacrimal duct, and premature aging
|
[NCBI]
|
9.44969e-05
|
|
|
hereditary motor and sensory neuropathy v
|
[NCBI]
|
9.44969e-05
|
|
|
PGL2
|
[NCBI]
|
9.44969e-05
|
|
|
diabetes mellitus, noninsulin-dependent, 3
|
[NCBI]
|
9.44969e-05
|
|
|
dysgnathia complex
|
[NCBI]
|
9.44969e-05
|
|
|
CLN4A
|
[NCBI]
|
9.44969e-05
|
|
|
OSCS
|
[NCBI]
|
9.44969e-05
|
|
|
microcephaly, hiatus hernia, and nephrotic syndrome
|
[NCBI]
|
9.44969e-05
|
|
|
CDAN3
|
[NCBI]
|
9.44969e-05
|
|
|
hemangioma, capillary infantile
|
[NCBI]
|
9.44969e-05
|
|
|
EKD2
|
[NCBI]
|
9.44969e-05
|
|
|
MCOPS6
|
[NCBI]
|
9.44969e-05
|
|
|
kyphomelic dysplasia
|
[NCBI]
|
9.44969e-05
|
|
|
CHED1
|
[NCBI]
|
9.44969e-05
|
|
|
NNO1
|
[NCBI]
|
9.44969e-05
|
|
|
CNC2
|
[NCBI]
|
9.44969e-05
|
|
|
SQSTM1
|
[NCBI]
|
9.43115e-05
|
|
|
USH1C
|
[NCBI]
|
9.43115e-05
|
|
|
CES
|
[NCBI]
|
9.39632e-05
|
|
|
MHA
|
[NCBI]
|
9.39332e-05
|
|
|
gaucher disease, type iii
|
[NCBI]
|
9.39332e-05
|
|
|
ODDD
|
[NCBI]
|
9.39332e-05
|
|
|
CPX
|
[NCBI]
|
9.39332e-05
|
|
|
EDMD
|
[NCBI]
|
9.39112e-05
|
|
|
GHRHR
|
[NCBI]
|
9.319e-05
|
|
|
SCO2
|
[NCBI]
|
9.29397e-05
|
|
|
OPMD
|
[NCBI]
|
9.27364e-05
|
|
|
MYBPC3
|
[NCBI]
|
9.20948e-05
|
|
|
OTOF
|
[NCBI]
|
9.20948e-05
|
|
|
SLC6A3
|
[NCBI]
|
9.19115e-05
|
|
|
BCNS
|
[NCBI]
|
9.17541e-05
|
|
|
ALS2
|
[NCBI]
|
9.14927e-05
|
|
|
USH3
|
[NCBI]
|
9.14927e-05
|
|
|
GRTH
|
[NCBI]
|
9.14927e-05
|
|
|
papillorenal syndrome
|
[NCBI]
|
9.14927e-05
|
|
|
synovitis, granulomatous, with uveitis and cranial neuropathies
|
[NCBI]
|
9.14927e-05
|
|
|
BBS1
|
[NCBI]
|
9.13119e-05
|
|
|
EDN3
|
[NCBI]
|
9.1236e-05
|
|
|
GCDH
|
[NCBI]
|
9.1236e-05
|
|
|
RMRP
|
[NCBI]
|
9.1151e-05
|
|
|
FA
|
[NCBI]
|
9.10154e-05
|
|
|
CACNA1A
|
[NCBI]
|
9.07111e-05
|
|
|
acromegaly
|
[NCBI]
|
9.04895e-05
|
|
|
pituitary dwarfism iii
|
[NCBI]
|
9.04895e-05
|
|
|
SCCMS
|
[NCBI]
|
9.04895e-05
|
|
|
CMT1A
|
[NCBI]
|
9.01593e-05
|
|
|
GRN
|
[NCBI]
|
8.99363e-05
|
|
|
GUCY2D
|
[NCBI]
|
8.98481e-05
|
|
|
SMN1
|
[NCBI]
|
8.96877e-05
|
|
|
APS1
|
[NCBI]
|
8.84767e-05
|
|
|
ERCC2
|
[NCBI]
|
8.83627e-05
|
|
|
fructose intolerance, hereditary
|
[NCBI]
|
8.83627e-05
|
|
|
dyschromatosis symmetrica hereditaria 1
|
[NCBI]
|
8.78122e-05
|
|
|
PANK2
|
[NCBI]
|
8.70271e-05
|
|
|
MEN1
|
[NCBI]
|
8.70123e-05
|
|
|
TNNT2
|
[NCBI]
|
8.68609e-05
|
|
|
FH
|
[NCBI]
|
8.67315e-05
|
|
|
MJD
|
[NCBI]
|
8.59463e-05
|
|
|
UROS
|
[NCBI]
|
8.58909e-05
|
|
|
proteus syndrome
|
[NCBI]
|
8.58457e-05
|
|
|
homocystinuria
|
[NCBI]
|
8.57077e-05
|
|
|
MLH1
|
[NCBI]
|
8.56435e-05
|
|
|
RECQL3
|
[NCBI]
|
8.56223e-05
|
|
|
TRAPPC2
|
[NCBI]
|
8.50835e-05
|
|
|
EIF2B5
|
[NCBI]
|
8.50835e-05
|
|
|
FIH
|
[NCBI]
|
8.50619e-05
|
|
|
OPA1
|
[NCBI]
|
8.50619e-05
|
|
|
alport syndrome, autosomal recessive
|
[NCBI]
|
8.5001e-05
|
|
|
alzheimer disease, susceptibility to, mitochondrial
|
[NCBI]
|
8.5001e-05
|
|
|
ATLD
|
[NCBI]
|
8.5001e-05
|
|
|
muenke syndrome
|
[NCBI]
|
8.5001e-05
|
|
|
DFNB9
|
[NCBI]
|
8.5001e-05
|
|
|
CHAC
|
[NCBI]
|
8.49129e-05
|
|
|
mucolipidosis iv
|
[NCBI]
|
8.49129e-05
|
|
|
MTHFR
|
[NCBI]
|
8.45494e-05
|
|
|
MKS4
|
[NCBI]
|
8.43367e-05
|
|
|
DFNA22
|
[NCBI]
|
8.43367e-05
|
|
|
cardiomyopathy, dilated, with quadriceps myopathy
|
[NCBI]
|
8.43367e-05
|
|
|
ARVD10
|
[NCBI]
|
8.43367e-05
|
|
|
caspase 8 deficiency
|
[NCBI]
|
8.43367e-05
|
|
|
parkinson-dementia syndrome
|
[NCBI]
|
8.43367e-05
|
|
|
t-box 24
|
[NCBI]
|
8.43367e-05
|
|
|
MCOPS5
|
[NCBI]
|
8.43367e-05
|
|
|
GS3
|
[NCBI]
|
8.43367e-05
|
|
|
DMAT
|
[NCBI]
|
8.43367e-05
|
|
|
DFNB28
|
[NCBI]
|
8.43367e-05
|
|
|
COXPD1
|
[NCBI]
|
8.43367e-05
|
|
|
metaphyseal dysplasia without hypotrichosis
|
[NCBI]
|
8.43367e-05
|
|
|
craniosynostosis-microcephaly with chromosomal breakage and other abnormalities
|
[NCBI]
|
8.43367e-05
|
|
|
PTHS
|
[NCBI]
|
8.43367e-05
|
|
|
SCAR8
|
[NCBI]
|
8.43367e-05
|
|
|
CDG1F
|
[NCBI]
|
8.43367e-05
|
|
|
CDG1E
|
[NCBI]
|
8.43367e-05
|
|
|
XMRE
|
[NCBI]
|
8.43367e-05
|
|
|
fanconi anemia, complementation group n
|
[NCBI]
|
8.43367e-05
|
|
|
deafness, autosomal recessive
|
[NCBI]
|
8.43367e-05
|
|
|
CDG1H
|
[NCBI]
|
8.43367e-05
|
|
|
MODY6
|
[NCBI]
|
8.43367e-05
|
|
|
CVID
|
[NCBI]
|
8.43258e-05
|
|
|
SCZD
|
[NCBI]
|
8.40668e-05
|
|
|
CORD6
|
[NCBI]
|
8.40465e-05
|
|
|
ARMD2
|
[NCBI]
|
8.40465e-05
|
|
|
TBDN
|
[NCBI]
|
8.40465e-05
|
|
|
FANCI
|
[NCBI]
|
8.40465e-05
|
|
|
sarcoidosis, early-onset
|
[NCBI]
|
8.40465e-05
|
|
|
fecundity gene, booroola, of sheep, homolog of
|
[NCBI]
|
8.40465e-05
|
|
|
spongiform encephalopathy with neuropsychiatric features
|
[NCBI]
|
8.40465e-05
|
|
|
MCOP2
|
[NCBI]
|
8.40465e-05
|
|
|
CLN7
|
[NCBI]
|
8.40465e-05
|
|
|
CMD1G
|
[NCBI]
|
8.40465e-05
|
|
|
CMT4H
|
[NCBI]
|
8.40465e-05
|
|
|
JBTS5
|
[NCBI]
|
8.40465e-05
|
|
|
fanconi anemia, complementation group j
|
[NCBI]
|
8.40465e-05
|
|
|
neuropathy, ataxia, and retinitis pigmentosa
|
[NCBI]
|
8.40465e-05
|
|
|
2-@methylbutyryl-coa dehydrogenase deficiency
|
[NCBI]
|
8.40465e-05
|
|
|
lig4 syndrome
|
[NCBI]
|
8.40465e-05
|
|
|
ARVD9
|
[NCBI]
|
8.40465e-05
|
|
|
FHL4
|
[NCBI]
|
8.40465e-05
|
|
|
leber congenital amaurosis, type iii
|
[NCBI]
|
8.40465e-05
|
|
|
USH1F
|
[NCBI]
|
8.40465e-05
|
|
|
PNMT
|
[NCBI]
|
8.36388e-05
|
|
|
ABCC1
|
[NCBI]
|
8.32904e-05
|
|
|
MAP2
|
[NCBI]
|
8.32207e-05
|
|
|
LHCGR
|
[NCBI]
|
8.29726e-05
|
|
|
FBS
|
[NCBI]
|
8.2853e-05
|
|
|
GABEB
|
[NCBI]
|
8.2853e-05
|
|
|
CHEK2
|
[NCBI]
|
8.2848e-05
|
|
|
CNTF
|
[NCBI]
|
8.26274e-05
|
|
|
NKX2E
|
[NCBI]
|
8.25856e-05
|
|
|
bullous erythroderma ichthyosiformis congenita of brocq
|
[NCBI]
|
8.25185e-05
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
8.24328e-05
|
|
|
MODY1
|
[NCBI]
|
8.2309e-05
|
|
|
niemann-pick disease, type b
|
[NCBI]
|
8.2309e-05
|
|
|
diabetes insipidus, nephrogenic, autosomal
|
[NCBI]
|
8.2309e-05
|
|
|
VDR
|
[NCBI]
|
8.20831e-05
|
|
|
PGR
|
[NCBI]
|
8.20141e-05
|
|
|
COL3A1
|
[NCBI]
|
8.19114e-05
|
|
|
WRN
|
[NCBI]
|
8.15111e-05
|
|
|
NPS
|
[NCBI]
|
8.14826e-05
|
|
|
WT1
|
[NCBI]
|
8.08188e-05
|
|
|
HGPPS
|
[NCBI]
|
8.07177e-05
|
|
|
methylcobalamin deficiency, cblg type
|
[NCBI]
|
8.07177e-05
|
|
|
aplastic anemia
|
[NCBI]
|
8.07177e-05
|
|
|
FMO3
|
[NCBI]
|
8.05e-05
|
|
|
MTMR2
|
[NCBI]
|
7.97886e-05
|
|
|
PCCA
|
[NCBI]
|
7.97886e-05
|
|
|
DHFR
|
[NCBI]
|
7.85858e-05
|
|
|
PIK3CA
|
[NCBI]
|
7.84486e-05
|
|
|
G6PD
|
[NCBI]
|
7.84208e-05
|
|
|
MLC1
|
[NCBI]
|
7.82271e-05
|
|
|
KCNQ4
|
[NCBI]
|
7.82271e-05
|
|
|
MTATP6
|
[NCBI]
|
7.70915e-05
|
|
|
HDC
|
[NCBI]
|
7.69771e-05
|
|
|
GAPDH
|
[NCBI]
|
7.68093e-05
|
|
|
TF
|
[NCBI]
|
7.66546e-05
|
|
|
MTND1
|
[NCBI]
|
7.6363e-05
|
|
|
CLN2
|
[NCBI]
|
7.59267e-05
|
|
|
acyl-coa dehydrogenase, very long-chain, deficiency of
|
[NCBI]
|
7.59267e-05
|
|
|
ALPL
|
[NCBI]
|
7.58093e-05
|
|
|
NDP
|
[NCBI]
|
7.57996e-05
|
|
|
VHL
|
[NCBI]
|
7.5261e-05
|
|
|
CYP1B1
|
[NCBI]
|
7.51712e-05
|
|
|
APTX
|
[NCBI]
|
7.51712e-05
|
|
|
BMPR2
|
[NCBI]
|
7.50931e-05
|
|
|
CRB1
|
[NCBI]
|
7.50931e-05
|
|
|
ENAM
|
[NCBI]
|
7.50931e-05
|
|
|
RP11
|
[NCBI]
|
7.46289e-05
|
|
|
3-@methylcrotonyl-coa carboxylase 1 deficiency
|
[NCBI]
|
7.46289e-05
|
|
|
SCAR1
|
[NCBI]
|
7.46289e-05
|
|
|
DRRS
|
[NCBI]
|
7.46289e-05
|
|
|
FXN
|
[NCBI]
|
7.46181e-05
|
|
|
KRIT1
|
[NCBI]
|
7.45111e-05
|
|
|
FOXL2
|
[NCBI]
|
7.45111e-05
|
|
|
UMS
|
[NCBI]
|
7.4204e-05
|
|
|
PALS
|
[NCBI]
|
7.4204e-05
|
|
|
muckle-wells syndrome
|
[NCBI]
|
7.4204e-05
|
|
|
IVD
|
[NCBI]
|
7.37718e-05
|
|
|
CHRNE
|
[NCBI]
|
7.37718e-05
|
|
|
PTCH1
|
[NCBI]
|
7.37718e-05
|
|
|
GRP
|
[NCBI]
|
7.37146e-05
|
|
|
FGG
|
[NCBI]
|
7.35898e-05
|
|
|
ATP7A
|
[NCBI]
|
7.35898e-05
|
|
|
FGFR1
|
[NCBI]
|
7.34104e-05
|
|
|
maxillonasal dysplasia, binder type
|
[NCBI]
|
7.30592e-05
|
|
|
omodysplasia, generalized form
|
[NCBI]
|
7.30592e-05
|
|
|
renal failure, progressive, with hypertension
|
[NCBI]
|
7.30592e-05
|
|
|
SPG5A
|
[NCBI]
|
7.30592e-05
|
|
|
MCOP1
|
[NCBI]
|
7.30592e-05
|
|
|
spiegler-brooke syndrome
|
[NCBI]
|
7.30592e-05
|
|
|
HMN1
|
[NCBI]
|
7.30592e-05
|
|
|
thyroid carcinoma, nonmedullary, with or without cell oxyphilia
|
[NCBI]
|
7.30592e-05
|
|
|
beta-aminoisobutyric acid, urinary excretion of
|
[NCBI]
|
7.30592e-05
|
|
|
pulmonary alveolar proteinosis, acquired
|
[NCBI]
|
7.30592e-05
|
|
|
progeroid syndrome, neonatal
|
[NCBI]
|
7.30592e-05
|
|
|
hodgkin disease, x-linked pseudoautosomal
|
[NCBI]
|
7.30592e-05
|
|
|
PHP
|
[NCBI]
|
7.30592e-05
|
|
|
DMD
|
[NCBI]
|
7.30168e-05
|
|
|
IP
|
[NCBI]
|
7.30136e-05
|
|
|
NPC2
|
[NCBI]
|
7.26178e-05
|
|
|
STGD1
|
[NCBI]
|
7.17568e-05
|
|
|
ACE
|
[NCBI]
|
7.17396e-05
|
|
|
CJD
|
[NCBI]
|
7.1593e-05
|
|
|
AMC
|
[NCBI]
|
7.15909e-05
|
|
|
RUNX2
|
[NCBI]
|
7.14654e-05
|
|
|
OPTN
|
[NCBI]
|
7.14654e-05
|
|
|
XDH
|
[NCBI]
|
7.13274e-05
|
|
|
SLC26A2
|
[NCBI]
|
7.08782e-05
|
|
|
ZEB2
|
[NCBI]
|
7.08782e-05
|
|
|
AAA
|
[NCBI]
|
6.96171e-05
|
|
|
NR0B1
|
[NCBI]
|
6.94212e-05
|
|
|
MYH9
|
[NCBI]
|
6.92241e-05
|
|
|
CLOCK
|
[NCBI]
|
6.92241e-05
|
|
|
SCS
|
[NCBI]
|
6.91579e-05
|
|
|
IKBKG
|
[NCBI]
|
6.87983e-05
|
|
|
BLM
|
[NCBI]
|
6.85372e-05
|
|
|
SH2D1A
|
[NCBI]
|
6.81406e-05
|
|
|
TRMA
|
[NCBI]
|
6.79978e-05
|
|
|
opitz syndrome
|
[NCBI]
|
6.79978e-05
|
|
|
cryptorchidism, unilateral or bilateral
|
[NCBI]
|
6.79978e-05
|
|
|
ACHM3
|
[NCBI]
|
6.79978e-05
|
|
|
proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis
|
[NCBI]
|
6.79978e-05
|
|
|
EVR2
|
[NCBI]
|
6.79978e-05
|
|
|
LADD
|
[NCBI]
|
6.79978e-05
|
|
|
PEX7
|
[NCBI]
|
6.77641e-05
|
|
|
HR
|
[NCBI]
|
6.77641e-05
|
|
|
MCOLN1
|
[NCBI]
|
6.77482e-05
|
|
|
HGD
|
[NCBI]
|
6.77482e-05
|
|
|
citrullinemia, classic
|
[NCBI]
|
6.76541e-05
|
|
|
SEDC
|
[NCBI]
|
6.76541e-05
|
|
|
PCTT
|
[NCBI]
|
6.72938e-05
|
|
|
OCA2
|
[NCBI]
|
6.72938e-05
|
|
|
GHRH
|
[NCBI]
|
6.71425e-05
|
|
|
HHC1
|
[NCBI]
|
6.70662e-05
|
|
|
DLB
|
[NCBI]
|
6.69931e-05
|
|
|
PFM
|
[NCBI]
|
6.69931e-05
|
|
|
IPEX
|
[NCBI]
|
6.69931e-05
|
|
|
UGT1A1
|
[NCBI]
|
6.6895e-05
|
|
|
HBG1
|
[NCBI]
|
6.67721e-05
|
|
|
SCN1A
|
[NCBI]
|
6.65122e-05
|
|
|
IL2RG
|
[NCBI]
|
6.65122e-05
|
|
|
POMC
|
[NCBI]
|
6.61063e-05
|
|
|
SACS
|
[NCBI]
|
6.57877e-05
|
|
|
glutathione synthetase deficiency
|
[NCBI]
|
6.57877e-05
|
|
|
MCDC1
|
[NCBI]
|
6.57877e-05
|
|
|
LGMD2D
|
[NCBI]
|
6.57877e-05
|
|
|
DA2B
|
[NCBI]
|
6.57877e-05
|
|
|
renal cysts and diabetes syndrome
|
[NCBI]
|
6.57877e-05
|
|
|
encephalopathy, neonatal severe, due to mecp2 mutations
|
[NCBI]
|
6.57877e-05
|
|
|
carnitine palmitoyltransferase ii deficiency, late-onset
|
[NCBI]
|
6.57877e-05
|
|
|
lipoid proteinosis of urbach and wiethe
|
[NCBI]
|
6.57877e-05
|
|
|
NODAL
|
[NCBI]
|
6.55529e-05
|
|
|
SIL1
|
[NCBI]
|
6.55066e-05
|
|
|
SLC25A13
|
[NCBI]
|
6.55066e-05
|
|
|
TSC2
|
[NCBI]
|
6.47671e-05
|
|
|
coproporphyria
|
[NCBI]
|
6.46047e-05
|
|
|
CBX5
|
[NCBI]
|
6.44964e-05
|
|
|
thrombocytopenia-absent radius syndrome
|
[NCBI]
|
6.44205e-05
|
|
|
gout, hprt-related
|
[NCBI]
|
6.42968e-05
|
|
|
PFIC2
|
[NCBI]
|
6.42968e-05
|
|
|
DFNA10
|
[NCBI]
|
6.42968e-05
|
|
|
young syndrome
|
[NCBI]
|
6.42968e-05
|
|
|
STL3
|
[NCBI]
|
6.42968e-05
|
|
|
budd-chiari syndrome
|
[NCBI]
|
6.42968e-05
|
|
|
beta thalassemia, dominant inclusion body type
|
[NCBI]
|
6.42968e-05
|
|
|
n-acetylglutamate synthase deficiency
|
[NCBI]
|
6.42968e-05
|
|
|
anemia, hypochromic microcytic
|
[NCBI]
|
6.42968e-05
|
|
|
RP15
|
[NCBI]
|
6.42968e-05
|
|
|
CMH3
|
[NCBI]
|
6.42968e-05
|
|
|
tropical calcific pancreatitis
|
[NCBI]
|
6.42968e-05
|
|
|
melanoma-pancreatic cancer syndrome
|
[NCBI]
|
6.42968e-05
|
|
|
PCWH
|
[NCBI]
|
6.42968e-05
|
|
|
schindler disease, type i
|
[NCBI]
|
6.42968e-05
|
|
|
PFM2
|
[NCBI]
|
6.42968e-05
|
|
|
RTADR
|
[NCBI]
|
6.42968e-05
|
|
|
HCHOLA3
|
[NCBI]
|
6.42968e-05
|
|
|
3-@methylcrotonyl-coa carboxylase 2 deficiency
|
[NCBI]
|
6.42968e-05
|
|
|
pseudohypoaldosteronism, type i, autosomal dominant
|
[NCBI]
|
6.42968e-05
|
|
|
retinitis pigmentosa, x-linked, with recurrent respiratory infections
|
[NCBI]
|
6.42968e-05
|
|
|
EBDSC
|
[NCBI]
|
6.42968e-05
|
|
|
hypophosphatemic rickets, x-linked recessive
|
[NCBI]
|
6.42968e-05
|
|
|
epidermolysis bullosa pruriginosa
|
[NCBI]
|
6.42968e-05
|
|
|
DFNA17
|
[NCBI]
|
6.42968e-05
|
|
|
CDHS
|
[NCBI]
|
6.42968e-05
|
|
|
PTPN11
|
[NCBI]
|
6.4012e-05
|
|
|
HNF1A
|
[NCBI]
|
6.39785e-05
|
|
|
OPA1
|
[NCBI]
|
6.3952e-05
|
|
|
EDMD2
|
[NCBI]
|
6.38479e-05
|
|
|
MNGIE
|
[NCBI]
|
6.38479e-05
|
|
|
pfeiffer syndrome
|
[NCBI]
|
6.38479e-05
|
|
|
APL
|
[NCBI]
|
6.38479e-05
|
|
|
HSAN1
|
[NCBI]
|
6.38479e-05
|
|
|
CGL2
|
[NCBI]
|
6.38479e-05
|
|
|
SCA17
|
[NCBI]
|
6.38479e-05
|
|
|
SMA1
|
[NCBI]
|
6.37279e-05
|
|
|
EXT2
|
[NCBI]
|
6.35712e-05
|
|
|
NEFL
|
[NCBI]
|
6.35712e-05
|
|
|
ADSL
|
[NCBI]
|
6.35712e-05
|
|
|
BCKDHA
|
[NCBI]
|
6.34496e-05
|
|
|
AGXT
|
[NCBI]
|
6.34496e-05
|
|
|
WFS1
|
[NCBI]
|
6.32669e-05
|
|
|
vitamin d-dependent rickets, type ii
|
[NCBI]
|
6.32669e-05
|
|
|
diabetes insipidus, nephrogenic, x-linked
|
[NCBI]
|
6.27126e-05
|
|
|
BCPM
|
[NCBI]
|
6.26621e-05
|
|
|
GJB3
|
[NCBI]
|
6.19263e-05
|
|
|
KIT
|
[NCBI]
|
6.18721e-05
|
|
|
oca2 gene
|
[NCBI]
|
6.18527e-05
|
|
|
FMR1
|
[NCBI]
|
6.14194e-05
|
|
|
PCOS1
|
[NCBI]
|
6.13522e-05
|
|
|
UNC13D
|
[NCBI]
|
6.08734e-05
|
|
|
C1GALT1C1
|
[NCBI]
|
6.08734e-05
|
|
|
FANCC
|
[NCBI]
|
6.07374e-05
|
|
|
PDE6B
|
[NCBI]
|
6.07374e-05
|
|
|
RECQL2
|
[NCBI]
|
6.07374e-05
|
|
|
aortic valve disease
|
[NCBI]
|
6.06964e-05
|
|
|
EEC3
|
[NCBI]
|
6.0536e-05
|
|
|
PHA
|
[NCBI]
|
6.0536e-05
|
|
|
SBDS
|
[NCBI]
|
6.04887e-05
|
|
|
BRIP1
|
[NCBI]
|
6.04399e-05
|
|
|
HADHA
|
[NCBI]
|
6.03662e-05
|
|
|
G6PT1
|
[NCBI]
|
6.03662e-05
|
|
|
SOX9
|
[NCBI]
|
6.02462e-05
|
|
|
MAFD6
|
[NCBI]
|
5.98204e-05
|
|
|
SOX10
|
[NCBI]
|
5.97888e-05
|
|
|
CYBB
|
[NCBI]
|
5.97888e-05
|
|
|
BTK
|
[NCBI]
|
5.96519e-05
|
|
|
oncogene dj1
|
[NCBI]
|
5.96069e-05
|
|
|
NAGLU
|
[NCBI]
|
5.96069e-05
|
|
|
AGL
|
[NCBI]
|
5.96069e-05
|
|
|
EMD
|
[NCBI]
|
5.92844e-05
|
|
|
MFN2
|
[NCBI]
|
5.92844e-05
|
|
|
SMPD1
|
[NCBI]
|
5.92324e-05
|
|
|
NOG
|
[NCBI]
|
5.92324e-05
|
|
|
LNS
|
[NCBI]
|
5.9015e-05
|
|
|
MKKS
|
[NCBI]
|
5.86688e-05
|
|
|
megaloblastic anemia 1
|
[NCBI]
|
5.85567e-05
|
|
|
mannosidosis, alpha b, lysosomal
|
[NCBI]
|
5.85567e-05
|
|
|
PPH1
|
[NCBI]
|
5.85567e-05
|
|
|
epidermolysis bullosa with pyloric atresia
|
[NCBI]
|
5.85567e-05
|
|
|
PEDF
|
[NCBI]
|
5.83985e-05
|
|
|
adrenal hyperplasia, congenital, due to 17-alpha-hydroxylase deficiency
|
[NCBI]
|
5.81469e-05
|
|
|
septooptic dysplasia
|
[NCBI]
|
5.81469e-05
|
|
|
adrenal hyperplasia, congenital, due to steroid 11-beta-hydroxylase deficiency
|
[NCBI]
|
5.81469e-05
|
|
|
XPD
|
[NCBI]
|
5.81469e-05
|
|
|
phosphoribosylpyrophosphate synthetase superactivity
|
[NCBI]
|
5.81469e-05
|
|
|
LDS
|
[NCBI]
|
5.81469e-05
|
|
|
WS2A
|
[NCBI]
|
5.81469e-05
|
|
|
VWS
|
[NCBI]
|
5.78635e-05
|
|
|
growth hormone insensitivity with immunodeficiency
|
[NCBI]
|
5.78294e-05
|
|
|
IHCM
|
[NCBI]
|
5.78294e-05
|
|
|
SYM1
|
[NCBI]
|
5.78294e-05
|
|
|
CMH4
|
[NCBI]
|
5.78294e-05
|
|
|
EDM4
|
[NCBI]
|
5.78294e-05
|
|
|
DMC
|
[NCBI]
|
5.78294e-05
|
|
|
currarino syndrome
|
[NCBI]
|
5.78294e-05
|
|
|
crigler-najjar syndrome, type ii
|
[NCBI]
|
5.78294e-05
|
|
|
GLB1
|
[NCBI]
|
5.78137e-05
|
|
|
LAM
|
[NCBI]
|
5.77451e-05
|
|
|
AKR1B1
|
[NCBI]
|
5.76816e-05
|
|
|
udp-n-acetylglucosamine 2-epimerase/n-acetylmannosamine kinase
|
[NCBI]
|
5.74053e-05
|
|
|
DHCR7
|
[NCBI]
|
5.74053e-05
|
|
|
SMS
|
[NCBI]
|
5.7374e-05
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
5.69963e-05
|
|
|
SLC3A1
|
[NCBI]
|
5.68015e-05
|
|
|
fabry disease
|
[NCBI]
|
5.67612e-05
|
|
|
TYMS
|
[NCBI]
|
5.67514e-05
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
5.67401e-05
|
|
|
OXT
|
[NCBI]
|
5.63024e-05
|
|
|
THAS
|
[NCBI]
|
5.62336e-05
|
|
|
gastroesophageal reflux
|
[NCBI]
|
5.62336e-05
|
|
|
skin creases, multiple benign ring-shaped, of limbs
|
[NCBI]
|
5.62336e-05
|
|
|
prostate cancer, hereditary, 8
|
[NCBI]
|
5.62336e-05
|
|
|
short rib-polydactyly syndrome, type iii
|
[NCBI]
|
5.62336e-05
|
|
|
AUTS9
|
[NCBI]
|
5.62336e-05
|
|
|
neutropenia, chronic familial
|
[NCBI]
|
5.62336e-05
|
|
|
ear, patella, short stature syndrome
|
[NCBI]
|
5.62336e-05
|
|
|
MCOPS1
|
[NCBI]
|
5.62336e-05
|
|
|
RCD1
|
[NCBI]
|
5.62336e-05
|
|
|
BCR
|
[NCBI]
|
5.61449e-05
|
|
|
FLG
|
[NCBI]
|
5.61377e-05
|
|
|
MTTS1
|
[NCBI]
|
5.61377e-05
|
|
|
SALL4
|
[NCBI]
|
5.60285e-05
|
|
|
SGCD
|
[NCBI]
|
5.60285e-05
|
|
|
RPGRIP1
|
[NCBI]
|
5.60285e-05
|
|
|
urogenital adysplasia, hereditary
|
[NCBI]
|
5.60265e-05
|
|
|
NF2
|
[NCBI]
|
5.5922e-05
|
|
|
GLC1A
|
[NCBI]
|
5.58422e-05
|
|
|
DBA
|
[NCBI]
|
5.50313e-05
|
|
|
bare lymphocyte syndrome, type ii
|
[NCBI]
|
5.50058e-05
|
|
|
TGFBR2
|
[NCBI]
|
5.49738e-05
|
|
|
CYP11B2
|
[NCBI]
|
5.49738e-05
|
|
|
CAV3
|
[NCBI]
|
5.49738e-05
|
|
|
ASL
|
[NCBI]
|
5.49444e-05
|
|
|
leopard syndrome 1
|
[NCBI]
|
5.47237e-05
|
|
|
ABS
|
[NCBI]
|
5.47237e-05
|
|
|
FTLDU
|
[NCBI]
|
5.47237e-05
|
|
|
PYGM
|
[NCBI]
|
5.46572e-05
|
|
|
CLCN5
|
[NCBI]
|
5.46572e-05
|
|
|
TBX5
|
[NCBI]
|
5.46572e-05
|
|
|
CPT2
|
[NCBI]
|
5.46572e-05
|
|
|
PMS2
|
[NCBI]
|
5.44617e-05
|
|
|
pta deficiency
|
[NCBI]
|
5.44617e-05
|
|
|
SLC4A1
|
[NCBI]
|
5.42545e-05
|
|
|
TFR2
|
[NCBI]
|
5.38314e-05
|
|
|
MADA
|
[NCBI]
|
5.36912e-05
|
|
|
diastrophic dysplasia
|
[NCBI]
|
5.36912e-05
|
|
|
SLC19A2
|
[NCBI]
|
5.31901e-05
|
|
|
RECQL4
|
[NCBI]
|
5.31901e-05
|
|
|
CNGB3
|
[NCBI]
|
5.31901e-05
|
|
|
ANKH
|
[NCBI]
|
5.31901e-05
|
|
|
DGS
|
[NCBI]
|
5.31312e-05
|
|
|
MSH2
|
[NCBI]
|
5.29904e-05
|
|
|
TBX1
|
[NCBI]
|
5.29808e-05
|
|
|
USH2A
|
[NCBI]
|
5.29808e-05
|
|
|
MYO6
|
[NCBI]
|
5.29808e-05
|
|
|
MHS1
|
[NCBI]
|
5.29616e-05
|
|
|
MAFD1
|
[NCBI]
|
5.25977e-05
|
|
|
ornithine aminotransferase deficiency
|
[NCBI]
|
5.23633e-05
|
|
|
ASPA
|
[NCBI]
|
5.23633e-05
|
|
|
glycogen storage disease i
|
[NCBI]
|
5.23633e-05
|
|
|
IKBKAP
|
[NCBI]
|
5.21552e-05
|
|
|
LDLRAP1
|
[NCBI]
|
5.21552e-05
|
|
|
MBTPS2
|
[NCBI]
|
5.21552e-05
|
|
|
SFTPC
|
[NCBI]
|
5.21552e-05
|
|
|
CLN2
|
[NCBI]
|
5.21363e-05
|
|
|
ATP2C1
|
[NCBI]
|
5.21363e-05
|
|
|
RFXAP
|
[NCBI]
|
5.21363e-05
|
|
|
HOXD13
|
[NCBI]
|
5.20968e-05
|
|
|
CHH
|
[NCBI]
|
5.18732e-05
|
|
|
NFNS
|
[NCBI]
|
5.14745e-05
|
|
|
ACHM2
|
[NCBI]
|
5.14745e-05
|
|
|
hypoascorbemia
|
[NCBI]
|
5.14745e-05
|
|
|
TERC
|
[NCBI]
|
5.1106e-05
|
|
|
DYT1
|
[NCBI]
|
5.10066e-05
|
|
|
ALGS1
|
[NCBI]
|
5.10066e-05
|
|
|
ectopia lentis, isolated
|
[NCBI]
|
5.09962e-05
|
|
|
CINCA
|
[NCBI]
|
5.09962e-05
|
|
|
LGMD2F
|
[NCBI]
|
5.09962e-05
|
|
|
PRTH
|
[NCBI]
|
5.09962e-05
|
|
|
mannosidosis, beta a, lysosomal
|
[NCBI]
|
5.09962e-05
|
|
|
CGL1
|
[NCBI]
|
5.09962e-05
|
|
|
polydactyly, preaxial iv
|
[NCBI]
|
5.09962e-05
|
|
|
creatine phosphokinase, elevated serum
|
[NCBI]
|
5.09962e-05
|
|
|
USH2C
|
[NCBI]
|
5.09962e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-negative
|
[NCBI]
|
5.09962e-05
|
|
|
EVR4
|
[NCBI]
|
5.09962e-05
|
|
|
CMRD
|
[NCBI]
|
5.09962e-05
|
|
|
DFNB7
|
[NCBI]
|
5.09962e-05
|
|
|
DFNB10
|
[NCBI]
|
5.09962e-05
|
|
|
OCA1B
|
[NCBI]
|
5.09962e-05
|
|
|
DFNB8
|
[NCBI]
|
5.09962e-05
|
|
|
ARVD2
|
[NCBI]
|
5.09962e-05
|
|
|
SHFM4
|
[NCBI]
|
5.09962e-05
|
|
|
SMDP2
|
[NCBI]
|
5.09962e-05
|
|
|
choreoathetosis, hypothyroidism, and neonatal respiratory distress
|
[NCBI]
|
5.09962e-05
|
|
|
corticosterone methyloxidase type i deficiency
|
[NCBI]
|
5.09962e-05
|
|
|
PVOD
|
[NCBI]
|
5.09962e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2j
|
[NCBI]
|
5.09962e-05
|
|
|
immunodeficiency-centromeric instability-facial anomalies syndrome
|
[NCBI]
|
5.09619e-05
|
|
|
MAFD2
|
[NCBI]
|
5.0854e-05
|
|
|
MC1R
|
[NCBI]
|
5.04131e-05
|
|
|
AICDA
|
[NCBI]
|
5.01598e-05
|
|
|
contractural arachnodactyly, congenital
|
[NCBI]
|
5.01598e-05
|
|
|
SURF1
|
[NCBI]
|
5.00891e-05
|
|
|
TSHB
|
[NCBI]
|
5.00891e-05
|
|
|
ATRX
|
[NCBI]
|
4.98288e-05
|
|
|
RPE65
|
[NCBI]
|
4.97029e-05
|
|
|
UBE3A
|
[NCBI]
|
4.97029e-05
|
|
|
CRY2
|
[NCBI]
|
4.97029e-05
|
|
|
osteogenesis imperfecta, type iv
|
[NCBI]
|
4.94692e-05
|
|
|
KAL2
|
[NCBI]
|
4.94692e-05
|
|
|
brugada syndrome 1
|
[NCBI]
|
4.94692e-05
|
|
|
ESCS
|
[NCBI]
|
4.94692e-05
|
|
|
PARK1
|
[NCBI]
|
4.94643e-05
|
|
|
afibrinogenemia, congenital
|
[NCBI]
|
4.94643e-05
|
|
|
erythermalgia, primary
|
[NCBI]
|
4.94643e-05
|
|
|
SXI1
|
[NCBI]
|
4.94643e-05
|
|
|
liddle syndrome
|
[NCBI]
|
4.94643e-05
|
|
|
CSNB2A
|
[NCBI]
|
4.94643e-05
|
|
|
CZP1
|
[NCBI]
|
4.94643e-05
|
|
|
CMT4D
|
[NCBI]
|
4.94643e-05
|
|
|
CMT4C
|
[NCBI]
|
4.94643e-05
|
|
|
AVSD
|
[NCBI]
|
4.94641e-05
|
|
|
MEN2A
|
[NCBI]
|
4.93943e-05
|
|
|
TLR2
|
[NCBI]
|
4.93111e-05
|
|
|
POU1F1
|
[NCBI]
|
4.9301e-05
|
|
|
myopathy, myofibrillar, desmin-related
|
[NCBI]
|
4.92074e-05
|
|
|
FOP
|
[NCBI]
|
4.91723e-05
|
|
|
PKLR
|
[NCBI]
|
4.9077e-05
|
|
|
PRX
|
[NCBI]
|
4.87094e-05
|
|
|
NOTCH3
|
[NCBI]
|
4.87094e-05
|
|
|
CACNA1F
|
[NCBI]
|
4.87094e-05
|
|
|
BTD
|
[NCBI]
|
4.87094e-05
|
|
|
IAHSP
|
[NCBI]
|
4.86832e-05
|
|
|
CIDX
|
[NCBI]
|
4.86832e-05
|
|
|
PFIC3
|
[NCBI]
|
4.86832e-05
|
|
|
slowed nerve conduction velocity, autosomal dominant
|
[NCBI]
|
4.86832e-05
|
|
|
toenail dystrophy, isolated
|
[NCBI]
|
4.86832e-05
|
|
|
PEOA4
|
[NCBI]
|
4.86832e-05
|
|
|
chromosome xp11.3 deletion syndrome
|
[NCBI]
|
4.86832e-05
|
|
|
DFNA36
|
[NCBI]
|
4.86832e-05
|
|
|
camptodactyly, tall stature, and hearing loss syndrome
|
[NCBI]
|
4.86832e-05
|
|
|
CMD1P
|
[NCBI]
|
4.86832e-05
|
|
|
DFNA15
|
[NCBI]
|
4.86832e-05
|
|
|
LCA4
|
[NCBI]
|
4.86832e-05
|
|
|
MCOPCB3
|
[NCBI]
|
4.86832e-05
|
|
|
lathosterolosis
|
[NCBI]
|
4.86832e-05
|
|
|
ACFD
|
[NCBI]
|
4.86832e-05
|
|
|
thyroid hormonogenesis, genetic defect in, 6
|
[NCBI]
|
4.86832e-05
|
|
|
aminoacylase 1 deficiency
|
[NCBI]
|
4.86832e-05
|
|
|
crisponi syndrome
|
[NCBI]
|
4.86832e-05
|
|
|
osteogenesis imperfecta, type iib
|
[NCBI]
|
4.86832e-05
|
|
|
parathyroid carcinoma
|
[NCBI]
|
4.86832e-05
|
|
|
HOMG4
|
[NCBI]
|
4.86832e-05
|
|
|
autism, x-linked, susceptibility to, 2
|
[NCBI]
|
4.86832e-05
|
|
|
combined saposin deficiency
|
[NCBI]
|
4.86832e-05
|
|
|
JPHT
|
[NCBI]
|
4.86832e-05
|
|
|
hypospadias, x-linked
|
[NCBI]
|
4.86832e-05
|
|
|
keutel syndrome
|
[NCBI]
|
4.86832e-05
|
|
|
spherocytosis, autosomal recessive
|
[NCBI]
|
4.86832e-05
|
|
|
DDSH
|
[NCBI]
|
4.86832e-05
|
|
|
EDMD3
|
[NCBI]
|
4.86832e-05
|
|
|
LDHCP
|
[NCBI]
|
4.86832e-05
|
|
|
ARVD11
|
[NCBI]
|
4.86832e-05
|
|
|
FGD1
|
[NCBI]
|
4.86187e-05
|
|
|
KERA
|
[NCBI]
|
4.86187e-05
|
|
|
MDM1
|
[NCBI]
|
4.86187e-05
|
|
|
AMN
|
[NCBI]
|
4.86187e-05
|
|
|
AAAS
|
[NCBI]
|
4.86187e-05
|
|
|
SLC17A5
|
[NCBI]
|
4.86187e-05
|
|
|
SGCG
|
[NCBI]
|
4.86187e-05
|
|
|
SGCB
|
[NCBI]
|
4.86187e-05
|
|
|
VANGL2
|
[NCBI]
|
4.86187e-05
|
|
|
COL17A1
|
[NCBI]
|
4.81761e-05
|
|
|
TRPS2
|
[NCBI]
|
4.79658e-05
|
|
|
GSN
|
[NCBI]
|
4.75739e-05
|
|
|
FCAS
|
[NCBI]
|
4.75078e-05
|
|
|
SGCE
|
[NCBI]
|
4.74258e-05
|
|
|
KCNJ2
|
[NCBI]
|
4.74258e-05
|
|
|
MUTYH
|
[NCBI]
|
4.74258e-05
|
|
|
KCNE1
|
[NCBI]
|
4.74258e-05
|
|
|
ARPKD
|
[NCBI]
|
4.74152e-05
|
|
|
MVP
|
[NCBI]
|
4.72763e-05
|
|
|
UNG
|
[NCBI]
|
4.71123e-05
|
|
|
SOD2
|
[NCBI]
|
4.69438e-05
|
|
|
PALB2
|
[NCBI]
|
4.64676e-05
|
|
|
EDARADD
|
[NCBI]
|
4.64676e-05
|
|
|
ROBO3
|
[NCBI]
|
4.64676e-05
|
|
|
LEFTY1
|
[NCBI]
|
4.64676e-05
|
|
|
EIF2B2
|
[NCBI]
|
4.64676e-05
|
|
|
CLN6
|
[NCBI]
|
4.64676e-05
|
|
|
DMPK
|
[NCBI]
|
4.64612e-05
|
|
|
TTN
|
[NCBI]
|
4.62916e-05
|
|
|
OMP
|
[NCBI]
|
4.61521e-05
|
|
|
PSTPIP1
|
[NCBI]
|
4.60441e-05
|
|
|
TRIM32
|
[NCBI]
|
4.60441e-05
|
|
|
USH3A
|
[NCBI]
|
4.60441e-05
|
|
|
CLDN14
|
[NCBI]
|
4.60441e-05
|
|
|
COLQ
|
[NCBI]
|
4.60441e-05
|
|
|
CHMP2B
|
[NCBI]
|
4.60441e-05
|
|
|
TYRP1
|
[NCBI]
|
4.59195e-05
|
|
|
pena-shokeir syndrome, type i
|
[NCBI]
|
4.58439e-05
|
|
|
JAK2
|
[NCBI]
|
4.57688e-05
|
|
|
SLC6A19
|
[NCBI]
|
4.56546e-05
|
|
|
SCO1
|
[NCBI]
|
4.56546e-05
|
|
|
MTTV
|
[NCBI]
|
4.56546e-05
|
|
|
FREM2
|
[NCBI]
|
4.56546e-05
|
|
|
MTMR9
|
[NCBI]
|
4.56546e-05
|
|
|
DYM
|
[NCBI]
|
4.56546e-05
|
|
|
PDCD10
|
[NCBI]
|
4.56546e-05
|
|
|
GDAP1
|
[NCBI]
|
4.56123e-05
|
|
|
PKHD1
|
[NCBI]
|
4.56123e-05
|
|
|
KCNQ2
|
[NCBI]
|
4.56123e-05
|
|
|
RAB27A
|
[NCBI]
|
4.56123e-05
|
|
|
SLC26A3
|
[NCBI]
|
4.56123e-05
|
|
|
SPG3A
|
[NCBI]
|
4.56123e-05
|
|
|
COCH
|
[NCBI]
|
4.56123e-05
|
|
|
propionic acidemia
|
[NCBI]
|
4.56004e-05
|
|
|
dent disease 1
|
[NCBI]
|
4.56004e-05
|
|
|
aging
|
[NCBI]
|
4.56004e-05
|
|
|
LMS
|
[NCBI]
|
4.56004e-05
|
|
|
esophageal cancer
|
[NCBI]
|
4.56004e-05
|
|
|
holocarboxylase synthetase deficiency
|
[NCBI]
|
4.56004e-05
|
|
|
PPCD1
|
[NCBI]
|
4.56004e-05
|
|
|
SRD5A2
|
[NCBI]
|
4.53472e-05
|
|
|
KLF6
|
[NCBI]
|
4.53472e-05
|
|
|
PDB
|
[NCBI]
|
4.50677e-05
|
|
|
hyperekplexia, hereditary
|
[NCBI]
|
4.50677e-05
|
|
|
DBT
|
[NCBI]
|
4.49612e-05
|
|
|
SLPI
|
[NCBI]
|
4.48424e-05
|
|
|
MTM1
|
[NCBI]
|
4.4818e-05
|
|
|
SLC7A9
|
[NCBI]
|
4.47037e-05
|
|
|
COL4A4
|
[NCBI]
|
4.47037e-05
|
|
|
IL12RB1
|
[NCBI]
|
4.47037e-05
|
|
|
FMN
|
[NCBI]
|
4.47037e-05
|
|
|
TBX3
|
[NCBI]
|
4.47037e-05
|
|
|
POU3F4
|
[NCBI]
|
4.47037e-05
|
|
|
canavan disease
|
[NCBI]
|
4.47025e-05
|
|
|
HEPOD
|
[NCBI]
|
4.47025e-05
|
|
|
epidermolysis bullosa letalis
|
[NCBI]
|
4.47025e-05
|
|
|
autonomic control, congenital failure of
|
[NCBI]
|
4.47025e-05
|
|
|
PLOSL
|
[NCBI]
|
4.47025e-05
|
|
|
mucopolysaccharidosis type iva
|
[NCBI]
|
4.45904e-05
|
|
|
CSTB
|
[NCBI]
|
4.44986e-05
|
|
|
KCNJ11
|
[NCBI]
|
4.44986e-05
|
|
|
MAG
|
[NCBI]
|
4.37251e-05
|
|
|
HFM
|
[NCBI]
|
4.34961e-05
|
|
|
PAX2
|
[NCBI]
|
4.33576e-05
|
|
|
MTM1
|
[NCBI]
|
4.33576e-05
|
|
|
HEXB
|
[NCBI]
|
4.32002e-05
|
|
|
MTCYB
|
[NCBI]
|
4.32002e-05
|
|
|
ASS
|
[NCBI]
|
4.31635e-05
|
|
|
digeorge syndrome/velocardiofacial syndrome spectrum of malformation 2
|
[NCBI]
|
4.28568e-05
|
|
|
GCY
|
[NCBI]
|
4.28568e-05
|
|
|
wernicke-korsakoff syndrome
|
[NCBI]
|
4.28568e-05
|
|
|
ADFN
|
[NCBI]
|
4.28568e-05
|
|
|
SCZD6
|
[NCBI]
|
4.28568e-05
|
|
|
constricting bands, congenital
|
[NCBI]
|
4.28568e-05
|
|
|
spinocerebellar ataxia 29
|
[NCBI]
|
4.28568e-05
|
|
|
XPA
|
[NCBI]
|
4.28108e-05
|
|
|
MTCO1
|
[NCBI]
|
4.28108e-05
|
|
|
APOC2
|
[NCBI]
|
4.28108e-05
|
|
|
CRYBB2
|
[NCBI]
|
4.28056e-05
|
|
|
RAPSN
|
[NCBI]
|
4.28056e-05
|
|
|
SGCA
|
[NCBI]
|
4.28056e-05
|
|
|
SDS
|
[NCBI]
|
4.27954e-05
|
|
|
IGF1R
|
[NCBI]
|
4.27901e-05
|
|
|
GLI3
|
[NCBI]
|
4.27901e-05
|
|
|
CRY1
|
[NCBI]
|
4.27901e-05
|
|
|
CLN3
|
[NCBI]
|
4.26713e-05
|
|
|
GJB6
|
[NCBI]
|
4.26713e-05
|
|
|
IGFALS
|
[NCBI]
|
4.26662e-05
|
|
|
CMT2A2
|
[NCBI]
|
4.24472e-05
|
|
|
MCOPS3
|
[NCBI]
|
4.24472e-05
|
|
|
PHA1
|
[NCBI]
|
4.24472e-05
|
|
|
XPV
|
[NCBI]
|
4.24472e-05
|
|
|
OSMED
|
[NCBI]
|
4.24472e-05
|
|
|
ABCC8
|
[NCBI]
|
4.24405e-05
|
|
|
hurler syndrome
|
[NCBI]
|
4.23316e-05
|
|
|
F2
|
[NCBI]
|
4.23191e-05
|
|
|
diabetes mellitus, neonatal, with congenital hypothyroidism
|
[NCBI]
|
4.21673e-05
|
|
|
DFNB37
|
[NCBI]
|
4.21673e-05
|
|
|
NLSDM
|
[NCBI]
|
4.21673e-05
|
|
|
craniosynostosis with ocular abnormalities and hallucal defects
|
[NCBI]
|
4.21673e-05
|
|
|
myotilinopathy
|
[NCBI]
|
4.21673e-05
|
|
|
MRX91
|
[NCBI]
|
4.21673e-05
|
|
|
androgen insensitivity syndrome due to coactivator deficiency
|
[NCBI]
|
4.21673e-05
|
|
|
FHL3
|
[NCBI]
|
4.21673e-05
|
|
|
myopathy, myofibrillar, zasp-related
|
[NCBI]
|
4.21673e-05
|
|
|
USH2D
|
[NCBI]
|
4.21673e-05
|
|
|
CISS1
|
[NCBI]
|
4.21673e-05
|
|
|
CDLS3
|
[NCBI]
|
4.21673e-05
|
|
|
SMDP3
|
[NCBI]
|
4.21673e-05
|
|
|
NPHS3
|
[NCBI]
|
4.21673e-05
|
|
|
hyperekplexia and epilepsy
|
[NCBI]
|
4.21673e-05
|
|
|
HHF5
|
[NCBI]
|
4.21673e-05
|
|
|
chondrodysplasia, acromesomelic, with genital anomalies
|
[NCBI]
|
4.21673e-05
|
|
|
aprosencephaly and cerebellar dysgenesis
|
[NCBI]
|
4.21673e-05
|
|
|
cataract, pulverulent, juvenile-onset
|
[NCBI]
|
4.21673e-05
|
|
|
aortic aneurysm, familial thoracic 5
|
[NCBI]
|
4.21673e-05
|
|
|
seborrhea-like dermatitis with psoriasiform elements
|
[NCBI]
|
4.21673e-05
|
|
|
JBTS6
|
[NCBI]
|
4.21673e-05
|
|
|
LCCS3
|
[NCBI]
|
4.21673e-05
|
|
|
epilepsy, x-linked, with variable learning disabilities and behavior disorders
|
[NCBI]
|
4.21673e-05
|
|
|
PCH6
|
[NCBI]
|
4.21673e-05
|
|
|
charcot-marie-tooth disease, demyelinating, type 1f
|
[NCBI]
|
4.21673e-05
|
|
|
CMD1O
|
[NCBI]
|
4.21673e-05
|
|
|
COXPD3
|
[NCBI]
|
4.21673e-05
|
|
|
cerebellar degeneration-related autoantigen 3
|
[NCBI]
|
4.21673e-05
|
|
|
hypercholesterolemia suppressor
|
[NCBI]
|
4.21673e-05
|
|
|
deafness, autosomal dominant 39, with dentinogenesis imperfecta 1
|
[NCBI]
|
4.21673e-05
|
|
|
myokymia with neonatal epilepsy
|
[NCBI]
|
4.21673e-05
|
|
|
ectrodactyly-cleft palate syndrome
|
[NCBI]
|
4.21673e-05
|
|
|
NEM7
|
[NCBI]
|
4.21673e-05
|
|
|
ATFB3
|
[NCBI]
|
4.21673e-05
|
|
|
ichthyosis with hypotrichosis, autosomal recessive
|
[NCBI]
|
4.21673e-05
|
|
|
muscular dystrophy, congenital, type 1d
|
[NCBI]
|
4.21673e-05
|
|
|
hypertension, diastolic, resistance to
|
[NCBI]
|
4.21673e-05
|
|
|
ASD4
|
[NCBI]
|
4.21673e-05
|
|
|
gil blood group
|
[NCBI]
|
4.21673e-05
|
|
|
parkes weber syndrome
|
[NCBI]
|
4.21673e-05
|
|
|
asperger syndrome, x-linked, susceptibility to, 2
|
[NCBI]
|
4.21673e-05
|
|
|
hypomagnesemia, hypertension, and hypercholesterolemia, mitochondrial
|
[NCBI]
|
4.21673e-05
|
|
|
IHG
|
[NCBI]
|
4.21673e-05
|
|
|
pyruvate dehydrogenase e2 deficiency
|
[NCBI]
|
4.21673e-05
|
|
|
herpes simplex encephalitis, unc93b-deficient
|
[NCBI]
|
4.21673e-05
|
|
|
AGS5
|
[NCBI]
|
4.21673e-05
|
|
|
DFNB22
|
[NCBI]
|
4.21673e-05
|
|
|
SLSN5
|
[NCBI]
|
4.21673e-05
|
|
|
VODI
|
[NCBI]
|
4.21673e-05
|
|
|
neurofaciodigitorenal syndrome
|
[NCBI]
|
4.21673e-05
|
|
|
COXPD4
|
[NCBI]
|
4.21673e-05
|
|
|
CSNB2B
|
[NCBI]
|
4.21673e-05
|
|
|
GCCD2
|
[NCBI]
|
4.21673e-05
|
|
|
ZNF204
|
[NCBI]
|
4.21673e-05
|
|
|
fascial dystrophy, congenital
|
[NCBI]
|
4.21673e-05
|
|
|
RCD3B
|
[NCBI]
|
4.21673e-05
|
|
|
CORD9
|
[NCBI]
|
4.21673e-05
|
|
|
AGS3
|
[NCBI]
|
4.21673e-05
|
|
|
epidermolysis bullosa, lethal acantholytic
|
[NCBI]
|
4.21673e-05
|
|
|
ROCA
|
[NCBI]
|
4.21673e-05
|
|
|
tn syndrome
|
[NCBI]
|
4.21673e-05
|
|
|
USH1H
|
[NCBI]
|
4.21673e-05
|
|
|
brachydactyly-syndactyly syndrome
|
[NCBI]
|
4.21673e-05
|
|
|
POF5
|
[NCBI]
|
4.21673e-05
|
|
|
RESDX
|
[NCBI]
|
4.21673e-05
|
|
|
external auditory canal, bilateral atresia of, with congenital vertical talus
|
[NCBI]
|
4.21673e-05
|
|
|
craniosynostosis syndrome, autosomal recessive
|
[NCBI]
|
4.21673e-05
|
|
|
NEM4
|
[NCBI]
|
4.21673e-05
|
|
|
ARVD12
|
[NCBI]
|
4.21673e-05
|
|
|
XLP2
|
[NCBI]
|
4.21673e-05
|
|
|
scaphocephaly, maxillary retrusion, and mental retardation
|
[NCBI]
|
4.21673e-05
|
|
|
cortical dysplasia-focal epilepsy syndrome
|
[NCBI]
|
4.21673e-05
|
|
|
alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity
|
[NCBI]
|
4.21673e-05
|
|
|
WS2E
|
[NCBI]
|
4.21673e-05
|
|
|
basal ganglia disease, biotin-responsive
|
[NCBI]
|
4.21673e-05
|
|
|
KAL3
|
[NCBI]
|
4.21673e-05
|
|
|
LIH
|
[NCBI]
|
4.21673e-05
|
|
|
EPM3
|
[NCBI]
|
4.21673e-05
|
|
|
NNO2
|
[NCBI]
|
4.21673e-05
|
|
|
DFNB24
|
[NCBI]
|
4.21673e-05
|
|
|
spondylometaphyseal dysplasia, algerian type
|
[NCBI]
|
4.21673e-05
|
|
|
mitochondrial phosphate carrier deficiency
|
[NCBI]
|
4.21673e-05
|
|
|
CMT4J
|
[NCBI]
|
4.21673e-05
|
|
|
NEM5
|
[NCBI]
|
4.21673e-05
|
|
|
oncogene yuasa
|
[NCBI]
|
4.21673e-05
|
|
|
spondyloepimetaphyseal dysplasia, matrilin-3 related
|
[NCBI]
|
4.21673e-05
|
|
|
epilepsy, childhood absence, 3
|
[NCBI]
|
4.21673e-05
|
|
|
glycosylphosphatidylinositol deficiency
|
[NCBI]
|
4.21673e-05
|
|
|
CDG2E
|
[NCBI]
|
4.21673e-05
|
|
|
DFNB30
|
[NCBI]
|
4.21673e-05
|
|
|
OLEDAID
|
[NCBI]
|
4.21673e-05
|
|
|
ciliary dyskinesia, primary, 3
|
[NCBI]
|
4.21673e-05
|
|
|
CATCN2
|
[NCBI]
|
4.21673e-05
|
|
|
CDLS2
|
[NCBI]
|
4.21673e-05
|
|
|
microphthalmia, posterior, with retinitis pigmentosa, foveoschisis, and optic disc drusen
|
[NCBI]
|
4.21673e-05
|
|
|
COXPD2
|
[NCBI]
|
4.21673e-05
|
|
|
epilepsy with grand mal seizures on awakening
|
[NCBI]
|
4.21673e-05
|
|
|
charcot-marie-tooth disease, dominant intermediate d
|
[NCBI]
|
4.21673e-05
|
|
|
ATD2
|
[NCBI]
|
4.21673e-05
|
|
|
FSGS3
|
[NCBI]
|
4.21673e-05
|
|
|
PERRS
|
[NCBI]
|
4.21673e-05
|
|
|
SSS1
|
[NCBI]
|
4.21673e-05
|
|
|
ECA4
|
[NCBI]
|
4.21673e-05
|
|
|
LCA12
|
[NCBI]
|
4.21673e-05
|
|
|
diamond-blackfan anemia 3
|
[NCBI]
|
4.21673e-05
|
|
|
PPNAD2
|
[NCBI]
|
4.21673e-05
|
|
|
NBIA2
|
[NCBI]
|
4.21673e-05
|
|
|
cataract, sutural, with punctate and cerulean opacities
|
[NCBI]
|
4.21673e-05
|
|
|
HPE9
|
[NCBI]
|
4.21673e-05
|
|
|
fertile eunuch syndrome
|
[NCBI]
|
4.21673e-05
|
|
|
DFNB53
|
[NCBI]
|
4.21673e-05
|
|
|
spinal dysplasia, anhalt type
|
[NCBI]
|
4.21673e-05
|
|
|
blepharoptosis, myopia, and ectopia lentis
|
[NCBI]
|
4.21673e-05
|
|
|
deafness, congenital, with inner ear agenesis, microtia, and microdontia
|
[NCBI]
|
4.21673e-05
|
|
|
asperger syndrome, x-linked, susceptibility to, 1
|
[NCBI]
|
4.21673e-05
|
|
|
hyperbilirubinemia, conjugated, type iii
|
[NCBI]
|
4.21673e-05
|
|
|
SLSN6
|
[NCBI]
|
4.21673e-05
|
|
|
cataract, cortical, juvenile-onset
|
[NCBI]
|
4.21673e-05
|
|
|
cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome
|
[NCBI]
|
4.21673e-05
|
|
|
annular erythema
|
[NCBI]
|
4.21673e-05
|
|
|
SCDO2
|
[NCBI]
|
4.21673e-05
|
|
|
sclerocornea, autosomal dominant
|
[NCBI]
|
4.21673e-05
|
|
|
cd8 deficiency, familial
|
[NCBI]
|
4.21673e-05
|
|
|
thalassemias
|
[NCBI]
|
4.21673e-05
|
|
|
KAL4
|
[NCBI]
|
4.21673e-05
|
|
|
CISS2
|
[NCBI]
|
4.21673e-05
|
|
|
fructose utilization
|
[NCBI]
|
4.21673e-05
|
|
|
noncompaction of left ventricular myocardium with congenital heart defects
|
[NCBI]
|
4.21673e-05
|
|
|
karak syndrome
|
[NCBI]
|
4.21673e-05
|
|
|
CMD1W
|
[NCBI]
|
4.21673e-05
|
|
|
CDG1M
|
[NCBI]
|
4.21673e-05
|
|
|
MDLS
|
[NCBI]
|
4.17756e-05
|
|
|
CHM
|
[NCBI]
|
4.14783e-05
|
|
|
COL4A3
|
[NCBI]
|
4.14783e-05
|
|
|
MATN3
|
[NCBI]
|
4.12885e-05
|
|
|
MID1
|
[NCBI]
|
4.12885e-05
|
|
|
COL6A2
|
[NCBI]
|
4.12885e-05
|
|
|
TREX1
|
[NCBI]
|
4.12885e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
4.12422e-05
|
|
|
atypical mycobacteriosis, familial
|
[NCBI]
|
4.12402e-05
|
|
|
CHX10
|
[NCBI]
|
4.12279e-05
|
|
|
COL9A2
|
[NCBI]
|
4.12279e-05
|
|
|
AHI1
|
[NCBI]
|
4.12279e-05
|
|
|
AIPL1
|
[NCBI]
|
4.12279e-05
|
|
|
TBCE
|
[NCBI]
|
4.12279e-05
|
|
|
CLN6
|
[NCBI]
|
4.11485e-05
|
|
|
HMS
|
[NCBI]
|
4.11485e-05
|
|
|
MCOPS9
|
[NCBI]
|
4.11485e-05
|
|
|
HHRH
|
[NCBI]
|
4.11485e-05
|
|
|
CCA2
|
[NCBI]
|
4.11485e-05
|
|
|
LGMD1C
|
[NCBI]
|
4.11485e-05
|
|
|
CZP3
|
[NCBI]
|
4.11485e-05
|
|
|
vater association
|
[NCBI]
|
4.11485e-05
|
|
|
short stature, idiopathic, autosomal
|
[NCBI]
|
4.11485e-05
|
|
|
CDG1C
|
[NCBI]
|
4.11485e-05
|
|
|
DSS
|
[NCBI]
|
4.11485e-05
|
|
|
FHL2
|
[NCBI]
|
4.11485e-05
|
|
|
ectodermal dysplasia, anhidrotic
|
[NCBI]
|
4.11485e-05
|
|
|
CCM3
|
[NCBI]
|
4.11485e-05
|
|
|
agammaglobulinemia, non-bruton type, autosomal recessive
|
[NCBI]
|
4.11485e-05
|
|
|
XRN
|
[NCBI]
|
4.11485e-05
|
|
|
EAD
|
[NCBI]
|
4.11485e-05
|
|
|
atrial septal defect with atrioventricular conduction defects
|
[NCBI]
|
4.11485e-05
|
|
|
BWS
|
[NCBI]
|
4.10121e-05
|
|
|
SRY
|
[NCBI]
|
4.09886e-05
|
|
|
SLC6A4
|
[NCBI]
|
4.09214e-05
|
|
|
breast cancer
|
[NCBI]
|
4.07534e-05
|
|
|
tyrosinemia, type i
|
[NCBI]
|
4.05616e-05
|
|
|
KAL1
|
[NCBI]
|
4.05616e-05
|
|
|
KRT1
|
[NCBI]
|
4.05362e-05
|
|
|
FSHR
|
[NCBI]
|
4.05205e-05
|
|
|
VCP
|
[NCBI]
|
4.05205e-05
|
|
|
XPA
|
[NCBI]
|
4.03992e-05
|
|
|
diabetes insipidus, neurohypophyseal type
|
[NCBI]
|
4.03966e-05
|
|
|
FED
|
[NCBI]
|
4.03966e-05
|
|
|
NBIA1
|
[NCBI]
|
4.03966e-05
|
|
|
VED
|
[NCBI]
|
4.03966e-05
|
|
|
PPAC
|
[NCBI]
|
4.03966e-05
|
|
|
HSAN2
|
[NCBI]
|
4.03966e-05
|
|
|
CSID
|
[NCBI]
|
4.03966e-05
|
|
|
mismatch repair cancer syndrome
|
[NCBI]
|
4.0366e-05
|
|
|
cutis laxa, x-linked
|
[NCBI]
|
4.0366e-05
|
|
|
GLC3A
|
[NCBI]
|
4.0366e-05
|
|
|
glycogen storage disease ii
|
[NCBI]
|
4.03565e-05
|
|
|
ROR2
|
[NCBI]
|
4.02446e-05
|
|
|
COL11A1
|
[NCBI]
|
4.02446e-05
|
|
|
SCNN1B
|
[NCBI]
|
4.02446e-05
|
|
|
HBD
|
[NCBI]
|
4.01162e-05
|
|
|
diabetes mellitus, transient neonatal, 1
|
[NCBI]
|
4.00571e-05
|
|
|
EEC1
|
[NCBI]
|
4.00571e-05
|
|
|
SLS
|
[NCBI]
|
3.99513e-05
|
|
|
DYT1
|
[NCBI]
|
3.96998e-05
|
|
|
PI
|
[NCBI]
|
3.91724e-05
|
|
|
SLC22A12
|
[NCBI]
|
3.91114e-05
|
|
|
HSN2
|
[NCBI]
|
3.91114e-05
|
|
|
COH1
|
[NCBI]
|
3.91114e-05
|
|
|
HAX1
|
[NCBI]
|
3.91114e-05
|
|
|
MTTH
|
[NCBI]
|
3.91114e-05
|
|
|
MOCS1
|
[NCBI]
|
3.91114e-05
|
|
|
GGA1
|
[NCBI]
|
3.91114e-05
|
|
|
SUMF1
|
[NCBI]
|
3.91114e-05
|
|
|
CHST6
|
[NCBI]
|
3.91114e-05
|
|
|
MFRP
|
[NCBI]
|
3.91114e-05
|
|
|
MCCC1
|
[NCBI]
|
3.91114e-05
|
|
|
GALT
|
[NCBI]
|
3.90535e-05
|
|
|
SMAX1
|
[NCBI]
|
3.89712e-05
|
|
|
TPMT
|
[NCBI]
|
3.88943e-05
|
|
|
DLD
|
[NCBI]
|
3.85393e-05
|
|
|
GDNF
|
[NCBI]
|
3.84183e-05
|
|
|
TLR9
|
[NCBI]
|
3.83408e-05
|
|
|
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity
|
[NCBI]
|
3.82858e-05
|
|
|
alsin
|
[NCBI]
|
3.82681e-05
|
|
|
ARRB2
|
[NCBI]
|
3.82681e-05
|
|
|
ERCC5
|
[NCBI]
|
3.8114e-05
|
|
|
ABCA1
|
[NCBI]
|
3.80969e-05
|
|
|
HRAS
|
[NCBI]
|
3.80295e-05
|
|
|
TAF1
|
[NCBI]
|
3.80136e-05
|
|
|
PTS
|
[NCBI]
|
3.78946e-05
|
|
|
AN2
|
[NCBI]
|
3.75992e-05
|
|
|
CP
|
[NCBI]
|
3.73568e-05
|
|
|
TNFSF10
|
[NCBI]
|
3.73067e-05
|
|
|
EDAR
|
[NCBI]
|
3.72525e-05
|
|
|
SCNN1G
|
[NCBI]
|
3.72525e-05
|
|
|
GBE1
|
[NCBI]
|
3.72525e-05
|
|
|
EYA4
|
[NCBI]
|
3.72525e-05
|
|
|
RP1
|
[NCBI]
|
3.72525e-05
|
|
|
MLPH
|
[NCBI]
|
3.72525e-05
|
|
|
SETX
|
[NCBI]
|
3.72525e-05
|
|
|
DSG4
|
[NCBI]
|
3.72525e-05
|
|
|
CDKL5
|
[NCBI]
|
3.72525e-05
|
|
|
ATP8B1
|
[NCBI]
|
3.72525e-05
|
|
|
DBI
|
[NCBI]
|
3.70618e-05
|
|
|
SERPINA6
|
[NCBI]
|
3.69428e-05
|
|
|
EDA
|
[NCBI]
|
3.66665e-05
|
|
|
HNF1B
|
[NCBI]
|
3.66665e-05
|
|
|
LHB
|
[NCBI]
|
3.66665e-05
|
|
|
CYP11B1
|
[NCBI]
|
3.66665e-05
|
|
|
THC1
|
[NCBI]
|
3.64783e-05
|
|
|
CMT4A
|
[NCBI]
|
3.64783e-05
|
|
|
MTC
|
[NCBI]
|
3.64783e-05
|
|
|
CLN5
|
[NCBI]
|
3.64783e-05
|
|
|
medulloblastoma
|
[NCBI]
|
3.64783e-05
|
|
|
CDA
|
[NCBI]
|
3.64783e-05
|
|
|
methylmalonic aciduria and homocystinuria, cblc type
|
[NCBI]
|
3.64783e-05
|
|
|
SEDT
|
[NCBI]
|
3.64783e-05
|
|
|
apolipoprotein c-ii deficiency
|
[NCBI]
|
3.64783e-05
|
|
|
corticosterone methyloxidase type ii deficiency
|
[NCBI]
|
3.64783e-05
|
|
|
LGMD2H
|
[NCBI]
|
3.64783e-05
|
|
|
ABCD1
|
[NCBI]
|
3.64191e-05
|
|
|
RYR2
|
[NCBI]
|
3.64126e-05
|
|
|
GP1BA
|
[NCBI]
|
3.64126e-05
|
|
|
TP73L
|
[NCBI]
|
3.64126e-05
|
|
|
sialuria, finnish type
|
[NCBI]
|
3.64117e-05
|
|
|
donohue syndrome
|
[NCBI]
|
3.64117e-05
|
|
|
deafness, conductive, with stapes fixation
|
[NCBI]
|
3.64117e-05
|
|
|
PGL1
|
[NCBI]
|
3.62734e-05
|
|
|
glycogen storage disease vii
|
[NCBI]
|
3.62734e-05
|
|
|
ARF6
|
[NCBI]
|
3.6032e-05
|
|
|
refsum disease
|
[NCBI]
|
3.57637e-05
|
|
|
alkaptonuria
|
[NCBI]
|
3.57637e-05
|
|
|
thyroid hormonogenesis, genetic defect in, 2a
|
[NCBI]
|
3.57637e-05
|
|
|
OPTB3
|
[NCBI]
|
3.57637e-05
|
|
|
hyperlipoproteinemia, type i
|
[NCBI]
|
3.57637e-05
|
|
|
PKS
|
[NCBI]
|
3.57294e-05
|
|
|
COL11A2
|
[NCBI]
|
3.57276e-05
|
|
|
XRCC9
|
[NCBI]
|
3.57276e-05
|
|
|
ERCC3
|
[NCBI]
|
3.57276e-05
|
|
|
RPS6KA1
|
[NCBI]
|
3.57276e-05
|
|
|
SMOH
|
[NCBI]
|
3.5568e-05
|
|
|
POLH
|
[NCBI]
|
3.5568e-05
|
|
|
PHEX
|
[NCBI]
|
3.53227e-05
|
|
|
RPS6KA3
|
[NCBI]
|
3.53227e-05
|
|
|
von willebrand disease
|
[NCBI]
|
3.49788e-05
|
|
|
EGR2
|
[NCBI]
|
3.49058e-05
|
|
|
TGM1
|
[NCBI]
|
3.49058e-05
|
|
|
MYO5A
|
[NCBI]
|
3.49058e-05
|
|
|
MSH6
|
[NCBI]
|
3.48901e-05
|
|
|
alopecia, androgenetic
|
[NCBI]
|
3.48196e-05
|
|
|
IAPP
|
[NCBI]
|
3.46049e-05
|
|
|
FAAH
|
[NCBI]
|
3.45559e-05
|
|
|
PLTP
|
[NCBI]
|
3.45488e-05
|
|
|
IBD1
|
[NCBI]
|
3.44188e-05
|
|
|
neural tube defects
|
[NCBI]
|
3.44134e-05
|
|
|
PHS
|
[NCBI]
|
3.44134e-05
|
|
|
SLOS
|
[NCBI]
|
3.4354e-05
|
|
|
HAE III
|
[NCBI]
|
3.39959e-05
|
|
|
LAH
|
[NCBI]
|
3.39959e-05
|
|
|
SPG8
|
[NCBI]
|
3.39959e-05
|
|
|
CHBL
|
[NCBI]
|
3.39959e-05
|
|
|
USH1G
|
[NCBI]
|
3.39959e-05
|
|
|
MRT2
|
[NCBI]
|
3.39959e-05
|
|
|
LCA5
|
[NCBI]
|
3.39959e-05
|
|
|
lipase deficiency, combined
|
[NCBI]
|
3.39959e-05
|
|
|
alpha-b crystallinopathy
|
[NCBI]
|
3.39959e-05
|
|
|
HPE5
|
[NCBI]
|
3.39959e-05
|
|
|
dyserythropoietic anemia with thrombocytopenia
|
[NCBI]
|
3.39959e-05
|
|
|
severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation
|
[NCBI]
|
3.39959e-05
|
|
|
CSB
|
[NCBI]
|
3.39959e-05
|
|
|
proprotein convertase 1 deficiency
|
[NCBI]
|
3.39959e-05
|
|
|
cortisone reductase deficiency
|
[NCBI]
|
3.39959e-05
|
|
|
bartter syndrome, antenatal, type 1
|
[NCBI]
|
3.39959e-05
|
|
|
glutathione synthetase deficiency of erythrocytes, hemolytic anemia due to
|
[NCBI]
|
3.39959e-05
|
|
|
charcot-marie-tooth disease, recessive intermediate a
|
[NCBI]
|
3.39959e-05
|
|
|
homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cble complementation type
|
[NCBI]
|
3.39959e-05
|
|
|
CFEOM2
|
[NCBI]
|
3.39959e-05
|
|
|
SPG20
|
[NCBI]
|
3.39959e-05
|
|
|
bare lymphocyte syndrome, type i
|
[NCBI]
|
3.39959e-05
|
|
|
CMD1C
|
[NCBI]
|
3.39959e-05
|
|
|
rett syndrome, atypical, cdkl5-related
|
[NCBI]
|
3.39959e-05
|
|
|
acth deficiency
|
[NCBI]
|
3.39959e-05
|
|
|
cervical cancer
|
[NCBI]
|
3.39959e-05
|
|
|
orofacial cleft 5
|
[NCBI]
|
3.39959e-05
|
|
|
bile acid synthesis defect, congenital, 1
|
[NCBI]
|
3.39959e-05
|
|
|
IGAD2
|
[NCBI]
|
3.39959e-05
|
|
|
SCA13
|
[NCBI]
|
3.39959e-05
|
|
|
kanzaki disease
|
[NCBI]
|
3.39959e-05
|
|
|
LGMD2K
|
[NCBI]
|
3.39959e-05
|
|
|
MRX30
|
[NCBI]
|
3.39959e-05
|
|
|
DFNB59
|
[NCBI]
|
3.39959e-05
|
|
|
HESX1
|
[NCBI]
|
3.38791e-05
|
|
|
CYP27A1
|
[NCBI]
|
3.38791e-05
|
|
|
PPP2R4
|
[NCBI]
|
3.38791e-05
|
|
|
CHD7
|
[NCBI]
|
3.38721e-05
|
|
|
TRMU
|
[NCBI]
|
3.38721e-05
|
|
|
lady bird late, drosophila, homolog of, 1
|
[NCBI]
|
3.38721e-05
|
|
|
VPS13A
|
[NCBI]
|
3.38721e-05
|
|
|
TBX22
|
[NCBI]
|
3.38721e-05
|
|
|
FANCB
|
[NCBI]
|
3.38721e-05
|
|
|
CLN8
|
[NCBI]
|
3.38721e-05
|
|
|
ND
|
[NCBI]
|
3.38649e-05
|
|
|
NEU1
|
[NCBI]
|
3.37211e-05
|
|
|
SFTPB
|
[NCBI]
|
3.37211e-05
|
|
|
ERCC6
|
[NCBI]
|
3.37211e-05
|
|
|
PHOX2B
|
[NCBI]
|
3.37211e-05
|
|
|
FTD
|
[NCBI]
|
3.36402e-05
|
|
|
PGL4
|
[NCBI]
|
3.34912e-05
|
|
|
aceruloplasminemia
|
[NCBI]
|
3.34912e-05
|
|
|
EPD
|
[NCBI]
|
3.34912e-05
|
|
|
CMT4B1
|
[NCBI]
|
3.34912e-05
|
|
|
ODG2
|
[NCBI]
|
3.34912e-05
|
|
|
mal de meleda
|
[NCBI]
|
3.34912e-05
|
|
|
hyperferritinemia-cataract syndrome
|
[NCBI]
|
3.34912e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 3
|
[NCBI]
|
3.34912e-05
|
|
|
ehlers-danlos syndrome, type vii, autosomal recessive
|
[NCBI]
|
3.34912e-05
|
|
|
epiphyseal dysplasia, multiple, with early-onset diabetes mellitus
|
[NCBI]
|
3.34912e-05
|
|
|
EPPK
|
[NCBI]
|
3.34912e-05
|
|
|
PARK7
|
[NCBI]
|
3.34912e-05
|
|
|
MCKD2
|
[NCBI]
|
3.34912e-05
|
|
|
GS1
|
[NCBI]
|
3.34912e-05
|
|
|
OPLL
|
[NCBI]
|
3.34912e-05
|
|
|
FANCB
|
[NCBI]
|
3.34912e-05
|
|
|
colorectal adenomatous polyposis, autosomal recessive
|
[NCBI]
|
3.34912e-05
|
|
|
congenital hemidysplasia with ichthyosiform erythroderma and limb defects
|
[NCBI]
|
3.34912e-05
|
|
|
PARK4
|
[NCBI]
|
3.34912e-05
|
|
|
glycogen storage disease ixa
|
[NCBI]
|
3.34404e-05
|
|
|
COL6A1
|
[NCBI]
|
3.34404e-05
|
|
|
SMAD4
|
[NCBI]
|
3.34404e-05
|
|
|
NRAS
|
[NCBI]
|
3.32469e-05
|
|
|
GALC
|
[NCBI]
|
3.32469e-05
|
|
|
ELA2
|
[NCBI]
|
3.32469e-05
|
|
|
AP3B1
|
[NCBI]
|
3.31333e-05
|
|
|
INVS
|
[NCBI]
|
3.31333e-05
|
|
|
CTNS
|
[NCBI]
|
3.31333e-05
|
|
|
glycogen storage disease iii
|
[NCBI]
|
3.27995e-05
|
|
|
DRD
|
[NCBI]
|
3.27995e-05
|
|
|
EKV
|
[NCBI]
|
3.27995e-05
|
|
|
CHNG2
|
[NCBI]
|
3.27995e-05
|
|
|
niemann-pick disease, type a
|
[NCBI]
|
3.27995e-05
|
|
|
SHOX
|
[NCBI]
|
3.27555e-05
|
|
|
LEMD3
|
[NCBI]
|
3.27521e-05
|
|
|
HPS4
|
[NCBI]
|
3.27521e-05
|
|
|
MCCC2
|
[NCBI]
|
3.27521e-05
|
|
|
L2HGDH
|
[NCBI]
|
3.27521e-05
|
|
|
SLC12A1
|
[NCBI]
|
3.27521e-05
|
|
|
PEX16
|
[NCBI]
|
3.27521e-05
|
|
|
HPS3
|
[NCBI]
|
3.27521e-05
|
|
|
COX15
|
[NCBI]
|
3.27521e-05
|
|
|
SLC34A3
|
[NCBI]
|
3.27521e-05
|
|
|
DND1
|
[NCBI]
|
3.27521e-05
|
|
|
USH1G
|
[NCBI]
|
3.27521e-05
|
|
|
MPDU1
|
[NCBI]
|
3.27521e-05
|
|
|
COG8
|
[NCBI]
|
3.27521e-05
|
|
|
PEX26
|
[NCBI]
|
3.27521e-05
|
|
|
TRPM6
|
[NCBI]
|
3.27521e-05
|
|
|
PNPLA6
|
[NCBI]
|
3.27142e-05
|
|
|
AMCN
|
[NCBI]
|
3.21573e-05
|
|
|
SHFLD1
|
[NCBI]
|
3.21573e-05
|
|
|
PARK3
|
[NCBI]
|
3.21573e-05
|
|
|
HPCX
|
[NCBI]
|
3.21573e-05
|
|
|
KRT5
|
[NCBI]
|
3.20584e-05
|
|
|
MTND6
|
[NCBI]
|
3.20584e-05
|
|
|
MN
|
[NCBI]
|
3.20584e-05
|
|
|
metachromatic leukodystrophy
|
[NCBI]
|
3.19577e-05
|
|
|
SPS
|
[NCBI]
|
3.18894e-05
|
|
|
NRL
|
[NCBI]
|
3.18566e-05
|
|
|
DCX
|
[NCBI]
|
3.18566e-05
|
|
|
FOXO3A
|
[NCBI]
|
3.16809e-05
|
|
|
EA2
|
[NCBI]
|
3.16232e-05
|
|
|
glucose transport defect, blood-brain barrier
|
[NCBI]
|
3.16232e-05
|
|
|
FHM2
|
[NCBI]
|
3.16232e-05
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
3.15297e-05
|
|
|
ARH
|
[NCBI]
|
3.13487e-05
|
|
|
mulibrey nanism
|
[NCBI]
|
3.13487e-05
|
|
|
argininosuccinic aciduria
|
[NCBI]
|
3.13487e-05
|
|
|
wolff-parkinson-white syndrome
|
[NCBI]
|
3.13487e-05
|
|
|
adult syndrome
|
[NCBI]
|
3.13487e-05
|
|
|
epidermolysis bullosa simplex and limb-girdle muscular dystrophy
|
[NCBI]
|
3.13487e-05
|
|
|
CMD3B
|
[NCBI]
|
3.13487e-05
|
|
|
crouzon syndrome
|
[NCBI]
|
3.13487e-05
|
|
|
FGF2
|
[NCBI]
|
3.12332e-05
|
|
|
IHH
|
[NCBI]
|
3.12106e-05
|
|
|
ERCC8
|
[NCBI]
|
3.09603e-05
|
|
|
ZIC3
|
[NCBI]
|
3.09603e-05
|
|
|
SPTLC1
|
[NCBI]
|
3.09603e-05
|
|
|
CNGB1
|
[NCBI]
|
3.09603e-05
|
|
|
FLCN
|
[NCBI]
|
3.09603e-05
|
|
|
TTPA
|
[NCBI]
|
3.09603e-05
|
|
|
HPS1
|
[NCBI]
|
3.09603e-05
|
|
|
SCN8A
|
[NCBI]
|
3.09603e-05
|
|
|
SOAT1
|
[NCBI]
|
3.09603e-05
|
|
|
NLRP3
|
[NCBI]
|
3.09603e-05
|
|
|
MERTK
|
[NCBI]
|
3.09603e-05
|
|
|
TIMELESS
|
[NCBI]
|
3.09603e-05
|
|
|
LYST
|
[NCBI]
|
3.09226e-05
|
|
|
MC3R
|
[NCBI]
|
3.09226e-05
|
|
|
COL5A1
|
[NCBI]
|
3.09226e-05
|
|
|
RCC1
|
[NCBI]
|
3.09226e-05
|
|
|
DNMT3B
|
[NCBI]
|
3.07394e-05
|
|
|
IL4
|
[NCBI]
|
3.06645e-05
|
|
|
hypertension, essential
|
[NCBI]
|
3.05665e-05
|
|
|
BMD
|
[NCBI]
|
3.05429e-05
|
|
|
CDSP
|
[NCBI]
|
3.05429e-05
|
|
|
CMAS
|
[NCBI]
|
3.04361e-05
|
|
|
TAF1L
|
[NCBI]
|
3.04361e-05
|
|
|
TTC8
|
[NCBI]
|
3.04361e-05
|
|
|
SAR1A
|
[NCBI]
|
3.04361e-05
|
|
|
CENPK
|
[NCBI]
|
3.04361e-05
|
|
|
STK11IP
|
[NCBI]
|
3.04361e-05
|
|
|
CHCHD4
|
[NCBI]
|
3.04361e-05
|
|
|
DOK7
|
[NCBI]
|
3.04361e-05
|
|
|
HLA-DMB
|
[NCBI]
|
3.04361e-05
|
|
|
BBS7
|
[NCBI]
|
3.04361e-05
|
|
|
FREM1
|
[NCBI]
|
3.04361e-05
|
|
|
ARV1
|
[NCBI]
|
3.04361e-05
|
|
|
CCDC28B
|
[NCBI]
|
3.04361e-05
|
|
|
RNASEH2C
|
[NCBI]
|
3.04361e-05
|
|
|
COG7
|
[NCBI]
|
3.04361e-05
|
|
|
MMAB
|
[NCBI]
|
3.04361e-05
|
|
|
LRRK1
|
[NCBI]
|
3.04361e-05
|
|
|
sulfatase-modifying factor 2
|
[NCBI]
|
3.04361e-05
|
|
|
RPS19BP1
|
[NCBI]
|
3.04361e-05
|
|
|
lipin 3
|
[NCBI]
|
3.04361e-05
|
|
|
NEK8
|
[NCBI]
|
3.04361e-05
|
|
|
COG4
|
[NCBI]
|
3.04361e-05
|
|
|
HHAT
|
[NCBI]
|
3.04361e-05
|
|
|
TMIE
|
[NCBI]
|
3.04361e-05
|
|
|
ichthyin
|
[NCBI]
|
3.04361e-05
|
|
|
HSD3B7
|
[NCBI]
|
3.04361e-05
|
|
|
HVCN1
|
[NCBI]
|
3.04361e-05
|
|
|
RNASEH2B
|
[NCBI]
|
3.04361e-05
|
|
|
CDC23
|
[NCBI]
|
3.04361e-05
|
|
|
CTSC
|
[NCBI]
|
3.03901e-05
|
|
|
DCT
|
[NCBI]
|
3.03901e-05
|
|
|
SMN2
|
[NCBI]
|
3.0387e-05
|
|
|
fucosidosis
|
[NCBI]
|
3.0387e-05
|
|
|
NGFR
|
[NCBI]
|
3.0141e-05
|
|
|
DKC1
|
[NCBI]
|
3.01184e-05
|
|
|
ATP2A2
|
[NCBI]
|
3.01184e-05
|
|
|
WT1
|
[NCBI]
|
3.00852e-05
|
|
|
ESD
|
[NCBI]
|
2.99881e-05
|
|
|
homocysteinemia
|
[NCBI]
|
2.9855e-05
|
|
|
graves disease
|
[NCBI]
|
2.9855e-05
|
|
|
BECN1
|
[NCBI]
|
2.98015e-05
|
|
|
COL9A3
|
[NCBI]
|
2.98015e-05
|
|
|
NNT
|
[NCBI]
|
2.98015e-05
|
|
|
TDP1
|
[NCBI]
|
2.98015e-05
|
|
|
TMC1
|
[NCBI]
|
2.98015e-05
|
|
|
NT5C3
|
[NCBI]
|
2.98015e-05
|
|
|
CNGA3
|
[NCBI]
|
2.98015e-05
|
|
|
NIPBL
|
[NCBI]
|
2.98015e-05
|
|
|
LPIN2
|
[NCBI]
|
2.98015e-05
|
|
|
SEPN1
|
[NCBI]
|
2.98015e-05
|
|
|
MOCS2
|
[NCBI]
|
2.98015e-05
|
|
|
FSCN2
|
[NCBI]
|
2.98015e-05
|
|
|
DCLRE1C
|
[NCBI]
|
2.98015e-05
|
|
|
TARDBP
|
[NCBI]
|
2.98015e-05
|
|
|
LGR8
|
[NCBI]
|
2.98015e-05
|
|
|
PRPF31
|
[NCBI]
|
2.98015e-05
|
|
|
acyl-coa dehydrogenase, medium-chain, deficiency of
|
[NCBI]
|
2.94952e-05
|
|
|
ALAD
|
[NCBI]
|
2.93744e-05
|
|
|
OFC1
|
[NCBI]
|
2.9292e-05
|
|
|
PTN
|
[NCBI]
|
2.92156e-05
|
|
|
KITLG
|
[NCBI]
|
2.91363e-05
|
|
|
CRX
|
[NCBI]
|
2.89032e-05
|
|
|
SOX2
|
[NCBI]
|
2.89032e-05
|
|
|
TAZ
|
[NCBI]
|
2.89032e-05
|
|
|
NSD1
|
[NCBI]
|
2.89032e-05
|
|
|
NR1I2
|
[NCBI]
|
2.88301e-05
|
|
|
PITX2
|
[NCBI]
|
2.87973e-05
|
|
|
CD2AP
|
[NCBI]
|
2.87973e-05
|
|
|
PRSS1
|
[NCBI]
|
2.87973e-05
|
|
|
STL1
|
[NCBI]
|
2.85442e-05
|
|
|
galactosemia
|
[NCBI]
|
2.85191e-05
|
|
|
NKX2-1
|
[NCBI]
|
2.84936e-05
|
|
|
GATA3
|
[NCBI]
|
2.84936e-05
|
|
|
PRKAG2
|
[NCBI]
|
2.8398e-05
|
|
|
CLCN7
|
[NCBI]
|
2.8398e-05
|
|
|
LGI1
|
[NCBI]
|
2.8398e-05
|
|
|
OA1
|
[NCBI]
|
2.82742e-05
|
|
|
INCENP
|
[NCBI]
|
2.82742e-05
|
|
|
AOS
|
[NCBI]
|
2.79344e-05
|
|
|
pseudohypoparathyroidism, type ib
|
[NCBI]
|
2.79117e-05
|
|
|
TTDP
|
[NCBI]
|
2.79117e-05
|
|
|
EBN1
|
[NCBI]
|
2.79117e-05
|
|
|
pancreatic carcinoma
|
[NCBI]
|
2.79117e-05
|
|
|
bethlem myopathy
|
[NCBI]
|
2.79117e-05
|
|
|
LPO
|
[NCBI]
|
2.76797e-05
|
|
|
factor vii deficiency
|
[NCBI]
|
2.74422e-05
|
|
|
TBG
|
[NCBI]
|
2.74422e-05
|
|
|
PLSJ
|
[NCBI]
|
2.73571e-05
|
|
|
iron overload in africa
|
[NCBI]
|
2.73571e-05
|
|
|
FTD3
|
[NCBI]
|
2.73571e-05
|
|
|
por deficiency
|
[NCBI]
|
2.73571e-05
|
|
|
OCA3
|
[NCBI]
|
2.73571e-05
|
|
|
macular dystrophy, vitelliform, adult-onset
|
[NCBI]
|
2.73571e-05
|
|
|
dyskeratosis congenita, autosomal dominant
|
[NCBI]
|
2.73571e-05
|
|
|
GGM
|
[NCBI]
|
2.73571e-05
|
|
|
immunoosseous dysplasia, schimke type
|
[NCBI]
|
2.73571e-05
|
|
|
SYNS1
|
[NCBI]
|
2.73571e-05
|
|
|
alpha-methylacetoacetic aciduria
|
[NCBI]
|
2.73571e-05
|
|
|
mucolipidosis iii, complementation group c
|
[NCBI]
|
2.73571e-05
|
|
|
hydrops-ectopic calcification-moth-eaten skeletal dysplasia
|
[NCBI]
|
2.73571e-05
|
|
|
BCL6
|
[NCBI]
|
2.71209e-05
|
|
|
PFKM
|
[NCBI]
|
2.70496e-05
|
|
|
UCHL1
|
[NCBI]
|
2.70496e-05
|
|
|
ACADVL
|
[NCBI]
|
2.70496e-05
|
|
|
SPG7
|
[NCBI]
|
2.70496e-05
|
|
|
WGN1
|
[NCBI]
|
2.69072e-05
|
|
|
CFEOM1
|
[NCBI]
|
2.69072e-05
|
|
|
erythrocytosis, familial, 2
|
[NCBI]
|
2.69072e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive
|
[NCBI]
|
2.69072e-05
|
|
|
sitosterolemia
|
[NCBI]
|
2.69072e-05
|
|
|
STGD3
|
[NCBI]
|
2.69072e-05
|
|
|
anemia, dyserythropoietic congenital, type i
|
[NCBI]
|
2.69072e-05
|
|
|
methionine adenosyltransferase deficiency
|
[NCBI]
|
2.69072e-05
|
|
|
BHD
|
[NCBI]
|
2.69072e-05
|
|
|
alpers diffuse degeneration of cerebral gray matter with hepatic cirrhosis
|
[NCBI]
|
2.69072e-05
|
|
|
SLC25A19
|
[NCBI]
|
2.65939e-05
|
|
|
GFM1
|
[NCBI]
|
2.65939e-05
|
|
|
TAF4
|
[NCBI]
|
2.65939e-05
|
|
|
ABCA12
|
[NCBI]
|
2.65939e-05
|
|
|
EIF5B
|
[NCBI]
|
2.65939e-05
|
|
|
MANBA
|
[NCBI]
|
2.65939e-05
|
|
|
GLRB
|
[NCBI]
|
2.65939e-05
|
|
|
RDH12
|
[NCBI]
|
2.65939e-05
|
|
|
anterior pharynx defective 1, c. elegans, homolog of, b
|
[NCBI]
|
2.65939e-05
|
|
|
LMF1
|
[NCBI]
|
2.65939e-05
|
|
|
GNPTAB
|
[NCBI]
|
2.65939e-05
|
|
|
ATP6AP2
|
[NCBI]
|
2.65939e-05
|
|
|
HIST2H2BE
|
[NCBI]
|
2.65939e-05
|
|
|
COQ2
|
[NCBI]
|
2.65939e-05
|
|
|
PHF6
|
[NCBI]
|
2.65939e-05
|
|
|
DPM1
|
[NCBI]
|
2.65939e-05
|
|
|
golgi-associated, gamma-adaptin ear-containing, arf-binding protein 2
|
[NCBI]
|
2.65939e-05
|
|
|
multiple coagulation factor deficiency protein 2
|
[NCBI]
|
2.65939e-05
|
|
|
SH3TC2
|
[NCBI]
|
2.65939e-05
|
|
|
BCAT2
|
[NCBI]
|
2.65939e-05
|
|
|
RNASE2
|
[NCBI]
|
2.65362e-05
|
|
|
obesity
|
[NCBI]
|
2.64955e-05
|
|
|
ST7
|
[NCBI]
|
2.64885e-05
|
|
|
SACS
|
[NCBI]
|
2.64885e-05
|
|
|
POR
|
[NCBI]
|
2.64885e-05
|
|
|
LAMC2
|
[NCBI]
|
2.64885e-05
|
|
|
NEDD8
|
[NCBI]
|
2.64885e-05
|
|
|
DFNA5
|
[NCBI]
|
2.64885e-05
|
|
|
LEPRE1
|
[NCBI]
|
2.64885e-05
|
|
|
CACNB4
|
[NCBI]
|
2.64885e-05
|
|
|
GART
|
[NCBI]
|
2.64885e-05
|
|
|
MAF
|
[NCBI]
|
2.64885e-05
|
|
|
HEY2
|
[NCBI]
|
2.64885e-05
|
|
|
PNKD1
|
[NCBI]
|
2.64695e-05
|
|
|
ehlers-danlos syndrome, type iv, autosomal dominant
|
[NCBI]
|
2.64695e-05
|
|
|
central core disease of muscle
|
[NCBI]
|
2.64695e-05
|
|
|
charge syndrome
|
[NCBI]
|
2.64695e-05
|
|
|
ALB
|
[NCBI]
|
2.62975e-05
|
|
|
CD40LG
|
[NCBI]
|
2.62031e-05
|
|
|
ATXN1
|
[NCBI]
|
2.62031e-05
|
|
|
GPC3
|
[NCBI]
|
2.62031e-05
|
|
|
GARS
|
[NCBI]
|
2.61232e-05
|
|
|
TPM1
|
[NCBI]
|
2.61232e-05
|
|
|
CPT1A
|
[NCBI]
|
2.61232e-05
|
|
|
KCNJ1
|
[NCBI]
|
2.61232e-05
|
|
|
MTP
|
[NCBI]
|
2.61232e-05
|
|
|
NAGA
|
[NCBI]
|
2.61232e-05
|
|
|
ACAT1
|
[NCBI]
|
2.61232e-05
|
|
|
WNK4
|
[NCBI]
|
2.61232e-05
|
|
|
FLNB
|
[NCBI]
|
2.61232e-05
|
|
|
HLCS
|
[NCBI]
|
2.61232e-05
|
|
|
FGA
|
[NCBI]
|
2.60779e-05
|
|
|
CDK5
|
[NCBI]
|
2.60543e-05
|
|
|
musical perfect pitch
|
[NCBI]
|
2.60519e-05
|
|
|
BOR1
|
[NCBI]
|
2.60519e-05
|
|
|
SPDA1
|
[NCBI]
|
2.60519e-05
|
|
|
RAG1
|
[NCBI]
|
2.60162e-05
|
|
|
CDG1A
|
[NCBI]
|
2.58584e-05
|
|
|
IGER
|
[NCBI]
|
2.58013e-05
|
|
|
klippel-trenaunay-weber syndrome
|
[NCBI]
|
2.57698e-05
|
|
|
PSAP
|
[NCBI]
|
2.5633e-05
|
|
|
CYP2D6
|
[NCBI]
|
2.5633e-05
|
|
|
SLC12A3
|
[NCBI]
|
2.55411e-05
|
|
|
LMX1B
|
[NCBI]
|
2.53407e-05
|
|
|
SPR
|
[NCBI]
|
2.53407e-05
|
|
|
SLC6A8
|
[NCBI]
|
2.53407e-05
|
|
|
ALDH3A2
|
[NCBI]
|
2.50014e-05
|
|
|
LCT
|
[NCBI]
|
2.48196e-05
|
|
|
FLNA
|
[NCBI]
|
2.47712e-05
|
|
|
SLC2A4
|
[NCBI]
|
2.47671e-05
|
|
|
EDM2
|
[NCBI]
|
2.47296e-05
|
|
|
ALSG
|
[NCBI]
|
2.47296e-05
|
|
|
vohwinkel syndrome, variant form
|
[NCBI]
|
2.47296e-05
|
|
|
RP7
|
[NCBI]
|
2.47296e-05
|
|
|
MKS3
|
[NCBI]
|
2.47296e-05
|
|
|
LVNC1
|
[NCBI]
|
2.47296e-05
|
|
|
gtp cyclohydrolase i deficiency
|
[NCBI]
|
2.47296e-05
|
|
|
cystinosis, adult nonnephropathic
|
[NCBI]
|
2.47296e-05
|
|
|
paroxysmal extreme pain disorder
|
[NCBI]
|
2.47296e-05
|
|
|
NPHP4
|
[NCBI]
|
2.47296e-05
|
|
|
dentinogenesis imperfecta, shields type iii
|
[NCBI]
|
2.47296e-05
|
|
|
LCA2
|
[NCBI]
|
2.47296e-05
|
|
|
macrocephaly/autism syndrome
|
[NCBI]
|
2.47296e-05
|
|
|
RCDP3
|
[NCBI]
|
2.47296e-05
|
|
|
ED3
|
[NCBI]
|
2.47296e-05
|
|
|
premature chromosome condensation with microcephaly and mental retardation
|
[NCBI]
|
2.47296e-05
|
|
|
PC2
|
[NCBI]
|
2.47296e-05
|
|
|
NEM1
|
[NCBI]
|
2.47296e-05
|
|
|
OUBR
|
[NCBI]
|
2.47296e-05
|
|
|
LISX2
|
[NCBI]
|
2.47296e-05
|
|
|
pyogenic sterile arthritis, pyoderma gangrenosum, and acne
|
[NCBI]
|
2.47296e-05
|
|
|
thyroid hormonogenesis, genetic defect in, 1
|
[NCBI]
|
2.47296e-05
|
|
|
desmosterolosis
|
[NCBI]
|
2.47296e-05
|
|
|
mental retardation, x-linked, with cerebellar hypoplasia and distinctive facial appearance
|
[NCBI]
|
2.47296e-05
|
|
|
porencephaly, familial
|
[NCBI]
|
2.47296e-05
|
|
|
DFNA13
|
[NCBI]
|
2.47296e-05
|
|
|
EDM3
|
[NCBI]
|
2.47296e-05
|
|
|
CMD1D
|
[NCBI]
|
2.47296e-05
|
|
|
DFNB6
|
[NCBI]
|
2.47296e-05
|
|
|
melorheostosis
|
[NCBI]
|
2.47296e-05
|
|
|
osteogenesis imperfecta, type viii
|
[NCBI]
|
2.47296e-05
|
|
|
TNFSF11
|
[NCBI]
|
2.46473e-05
|
|
|
HNF4A
|
[NCBI]
|
2.45874e-05
|
|
|
TNC
|
[NCBI]
|
2.44401e-05
|
|
|
OKS
|
[NCBI]
|
2.41893e-05
|
|
|
NPM1
|
[NCBI]
|
2.40976e-05
|
|
|
PCSK9
|
[NCBI]
|
2.40855e-05
|
|
|
SLC5A1
|
[NCBI]
|
2.40855e-05
|
|
|
EPM2A
|
[NCBI]
|
2.40855e-05
|
|
|
TNNI3
|
[NCBI]
|
2.40855e-05
|
|
|
DCTN1
|
[NCBI]
|
2.40855e-05
|
|
|
DNAH11
|
[NCBI]
|
2.40855e-05
|
|
|
SST
|
[NCBI]
|
2.4063e-05
|
|
|
MB
|
[NCBI]
|
2.39032e-05
|
|
|
MTND5
|
[NCBI]
|
2.38574e-05
|
|
|
CACNA1S
|
[NCBI]
|
2.37596e-05
|
|
|
RAG2
|
[NCBI]
|
2.37596e-05
|
|
|
WNK1
|
[NCBI]
|
2.37596e-05
|
|
|
PHB
|
[NCBI]
|
2.37596e-05
|
|
|
tay-sachs disease, ab variant
|
[NCBI]
|
2.37596e-05
|
|
|
GALK1
|
[NCBI]
|
2.37596e-05
|
|
|
LITAF
|
[NCBI]
|
2.37111e-05
|
|
|
KRT2A
|
[NCBI]
|
2.37111e-05
|
|
|
SYCP3
|
[NCBI]
|
2.37111e-05
|
|
|
PABPN1
|
[NCBI]
|
2.37111e-05
|
|
|
TACSTD2
|
[NCBI]
|
2.37111e-05
|
|
|
FBXW7
|
[NCBI]
|
2.37111e-05
|
|
|
ERN1
|
[NCBI]
|
2.37111e-05
|
|
|
FZD4
|
[NCBI]
|
2.37111e-05
|
|
|
CLDN16
|
[NCBI]
|
2.37111e-05
|
|
|
PEX12
|
[NCBI]
|
2.37111e-05
|
|
|
TRPS1
|
[NCBI]
|
2.37111e-05
|
|
|
LEFTY2
|
[NCBI]
|
2.37111e-05
|
|
|
MYOCD
|
[NCBI]
|
2.37111e-05
|
|
|
ZIC2
|
[NCBI]
|
2.37111e-05
|
|
|
SMA2
|
[NCBI]
|
2.36971e-05
|
|
|
pheochromocytoma
|
[NCBI]
|
2.36971e-05
|
|
|
aHUS
|
[NCBI]
|
2.36537e-05
|
|
|
pygmy
|
[NCBI]
|
2.35969e-05
|
|
|
dandy-walker-like malformation with atrioventricular septal defect
|
[NCBI]
|
2.35969e-05
|
|
|
storage pool platelet disease
|
[NCBI]
|
2.35969e-05
|
|
|
epilepsy, myoclonic, benign adult familial, type 1
|
[NCBI]
|
2.35969e-05
|
|
|
OTSC1
|
[NCBI]
|
2.35969e-05
|
|
|
PDCD8
|
[NCBI]
|
2.34962e-05
|
|
|
gastric cancer
|
[NCBI]
|
2.34906e-05
|
|
|
methemoglobinemia due to deficiency of methemoglobin reductase
|
[NCBI]
|
2.33818e-05
|
|
|
hypophosphatasia, adult type
|
[NCBI]
|
2.30404e-05
|
|
|
ADLTE
|
[NCBI]
|
2.30404e-05
|
|
|
potocki-shaffer syndrome
|
[NCBI]
|
2.30404e-05
|
|
|
complement factor h deficiency
|
[NCBI]
|
2.30404e-05
|
|
|
BHC
|
[NCBI]
|
2.30404e-05
|
|
|
JH
|
[NCBI]
|
2.30404e-05
|
|
|
ichthyosis congenita, harlequin fetus type
|
[NCBI]
|
2.30404e-05
|
|
|
DES
|
[NCBI]
|
2.29668e-05
|
|
|
HM13
|
[NCBI]
|
2.29271e-05
|
|
|
EYA1
|
[NCBI]
|
2.29271e-05
|
|
|
PG
|
[NCBI]
|
2.27815e-05
|
|
|
STC1
|
[NCBI]
|
2.27662e-05
|
|
|
LPI
|
[NCBI]
|
2.26615e-05
|
|
|
EPOR
|
[NCBI]
|
2.25816e-05
|
|
|
CPB2
|
[NCBI]
|
2.24112e-05
|
|
|
HRG
|
[NCBI]
|
2.2358e-05
|
|
|
EIF2B4
|
[NCBI]
|
2.23507e-05
|
|
|
VSX1
|
[NCBI]
|
2.23507e-05
|
|
|
MESP2
|
[NCBI]
|
2.23507e-05
|
|
|
GGA3
|
[NCBI]
|
2.23507e-05
|
|
|
RDX
|
[NCBI]
|
2.23507e-05
|
|
|
TRIM37
|
[NCBI]
|
2.23507e-05
|
|
|
CDAN1
|
[NCBI]
|
2.23507e-05
|
|
|
TMEM142A
|
[NCBI]
|
2.23507e-05
|
|
|
SBF2
|
[NCBI]
|
2.23507e-05
|
|
|
FTSJ1
|
[NCBI]
|
2.23507e-05
|
|
|
anterior pharynx defective 1, c. elegans, homolog of, a
|
[NCBI]
|
2.23507e-05
|
|
|
PMS1
|
[NCBI]
|
2.23507e-05
|
|
|
MYL2
|
[NCBI]
|
2.23507e-05
|
|
|
ATP6V1B1
|
[NCBI]
|
2.23507e-05
|
|
|
AUH
|
[NCBI]
|
2.23507e-05
|
|
|
MTTF
|
[NCBI]
|
2.23507e-05
|
|
|
BLOC1S1
|
[NCBI]
|
2.23507e-05
|
|
|
ALG6
|
[NCBI]
|
2.23507e-05
|
|
|
MPV17
|
[NCBI]
|
2.23507e-05
|
|
|
HSD17B3
|
[NCBI]
|
2.23507e-05
|
|
|
MTMR1
|
[NCBI]
|
2.23507e-05
|
|
|
TBX19
|
[NCBI]
|
2.23507e-05
|
|
|
FANCM
|
[NCBI]
|
2.23507e-05
|
|
|
COX10
|
[NCBI]
|
2.23507e-05
|
|
|
CASP12
|
[NCBI]
|
2.23507e-05
|
|
|
NETH
|
[NCBI]
|
2.23471e-05
|
|
|
XPG
|
[NCBI]
|
2.23471e-05
|
|
|
sialuria
|
[NCBI]
|
2.23471e-05
|
|
|
BRIC1
|
[NCBI]
|
2.23471e-05
|
|
|
hypoparathyroidism, sensorineural deafness, and renal disease
|
[NCBI]
|
2.23471e-05
|
|
|
glycogen storage disease ic
|
[NCBI]
|
2.23471e-05
|
|
|
SCN3
|
[NCBI]
|
2.23471e-05
|
|
|
gm1-gangliosidosis, type ii
|
[NCBI]
|
2.23471e-05
|
|
|
spondyloepimetaphyseal dysplasia, strudwick type
|
[NCBI]
|
2.23471e-05
|
|
|
gaucher disease, perinatal lethal
|
[NCBI]
|
2.23471e-05
|
|
|
ankyloblepharon-ectodermal defects-cleft lip/palate
|
[NCBI]
|
2.23471e-05
|
|
|
DFNA2
|
[NCBI]
|
2.23471e-05
|
|
|
trifunctional protein deficiency
|
[NCBI]
|
2.23471e-05
|
|
|
argininemia
|
[NCBI]
|
2.23471e-05
|
|
|
PKD3
|
[NCBI]
|
2.23471e-05
|
|
|
MCPH5
|
[NCBI]
|
2.23471e-05
|
|
|
FMD
|
[NCBI]
|
2.23471e-05
|
|
|
LBR
|
[NCBI]
|
2.23441e-05
|
|
|
CUBN
|
[NCBI]
|
2.2292e-05
|
|
|
DSP
|
[NCBI]
|
2.2292e-05
|
|
|
DICER1
|
[NCBI]
|
2.2292e-05
|
|
|
UBE1
|
[NCBI]
|
2.22468e-05
|
|
|
POMT1
|
[NCBI]
|
2.22468e-05
|
|
|
LIG4
|
[NCBI]
|
2.22468e-05
|
|
|
GPHN
|
[NCBI]
|
2.22468e-05
|
|
|
ABCB1
|
[NCBI]
|
2.21561e-05
|
|
|
EIG
|
[NCBI]
|
2.21501e-05
|
|
|
SPINK1
|
[NCBI]
|
2.20915e-05
|
|
|
SIRT1
|
[NCBI]
|
2.20306e-05
|
|
|
EKD1
|
[NCBI]
|
2.20079e-05
|
|
|
PRKDC
|
[NCBI]
|
2.17276e-05
|
|
|
PEPD
|
[NCBI]
|
2.17276e-05
|
|
|
NTRK1
|
[NCBI]
|
2.16853e-05
|
|
|
growth hormone insensitivity syndrome
|
[NCBI]
|
2.15897e-05
|
|
|
NHS
|
[NCBI]
|
2.1578e-05
|
|
|
FCMD
|
[NCBI]
|
2.15423e-05
|
|
|
ZMPSTE24
|
[NCBI]
|
2.13339e-05
|
|
|
STXBP1
|
[NCBI]
|
2.13339e-05
|
|
|
RPA1
|
[NCBI]
|
2.13339e-05
|
|
|
POMGNT1
|
[NCBI]
|
2.13339e-05
|
|
|
NEUROD1
|
[NCBI]
|
2.13339e-05
|
|
|
NAGS
|
[NCBI]
|
2.13339e-05
|
|
|
MTTI
|
[NCBI]
|
2.13339e-05
|
|
|
VIM
|
[NCBI]
|
2.13067e-05
|
|
|
SDC2
|
[NCBI]
|
2.12482e-05
|
|
|
HBFQTL1
|
[NCBI]
|
2.11563e-05
|
|
|
UGB
|
[NCBI]
|
2.11387e-05
|
|
|
NOTCH1
|
[NCBI]
|
2.09616e-05
|
|
|
ARNTL
|
[NCBI]
|
2.0926e-05
|
|
|
CYP27B1
|
[NCBI]
|
2.0926e-05
|
|
|
RP2
|
[NCBI]
|
2.08804e-05
|
|
|
ARF1
|
[NCBI]
|
2.08804e-05
|
|
|
PON1
|
[NCBI]
|
2.08753e-05
|
|
|
ARSB
|
[NCBI]
|
2.05975e-05
|
|
|
KRT14
|
[NCBI]
|
2.05975e-05
|
|
|
JARID2
|
[NCBI]
|
2.05777e-05
|
|
|
ELAC2
|
[NCBI]
|
2.05777e-05
|
|
|
PCSK1
|
[NCBI]
|
2.05777e-05
|
|
|
IRF6
|
[NCBI]
|
2.05777e-05
|
|
|
RAN
|
[NCBI]
|
2.05777e-05
|
|
|
BMPR1A
|
[NCBI]
|
2.05777e-05
|
|
|
LHX3
|
[NCBI]
|
2.05777e-05
|
|
|
LAMA2
|
[NCBI]
|
2.05777e-05
|
|
|
APAF1
|
[NCBI]
|
2.05777e-05
|
|
|
NPHS1
|
[NCBI]
|
2.05777e-05
|
|
|
BEST1
|
[NCBI]
|
2.05777e-05
|
|
|
FDH
|
[NCBI]
|
2.05521e-05
|
|
|
DCK
|
[NCBI]
|
2.05048e-05
|
|
|
LWD
|
[NCBI]
|
2.03045e-05
|
|
|
UCP1
|
[NCBI]
|
2.02414e-05
|
|
|
sickle cell anemia
|
[NCBI]
|
2.01899e-05
|
|
|
PTGS2
|
[NCBI]
|
1.98493e-05
|
|
|
PAEP
|
[NCBI]
|
1.98493e-05
|
|
|
CMDD
|
[NCBI]
|
1.96607e-05
|
|
|
PFIC1
|
[NCBI]
|
1.96607e-05
|
|
|
lecithin:cholesterol acyltransferase deficiency
|
[NCBI]
|
1.96607e-05
|
|
|
GSD
|
[NCBI]
|
1.96607e-05
|
|
|
SDHD
|
[NCBI]
|
1.96513e-05
|
|
|
TCOF1
|
[NCBI]
|
1.96513e-05
|
|
|
NR3C2
|
[NCBI]
|
1.96513e-05
|
|
|
MAP4K1
|
[NCBI]
|
1.96513e-05
|
|
|
MYH14
|
[NCBI]
|
1.95552e-05
|
|
|
ectodysplasin receptor, x-linked
|
[NCBI]
|
1.95552e-05
|
|
|
NHP2L1
|
[NCBI]
|
1.95552e-05
|
|
|
OSTN
|
[NCBI]
|
1.95552e-05
|
|
|
ARID5A
|
[NCBI]
|
1.95552e-05
|
|
|
FANCI
|
[NCBI]
|
1.95552e-05
|
|
|
CC2D1A
|
[NCBI]
|
1.95552e-05
|
|
|
DNAI1
|
[NCBI]
|
1.95552e-05
|
|
|
MYO1D
|
[NCBI]
|
1.95552e-05
|
|
|
acidic cluster protein, 33-kd
|
[NCBI]
|
1.95552e-05
|
|
|
PEX10
|
[NCBI]
|
1.95552e-05
|
|
|
ZDHHC17
|
[NCBI]
|
1.95552e-05
|
|
|
vesicle amine transport protein 1
|
[NCBI]
|
1.95552e-05
|
|
|
OLFM3
|
[NCBI]
|
1.95552e-05
|
|
|
MRAP
|
[NCBI]
|
1.95552e-05
|
|
|
RRM2B
|
[NCBI]
|
1.95552e-05
|
|
|
STXBP4
|
[NCBI]
|
1.95552e-05
|
|
|
ZFYVE20
|
[NCBI]
|
1.95552e-05
|
|
|
PAICS
|
[NCBI]
|
1.95552e-05
|
|
|
POMT2
|
[NCBI]
|
1.95552e-05
|
|
|
RBCK1
|
[NCBI]
|
1.95552e-05
|
|
|
SH3BP2
|
[NCBI]
|
1.95552e-05
|
|
|
EPHA7
|
[NCBI]
|
1.95552e-05
|
|
|
SAR1B
|
[NCBI]
|
1.95552e-05
|
|
|
ARHGEF10
|
[NCBI]
|
1.95552e-05
|
|
|
ARHGEF4
|
[NCBI]
|
1.95552e-05
|
|
|
NCAPH
|
[NCBI]
|
1.95552e-05
|
|
|
MTTA
|
[NCBI]
|
1.95552e-05
|
|
|
ETHE1
|
[NCBI]
|
1.95552e-05
|
|
|
locus control region, alpha
|
[NCBI]
|
1.95552e-05
|
|
|
COG6
|
[NCBI]
|
1.95552e-05
|
|
|
PIGK
|
[NCBI]
|
1.95552e-05
|
|
|
SUCLA2
|
[NCBI]
|
1.95552e-05
|
|
|
ATP6V0A4
|
[NCBI]
|
1.95552e-05
|
|
|
DBNL
|
[NCBI]
|
1.95552e-05
|
|
|
CKS2
|
[NCBI]
|
1.95552e-05
|
|
|
TMEM67
|
[NCBI]
|
1.95552e-05
|
|
|
PPEF1
|
[NCBI]
|
1.95552e-05
|
|
|
EXOSC2
|
[NCBI]
|
1.95552e-05
|
|
|
KY
|
[NCBI]
|
1.95552e-05
|
|
|
NUP62
|
[NCBI]
|
1.95552e-05
|
|
|
FOXH1
|
[NCBI]
|
1.95552e-05
|
|
|
MGRN1
|
[NCBI]
|
1.95552e-05
|
|
|
MTTS2
|
[NCBI]
|
1.95552e-05
|
|
|
LRRC8
|
[NCBI]
|
1.95552e-05
|
|
|
COX17
|
[NCBI]
|
1.95552e-05
|
|
|
C1GALT1
|
[NCBI]
|
1.95552e-05
|
|
|
IL3
|
[NCBI]
|
1.95264e-05
|
|
|
XPC
|
[NCBI]
|
1.95258e-05
|
|
|
CDH1
|
[NCBI]
|
1.94406e-05
|
|
|
KRT17
|
[NCBI]
|
1.9268e-05
|
|
|
TIMM8A
|
[NCBI]
|
1.9268e-05
|
|
|
CXORF5
|
[NCBI]
|
1.9268e-05
|
|
|
EIF2AK3
|
[NCBI]
|
1.9268e-05
|
|
|
DGUOK
|
[NCBI]
|
1.9268e-05
|
|
|
AL-A1
|
[NCBI]
|
1.9268e-05
|
|
|
MYO15A
|
[NCBI]
|
1.9268e-05
|
|
|
RFX5
|
[NCBI]
|
1.9268e-05
|
|
|
ASPM
|
[NCBI]
|
1.9268e-05
|
|
|
DNM2
|
[NCBI]
|
1.9268e-05
|
|
|
SMARCA4
|
[NCBI]
|
1.9268e-05
|
|
|
ZNF9
|
[NCBI]
|
1.9268e-05
|
|
|
C10ORF2
|
[NCBI]
|
1.9268e-05
|
|
|
TTID
|
[NCBI]
|
1.9133e-05
|
|
|
NSDHL
|
[NCBI]
|
1.9133e-05
|
|
|
PTPN12
|
[NCBI]
|
1.9133e-05
|
|
|
KCNQ3
|
[NCBI]
|
1.9133e-05
|
|
|
FGD4
|
[NCBI]
|
1.9133e-05
|
|
|
ROBO2
|
[NCBI]
|
1.9133e-05
|
|
|
PHKG2
|
[NCBI]
|
1.9133e-05
|
|
|
myofibrillogenesis regulator 1
|
[NCBI]
|
1.9133e-05
|
|
|
UNC5C
|
[NCBI]
|
1.9133e-05
|
|
|
NPHP4
|
[NCBI]
|
1.9133e-05
|
|
|
RABGGTA
|
[NCBI]
|
1.9133e-05
|
|
|
CLSPN
|
[NCBI]
|
1.9133e-05
|
|
|
NHS
|
[NCBI]
|
1.9133e-05
|
|
|
HRPT2
|
[NCBI]
|
1.9133e-05
|
|
|
SLURP1
|
[NCBI]
|
1.9133e-05
|
|
|
CNGA1
|
[NCBI]
|
1.9133e-05
|
|
|
ARFIP2
|
[NCBI]
|
1.9133e-05
|
|
|
WHRN
|
[NCBI]
|
1.9133e-05
|
|
|
ATXN7
|
[NCBI]
|
1.90548e-05
|
|
|
APOBEC3G
|
[NCBI]
|
1.90548e-05
|
|
|
SLC16A2
|
[NCBI]
|
1.90548e-05
|
|
|
SLC45A2
|
[NCBI]
|
1.90548e-05
|
|
|
PAK2
|
[NCBI]
|
1.90548e-05
|
|
|
STX1A
|
[NCBI]
|
1.90548e-05
|
|
|
UCN
|
[NCBI]
|
1.89867e-05
|
|
|
ACADS
|
[NCBI]
|
1.88808e-05
|
|
|
cardiofaciocutaneous syndrome
|
[NCBI]
|
1.88771e-05
|
|
|
CNC1
|
[NCBI]
|
1.88771e-05
|
|
|
myoclonic epilepsy of lafora
|
[NCBI]
|
1.88276e-05
|
|
|
LIP
|
[NCBI]
|
1.87824e-05
|
|
|
CMM2
|
[NCBI]
|
1.87824e-05
|
|
|
PENK
|
[NCBI]
|
1.87264e-05
|
|
|
DPYD
|
[NCBI]
|
1.85101e-05
|
|
|
SLC25A20
|
[NCBI]
|
1.84595e-05
|
|
|
OSBP
|
[NCBI]
|
1.84595e-05
|
|
|
IL10
|
[NCBI]
|
1.83281e-05
|
|
|
PAM
|
[NCBI]
|
1.83257e-05
|
|
|
DFNA4
|
[NCBI]
|
1.8237e-05
|
|
|
DFNA1
|
[NCBI]
|
1.8237e-05
|
|
|
PLSDT
|
[NCBI]
|
1.8237e-05
|
|
|
hyalinosis, infantile systemic
|
[NCBI]
|
1.8237e-05
|
|
|
CMD1E
|
[NCBI]
|
1.8237e-05
|
|
|
leukodystrophy, adult-onset, autosomal dominant
|
[NCBI]
|
1.8237e-05
|
|
|
minicore myopathy with external ophthalmoplegia
|
[NCBI]
|
1.8237e-05
|
|
|
DFNA5
|
[NCBI]
|
1.8237e-05
|
|
|
buschke-ollendorff syndrome
|
[NCBI]
|
1.8237e-05
|
|
|
peroxidase and phospholipid deficiency in eosinophils
|
[NCBI]
|
1.8237e-05
|
|
|
paget disease, juvenile
|
[NCBI]
|
1.8237e-05
|
|
|
HDL1
|
[NCBI]
|
1.8237e-05
|
|
|
osseous heteroplasia, progressive
|
[NCBI]
|
1.8237e-05
|
|
|
noonan-like/multiple giant cell lesion syndrome
|
[NCBI]
|
1.8237e-05
|
|
|
CCM2
|
[NCBI]
|
1.8237e-05
|
|
|
ATCAY
|
[NCBI]
|
1.8237e-05
|
|
|
frasier syndrome
|
[NCBI]
|
1.8237e-05
|
|
|
amyloidosis vii
|
[NCBI]
|
1.8237e-05
|
|
|
CNA2
|
[NCBI]
|
1.8237e-05
|
|
|
naxos disease
|
[NCBI]
|
1.8237e-05
|
|
|
ectodermal dysplasia/skin fragility syndrome
|
[NCBI]
|
1.8237e-05
|
|
|
BDA2
|
[NCBI]
|
1.8237e-05
|
|
|
fumarase deficiency
|
[NCBI]
|
1.8237e-05
|
|
|
RP17
|
[NCBI]
|
1.8237e-05
|
|
|
myotonia, potassium-aggravated
|
[NCBI]
|
1.8237e-05
|
|
|
galactokinase deficiency
|
[NCBI]
|
1.82023e-05
|
|
|
platelet glycoprotein iv deficiency
|
[NCBI]
|
1.82023e-05
|
|
|
ehlers-danlos syndrome, type ii
|
[NCBI]
|
1.82023e-05
|
|
|
DGI1
|
[NCBI]
|
1.82023e-05
|
|
|
BDC
|
[NCBI]
|
1.82023e-05
|
|
|
BOS1
|
[NCBI]
|
1.82023e-05
|
|
|
WS3
|
[NCBI]
|
1.82023e-05
|
|
|
BDB1
|
[NCBI]
|
1.82023e-05
|
|
|
scheie syndrome
|
[NCBI]
|
1.82023e-05
|
|
|
coloboma, ocular
|
[NCBI]
|
1.82023e-05
|
|
|
marshall syndrome
|
[NCBI]
|
1.82023e-05
|
|
|
malaria, susceptibility to
|
[NCBI]
|
1.81285e-05
|
|
|
CPE
|
[NCBI]
|
1.80588e-05
|
|
|
RS1
|
[NCBI]
|
1.80139e-05
|
|
|
ITGB2
|
[NCBI]
|
1.79224e-05
|
|
|
SLC18A3
|
[NCBI]
|
1.77313e-05
|
|
|
GHR
|
[NCBI]
|
1.77047e-05
|
|
|
ITGB4
|
[NCBI]
|
1.76592e-05
|
|
|
FOXC1
|
[NCBI]
|
1.76592e-05
|
|
|
GJA3
|
[NCBI]
|
1.76592e-05
|
|
|
SLC40A1
|
[NCBI]
|
1.75464e-05
|
|
|
CCL2
|
[NCBI]
|
1.75348e-05
|
|
|
WWOX
|
[NCBI]
|
1.74514e-05
|
|
|
USP7
|
[NCBI]
|
1.74514e-05
|
|
|
OTX2
|
[NCBI]
|
1.74514e-05
|
|
|
COL6A3
|
[NCBI]
|
1.74514e-05
|
|
|
PAK3
|
[NCBI]
|
1.74514e-05
|
|
|
PTPN6
|
[NCBI]
|
1.74514e-05
|
|
|
ZFY
|
[NCBI]
|
1.74514e-05
|
|
|
PLAUR
|
[NCBI]
|
1.73437e-05
|
|
|
LRP5
|
[NCBI]
|
1.73428e-05
|
|
|
campomelic dysplasia
|
[NCBI]
|
1.71997e-05
|
|
|
sandhoff disease
|
[NCBI]
|
1.71997e-05
|
|
|
CADASIL
|
[NCBI]
|
1.71997e-05
|
|
|
GAMT
|
[NCBI]
|
1.71842e-05
|
|
|
PPT1
|
[NCBI]
|
1.71842e-05
|
|
|
TNFRSF6
|
[NCBI]
|
1.71223e-05
|
|
|
TS
|
[NCBI]
|
1.70949e-05
|
|
|
filaminopathy, autosomal dominant
|
[NCBI]
|
1.69972e-05
|
|
|
eem syndrome
|
[NCBI]
|
1.69972e-05
|
|
|
hypomagnesemia, renal, with ocular involvement
|
[NCBI]
|
1.69972e-05
|
|
|
fibromuscular dysplasia of arteries
|
[NCBI]
|
1.69972e-05
|
|
|
tetra-amelia, autosomal recessive
|
[NCBI]
|
1.69972e-05
|
|
|
CDD
|
[NCBI]
|
1.69972e-05
|
|
|
hypoproteinemia, hypercatabolic
|
[NCBI]
|
1.69972e-05
|
|
|
internal carotid artery, spontaneous dissection of
|
[NCBI]
|
1.69972e-05
|
|
|
3-@hydroxy-3-methylglutaryl-coa synthase 2, mitochondrial, deficiency of
|
[NCBI]
|
1.69972e-05
|
|
|
wiskott-aldrich syndrome
|
[NCBI]
|
1.69972e-05
|
|
|
ASD2
|
[NCBI]
|
1.69972e-05
|
|
|
aortic aneurysm, familial thoracic 3
|
[NCBI]
|
1.69972e-05
|
|
|
VUR2
|
[NCBI]
|
1.69972e-05
|
|
|
erythrocytosis, familial, 3
|
[NCBI]
|
1.69972e-05
|
|
|
abcd syndrome
|
[NCBI]
|
1.69972e-05
|
|
|
cardiomyopathy-hypogonadism-collagenoma syndrome
|
[NCBI]
|
1.69972e-05
|
|
|
t-cell immunodeficiency, congenital alopecia, and nail dystrophy
|
[NCBI]
|
1.69972e-05
|
|
|
LIS3
|
[NCBI]
|
1.69972e-05
|
|
|
LCCS2
|
[NCBI]
|
1.69972e-05
|
|
|
hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration
|
[NCBI]
|
1.69972e-05
|
|
|
aicar transformylase/imp cyclohydrolase, deficiency of
|
[NCBI]
|
1.69972e-05
|
|
|
optic atrophy 3, autosomal dominant
|
[NCBI]
|
1.69972e-05
|
|
|
cholesteatoma, congenital
|
[NCBI]
|
1.69972e-05
|
|
|
amelogenesis imperfecta, pigmented hypomaturation type
|
[NCBI]
|
1.69972e-05
|
|
|
CDL3A
|
[NCBI]
|
1.69972e-05
|
|
|
cataract, autosomal dominant
|
[NCBI]
|
1.69972e-05
|
|
|
lymphedema and ptosis
|
[NCBI]
|
1.69972e-05
|
|
|
myopathy, spheroid body
|
[NCBI]
|
1.69972e-05
|
|
|
AGS4
|
[NCBI]
|
1.69972e-05
|
|
|
RP31
|
[NCBI]
|
1.69972e-05
|
|
|
ectrodactyly and ectodermal dysplasia without cleft lip/palate
|
[NCBI]
|
1.69972e-05
|
|
|
nevus, keratinocytic, nonepidermolytic
|
[NCBI]
|
1.69972e-05
|
|
|
MRXS14
|
[NCBI]
|
1.69972e-05
|
|
|
colchicine resistance
|
[NCBI]
|
1.69972e-05
|
|
|
ehlers-danlos syndrome, autosomal recessive, cardiac valvular form
|
[NCBI]
|
1.69972e-05
|
|
|
CLSD
|
[NCBI]
|
1.69972e-05
|
|
|
capillary malformation-arteriovenous malformation
|
[NCBI]
|
1.69972e-05
|
|
|
CMH10
|
[NCBI]
|
1.69972e-05
|
|
|
DFNA23
|
[NCBI]
|
1.69972e-05
|
|
|
autism, x-linked, susceptibility to, 3
|
[NCBI]
|
1.69972e-05
|
|
|
protein-tyrosine kinase 2 deficiency
|
[NCBI]
|
1.69972e-05
|
|
|
MRX45
|
[NCBI]
|
1.69972e-05
|
|
|
hypomyelination and congenital cataract
|
[NCBI]
|
1.69972e-05
|
|
|
mental retardation, x-linked, with brachydactyly and macroglossia
|
[NCBI]
|
1.69972e-05
|
|
|
SPG31
|
[NCBI]
|
1.69972e-05
|
|
|
ALGS2
|
[NCBI]
|
1.69972e-05
|
|
|
CC
|
[NCBI]
|
1.69972e-05
|
|
|
MRX93
|
[NCBI]
|
1.69972e-05
|
|
|
MCPH3
|
[NCBI]
|
1.69972e-05
|
|
|
camptodactyly, myopia, and fibrosis of the medial rectus muscle of eye
|
[NCBI]
|
1.69972e-05
|
|
|
xeroderma pigmentosum, autosomal dominant, mild
|
[NCBI]
|
1.69972e-05
|
|
|
creases, infra-auricular cutaneous, with tall stature and advanced bone age
|
[NCBI]
|
1.69972e-05
|
|
|
epidermolysis bullosa simplex with migratory circinate erythema
|
[NCBI]
|
1.69972e-05
|
|
|
AGS2
|
[NCBI]
|
1.69972e-05
|
|
|
hypertrichosis, anterior cervical
|
[NCBI]
|
1.69972e-05
|
|
|
cholesteryl ester transfer protein deficiency
|
[NCBI]
|
1.69972e-05
|
|
|
PPCD3
|
[NCBI]
|
1.69972e-05
|
|
|
NFTC
|
[NCBI]
|
1.69972e-05
|
|
|
pyridoxamine 5-prime-phosphate oxidase deficiency
|
[NCBI]
|
1.69972e-05
|
|
|
atrial standstill
|
[NCBI]
|
1.69972e-05
|
|
|
chromosome 9q subtelomeric deletion syndrome
|
[NCBI]
|
1.69972e-05
|
|
|
adie pupil
|
[NCBI]
|
1.69972e-05
|
|
|
mast syndrome
|
[NCBI]
|
1.69972e-05
|
|
|
JBTS4
|
[NCBI]
|
1.69972e-05
|
|
|
pilomatrixoma
|
[NCBI]
|
1.69972e-05
|
|
|
hypoplastic left heart syndrome
|
[NCBI]
|
1.69972e-05
|
|
|
hypophosphatasia, childhood
|
[NCBI]
|
1.69972e-05
|
|
|
cataract, lamellar 2
|
[NCBI]
|
1.69972e-05
|
|
|
SCAN1
|
[NCBI]
|
1.69972e-05
|
|
|
CDG2H
|
[NCBI]
|
1.69972e-05
|
|
|
methylmalonyl-coa epimerase deficiency
|
[NCBI]
|
1.69972e-05
|
|
|
corpus callosum, agenesis of, with abnormal genitalia
|
[NCBI]
|
1.69972e-05
|
|
|
rapadilino syndrome
|
[NCBI]
|
1.69972e-05
|
|
|
SQT2
|
[NCBI]
|
1.69972e-05
|
|
|
epilepsy, myoclonic, x-linked, with mental retardation and spasticity
|
[NCBI]
|
1.69972e-05
|
|
|
diabetes mellitus, transient neonatal, 3
|
[NCBI]
|
1.69972e-05
|
|
|
heterotopia, periventricular, autosomal recessive
|
[NCBI]
|
1.69972e-05
|
|
|
hirsutism--skeletal dysplasia--mental retardation syndrome
|
[NCBI]
|
1.69972e-05
|
|
|
ear pits, posterior helical
|
[NCBI]
|
1.69972e-05
|
|
|
brain small vessel disease with hemorrhage
|
[NCBI]
|
1.69972e-05
|
|
|
cholestasis, benign recurrent intrahepatic 2
|
[NCBI]
|
1.69972e-05
|
|
|
cataract, nonnuclear polymorphic congenital, autosomal dominant
|
[NCBI]
|
1.69972e-05
|
|
|
albinism, ocular, with sensorineural deafness
|
[NCBI]
|
1.69972e-05
|
|
|
SHEP4
|
[NCBI]
|
1.69972e-05
|
|
|
factor viii deficiency
|
[NCBI]
|
1.69972e-05
|
|
|
spondyloepimetaphyseal dysplasia, type ii
|
[NCBI]
|
1.69972e-05
|
|
|
CMT2K
|
[NCBI]
|
1.69972e-05
|
|
|
mental retardation, x-linked, with short stature, small testes, muscle wasting, and tremor
|
[NCBI]
|
1.69972e-05
|
|
|
SIDDT
|
[NCBI]
|
1.69972e-05
|
|
|
syndactyly, type v
|
[NCBI]
|
1.69972e-05
|
|
|
spondyloepimetaphyseal dysplasia, x-linked
|
[NCBI]
|
1.69972e-05
|
|
|
atpaf2 deficiency
|
[NCBI]
|
1.69972e-05
|
|
|
bruck syndrome 2
|
[NCBI]
|
1.69972e-05
|
|
|
waardenburg syndrome, type iid
|
[NCBI]
|
1.69972e-05
|
|
|
NFRCD
|
[NCBI]
|
1.69972e-05
|
|
|
MCOP3
|
[NCBI]
|
1.69972e-05
|
|
|
HMPS2
|
[NCBI]
|
1.69972e-05
|
|
|
bronchiectasis
|
[NCBI]
|
1.69972e-05
|
|
|
SQT3
|
[NCBI]
|
1.69972e-05
|
|
|
tetramelic monodactyly
|
[NCBI]
|
1.69972e-05
|
|
|
SPG5B
|
[NCBI]
|
1.69972e-05
|
|
|
3-@methylglutaconic aciduria, type iv
|
[NCBI]
|
1.69972e-05
|
|
|
craniofacial dysmorphism with ocular coloboma, absent corpus callosum, and aortic dilatation
|
[NCBI]
|
1.69972e-05
|
|
|
stocco dos santos x-linked mental retardation syndrome
|
[NCBI]
|
1.69972e-05
|
|
|
PLGL
|
[NCBI]
|
1.69972e-05
|
|
|
glycinuria with or without oxalate urolithiasis
|
[NCBI]
|
1.69972e-05
|
|
|
anauxetic dysplasia
|
[NCBI]
|
1.69972e-05
|
|
|
NEPPK
|
[NCBI]
|
1.69972e-05
|
|
|
nephropathy, chronic tubulointerstitial
|
[NCBI]
|
1.69972e-05
|
|
|
DFNB49
|
[NCBI]
|
1.69972e-05
|
|
|
beta-hydroxyisobutyryl coa deacylase, deficiency of
|
[NCBI]
|
1.69972e-05
|
|
|
PPCD2
|
[NCBI]
|
1.69972e-05
|
|
|
LFS2
|
[NCBI]
|
1.69972e-05
|
|
|
HPE7
|
[NCBI]
|
1.69972e-05
|
|
|
MCPHA
|
[NCBI]
|
1.69972e-05
|
|
|
SCDO3
|
[NCBI]
|
1.69972e-05
|
|
|
c-like syndrome
|
[NCBI]
|
1.69972e-05
|
|
|
corneal dystrophy, juvenile epithelial, of meesmann
|
[NCBI]
|
1.69972e-05
|
|
|
DFNA44
|
[NCBI]
|
1.69972e-05
|
|
|
CCA3
|
[NCBI]
|
1.69972e-05
|
|
|
CSNBAD3
|
[NCBI]
|
1.69972e-05
|
|
|
MRXS10
|
[NCBI]
|
1.69972e-05
|
|
|
OPTB6
|
[NCBI]
|
1.69972e-05
|
|
|
HMN7B
|
[NCBI]
|
1.69972e-05
|
|
|
charcot-marie-tooth disease, dominant intermediate c
|
[NCBI]
|
1.69972e-05
|
|
|
mental and growth retardation with amblyopia
|
[NCBI]
|
1.69972e-05
|
|
|
chorea, benign familial
|
[NCBI]
|
1.69972e-05
|
|
|
glioma of brain, familial
|
[NCBI]
|
1.69918e-05
|
|
|
BRRS
|
[NCBI]
|
1.69918e-05
|
|
|
marden-walker syndrome
|
[NCBI]
|
1.67852e-05
|
|
|
anencephaly
|
[NCBI]
|
1.67852e-05
|
|
|
CCL17
|
[NCBI]
|
1.67463e-05
|
|
|
MKKS
|
[NCBI]
|
1.66996e-05
|
|
|
diabetes-deafness syndrome, maternally transmitted
|
[NCBI]
|
1.66996e-05
|
|
|
hydatidiform mole
|
[NCBI]
|
1.66996e-05
|
|
|
FXTAS
|
[NCBI]
|
1.66996e-05
|
|
|
neural tube defects, folate-sensitive
|
[NCBI]
|
1.66996e-05
|
|
|
AHDS
|
[NCBI]
|
1.66996e-05
|
|
|
neuropathy, congenital hypomyelinating
|
[NCBI]
|
1.66996e-05
|
|
|
MVA
|
[NCBI]
|
1.66996e-05
|
|
|
CIPA
|
[NCBI]
|
1.66996e-05
|
|
|
RSMD1
|
[NCBI]
|
1.66996e-05
|
|
|
infantile spasm syndrome, x-linked
|
[NCBI]
|
1.66996e-05
|
|
|
mucopolysaccharidosis type iiia
|
[NCBI]
|
1.66996e-05
|
|
|
CORD2
|
[NCBI]
|
1.66996e-05
|
|
|
ADA
|
[NCBI]
|
1.66163e-05
|
|
|
ABCG5
|
[NCBI]
|
1.65657e-05
|
|
|
NLGN3
|
[NCBI]
|
1.65657e-05
|
|
|
BAG1
|
[NCBI]
|
1.65657e-05
|
|
|
NEDD4
|
[NCBI]
|
1.65657e-05
|
|
|
MUSK
|
[NCBI]
|
1.65657e-05
|
|
|
SLC39A4
|
[NCBI]
|
1.65657e-05
|
|
|
ALX4
|
[NCBI]
|
1.65657e-05
|
|
|
HSPA5
|
[NCBI]
|
1.65657e-05
|
|
|
SLC7A7
|
[NCBI]
|
1.65657e-05
|
|
|
SDHA
|
[NCBI]
|
1.65657e-05
|
|
|
HLXB9
|
[NCBI]
|
1.65657e-05
|
|
|
PEX6
|
[NCBI]
|
1.65657e-05
|
|
|
MLLT7
|
[NCBI]
|
1.65657e-05
|
|
|
TMPRSS3
|
[NCBI]
|
1.65657e-05
|
|
|
INHBB
|
[NCBI]
|
1.65657e-05
|
|
|
ROBO1
|
[NCBI]
|
1.65657e-05
|
|
|
CUL4B
|
[NCBI]
|
1.65657e-05
|
|
|
CUL2
|
[NCBI]
|
1.65657e-05
|
|
|
SLC31A1
|
[NCBI]
|
1.65657e-05
|
|
|
ROM1
|
[NCBI]
|
1.65657e-05
|
|
|
COPS5
|
[NCBI]
|
1.65657e-05
|
|
|
glycogen storage disease vi
|
[NCBI]
|
1.65657e-05
|
|
|
CSNB1A
|
[NCBI]
|
1.64443e-05
|
|
|
MADD
|
[NCBI]
|
1.64443e-05
|
|
|
HBG2
|
[NCBI]
|
1.6408e-05
|
|
|
FRAXE
|
[NCBI]
|
1.63757e-05
|
|
|
PRKCG
|
[NCBI]
|
1.63757e-05
|
|
|
PER2
|
[NCBI]
|
1.63757e-05
|
|
|
IFNA1
|
[NCBI]
|
1.63737e-05
|
|
|
BMP15
|
[NCBI]
|
1.62949e-05
|
|
|
PRLH
|
[NCBI]
|
1.59629e-05
|
|
|
GABRA1
|
[NCBI]
|
1.5839e-05
|
|
|
MSR1
|
[NCBI]
|
1.5839e-05
|
|
|
COL9A1
|
[NCBI]
|
1.5839e-05
|
|
|
XRCC2
|
[NCBI]
|
1.5839e-05
|
|
|
TCIRG1
|
[NCBI]
|
1.5839e-05
|
|
|
FEN1
|
[NCBI]
|
1.5839e-05
|
|
|
MAT1A
|
[NCBI]
|
1.5839e-05
|
|
|
ABCB4
|
[NCBI]
|
1.5839e-05
|
|
|
DUOX2
|
[NCBI]
|
1.5839e-05
|
|
|
MSX2
|
[NCBI]
|
1.5839e-05
|
|
|
GSK3A
|
[NCBI]
|
1.5839e-05
|
|
|
KRT9
|
[NCBI]
|
1.5839e-05
|
|
|
UCP3
|
[NCBI]
|
1.55959e-05
|
|
|
BTC
|
[NCBI]
|
1.55732e-05
|
|
|
GC
|
[NCBI]
|
1.55153e-05
|
|
|
giant platelet syndrome
|
[NCBI]
|
1.5406e-05
|
|
|
GCPS
|
[NCBI]
|
1.54023e-05
|
|
|
MEB
|
[NCBI]
|
1.54023e-05
|
|
|
kartagener syndrome
|
[NCBI]
|
1.54023e-05
|
|
|
CMTX1
|
[NCBI]
|
1.54023e-05
|
|
|
thrombocythemia, essential
|
[NCBI]
|
1.53554e-05
|
|
|
ATF6
|
[NCBI]
|
1.53099e-05
|
|
|
CTSK
|
[NCBI]
|
1.53099e-05
|
|
|
TSG101
|
[NCBI]
|
1.53099e-05
|
|
|
CDC42
|
[NCBI]
|
1.53099e-05
|
|
|
CNOT3
|
[NCBI]
|
1.52179e-05
|
|
|
CYP4F22
|
[NCBI]
|
1.52179e-05
|
|
|
HAR1A
|
[NCBI]
|
1.52179e-05
|
|
|
TM2D3
|
[NCBI]
|
1.52179e-05
|
|
|
THUMPD2
|
[NCBI]
|
1.52179e-05
|
|
|
ZNF363
|
[NCBI]
|
1.52179e-05
|
|
|
forkhead box o6
|
[NCBI]
|
1.52179e-05
|
|
|
PLRG1
|
[NCBI]
|
1.52179e-05
|
|
|
COX11
|
[NCBI]
|
1.52179e-05
|
|
|
aurora borealis
|
[NCBI]
|
1.52179e-05
|
|
|
NARS
|
[NCBI]
|
1.52179e-05
|
|
|
flj10986
|
[NCBI]
|
1.52179e-05
|
|
|
TBL3
|
[NCBI]
|
1.52179e-05
|
|
|
AASS
|
[NCBI]
|
1.52179e-05
|
|
|
RRBP1
|
[NCBI]
|
1.52179e-05
|
|
|
PKHD1L1
|
[NCBI]
|
1.52179e-05
|
|
|
HPS6
|
[NCBI]
|
1.52179e-05
|
|
|
RASEF
|
[NCBI]
|
1.52179e-05
|
|
|
HAR1B
|
[NCBI]
|
1.52179e-05
|
|
|
CNOT2
|
[NCBI]
|
1.52179e-05
|
|
|
GTPBP3
|
[NCBI]
|
1.52179e-05
|
|
|
UTP14A
|
[NCBI]
|
1.52179e-05
|
|
|
PIGY
|
[NCBI]
|
1.52179e-05
|
|
|
CENPL
|
[NCBI]
|
1.52179e-05
|
|
|
LIN9
|
[NCBI]
|
1.52179e-05
|
|
|
GALNT8
|
[NCBI]
|
1.52179e-05
|
|
|
ELAC1
|
[NCBI]
|
1.52179e-05
|
|
|
DPH4
|
[NCBI]
|
1.52179e-05
|
|
|
DISP2
|
[NCBI]
|
1.52179e-05
|
|
|
ZDHHC15
|
[NCBI]
|
1.52179e-05
|
|
|
MED6
|
[NCBI]
|
1.52179e-05
|
|
|
BLOC1S2
|
[NCBI]
|
1.52179e-05
|
|
|
ESAT
|
[NCBI]
|
1.52179e-05
|
|
|
TRAPPC6A
|
[NCBI]
|
1.52179e-05
|
|
|
MIRN29B1
|
[NCBI]
|
1.52179e-05
|
|
|
WDR4
|
[NCBI]
|
1.52179e-05
|
|
|
TRAF3IP1
|
[NCBI]
|
1.52179e-05
|
|
|
LRRC16
|
[NCBI]
|
1.52179e-05
|
|
|
DISP1
|
[NCBI]
|
1.52179e-05
|
|
|
SLC19A3
|
[NCBI]
|
1.52179e-05
|
|
|
LRRN6D
|
[NCBI]
|
1.52179e-05
|
|
|
INGX
|
[NCBI]
|
1.52179e-05
|
|
|
PRPS1L1
|
[NCBI]
|
1.52179e-05
|
|
|
ELOVL1
|
[NCBI]
|
1.52179e-05
|
|
|
TM2D1
|
[NCBI]
|
1.52179e-05
|
|
|
FRMD7
|
[NCBI]
|
1.52179e-05
|
|
|
ELL2
|
[NCBI]
|
1.52179e-05
|
|
|
RHOJ
|
[NCBI]
|
1.52179e-05
|
|
|
MIRN29C
|
[NCBI]
|
1.52179e-05
|
|
|
TMEM2
|
[NCBI]
|
1.52179e-05
|
|
|
GGN
|
[NCBI]
|
1.52179e-05
|
|
|
UNC93A
|
[NCBI]
|
1.52179e-05
|
|
|
oxidored-nitro domain-containing protein 1
|
[NCBI]
|
1.52179e-05
|
|
|
COQ3
|
[NCBI]
|
1.52179e-05
|
|
|
RP1L1
|
[NCBI]
|
1.52179e-05
|
|
|
DIRC2
|
[NCBI]
|
1.52179e-05
|
|
|
hakai, mouse, homolog of
|
[NCBI]
|
1.52179e-05
|
|
|
C9ORF103
|
[NCBI]
|
1.52179e-05
|
|
|
RTTN
|
[NCBI]
|
1.52179e-05
|
|
|
HEYL
|
[NCBI]
|
1.52179e-05
|
|
|
KCTD7
|
[NCBI]
|
1.52179e-05
|
|
|
PET112L
|
[NCBI]
|
1.52179e-05
|
|
|
BBS12
|
[NCBI]
|
1.52179e-05
|
|
|
ZNF699
|
[NCBI]
|
1.52179e-05
|
|
|
fras1-related extracellular matrix protein 3
|
[NCBI]
|
1.52179e-05
|
|
|
RNF135
|
[NCBI]
|
1.52179e-05
|
|
|
NUDCD1
|
[NCBI]
|
1.52179e-05
|
|
|
gene beside the ma29 deletion
|
[NCBI]
|
1.52179e-05
|
|
|
BMF
|
[NCBI]
|
1.52179e-05
|
|
|
C9ORF64
|
[NCBI]
|
1.52179e-05
|
|
|
ADAMTS10
|
[NCBI]
|
1.52179e-05
|
|
|
RFFL
|
[NCBI]
|
1.52179e-05
|
|
|
KLHL4
|
[NCBI]
|
1.52179e-05
|
|
|
ZWILCH
|
[NCBI]
|
1.52179e-05
|
|
|
OLIG3
|
[NCBI]
|
1.52179e-05
|
|
|
pantothenate kinase 1
|
[NCBI]
|
1.52179e-05
|
|
|
TRIM67
|
[NCBI]
|
1.52179e-05
|
|
|
utp14, s. cerevisiae, homolog of, b
|
[NCBI]
|
1.52179e-05
|
|
|
CLDN18
|
[NCBI]
|
1.52179e-05
|
|
|
SLC31A2
|
[NCBI]
|
1.52179e-05
|
|
|
aldo-keto reductase family 7, member a4
|
[NCBI]
|
1.52179e-05
|
|
|
BBS10
|
[NCBI]
|
1.52179e-05
|
|
|
GJB5
|
[NCBI]
|
1.52179e-05
|
|
|
aurora kinase a-interacting protein
|
[NCBI]
|
1.52179e-05
|
|
|
pantothenate kinase 3
|
[NCBI]
|
1.52179e-05
|
|
|
TRPT1
|
[NCBI]
|
1.52179e-05
|
|
|
RAB17
|
[NCBI]
|
1.52179e-05
|
|
|
CENPQ
|
[NCBI]
|
1.52179e-05
|
|
|
otopetrin 3
|
[NCBI]
|
1.52179e-05
|
|
|
DCDC1
|
[NCBI]
|
1.52179e-05
|
|
|
ZNF750
|
[NCBI]
|
1.52179e-05
|
|
|
NMD3
|
[NCBI]
|
1.52179e-05
|
|
|
MYO18B
|
[NCBI]
|
1.52179e-05
|
|
|
SC4MOL
|
[NCBI]
|
1.52179e-05
|
|
|
CASD1
|
[NCBI]
|
1.52179e-05
|
|
|
A11
|
[NCBI]
|
1.52179e-05
|
|
|
otopetrin 1
|
[NCBI]
|
1.52179e-05
|
|
|
ALG5
|
[NCBI]
|
1.52179e-05
|
|
|
otopetrin 2
|
[NCBI]
|
1.52179e-05
|
|
|
CMYA3
|
[NCBI]
|
1.52179e-05
|
|
|
HOXD9
|
[NCBI]
|
1.52179e-05
|
|
|
TRMT1
|
[NCBI]
|
1.52179e-05
|
|
|
MUTED
|
[NCBI]
|
1.52179e-05
|
|
|
LMLN
|
[NCBI]
|
1.52179e-05
|
|
|
TM2D2
|
[NCBI]
|
1.52179e-05
|
|
|
mmachc gene
|
[NCBI]
|
1.52179e-05
|
|
|
DBR1
|
[NCBI]
|
1.52179e-05
|
|
|
NOT1
|
[NCBI]
|
1.52179e-05
|
|
|
NOTUM
|
[NCBI]
|
1.52179e-05
|
|
|
NEURL2
|
[NCBI]
|
1.52179e-05
|
|
|
TMC2
|
[NCBI]
|
1.52179e-05
|
|
|
SUDD
|
[NCBI]
|
1.52179e-05
|
|
|
ANAPC4
|
[NCBI]
|
1.52179e-05
|
|
|
FEA
|
[NCBI]
|
1.52179e-05
|
|
|
SMEK1
|
[NCBI]
|
1.52179e-05
|
|
|
MPP2
|
[NCBI]
|
1.52179e-05
|
|
|
SPATA16
|
[NCBI]
|
1.52179e-05
|
|
|
SMC6
|
[NCBI]
|
1.52179e-05
|
|
|
NDRG3
|
[NCBI]
|
1.52179e-05
|
|
|
PIGX
|
[NCBI]
|
1.52179e-05
|
|
|
dedicator of cytokinesis 4
|
[NCBI]
|
1.52179e-05
|
|
|
GCC1
|
[NCBI]
|
1.52179e-05
|
|
|
MIRN29A
|
[NCBI]
|
1.52179e-05
|
|
|
CENPO
|
[NCBI]
|
1.52179e-05
|
|
|
kaiso gene
|
[NCBI]
|
1.52179e-05
|
|
|
MOBKL1A
|
[NCBI]
|
1.52179e-05
|
|
|
PKD2L2
|
[NCBI]
|
1.52179e-05
|
|
|
CNOT4
|
[NCBI]
|
1.52179e-05
|
|
|
DCP1B
|
[NCBI]
|
1.52179e-05
|
|
|
cell death regulator aven
|
[NCBI]
|
1.52179e-05
|
|
|
CENPP
|
[NCBI]
|
1.52179e-05
|
|
|
MOBKL1B
|
[NCBI]
|
1.52179e-05
|
|
|
SUGT1
|
[NCBI]
|
1.52179e-05
|
|
|
SCNM1
|
[NCBI]
|
1.52179e-05
|
|
|
ARL2L1
|
[NCBI]
|
1.52179e-05
|
|
|
ATP11C
|
[NCBI]
|
1.52179e-05
|
|
|
MFSD8
|
[NCBI]
|
1.52179e-05
|
|
|
CHORDC1
|
[NCBI]
|
1.52179e-05
|
|
|
kielin/chordin-like protein
|
[NCBI]
|
1.52179e-05
|
|
|
BBS5
|
[NCBI]
|
1.52179e-05
|
|
|
FBXL15
|
[NCBI]
|
1.52179e-05
|
|
|
PIGW
|
[NCBI]
|
1.52179e-05
|
|
|
AMELX
|
[NCBI]
|
1.51915e-05
|
|
|
phenylketonuria ii
|
[NCBI]
|
1.51915e-05
|
|
|
LCN2
|
[NCBI]
|
1.51849e-05
|
|
|
PTK2
|
[NCBI]
|
1.51235e-05
|
|
|
MAP3K5
|
[NCBI]
|
1.49394e-05
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
1.49346e-05
|
|
|
UPF2
|
[NCBI]
|
1.49003e-05
|
|
|
pejvakin
|
[NCBI]
|
1.49003e-05
|
|
|
TBX10
|
[NCBI]
|
1.49003e-05
|
|
|
BBS2
|
[NCBI]
|
1.49003e-05
|
|
|
UBR1
|
[NCBI]
|
1.49003e-05
|
|
|
PNPO
|
[NCBI]
|
1.49003e-05
|
|
|
RAB23
|
[NCBI]
|
1.49003e-05
|
|
|
SUOX
|
[NCBI]
|
1.49003e-05
|
|
|
SMPD3
|
[NCBI]
|
1.49003e-05
|
|
|
FRAS1
|
[NCBI]
|
1.49003e-05
|
|
|
ERAS
|
[NCBI]
|
1.49003e-05
|
|
|
NEDD4L
|
[NCBI]
|
1.49003e-05
|
|
|
MTTG
|
[NCBI]
|
1.49003e-05
|
|
|
SLC25A15
|
[NCBI]
|
1.49003e-05
|
|
|
NDUFS2
|
[NCBI]
|
1.49003e-05
|
|
|
STRA6
|
[NCBI]
|
1.49003e-05
|
|
|
RAD18
|
[NCBI]
|
1.49003e-05
|
|
|
RNASEH2A
|
[NCBI]
|
1.49003e-05
|
|
|
ARHGEF9
|
[NCBI]
|
1.49003e-05
|
|
|
ARHGAP24
|
[NCBI]
|
1.49003e-05
|
|
|
STRBP
|
[NCBI]
|
1.49003e-05
|
|
|
EIF2B3
|
[NCBI]
|
1.49003e-05
|
|
|
DPH2
|
[NCBI]
|
1.49003e-05
|
|
|
TMEM15
|
[NCBI]
|
1.49003e-05
|
|
|
CELSR3
|
[NCBI]
|
1.49003e-05
|
|
|
DOHH
|
[NCBI]
|
1.49003e-05
|
|
|
DYNLT1
|
[NCBI]
|
1.49003e-05
|
|
|
AP3D1
|
[NCBI]
|
1.49003e-05
|
|
|
NELF
|
[NCBI]
|
1.49003e-05
|
|
|
PSENEN
|
[NCBI]
|
1.49003e-05
|
|
|
PTPN3
|
[NCBI]
|
1.49003e-05
|
|
|
ALG1
|
[NCBI]
|
1.49003e-05
|
|
|
SUPT6H
|
[NCBI]
|
1.49003e-05
|
|
|
CCDC50
|
[NCBI]
|
1.49003e-05
|
|
|
POLM
|
[NCBI]
|
1.49003e-05
|
|
|
ALOXE3
|
[NCBI]
|
1.49003e-05
|
|
|
kindlin 1
|
[NCBI]
|
1.49003e-05
|
|
|
RMI1
|
[NCBI]
|
1.49003e-05
|
|
|
FKBP6
|
[NCBI]
|
1.49003e-05
|
|
|
CDC14A
|
[NCBI]
|
1.49003e-05
|
|
|
PLEKHG4
|
[NCBI]
|
1.49003e-05
|
|
|
TRIOBP
|
[NCBI]
|
1.49003e-05
|
|
|
ACTN2
|
[NCBI]
|
1.49003e-05
|
|
|
ALDH7A1
|
[NCBI]
|
1.49003e-05
|
|
|
alg8, s. cerevisiae, homolog of
|
[NCBI]
|
1.49003e-05
|
|
|
RHS
|
[NCBI]
|
1.47445e-05
|
|
|
HOMG
|
[NCBI]
|
1.47445e-05
|
|
|
HRPT2
|
[NCBI]
|
1.47445e-05
|
|
|
LIS1
|
[NCBI]
|
1.47445e-05
|
|
|
pycnodysostosis
|
[NCBI]
|
1.47445e-05
|
|
|
chloramphenicol toxicity
|
[NCBI]
|
1.47445e-05
|
|
|
amyloidosis, primary cutaneous
|
[NCBI]
|
1.47445e-05
|
|
|
congenital cataracts, facial dysmorphism, and neuropathy
|
[NCBI]
|
1.47445e-05
|
|
|
diabetes mellitus, insulin-dependent, 2
|
[NCBI]
|
1.4642e-05
|
|
|
NR5A1
|
[NCBI]
|
1.45867e-05
|
|
|
PLN
|
[NCBI]
|
1.45838e-05
|
|
|
APOA1
|
[NCBI]
|
1.45454e-05
|
|
|
FRDA
|
[NCBI]
|
1.4487e-05
|
|
|
PEX13
|
[NCBI]
|
1.44507e-05
|
|
|
HDAC9
|
[NCBI]
|
1.44507e-05
|
|
|
LLGL1
|
[NCBI]
|
1.44507e-05
|
|
|
GRHPR
|
[NCBI]
|
1.44507e-05
|
|
|
PEX5
|
[NCBI]
|
1.44507e-05
|
|
|
ANTXR2
|
[NCBI]
|
1.44507e-05
|
|
|
CARD11
|
[NCBI]
|
1.44507e-05
|
|
|
hemojuvelin
|
[NCBI]
|
1.44507e-05
|
|
|
PDE11A
|
[NCBI]
|
1.44507e-05
|
|
|
CRLF1
|
[NCBI]
|
1.44507e-05
|
|
|
DDB2
|
[NCBI]
|
1.44507e-05
|
|
|
PKP2
|
[NCBI]
|
1.44507e-05
|
|
|
BCKDHB
|
[NCBI]
|
1.44507e-05
|
|
|
CLCNKB
|
[NCBI]
|
1.44507e-05
|
|
|
TPR
|
[NCBI]
|
1.44507e-05
|
|
|
CD244
|
[NCBI]
|
1.44507e-05
|
|
|
MTTE
|
[NCBI]
|
1.44507e-05
|
|
|
APOC3
|
[NCBI]
|
1.43973e-05
|
|
|
HSPD1
|
[NCBI]
|
1.43973e-05
|
|
|
CRYGD
|
[NCBI]
|
1.43973e-05
|
|
|
SMARCB1
|
[NCBI]
|
1.43973e-05
|
|
|
HSPG2
|
[NCBI]
|
1.43973e-05
|
|
|
GJA8
|
[NCBI]
|
1.4383e-05
|
|
|
hyperglycerolemia
|
[NCBI]
|
1.42539e-05
|
|
|
HOKPP
|
[NCBI]
|
1.42539e-05
|
|
|
MTCO2
|
[NCBI]
|
1.41473e-05
|
|
|
aspartylglucosaminuria
|
[NCBI]
|
1.41473e-05
|
|
|
camurati-engelmann disease
|
[NCBI]
|
1.4102e-05
|
|
|
glycogen storage disease iv
|
[NCBI]
|
1.4102e-05
|
|
|
EAOH
|
[NCBI]
|
1.4102e-05
|
|
|
WIPF1
|
[NCBI]
|
1.40961e-05
|
|
|
NTN1
|
[NCBI]
|
1.40961e-05
|
|
|
MMP9
|
[NCBI]
|
1.40288e-05
|
|
|
GJA1
|
[NCBI]
|
1.39079e-05
|
|
|
costello syndrome
|
[NCBI]
|
1.39059e-05
|
|
|
STAT6
|
[NCBI]
|
1.38846e-05
|
|
|
histidinemia
|
[NCBI]
|
1.37052e-05
|
|
|
ETM1
|
[NCBI]
|
1.37052e-05
|
|
|
CCR5
|
[NCBI]
|
1.35427e-05
|
|
|
AQP2
|
[NCBI]
|
1.35427e-05
|
|
|
IPF1
|
[NCBI]
|
1.35096e-05
|
|
|
IGF2R
|
[NCBI]
|
1.35096e-05
|
|
|
mitochondrial myopathy with diabetes
|
[NCBI]
|
1.34519e-05
|
|
|
KNO
|
[NCBI]
|
1.34519e-05
|
|
|
STHAG3
|
[NCBI]
|
1.34519e-05
|
|
|
xeroderma pigmentosum, complementation group e
|
[NCBI]
|
1.34519e-05
|
|
|
hyperthyroidism, nonautoimmune
|
[NCBI]
|
1.34519e-05
|
|
|
ichthyosis, bullous type
|
[NCBI]
|
1.34519e-05
|
|
|
SQT1
|
[NCBI]
|
1.34519e-05
|
|
|
HOMG3
|
[NCBI]
|
1.34519e-05
|
|
|
CMAH
|
[NCBI]
|
1.34519e-05
|
|
|
anonychia congenita
|
[NCBI]
|
1.34519e-05
|
|
|
charcot-marie-tooth disease, dominant intermediate b
|
[NCBI]
|
1.34519e-05
|
|
|
wolfram syndrome, mitochondrial form
|
[NCBI]
|
1.34519e-05
|
|
|
CO
|
[NCBI]
|
1.34519e-05
|
|
|
cataract-microcornea syndrome
|
[NCBI]
|
1.34519e-05
|
|
|
CSNB1B
|
[NCBI]
|
1.34519e-05
|
|
|
cardiomyopathy, dilated, with woolly hair and keratoderma
|
[NCBI]
|
1.34519e-05
|
|
|
naegeli syndrome
|
[NCBI]
|
1.34519e-05
|
|
|
CPVT
|
[NCBI]
|
1.34519e-05
|
|
|
ehlers-danlos syndrome, progeroid form
|
[NCBI]
|
1.34519e-05
|
|
|
deafness, congenital, with keratopachydermia and constrictions of fingers and toes
|
[NCBI]
|
1.34519e-05
|
|
|
LSFC
|
[NCBI]
|
1.34519e-05
|
|
|
UCP2
|
[NCBI]
|
1.33141e-05
|
|
|
DDC
|
[NCBI]
|
1.324e-05
|
|
|
LAD
|
[NCBI]
|
1.3121e-05
|
|
|
TUBB
|
[NCBI]
|
1.31002e-05
|
|
|
SLC1A3
|
[NCBI]
|
1.31002e-05
|
|
|
LOR
|
[NCBI]
|
1.31002e-05
|
|
|
MHC2TA
|
[NCBI]
|
1.31002e-05
|
|
|
MADHIP
|
[NCBI]
|
1.31002e-05
|
|
|
FOXP2
|
[NCBI]
|
1.31002e-05
|
|
|
MC2R
|
[NCBI]
|
1.30802e-05
|
|
|
PDGFRA
|
[NCBI]
|
1.30802e-05
|
|
|
ADAMTS13
|
[NCBI]
|
1.30802e-05
|
|
|
SLC5A5
|
[NCBI]
|
1.30802e-05
|
|
|
PLOD1
|
[NCBI]
|
1.30802e-05
|
|
|
F12
|
[NCBI]
|
1.30802e-05
|
|
|
EBP
|
[NCBI]
|
1.30802e-05
|
|
|
ITGB3
|
[NCBI]
|
1.30659e-05
|
|
|
PPARG
|
[NCBI]
|
1.30427e-05
|
|
|
LRP1
|
[NCBI]
|
1.30133e-05
|
|
|
lipomatosis, multiple
|
[NCBI]
|
1.30021e-05
|
|
|
IL6
|
[NCBI]
|
1.29677e-05
|
|
|
LGMD2C
|
[NCBI]
|
1.29556e-05
|
|
|
TLR4
|
[NCBI]
|
1.29069e-05
|
|
|
REN
|
[NCBI]
|
1.28868e-05
|
|
|
ESR1
|
[NCBI]
|
1.26747e-05
|
|
|
KCNJ6
|
[NCBI]
|
1.26695e-05
|
|
|
AIP
|
[NCBI]
|
1.26695e-05
|
|
|
GCNT2
|
[NCBI]
|
1.26695e-05
|
|
|
IMPDH1
|
[NCBI]
|
1.26695e-05
|
|
|
FOXN1
|
[NCBI]
|
1.26695e-05
|
|
|
TUB
|
[NCBI]
|
1.26695e-05
|
|
|
SIAH1
|
[NCBI]
|
1.26695e-05
|
|
|
TTC10
|
[NCBI]
|
1.26695e-05
|
|
|
ELOVL4
|
[NCBI]
|
1.26695e-05
|
|
|
GUCA1A
|
[NCBI]
|
1.26695e-05
|
|
|
CUL3
|
[NCBI]
|
1.26695e-05
|
|
|
ACVR1
|
[NCBI]
|
1.26695e-05
|
|
|
LDB3
|
[NCBI]
|
1.26695e-05
|
|
|
PHYH
|
[NCBI]
|
1.26695e-05
|
|
|
CSNK2A1
|
[NCBI]
|
1.26695e-05
|
|
|
LARGE
|
[NCBI]
|
1.26695e-05
|
|
|
TNFRSF13C
|
[NCBI]
|
1.26695e-05
|
|
|
SHC1
|
[NCBI]
|
1.26695e-05
|
|
|
ALMS1
|
[NCBI]
|
1.26695e-05
|
|
|
LMAN1
|
[NCBI]
|
1.26695e-05
|
|
|
MTR
|
[NCBI]
|
1.2647e-05
|
|
|
human immunodeficiency virus type 1, susceptibility to
|
[NCBI]
|
1.25738e-05
|
|
|
CDLS1
|
[NCBI]
|
1.23295e-05
|
|
|
AHC
|
[NCBI]
|
1.22835e-05
|
|
|
CFNS
|
[NCBI]
|
1.22835e-05
|
|
|
myoclonic epilepsy of unverricht and lundborg
|
[NCBI]
|
1.2203e-05
|
|
|
RCC1
|
[NCBI]
|
1.21596e-05
|
|
|
PAX8
|
[NCBI]
|
1.21363e-05
|
|
|
SLC18A2
|
[NCBI]
|
1.21341e-05
|
|
|
wolman disease
|
[NCBI]
|
1.20023e-05
|
|
|
LRAT
|
[NCBI]
|
1.19275e-05
|
|
|
STIM1
|
[NCBI]
|
1.19275e-05
|
|
|
UGDH
|
[NCBI]
|
1.19275e-05
|
|
|
SNAP25
|
[NCBI]
|
1.19275e-05
|
|
|
CAMK2A
|
[NCBI]
|
1.19275e-05
|
|
|
NCOR2
|
[NCBI]
|
1.19275e-05
|
|
|
PLA2G2A
|
[NCBI]
|
1.19275e-05
|
|
|
ATXN3
|
[NCBI]
|
1.19275e-05
|
|
|
CEBPA
|
[NCBI]
|
1.19275e-05
|
|
|
CPS1
|
[NCBI]
|
1.19275e-05
|
|
|
CUL1
|
[NCBI]
|
1.19275e-05
|
|
|
ALK
|
[NCBI]
|
1.19193e-05
|
|
|
SLBP
|
[NCBI]
|
1.19082e-05
|
|
|
ICAP1
|
[NCBI]
|
1.18551e-05
|
|
|
MTMR3
|
[NCBI]
|
1.18551e-05
|
|
|
DRAP1
|
[NCBI]
|
1.18551e-05
|
|
|
SLC5A2
|
[NCBI]
|
1.18551e-05
|
|
|
ACADSB
|
[NCBI]
|
1.18551e-05
|
|
|
STRC
|
[NCBI]
|
1.18551e-05
|
|
|
lipin 1
|
[NCBI]
|
1.18551e-05
|
|
|
RHOH
|
[NCBI]
|
1.18551e-05
|
|
|
DBF4
|
[NCBI]
|
1.18551e-05
|
|
|
NAPA
|
[NCBI]
|
1.18551e-05
|
|
|
CSNK1E
|
[NCBI]
|
1.18551e-05
|
|
|
TTDN1
|
[NCBI]
|
1.18551e-05
|
|
|
MMP20
|
[NCBI]
|
1.18551e-05
|
|
|
FOXE3
|
[NCBI]
|
1.18551e-05
|
|
|
PLXND1
|
[NCBI]
|
1.18551e-05
|
|
|
NYX
|
[NCBI]
|
1.18551e-05
|
|
|
CACNA1G
|
[NCBI]
|
1.18551e-05
|
|
|
EPHB1
|
[NCBI]
|
1.18551e-05
|
|
|
PPP2R1A
|
[NCBI]
|
1.18551e-05
|
|
|
ARID5B
|
[NCBI]
|
1.18551e-05
|
|
|
FOXI1
|
[NCBI]
|
1.18551e-05
|
|
|
ZW10
|
[NCBI]
|
1.18551e-05
|
|
|
EFEMP1
|
[NCBI]
|
1.18551e-05
|
|
|
CHN2
|
[NCBI]
|
1.18551e-05
|
|
|
FAF1
|
[NCBI]
|
1.18551e-05
|
|
|
DIAPH1
|
[NCBI]
|
1.18551e-05
|
|
|
INTS6
|
[NCBI]
|
1.18551e-05
|
|
|
NDUFV2
|
[NCBI]
|
1.18551e-05
|
|
|
CCM2
|
[NCBI]
|
1.18551e-05
|
|
|
GCM2
|
[NCBI]
|
1.18551e-05
|
|
|
ETFA
|
[NCBI]
|
1.18551e-05
|
|
|
MCC
|
[NCBI]
|
1.18551e-05
|
|
|
KCNC3
|
[NCBI]
|
1.18551e-05
|
|
|
MYH3
|
[NCBI]
|
1.18551e-05
|
|
|
TRIM5
|
[NCBI]
|
1.18551e-05
|
|
|
NPR2
|
[NCBI]
|
1.18551e-05
|
|
|
PEX3
|
[NCBI]
|
1.18551e-05
|
|
|
CD79B
|
[NCBI]
|
1.18551e-05
|
|
|
PPP1R13L
|
[NCBI]
|
1.18551e-05
|
|
|
MYBL2
|
[NCBI]
|
1.18551e-05
|
|
|
UPF3B
|
[NCBI]
|
1.18551e-05
|
|
|
TSPYL2
|
[NCBI]
|
1.18551e-05
|
|
|
AP3B2
|
[NCBI]
|
1.18551e-05
|
|
|
RABIF
|
[NCBI]
|
1.18551e-05
|
|
|
CABP4
|
[NCBI]
|
1.18551e-05
|
|
|
GSPT1
|
[NCBI]
|
1.18551e-05
|
|
|
REEP5
|
[NCBI]
|
1.18551e-05
|
|
|
PLA2G6
|
[NCBI]
|
1.18551e-05
|
|
|
SS18L1
|
[NCBI]
|
1.18551e-05
|
|
|
CMT2A1
|
[NCBI]
|
1.1846e-05
|
|
|
OPD1
|
[NCBI]
|
1.1846e-05
|
|
|
denys-drash syndrome
|
[NCBI]
|
1.1846e-05
|
|
|
CDGG1
|
[NCBI]
|
1.1846e-05
|
|
|
acyl-coa dehydrogenase, short-chain, deficiency of
|
[NCBI]
|
1.1846e-05
|
|
|
pick disease of brain
|
[NCBI]
|
1.1846e-05
|
|
|
amyloidosis v
|
[NCBI]
|
1.1846e-05
|
|
|
ED2
|
[NCBI]
|
1.1846e-05
|
|
|
NM
|
[NCBI]
|
1.1846e-05
|
|
|
DSMA1
|
[NCBI]
|
1.1846e-05
|
|
|
RENS1
|
[NCBI]
|
1.1846e-05
|
|
|
NPHP1
|
[NCBI]
|
1.18232e-05
|
|
|
BFLS
|
[NCBI]
|
1.18232e-05
|
|
|
SCIDX1
|
[NCBI]
|
1.17537e-05
|
|
|
sotos syndrome
|
[NCBI]
|
1.17537e-05
|
|
|
CREBBP
|
[NCBI]
|
1.16743e-05
|
|
|
factor x deficiency
|
[NCBI]
|
1.16743e-05
|
|
|
FOXP3
|
[NCBI]
|
1.15472e-05
|
|
|
OPRM1
|
[NCBI]
|
1.14341e-05
|
|
|
megacystis-microcolon-intestinal hypoperistalsis syndrome
|
[NCBI]
|
1.14297e-05
|
|
|
MRD
|
[NCBI]
|
1.14297e-05
|
|
|
MCKD1
|
[NCBI]
|
1.14297e-05
|
|
|
RHCE
|
[NCBI]
|
1.1353e-05
|
|
|
DJS
|
[NCBI]
|
1.1325e-05
|
|
|
TGFBI
|
[NCBI]
|
1.12577e-05
|
|
|
neuraminidase deficiency with beta-galactosidase deficiency
|
[NCBI]
|
1.11735e-05
|
|
|
CETP
|
[NCBI]
|
1.11735e-05
|
|
|
PRMT1
|
[NCBI]
|
1.11452e-05
|
|
|
EIF5
|
[NCBI]
|
1.11452e-05
|
|
|
BARD1
|
[NCBI]
|
1.11452e-05
|
|
|
RAP1A
|
[NCBI]
|
1.11452e-05
|
|
|
MXI1
|
[NCBI]
|
1.11452e-05
|
|
|
SGKL
|
[NCBI]
|
1.11452e-05
|
|
|
BUB1B
|
[NCBI]
|
1.11452e-05
|
|
|
MAP3K7IP1
|
[NCBI]
|
1.11452e-05
|
|
|
TREM2
|
[NCBI]
|
1.11452e-05
|
|
|
NPHP1
|
[NCBI]
|
1.11452e-05
|
|
|
TYROBP
|
[NCBI]
|
1.11452e-05
|
|
|
T
|
[NCBI]
|
1.11452e-05
|
|
|
CYLD1
|
[NCBI]
|
1.11452e-05
|
|
|
HOXA13
|
[NCBI]
|
1.11452e-05
|
|
|
HSD17B10
|
[NCBI]
|
1.11452e-05
|
|
|
GSS
|
[NCBI]
|
1.11452e-05
|
|
|
NR2E3
|
[NCBI]
|
1.11452e-05
|
|
|
KCNMB1
|
[NCBI]
|
1.11452e-05
|
|
|
ABCC2
|
[NCBI]
|
1.11402e-05
|
|
|
CFB
|
[NCBI]
|
1.10193e-05
|
|
|
EN1
|
[NCBI]
|
1.08627e-05
|
|
|
MEF2A
|
[NCBI]
|
1.08627e-05
|
|
|
DLL1
|
[NCBI]
|
1.08627e-05
|
|
|
MAN2B1
|
[NCBI]
|
1.08627e-05
|
|
|
CRYBA1
|
[NCBI]
|
1.08627e-05
|
|
|
SCNN1A
|
[NCBI]
|
1.08627e-05
|
|
|
RAD51
|
[NCBI]
|
1.08627e-05
|
|
|
RPS14
|
[NCBI]
|
1.08627e-05
|
|
|
BTRC
|
[NCBI]
|
1.08627e-05
|
|
|
FGB
|
[NCBI]
|
1.08627e-05
|
|
|
MAOA
|
[NCBI]
|
1.08191e-05
|
|
|
SCA1
|
[NCBI]
|
1.06923e-05
|
|
|
DSG3
|
[NCBI]
|
1.06517e-05
|
|
|
ACLS
|
[NCBI]
|
1.05533e-05
|
|
|
PCI
|
[NCBI]
|
1.05508e-05
|
|
|
SLC2A2
|
[NCBI]
|
1.05375e-05
|
|
|
lung cancer
|
[NCBI]
|
1.05136e-05
|
|
|
HNFJ
|
[NCBI]
|
1.05136e-05
|
|
|
BANF1
|
[NCBI]
|
1.04789e-05
|
|
|
JMML
|
[NCBI]
|
1.04257e-05
|
|
|
F2R
|
[NCBI]
|
1.02765e-05
|
|
|
NIDDM
|
[NCBI]
|
1.014e-05
|
|
|
DKC
|
[NCBI]
|
1.00378e-05
|
|
|
NRG1
|
[NCBI]
|
1.00199e-05
|
|
|
ichthyosis, x-linked
|
[NCBI]
|
9.98453e-06
|
|
|
GLRA1
|
[NCBI]
|
9.89246e-06
|
|
|
EPB42
|
[NCBI]
|
9.89246e-06
|
|
|
GLDC
|
[NCBI]
|
9.89246e-06
|
|
|
TPM3
|
[NCBI]
|
9.89246e-06
|
|
|
SPG3A
|
[NCBI]
|
9.83908e-06
|
|
|
CHED2
|
[NCBI]
|
9.82899e-06
|
|
|
prostate cancer/brain cancer susceptibility
|
[NCBI]
|
9.82899e-06
|
|
|
IBMPFD
|
[NCBI]
|
9.82899e-06
|
|
|
pseudo-von willebrand disease
|
[NCBI]
|
9.82899e-06
|
|
|
char syndrome
|
[NCBI]
|
9.82899e-06
|
|
|
GLYS1
|
[NCBI]
|
9.82899e-06
|
|
|
MFS2
|
[NCBI]
|
9.82899e-06
|
|
|
HRD
|
[NCBI]
|
9.82899e-06
|
|
|
VMCM
|
[NCBI]
|
9.82899e-06
|
|
|
PHA2
|
[NCBI]
|
9.82899e-06
|
|
|
SANDO
|
[NCBI]
|
9.82899e-06
|
|
|
chondrodysplasia, grebe type
|
[NCBI]
|
9.82899e-06
|
|
|
CDG1B
|
[NCBI]
|
9.82899e-06
|
|
|
HPS2
|
[NCBI]
|
9.82899e-06
|
|
|
MCOPS2
|
[NCBI]
|
9.82899e-06
|
|
|
myopathy, myosin storage
|
[NCBI]
|
9.82899e-06
|
|
|
EBS-MP
|
[NCBI]
|
9.82899e-06
|
|
|
epilepsy, nocturnal frontal lobe, type 1
|
[NCBI]
|
9.82899e-06
|
|
|
MDC1C
|
[NCBI]
|
9.82899e-06
|
|
|
DFNB3
|
[NCBI]
|
9.82899e-06
|
|
|
desmoid disease, hereditary
|
[NCBI]
|
9.82899e-06
|
|
|
mucopolysaccharidosis type iiib
|
[NCBI]
|
9.826e-06
|
|
|
MEN2B
|
[NCBI]
|
9.826e-06
|
|
|
porphyria, congenital erythropoietic
|
[NCBI]
|
9.826e-06
|
|
|
MSS
|
[NCBI]
|
9.826e-06
|
|
|
IGHMBP2
|
[NCBI]
|
9.82494e-06
|
|
|
MSH3
|
[NCBI]
|
9.82494e-06
|
|
|
RAB7
|
[NCBI]
|
9.82494e-06
|
|
|
ECGF1
|
[NCBI]
|
9.82494e-06
|
|
|
RANBP1
|
[NCBI]
|
9.82494e-06
|
|
|
TFAP2B
|
[NCBI]
|
9.82494e-06
|
|
|
POLB
|
[NCBI]
|
9.82494e-06
|
|
|
CDKN2B
|
[NCBI]
|
9.82494e-06
|
|
|
BFSP2
|
[NCBI]
|
9.82494e-06
|
|
|
PITX3
|
[NCBI]
|
9.82494e-06
|
|
|
RAD50
|
[NCBI]
|
9.82494e-06
|
|
|
PRKR
|
[NCBI]
|
9.82494e-06
|
|
|
SLIT2
|
[NCBI]
|
9.82494e-06
|
|
|
DNAJC5
|
[NCBI]
|
9.82176e-06
|
|
|
CDKN1C
|
[NCBI]
|
9.67418e-06
|
|
|
DAG1
|
[NCBI]
|
9.67418e-06
|
|
|
SLC29A2
|
[NCBI]
|
9.6336e-06
|
|
|
NMNAT1
|
[NCBI]
|
9.6336e-06
|
|
|
SLC4A3
|
[NCBI]
|
9.6336e-06
|
|
|
AKAP5
|
[NCBI]
|
9.6336e-06
|
|
|
FRS2
|
[NCBI]
|
9.6336e-06
|
|
|
LHX9
|
[NCBI]
|
9.6336e-06
|
|
|
NLRP7
|
[NCBI]
|
9.6336e-06
|
|
|
NPHP3
|
[NCBI]
|
9.6336e-06
|
|
|
NHEJ1
|
[NCBI]
|
9.6336e-06
|
|
|
ARNT2
|
[NCBI]
|
9.6336e-06
|
|
|
MLH3
|
[NCBI]
|
9.6336e-06
|
|
|
SOX5
|
[NCBI]
|
9.6336e-06
|
|
|
KCNE2
|
[NCBI]
|
9.6336e-06
|
|
|
bsnd gene
|
[NCBI]
|
9.6336e-06
|
|
|
NPHS2
|
[NCBI]
|
9.6336e-06
|
|
|
GRM6
|
[NCBI]
|
9.6336e-06
|
|
|
DLC1
|
[NCBI]
|
9.6336e-06
|
|
|
NLGN4
|
[NCBI]
|
9.6336e-06
|
|
|
VANGL1
|
[NCBI]
|
9.6336e-06
|
|
|
HLA-DMA
|
[NCBI]
|
9.6336e-06
|
|
|
CFC1
|
[NCBI]
|
9.6336e-06
|
|
|
SLC4A11
|
[NCBI]
|
9.6336e-06
|
|
|
RSPO4
|
[NCBI]
|
9.6336e-06
|
|
|
GJB4
|
[NCBI]
|
9.6336e-06
|
|
|
RABGGTB
|
[NCBI]
|
9.6336e-06
|
|
|
ARL6
|
[NCBI]
|
9.6336e-06
|
|
|
OLIG1
|
[NCBI]
|
9.6336e-06
|
|
|
ALOX12B
|
[NCBI]
|
9.6336e-06
|
|
|
MAP3K2
|
[NCBI]
|
9.6336e-06
|
|
|
SEC23A
|
[NCBI]
|
9.6336e-06
|
|
|
GDA
|
[NCBI]
|
9.6336e-06
|
|
|
MAFK
|
[NCBI]
|
9.6336e-06
|
|
|
ACD
|
[NCBI]
|
9.6336e-06
|
|
|
PMPCB
|
[NCBI]
|
9.6336e-06
|
|
|
RNF139
|
[NCBI]
|
9.6336e-06
|
|
|
SMG7
|
[NCBI]
|
9.6336e-06
|
|
|
SGTA
|
[NCBI]
|
9.6336e-06
|
|
|
ST8SIA1
|
[NCBI]
|
9.6336e-06
|
|
|
VPS4A
|
[NCBI]
|
9.6336e-06
|
|
|
STX11
|
[NCBI]
|
9.6336e-06
|
|
|
SESN1
|
[NCBI]
|
9.6336e-06
|
|
|
EGLN1
|
[NCBI]
|
9.6336e-06
|
|
|
POU4F3
|
[NCBI]
|
9.6336e-06
|
|
|
RAB6IP2
|
[NCBI]
|
9.6336e-06
|
|
|
TWIST2
|
[NCBI]
|
9.6336e-06
|
|
|
SYNJ1
|
[NCBI]
|
9.6336e-06
|
|
|
GDF7
|
[NCBI]
|
9.6336e-06
|
|
|
TRAK1
|
[NCBI]
|
9.6336e-06
|
|
|
CFL2
|
[NCBI]
|
9.6336e-06
|
|
|
UBE2N
|
[NCBI]
|
9.6336e-06
|
|
|
UBE2B
|
[NCBI]
|
9.6336e-06
|
|
|
RFXANK
|
[NCBI]
|
9.6336e-06
|
|
|
VPS4B
|
[NCBI]
|
9.6336e-06
|
|
|
PTGIS
|
[NCBI]
|
9.6336e-06
|
|
|
DIDO1
|
[NCBI]
|
9.6336e-06
|
|
|
HRB
|
[NCBI]
|
9.6336e-06
|
|
|
COQ7
|
[NCBI]
|
9.6336e-06
|
|
|
LYPLA3
|
[NCBI]
|
9.6336e-06
|
|
|
SET
|
[NCBI]
|
9.6336e-06
|
|
|
MTTN
|
[NCBI]
|
9.6336e-06
|
|
|
TNNT3
|
[NCBI]
|
9.6336e-06
|
|
|
SEMA3E
|
[NCBI]
|
9.6336e-06
|
|
|
CKS1B
|
[NCBI]
|
9.6336e-06
|
|
|
PROK2
|
[NCBI]
|
9.6336e-06
|
|
|
CRTAP
|
[NCBI]
|
9.6336e-06
|
|
|
RNU6
|
[NCBI]
|
9.6336e-06
|
|
|
calcineurin-binding protein 1
|
[NCBI]
|
9.6336e-06
|
|
|
PITPNM1
|
[NCBI]
|
9.6336e-06
|
|
|
NDUFS1
|
[NCBI]
|
9.6336e-06
|
|
|
BOP1
|
[NCBI]
|
9.6336e-06
|
|
|
AGPAT2
|
[NCBI]
|
9.6336e-06
|
|
|
PHF9
|
[NCBI]
|
9.6336e-06
|
|
|
ENPP2
|
[NCBI]
|
9.56236e-06
|
|
|
HS
|
[NCBI]
|
9.52988e-06
|
|
|
PIGR
|
[NCBI]
|
9.4969e-06
|
|
|
hypophosphatemic rickets, x-linked dominant
|
[NCBI]
|
9.48088e-06
|
|
|
CDS
|
[NCBI]
|
9.41162e-06
|
|
|
coenzyme q10 deficiency
|
[NCBI]
|
9.41162e-06
|
|
|
mitochondrial dna depletion syndrome, hepatocerebral form
|
[NCBI]
|
9.41162e-06
|
|
|
cerebrotendinous xanthomatosis
|
[NCBI]
|
9.41162e-06
|
|
|
tetralogy of fallot
|
[NCBI]
|
9.41162e-06
|
|
|
HSCR2
|
[NCBI]
|
9.41162e-06
|
|
|
SPD1
|
[NCBI]
|
9.41162e-06
|
|
|
USH1C
|
[NCBI]
|
9.41162e-06
|
|
|
mucolipidosis iiia
|
[NCBI]
|
9.41162e-06
|
|
|
GCCD1
|
[NCBI]
|
9.41162e-06
|
|
|
ARVD1
|
[NCBI]
|
9.41162e-06
|
|
|
langer mesomelic dysplasia
|
[NCBI]
|
9.41162e-06
|
|
|
TERT
|
[NCBI]
|
9.35251e-06
|
|
|
ABCB11
|
[NCBI]
|
9.3509e-06
|
|
|
APOD
|
[NCBI]
|
9.33637e-06
|
|
|
TFF3
|
[NCBI]
|
9.33637e-06
|
|
|
THPO
|
[NCBI]
|
9.33637e-06
|
|
|
IFNG
|
[NCBI]
|
9.20397e-06
|
|
|
APCS
|
[NCBI]
|
9.20397e-06
|
|
|
QTRT1
|
[NCBI]
|
9.19983e-06
|
|
|
ABCG2
|
[NCBI]
|
9.13644e-06
|
|
|
MCPH6
|
[NCBI]
|
9.11799e-06
|
|
|
steatocystoma multiplex
|
[NCBI]
|
9.11799e-06
|
|
|
ventricular tachycardia, familial
|
[NCBI]
|
9.11799e-06
|
|
|
CSNBAD2
|
[NCBI]
|
9.11799e-06
|
|
|
aglossia-adactylia
|
[NCBI]
|
9.11799e-06
|
|
|
MODY8
|
[NCBI]
|
9.11799e-06
|
|
|
DFNB31
|
[NCBI]
|
9.11799e-06
|
|
|
MRX63
|
[NCBI]
|
9.11799e-06
|
|
|
NSIAD
|
[NCBI]
|
9.11799e-06
|
|
|
aortic aneurysm, familial thoracic 4
|
[NCBI]
|
9.11799e-06
|
|
|
CLN10
|
[NCBI]
|
9.11799e-06
|
|
|
MADB
|
[NCBI]
|
9.11799e-06
|
|
|
ehlers-danlos-like syndrome due to tenascin-x deficiency
|
[NCBI]
|
9.11799e-06
|
|
|
cafe-au-lait spots, multiple
|
[NCBI]
|
9.11799e-06
|
|
|
ADCAD1
|
[NCBI]
|
9.11799e-06
|
|
|
glycogen storage disease 0, liver
|
[NCBI]
|
9.11799e-06
|
|
|
osteoarthritis with mild chondrodysplasia
|
[NCBI]
|
9.11799e-06
|
|
|
FEB8
|
[NCBI]
|
9.11799e-06
|
|
|
carcinoid tumors, intestinal
|
[NCBI]
|
9.11799e-06
|
|
|
MRX46
|
[NCBI]
|
9.11799e-06
|
|
|
pelvis-shoulder dysplasia
|
[NCBI]
|
9.11799e-06
|
|
|
sertoli cell-only syndrome
|
[NCBI]
|
9.11799e-06
|
|
|
brunner syndrome
|
[NCBI]
|
9.11799e-06
|
|
|
DFNB16
|
[NCBI]
|
9.11799e-06
|
|
|
bile acid synthesis defect, congenital, 4
|
[NCBI]
|
9.11799e-06
|
|
|
siderius x-linked mental retardation syndrome
|
[NCBI]
|
9.11799e-06
|
|
|
HMERF
|
[NCBI]
|
9.11799e-06
|
|
|
amelogenesis imperfecta, hypoplastic, and openbite malocclusion, autosomal recessive
|
[NCBI]
|
9.11799e-06
|
|
|
HHS
|
[NCBI]
|
9.11799e-06
|
|
|
MRGH
|
[NCBI]
|
9.11799e-06
|
|
|
epidermolysis bullosa with congenital localized absence of skin and deformity of nails
|
[NCBI]
|
9.11799e-06
|
|
|
brugada syndrome 2
|
[NCBI]
|
9.11799e-06
|
|
|
deafness, sensorineural, and male infertility
|
[NCBI]
|
9.11799e-06
|
|
|
charcot-marie-tooth disease, axonal, type 2e
|
[NCBI]
|
9.11799e-06
|
|
|
BOS3
|
[NCBI]
|
9.11799e-06
|
|
|
rokitansky-kuster-hauser syndrome
|
[NCBI]
|
9.11799e-06
|
|
|
DFNB21
|
[NCBI]
|
9.11799e-06
|
|
|
ATMDS
|
[NCBI]
|
9.11799e-06
|
|
|
encephalopathy, ethylmalonic
|
[NCBI]
|
9.11799e-06
|
|
|
EDM5
|
[NCBI]
|
9.11799e-06
|
|
|
proopiomelanocortin deficiency
|
[NCBI]
|
9.11799e-06
|
|
|
steatocystoma multiplex with natal teeth
|
[NCBI]
|
9.11799e-06
|
|
|
GUD
|
[NCBI]
|
9.11799e-06
|
|
|
phosphoglycerate dehydrogenase deficiency
|
[NCBI]
|
9.11799e-06
|
|
|
glomerulocystic kidney disease with hyperuricemia and isosthenuria
|
[NCBI]
|
9.11799e-06
|
|
|
gonadal dysgenesis, 46,xy, partial, with minifascicular neuropathy
|
[NCBI]
|
9.11799e-06
|
|
|
epidermolysis bullosa, pretibial
|
[NCBI]
|
9.11799e-06
|
|
|
NEK1
|
[NCBI]
|
9.11799e-06
|
|
|
GEPD
|
[NCBI]
|
9.11799e-06
|
|
|
SRN1
|
[NCBI]
|
9.11799e-06
|
|
|
stapes ankylosis with broad thumb and toes
|
[NCBI]
|
9.11799e-06
|
|
|
polydactyly
|
[NCBI]
|
9.11799e-06
|
|
|
DTGA1
|
[NCBI]
|
9.11799e-06
|
|
|
FECD1
|
[NCBI]
|
9.11799e-06
|
|
|
moved to 310600
|
[NCBI]
|
9.11799e-06
|
|
|
OPTB4
|
[NCBI]
|
9.11799e-06
|
|
|
barraquer-simons syndrome
|
[NCBI]
|
9.11799e-06
|
|
|
FEB4
|
[NCBI]
|
9.11799e-06
|
|
|
chondrosarcoma
|
[NCBI]
|
9.11799e-06
|
|
|
mass syndrome
|
[NCBI]
|
9.11799e-06
|
|
|
SPS
|
[NCBI]
|
9.11799e-06
|
|
|
FENIB
|
[NCBI]
|
9.11799e-06
|
|
|
ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis
|
[NCBI]
|
9.11799e-06
|
|
|
coloboma of optic nerve
|
[NCBI]
|
9.11799e-06
|
|
|
diabetes mellitus, permanent neonatal, with cerebellar agenesis
|
[NCBI]
|
9.11799e-06
|
|
|
LORD
|
[NCBI]
|
9.11799e-06
|
|
|
majeed syndrome
|
[NCBI]
|
9.11799e-06
|
|
|
COD3
|
[NCBI]
|
9.11799e-06
|
|
|
irak4 deficiency
|
[NCBI]
|
9.11799e-06
|
|
|
HJMD
|
[NCBI]
|
9.11799e-06
|
|
|
autism, x-linked, susceptibility to, 1
|
[NCBI]
|
9.11799e-06
|
|
|
basal cell carcinoma, multiple
|
[NCBI]
|
9.11799e-06
|
|
|
NS4
|
[NCBI]
|
9.11799e-06
|
|
|
RP26
|
[NCBI]
|
9.11799e-06
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
9.06239e-06
|
|
|
factor xii deficiency
|
[NCBI]
|
9.06239e-06
|
|
|
3-@beta-hydroxysteroid dehydrogenase, type ii, deficiency of
|
[NCBI]
|
9.00591e-06
|
|
|
CRHR1
|
[NCBI]
|
9.00591e-06
|
|
|
BMP7
|
[NCBI]
|
9.00591e-06
|
|
|
PQBP1
|
[NCBI]
|
9.00591e-06
|
|
|
DNM1L
|
[NCBI]
|
9.00591e-06
|
|
|
FUT2
|
[NCBI]
|
9.00591e-06
|
|
|
EP300
|
[NCBI]
|
9.00591e-06
|
|
|
CRYAB
|
[NCBI]
|
8.9598e-06
|
|
|
FHM1
|
[NCBI]
|
8.92745e-06
|
|
|
mycobacterium tuberculosis, susceptibility to
|
[NCBI]
|
8.83986e-06
|
|
|
PPIA
|
[NCBI]
|
8.74388e-06
|
|
|
CFH
|
[NCBI]
|
8.74388e-06
|
|
|
GNAQ
|
[NCBI]
|
8.67072e-06
|
|
|
SPINK5
|
[NCBI]
|
8.67072e-06
|
|
|
CRYGC
|
[NCBI]
|
8.67072e-06
|
|
|
NDRG1
|
[NCBI]
|
8.67072e-06
|
|
|
plasmin inhibitor deficiency
|
[NCBI]
|
8.67072e-06
|
|
|
ATP2A1
|
[NCBI]
|
8.67072e-06
|
|
|
GALNT3
|
[NCBI]
|
8.67072e-06
|
|
|
KRT8
|
[NCBI]
|
8.67072e-06
|
|
|
OCRL
|
[NCBI]
|
8.67072e-06
|
|
|
XBP1
|
[NCBI]
|
8.67072e-06
|
|
|
PAPSS2
|
[NCBI]
|
8.67072e-06
|
|
|
SOX3
|
[NCBI]
|
8.67072e-06
|
|
|
XRN1
|
[NCBI]
|
8.67072e-06
|
|
|
RIMS1
|
[NCBI]
|
8.67072e-06
|
|
|
BLNK
|
[NCBI]
|
8.67072e-06
|
|
|
SIRT2
|
[NCBI]
|
8.67072e-06
|
|
|
RBPSUH
|
[NCBI]
|
8.67072e-06
|
|
|
FKTN
|
[NCBI]
|
8.67072e-06
|
|
|
GFI1
|
[NCBI]
|
8.67072e-06
|
|
|
TBP
|
[NCBI]
|
8.61862e-06
|
|
|
GDXY
|
[NCBI]
|
8.61097e-06
|
|
|
STAT5B
|
[NCBI]
|
8.61097e-06
|
|
|
USF1
|
[NCBI]
|
8.52517e-06
|
|
|
C4A
|
[NCBI]
|
8.49491e-06
|
|
|
PCD
|
[NCBI]
|
8.49395e-06
|
|
|
polycystic kidneys
|
[NCBI]
|
8.36895e-06
|
|
|
CYP19A1
|
[NCBI]
|
8.30752e-06
|
|
|
TIMP3
|
[NCBI]
|
8.29165e-06
|
|
|
IFNGR1
|
[NCBI]
|
8.29165e-06
|
|
|
HNPP
|
[NCBI]
|
8.28972e-06
|
|
|
KRT20
|
[NCBI]
|
8.22586e-06
|
|
|
CHRNA4
|
[NCBI]
|
8.19386e-06
|
|
|
CCNE1
|
[NCBI]
|
8.19386e-06
|
|
|
CA2
|
[NCBI]
|
8.19386e-06
|
|
|
C9
|
[NCBI]
|
8.19386e-06
|
|
|
EPB41
|
[NCBI]
|
8.19386e-06
|
|
|
DMBT1
|
[NCBI]
|
8.19386e-06
|
|
|
CYP2C19
|
[NCBI]
|
8.19386e-06
|
|
|
NEB
|
[NCBI]
|
8.19386e-06
|
|
|
BIRC1
|
[NCBI]
|
8.11726e-06
|
|
|
BCL2
|
[NCBI]
|
8.11726e-06
|
|
|
FGF10
|
[NCBI]
|
8.05325e-06
|
|
|
PTHR1
|
[NCBI]
|
8.05325e-06
|
|
|
DLX2
|
[NCBI]
|
7.91914e-06
|
|
|
SP110
|
[NCBI]
|
7.91914e-06
|
|
|
PHKB
|
[NCBI]
|
7.91914e-06
|
|
|
ABCA3
|
[NCBI]
|
7.91914e-06
|
|
|
CTNNA2
|
[NCBI]
|
7.91914e-06
|
|
|
ACTN4
|
[NCBI]
|
7.91914e-06
|
|
|
GBX2
|
[NCBI]
|
7.91914e-06
|
|
|
RAB1
|
[NCBI]
|
7.91914e-06
|
|
|
WISP3
|
[NCBI]
|
7.91914e-06
|
|
|
ARIX
|
[NCBI]
|
7.91914e-06
|
|
|
DMP1
|
[NCBI]
|
7.91914e-06
|
|
|
AXL
|
[NCBI]
|
7.91914e-06
|
|
|
GRM5
|
[NCBI]
|
7.91914e-06
|
|
|
NKX2-2
|
[NCBI]
|
7.91914e-06
|
|
|
NFATC4
|
[NCBI]
|
7.91914e-06
|
|
|
HSF4
|
[NCBI]
|
7.91914e-06
|
|
|
NDUFS8
|
[NCBI]
|
7.91914e-06
|
|
|
TCF8
|
[NCBI]
|
7.91914e-06
|
|
|
PRSS12
|
[NCBI]
|
7.91914e-06
|
|
|
SRP19
|
[NCBI]
|
7.91914e-06
|
|
|
NHLRC1
|
[NCBI]
|
7.91914e-06
|
|
|
HMGCS2
|
[NCBI]
|
7.91914e-06
|
|
|
SOX6
|
[NCBI]
|
7.91914e-06
|
|
|
TAP2
|
[NCBI]
|
7.91914e-06
|
|
|
SART3
|
[NCBI]
|
7.91914e-06
|
|
|
MYH10
|
[NCBI]
|
7.91914e-06
|
|
|
TPM2
|
[NCBI]
|
7.91914e-06
|
|
|
CSNK2A2
|
[NCBI]
|
7.91914e-06
|
|
|
MAP3K7IP2
|
[NCBI]
|
7.91914e-06
|
|
|
CACNA2D1
|
[NCBI]
|
7.91914e-06
|
|
|
PLCE1
|
[NCBI]
|
7.91914e-06
|
|
|
LHX4
|
[NCBI]
|
7.91914e-06
|
|
|
GREM1
|
[NCBI]
|
7.91914e-06
|
|
|
PDE6G
|
[NCBI]
|
7.91914e-06
|
|
|
B3GALNT1
|
[NCBI]
|
7.91914e-06
|
|
|
UCHL3
|
[NCBI]
|
7.91914e-06
|
|
|
SYNE1
|
[NCBI]
|
7.91914e-06
|
|
|
MAFG
|
[NCBI]
|
7.91914e-06
|
|
|
ESPN
|
[NCBI]
|
7.91914e-06
|
|
|
BUB1
|
[NCBI]
|
7.91914e-06
|
|
|
KCNE3
|
[NCBI]
|
7.91914e-06
|
|
|
ALDH5A1
|
[NCBI]
|
7.91914e-06
|
|
|
XRCC4
|
[NCBI]
|
7.91914e-06
|
|
|
DNTT
|
[NCBI]
|
7.81913e-06
|
|
|
NS1
|
[NCBI]
|
7.73612e-06
|
|
|
ALD
|
[NCBI]
|
7.72382e-06
|
|
|
POF1
|
[NCBI]
|
7.69318e-06
|
|
|
HSAS
|
[NCBI]
|
7.69318e-06
|
|
|
AIMAH
|
[NCBI]
|
7.69318e-06
|
|
|
APEX
|
[NCBI]
|
7.66628e-06
|
|
|
BACE1
|
[NCBI]
|
7.66628e-06
|
|
|
KIF2C
|
[NCBI]
|
7.65434e-06
|
|
|
HCRTR2
|
[NCBI]
|
7.65434e-06
|
|
|
MBTPS1
|
[NCBI]
|
7.65434e-06
|
|
|
MTHFD1
|
[NCBI]
|
7.65434e-06
|
|
|
TCF4
|
[NCBI]
|
7.65434e-06
|
|
|
FANCD2
|
[NCBI]
|
7.65434e-06
|
|
|
PXMP3
|
[NCBI]
|
7.65434e-06
|
|
|
SDHC
|
[NCBI]
|
7.65434e-06
|
|
|
RAI1
|
[NCBI]
|
7.65434e-06
|
|
|
CCS
|
[NCBI]
|
7.65434e-06
|
|
|
longevity
|
[NCBI]
|
7.63714e-06
|
|
|
blood group, p system
|
[NCBI]
|
7.63714e-06
|
|
|
SPCH1
|
[NCBI]
|
7.63714e-06
|
|
|
NPHS1
|
[NCBI]
|
7.63714e-06
|
|
|
DYT3
|
[NCBI]
|
7.63714e-06
|
|
|
periodontitis, aggressive, 1
|
[NCBI]
|
7.63714e-06
|
|
|
dopamine beta-hydroxylase deficiency, congenital
|
[NCBI]
|
7.63714e-06
|
|
|
RELN
|
[NCBI]
|
7.56522e-06
|
|
|
FOXO1A
|
[NCBI]
|
7.52489e-06
|
|
|
GK
|
[NCBI]
|
7.52489e-06
|
|
|
BAX
|
[NCBI]
|
7.52489e-06
|
|
|
JAK3
|
[NCBI]
|
7.52222e-06
|
|
|
usher syndrome, type i
|
[NCBI]
|
7.51009e-06
|
|
|
FOLH1
|
[NCBI]
|
7.4523e-06
|
|
|
MMP3
|
[NCBI]
|
7.4523e-06
|
|
|
TCRG
|
[NCBI]
|
7.4523e-06
|
|
|
PDSS2
|
[NCBI]
|
7.45e-06
|
|
|
PAK6
|
[NCBI]
|
7.45e-06
|
|
|
LOH11CR2A
|
[NCBI]
|
7.45e-06
|
|
|
GLIS3
|
[NCBI]
|
7.45e-06
|
|
|
rab-interacting lysosomal protein
|
[NCBI]
|
7.45e-06
|
|
|
C1ORF27
|
[NCBI]
|
7.45e-06
|
|
|
RCL1
|
[NCBI]
|
7.45e-06
|
|
|
ww domain-containing protein, 45-kd
|
[NCBI]
|
7.45e-06
|
|
|
RARS2
|
[NCBI]
|
7.45e-06
|
|
|
PPEF2
|
[NCBI]
|
7.45e-06
|
|
|
ELMO2
|
[NCBI]
|
7.45e-06
|
|
|
TDO2
|
[NCBI]
|
7.45e-06
|
|
|
RYBP
|
[NCBI]
|
7.45e-06
|
|
|
POLS
|
[NCBI]
|
7.45e-06
|
|
|
early lymphoid activation gene
|
[NCBI]
|
7.45e-06
|
|
|
POLQ
|
[NCBI]
|
7.45e-06
|
|
|
DUX4
|
[NCBI]
|
7.45e-06
|
|
|
LSM8
|
[NCBI]
|
7.45e-06
|
|
|
TRAPPC6B
|
[NCBI]
|
7.45e-06
|
|
|
PXK
|
[NCBI]
|
7.45e-06
|
|
|
AP2A2
|
[NCBI]
|
7.45e-06
|
|
|
TTYH1
|
[NCBI]
|
7.45e-06
|
|
|
FAM126A
|
[NCBI]
|
7.45e-06
|
|
|
toll-interacting protein
|
[NCBI]
|
7.45e-06
|
|
|
CUTC
|
[NCBI]
|
7.45e-06
|
|
|
NDUFAF1
|
[NCBI]
|
7.45e-06
|
|
|
NCAPH2
|
[NCBI]
|
7.45e-06
|
|
|
DDX19
|
[NCBI]
|
7.45e-06
|
|
|
SLC25A37
|
[NCBI]
|
7.45e-06
|
|
|
ADPRHL1
|
[NCBI]
|
7.45e-06
|
|
|
BTBD2
|
[NCBI]
|
7.45e-06
|
|
|
B3GALTL
|
[NCBI]
|
7.45e-06
|
|
|
MED12L
|
[NCBI]
|
7.45e-06
|
|
|
flavoprotein oxidoreductase mical2
|
[NCBI]
|
7.45e-06
|
|
|
CARD6
|
[NCBI]
|
7.45e-06
|
|
|
SOX8
|
[NCBI]
|
7.45e-06
|
|
|
PDZD11
|
[NCBI]
|
7.45e-06
|
|
|
SYNJ2BP
|
[NCBI]
|
7.45e-06
|
|
|
VEPH1
|
[NCBI]
|
7.45e-06
|
|
|
ZNF673
|
[NCBI]
|
7.45e-06
|
|
|
solute carrier family 22 (organic anion/cation transporter), member 11
|
[NCBI]
|
7.45e-06
|
|
|
PTPN14
|
[NCBI]
|
7.45e-06
|
|
|
PIGM
|
[NCBI]
|
7.45e-06
|
|
|
LSM7
|
[NCBI]
|
7.45e-06
|
|
|
TELO2
|
[NCBI]
|
7.45e-06
|
|
|
TES
|
[NCBI]
|
7.45e-06
|
|
|
TTC7A
|
[NCBI]
|
7.45e-06
|
|
|
LAMA5
|
[NCBI]
|
7.45e-06
|
|
|
sen15, yeast, homolog of
|
[NCBI]
|
7.45e-06
|
|
|
MMAA
|
[NCBI]
|
7.45e-06
|
|
|
KIF21A
|
[NCBI]
|
7.45e-06
|
|
|
CTPP4
|
[NCBI]
|
7.45e-06
|
|
|
mesoderm posterior 1
|
[NCBI]
|
7.45e-06
|
|
|
SHOXY
|
[NCBI]
|
7.45e-06
|
|
|
TMEM142C
|
[NCBI]
|
7.45e-06
|
|
|
PTPLA
|
[NCBI]
|
7.45e-06
|
|
|
activating molecule in beclin 1-regulated autophagy
|
[NCBI]
|
7.45e-06
|
|
|
PTCH2
|
[NCBI]
|
7.45e-06
|
|
|
GLY B+
|
[NCBI]
|
7.45e-06
|
|
|
EML4
|
[NCBI]
|
7.45e-06
|
|
|
KRTAP1-1
|
[NCBI]
|
7.45e-06
|
|
|
FOXP4
|
[NCBI]
|
7.45e-06
|
|
|
KIF5C
|
[NCBI]
|
7.45e-06
|
|
|
AKR7A3
|
[NCBI]
|
7.45e-06
|
|
|
TMEM142B
|
[NCBI]
|
7.45e-06
|
|
|
CROT
|
[NCBI]
|
7.45e-06
|
|
|
NICAL
|
[NCBI]
|
7.45e-06
|
|
|
BTBD1
|
[NCBI]
|
7.45e-06
|
|
|
SMARCE1
|
[NCBI]
|
7.45e-06
|
|
|
NLRP2
|
[NCBI]
|
7.45e-06
|
|
|
ESRRBL1
|
[NCBI]
|
7.45e-06
|
|
|
SIDT1
|
[NCBI]
|
7.45e-06
|
|
|
NOX3
|
[NCBI]
|
7.45e-06
|
|
|
SYCE2
|
[NCBI]
|
7.45e-06
|
|
|
dynein, axonemal, intermediate chain 2
|
[NCBI]
|
7.45e-06
|
|
|
USP16
|
[NCBI]
|
7.45e-06
|
|
|
GLIS1
|
[NCBI]
|
7.45e-06
|
|
|
DULLARD
|
[NCBI]
|
7.45e-06
|
|
|
PDGFRL
|
[NCBI]
|
7.45e-06
|
|
|
OTOA
|
[NCBI]
|
7.45e-06
|
|
|
SAPS2
|
[NCBI]
|
7.45e-06
|
|
|
MAP3K9
|
[NCBI]
|
7.45e-06
|
|
|
SRPX2
|
[NCBI]
|
7.45e-06
|
|
|
HELZ
|
[NCBI]
|
7.45e-06
|
|
|
neurotrimin
|
[NCBI]
|
7.45e-06
|
|
|
PILRB
|
[NCBI]
|
7.45e-06
|
|
|
LHX5
|
[NCBI]
|
7.45e-06
|
|
|
DDX8
|
[NCBI]
|
7.45e-06
|
|
|
MTATP8
|
[NCBI]
|
7.45e-06
|
|
|
PNMA3
|
[NCBI]
|
7.45e-06
|
|
|
cisplatin resistance-associated overexpressed protein
|
[NCBI]
|
7.45e-06
|
|
|
DACT2
|
[NCBI]
|
7.45e-06
|
|
|
REEP1
|
[NCBI]
|
7.45e-06
|
|
|
ran guanine nucleotide release factor
|
[NCBI]
|
7.45e-06
|
|
|
ataxin 2-binding protein 1
|
[NCBI]
|
7.45e-06
|
|
|
BCL9L
|
[NCBI]
|
7.45e-06
|
|
|
nedd8 ultimate buster 1
|
[NCBI]
|
7.45e-06
|
|
|
PRR5
|
[NCBI]
|
7.45e-06
|
|
|
DPH5
|
[NCBI]
|
7.45e-06
|
|
|
NPL
|
[NCBI]
|
7.45e-06
|
|
|
SRPX
|
[NCBI]
|
7.45e-06
|
|
|
CDCA8
|
[NCBI]
|
7.45e-06
|
|
|
FGF11
|
[NCBI]
|
7.45e-06
|
|
|
mitochondrial ribosomal protein s16: mrps16
|
[NCBI]
|
7.45e-06
|
|
|
CRSP3
|
[NCBI]
|
7.45e-06
|
|
|
ELOVL2
|
[NCBI]
|
7.45e-06
|
|
|
RNF4
|
[NCBI]
|
7.45e-06
|
|
|
TRIM46
|
[NCBI]
|
7.45e-06
|
|
|
translokin
|
[NCBI]
|
7.45e-06
|
|
|
OCLM
|
[NCBI]
|
7.45e-06
|
|
|
SOLH
|
[NCBI]
|
7.45e-06
|
|
|
KPNA6
|
[NCBI]
|
7.45e-06
|
|
|
YAF2
|
[NCBI]
|
7.45e-06
|
|
|
KCNV2
|
[NCBI]
|
7.45e-06
|
|
|
abl interactor 2
|
[NCBI]
|
7.45e-06
|
|
|
LSM5
|
[NCBI]
|
7.45e-06
|
|
|
EVI2B
|
[NCBI]
|
7.45e-06
|
|
|
MARVELD2
|
[NCBI]
|
7.45e-06
|
|
|
PLCB4
|
[NCBI]
|
7.45e-06
|
|
|
MARS
|
[NCBI]
|
7.45e-06
|
|
|
TRIP13
|
[NCBI]
|
7.45e-06
|
|
|
NANOS1
|
[NCBI]
|
7.45e-06
|
|
|
EPHA1
|
[NCBI]
|
7.45e-06
|
|
|
SLC17A3
|
[NCBI]
|
7.45e-06
|
|
|
STOML3
|
[NCBI]
|
7.45e-06
|
|
|
ZNF395
|
[NCBI]
|
7.45e-06
|
|
|
KCNS2
|
[NCBI]
|
7.45e-06
|
|
|
COG2
|
[NCBI]
|
7.45e-06
|
|
|
SF3A3
|
[NCBI]
|
7.45e-06
|
|
|
GKAP1
|
[NCBI]
|
7.45e-06
|
|
|
ATPAF2
|
[NCBI]
|
7.45e-06
|
|
|
B3GALT5
|
[NCBI]
|
7.45e-06
|
|
|
SPBC24
|
[NCBI]
|
7.45e-06
|
|
|
HECW1
|
[NCBI]
|
7.45e-06
|
|
|
DACH2
|
[NCBI]
|
7.45e-06
|
|
|
APOBEC2
|
[NCBI]
|
7.45e-06
|
|
|
hematopoietic sh2 domain-containing protein
|
[NCBI]
|
7.45e-06
|
|
|
DPH3
|
[NCBI]
|
7.45e-06
|
|
|
CGNL1
|
[NCBI]
|
7.45e-06
|
|
|
SEC61G
|
[NCBI]
|
7.45e-06
|
|
|
KRTAP1-5
|
[NCBI]
|
7.45e-06
|
|
|
CMYA1
|
[NCBI]
|
7.45e-06
|
|
|
MTMR7
|
[NCBI]
|
7.45e-06
|
|
|
RAB11FIP1
|
[NCBI]
|
7.45e-06
|
|
|
kiaa0274
|
[NCBI]
|
7.45e-06
|
|
|
LRPPRC
|
[NCBI]
|
7.45e-06
|
|
|
SRFBP1
|
[NCBI]
|
7.45e-06
|
|
|
PELI3
|
[NCBI]
|
7.45e-06
|
|
|
NDUFV3
|
[NCBI]
|
7.45e-06
|
|
|
CSMD3
|
[NCBI]
|
7.45e-06
|
|
|
SAPS1
|
[NCBI]
|
7.45e-06
|
|
|
ANAPC5
|
[NCBI]
|
7.45e-06
|
|
|
LSM4
|
[NCBI]
|
7.45e-06
|
|
|
CHAF1A
|
[NCBI]
|
7.45e-06
|
|
|
SP2
|
[NCBI]
|
7.45e-06
|
|
|
minisatellite 33.6
|
[NCBI]
|
7.45e-06
|
|
|
PLEKHM1
|
[NCBI]
|
7.45e-06
|
|
|
ETV2
|
[NCBI]
|
7.45e-06
|
|
|
EDEM3
|
[NCBI]
|
7.45e-06
|
|
|
minisatellite 33.15
|
[NCBI]
|
7.45e-06
|
|
|
AP1G1
|
[NCBI]
|
7.45e-06
|
|
|
PLDN
|
[NCBI]
|
7.45e-06
|
|
|
GPR177
|
[NCBI]
|
7.45e-06
|
|
|
SLC30A2
|
[NCBI]
|
7.45e-06
|
|
|
NEK11
|
[NCBI]
|
7.45e-06
|
|
|
AGGF1
|
[NCBI]
|
7.45e-06
|
|
|
OIT3
|
[NCBI]
|
7.45e-06
|
|
|
TTYH3
|
[NCBI]
|
7.45e-06
|
|
|
MTMR6
|
[NCBI]
|
7.45e-06
|
|
|
ZDHHC9
|
[NCBI]
|
7.45e-06
|
|
|
ARHGAP6
|
[NCBI]
|
7.45e-06
|
|
|
CASC2
|
[NCBI]
|
7.45e-06
|
|
|
SNAPAP
|
[NCBI]
|
7.45e-06
|
|
|
TDRD1
|
[NCBI]
|
7.45e-06
|
|
|
proapoptotic caspase adaptor protein
|
[NCBI]
|
7.45e-06
|
|
|
HIRIP5
|
[NCBI]
|
7.45e-06
|
|
|
NEURL
|
[NCBI]
|
7.45e-06
|
|
|
DVL1L1
|
[NCBI]
|
7.45e-06
|
|
|
LSM3
|
[NCBI]
|
7.45e-06
|
|
|
IFT80
|
[NCBI]
|
7.45e-06
|
|
|
BRWD2
|
[NCBI]
|
7.45e-06
|
|
|
atr-interacting protein
|
[NCBI]
|
7.45e-06
|
|
|
PJA1
|
[NCBI]
|
7.45e-06
|
|
|
PILRA
|
[NCBI]
|
7.45e-06
|
|
|
RAB38
|
[NCBI]
|
7.45e-06
|
|
|
npl4, s. cerevisiae, homolog of
|
[NCBI]
|
7.45e-06
|
|
|
PANK4
|
[NCBI]
|
7.45e-06
|
|
|
TRIM36
|
[NCBI]
|
7.45e-06
|
|
|
RC3H1
|
[NCBI]
|
7.45e-06
|
|
|
MTNR1B
|
[NCBI]
|
7.45e-06
|
|
|
RECQL5
|
[NCBI]
|
7.45e-06
|
|
|
ARL5
|
[NCBI]
|
7.45e-06
|
|
|
BRSK1
|
[NCBI]
|
7.45e-06
|
|
|
CDKL3
|
[NCBI]
|
7.45e-06
|
|
|
KRTAP1-3
|
[NCBI]
|
7.45e-06
|
|
|
flavoprotein oxidoreductase mical3
|
[NCBI]
|
7.45e-06
|
|
|
CARKL
|
[NCBI]
|
7.45e-06
|
|
|
ZSCAN20
|
[NCBI]
|
7.45e-06
|
|
|
TNRC6C
|
[NCBI]
|
7.45e-06
|
|
|
SPRY3
|
[NCBI]
|
7.45e-06
|
|
|
CAPZA2
|
[NCBI]
|
7.45e-06
|
|
|
MYO3A
|
[NCBI]
|
7.45e-06
|
|
|
SRGAP2
|
[NCBI]
|
7.45e-06
|
|
|
TBX20
|
[NCBI]
|
7.45e-06
|
|
|
TMEM113
|
[NCBI]
|
7.45e-06
|
|
|
CDX4
|
[NCBI]
|
7.45e-06
|
|
|
SPG11
|
[NCBI]
|
7.45e-06
|
|
|
CPEB3
|
[NCBI]
|
7.45e-06
|
|
|
kpl2 gene
|
[NCBI]
|
7.45e-06
|
|
|
TUSC2
|
[NCBI]
|
7.45e-06
|
|
|
tetracycline transporter-like protein
|
[NCBI]
|
7.45e-06
|
|
|
SMEK2
|
[NCBI]
|
7.45e-06
|
|
|
SRGAP1
|
[NCBI]
|
7.45e-06
|
|
|
CCRK
|
[NCBI]
|
7.45e-06
|
|
|
ZNF674
|
[NCBI]
|
7.45e-06
|
|
|
SETBP1
|
[NCBI]
|
7.45e-06
|
|
|
LRRN6A
|
[NCBI]
|
7.45e-06
|
|
|
RAB18
|
[NCBI]
|
7.45e-06
|
|
|
KCNH3
|
[NCBI]
|
7.45e-06
|
|
|
ANAPC7
|
[NCBI]
|
7.45e-06
|
|
|
COG3
|
[NCBI]
|
7.45e-06
|
|
|
DSPG3
|
[NCBI]
|
7.45e-06
|
|
|
KRTAP1-4
|
[NCBI]
|
7.45e-06
|
|
|
LSM2
|
[NCBI]
|
7.45e-06
|
|
|
wildtype p53-induced gene
|
[NCBI]
|
7.45e-06
|
|
|
SMC5
|
[NCBI]
|
7.45e-06
|
|
|
ninein-like protein
|
[NCBI]
|
7.45e-06
|
|
|
EIF3M
|
[NCBI]
|
7.45e-06
|
|
|
ADAMTS2
|
[NCBI]
|
7.45e-06
|
|
|
APITD1
|
[NCBI]
|
7.45e-06
|
|
|
RPS6KA6
|
[NCBI]
|
7.45e-06
|
|
|
SLC5A11
|
[NCBI]
|
7.45e-06
|
|
|
FMNL
|
[NCBI]
|
7.45e-06
|
|
|
CNOT8
|
[NCBI]
|
7.45e-06
|
|
|
PIGN
|
[NCBI]
|
7.45e-06
|
|
|
BLOC1S3
|
[NCBI]
|
7.45e-06
|
|
|
DIRC1
|
[NCBI]
|
7.45e-06
|
|
|
CBX7
|
[NCBI]
|
7.45e-06
|
|
|
CAPZA1
|
[NCBI]
|
7.45e-06
|
|
|
COG5
|
[NCBI]
|
7.45e-06
|
|
|
TTYH2
|
[NCBI]
|
7.45e-06
|
|
|
SEC15L1
|
[NCBI]
|
7.45e-06
|
|
|
GYLTL1B
|
[NCBI]
|
7.45e-06
|
|
|
APOBEC3C
|
[NCBI]
|
7.45e-06
|
|
|
CABP2
|
[NCBI]
|
7.45e-06
|
|
|
APOBEC3H
|
[NCBI]
|
7.45e-06
|
|
|
cytochrome p450, family 4, subfamily v, polypeptide 2
|
[NCBI]
|
7.45e-06
|
|
|
SHOC2
|
[NCBI]
|
7.45e-06
|
|
|
HSPCA
|
[NCBI]
|
7.44856e-06
|
|
|
FLT3
|
[NCBI]
|
7.44856e-06
|
|
|
EIF5A
|
[NCBI]
|
7.44856e-06
|
|
|
HAMP
|
[NCBI]
|
7.44856e-06
|
|
|
RXRA
|
[NCBI]
|
7.44856e-06
|
|
|
EPHB2
|
[NCBI]
|
7.44856e-06
|
|
|
GPR54
|
[NCBI]
|
7.44856e-06
|
|
|
myotonia congenita, autosomal dominant
|
[NCBI]
|
7.3689e-06
|
|
|
MTS
|
[NCBI]
|
7.3689e-06
|
|
|
gilbert syndrome
|
[NCBI]
|
7.3689e-06
|
|
|
MCPH1
|
[NCBI]
|
7.3689e-06
|
|
|
lymphedema-distichiasis syndrome
|
[NCBI]
|
7.3689e-06
|
|
|
succinic semialdehyde dehydrogenase deficiency
|
[NCBI]
|
7.3689e-06
|
|
|
glutaric acidemia i
|
[NCBI]
|
7.3689e-06
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 1
|
[NCBI]
|
7.3689e-06
|
|
|
omenn syndrome
|
[NCBI]
|
7.3689e-06
|
|
|
coffin-siris syndrome
|
[NCBI]
|
7.30605e-06
|
|
|
BPES
|
[NCBI]
|
7.28463e-06
|
|
|
down syndrome
|
[NCBI]
|
7.20342e-06
|
|
|
HAE
|
[NCBI]
|
7.18453e-06
|
|
|
HSAN3
|
[NCBI]
|
7.18453e-06
|
|
|
GUSB
|
[NCBI]
|
7.17318e-06
|
|
|
CSF2
|
[NCBI]
|
7.11088e-06
|
|
|
H19
|
[NCBI]
|
7.11088e-06
|
|
|
ALDH1A2
|
[NCBI]
|
7.0806e-06
|
|
|
osteogenic sarcoma
|
[NCBI]
|
7.04996e-06
|
|
|
fructose-1,6-bisphosphatase deficiency
|
[NCBI]
|
7.04996e-06
|
|
|
cutis laxa, autosomal dominant
|
[NCBI]
|
7.04996e-06
|
|
|
gitelman syndrome
|
[NCBI]
|
7.04996e-06
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-negative
|
[NCBI]
|
7.04996e-06
|
|
|
SPG11
|
[NCBI]
|
7.04996e-06
|
|
|
NSHPT
|
[NCBI]
|
7.04996e-06
|
|
|
caffey disease
|
[NCBI]
|
7.04996e-06
|
|
|
INAD1
|
[NCBI]
|
7.04996e-06
|
|
|
ADHR
|
[NCBI]
|
7.04996e-06
|
|
|
HHF6
|
[NCBI]
|
7.04996e-06
|
|
|
corticosteroid-binding globulin deficiency
|
[NCBI]
|
7.04996e-06
|
|
|
epidermolysis bullosa dystrophica, pasini type
|
[NCBI]
|
7.04996e-06
|
|
|
RMS1
|
[NCBI]
|
7.04996e-06
|
|
|
BOCD
|
[NCBI]
|
7.04996e-06
|
|
|
hypoalphalipoproteinemia, primary
|
[NCBI]
|
7.04996e-06
|
|
|
GS2
|
[NCBI]
|
7.04996e-06
|
|
|
SPG10
|
[NCBI]
|
7.04996e-06
|
|
|
mitochondrial myopathy
|
[NCBI]
|
7.04996e-06
|
|
|
carnitine palmitoyltransferase ii deficiency, lethal neonatal
|
[NCBI]
|
7.04996e-06
|
|
|
DDD
|
[NCBI]
|
7.04996e-06
|
|
|
3-@methylglutaconic aciduria, type i
|
[NCBI]
|
7.04996e-06
|
|
|
TPI1
|
[NCBI]
|
7.02429e-06
|
|
|
AQP4
|
[NCBI]
|
6.94199e-06
|
|
|
NAT1
|
[NCBI]
|
6.89889e-06
|
|
|
DCC
|
[NCBI]
|
6.89889e-06
|
|
|
ARMD1
|
[NCBI]
|
6.8204e-06
|
|
|
MKS1
|
[NCBI]
|
6.8204e-06
|
|
|
SNRPN
|
[NCBI]
|
6.77275e-06
|
|
|
LIF
|
[NCBI]
|
6.77275e-06
|
|
|
ASIP
|
[NCBI]
|
6.76343e-06
|
|
|
GATA4
|
[NCBI]
|
6.76343e-06
|
|
|
ERCC1
|
[NCBI]
|
6.76343e-06
|
|
|
FOXC2
|
[NCBI]
|
6.76343e-06
|
|
|
FUT1
|
[NCBI]
|
6.75424e-06
|
|
|
EFNB1
|
[NCBI]
|
6.75424e-06
|
|
|
GRB10
|
[NCBI]
|
6.75424e-06
|
|
|
DSG2
|
[NCBI]
|
6.75424e-06
|
|
|
TECTA
|
[NCBI]
|
6.75424e-06
|
|
|
ETF1
|
[NCBI]
|
6.75424e-06
|
|
|
JUP
|
[NCBI]
|
6.75424e-06
|
|
|
AGTR2
|
[NCBI]
|
6.75424e-06
|
|
|
RHAG
|
[NCBI]
|
6.75424e-06
|
|
|
PLA2G7
|
[NCBI]
|
6.75424e-06
|
|
|
HTATIP
|
[NCBI]
|
6.75424e-06
|
|
|
INS
|
[NCBI]
|
6.71759e-06
|
|
|
TNFRSF10B
|
[NCBI]
|
6.65568e-06
|
|
|
DRPLA
|
[NCBI]
|
6.63416e-06
|
|
|
EVC
|
[NCBI]
|
6.60163e-06
|
|
|
ehlers-danlos syndrome, type i
|
[NCBI]
|
6.55825e-06
|
|
|
faciogenital dysplasia
|
[NCBI]
|
6.55825e-06
|
|
|
ulcerative colitis, susceptibility to
|
[NCBI]
|
6.55825e-06
|
|
|
mucopolysaccharidosis type vi
|
[NCBI]
|
6.55825e-06
|
|
|
long-chain 3-hydroxyacyl-coa dehydrogenase deficiency
|
[NCBI]
|
6.55825e-06
|
|
|
DMRT1
|
[NCBI]
|
6.54979e-06
|
|
|
HADHB
|
[NCBI]
|
6.54979e-06
|
|
|
LAMB2
|
[NCBI]
|
6.54979e-06
|
|
|
TRPM7
|
[NCBI]
|
6.54979e-06
|
|
|
ANGPTL3
|
[NCBI]
|
6.54979e-06
|
|
|
CTF1
|
[NCBI]
|
6.54979e-06
|
|
|
PAK1
|
[NCBI]
|
6.54979e-06
|
|
|
MAP2K4
|
[NCBI]
|
6.54979e-06
|
|
|
TNP1
|
[NCBI]
|
6.54979e-06
|
|
|
HIST2H2AA
|
[NCBI]
|
6.54979e-06
|
|
|
DAB2IP
|
[NCBI]
|
6.54979e-06
|
|
|
FLNC
|
[NCBI]
|
6.54979e-06
|
|
|
RHOC
|
[NCBI]
|
6.54979e-06
|
|
|
PCBD1
|
[NCBI]
|
6.54979e-06
|
|
|
MAP3K14
|
[NCBI]
|
6.54979e-06
|
|
|
CHRM1
|
[NCBI]
|
6.54979e-06
|
|
|
VRK1
|
[NCBI]
|
6.54979e-06
|
|
|
CHIT1
|
[NCBI]
|
6.54979e-06
|
|
|
KLF3
|
[NCBI]
|
6.54979e-06
|
|
|
MAPK8IP3
|
[NCBI]
|
6.54979e-06
|
|
|
SPRY1
|
[NCBI]
|
6.54979e-06
|
|
|
FANCE
|
[NCBI]
|
6.54979e-06
|
|
|
SMC1A
|
[NCBI]
|
6.54979e-06
|
|
|
GNAT2
|
[NCBI]
|
6.54979e-06
|
|
|
complement component 8 deficiency, type ii
|
[NCBI]
|
6.54979e-06
|
|
|
RNU2
|
[NCBI]
|
6.54979e-06
|
|
|
RAD17
|
[NCBI]
|
6.54979e-06
|
|
|
PARD6A
|
[NCBI]
|
6.54979e-06
|
|
|
RENT1
|
[NCBI]
|
6.54979e-06
|
|
|
BMPR1B
|
[NCBI]
|
6.54979e-06
|
|
|
EVPL
|
[NCBI]
|
6.54979e-06
|
|
|
ABCC9
|
[NCBI]
|
6.54979e-06
|
|
|
PKN1
|
[NCBI]
|
6.54979e-06
|
|
|
ISL1
|
[NCBI]
|
6.54979e-06
|
|
|
GNS
|
[NCBI]
|
6.54979e-06
|
|
|
PLCG1
|
[NCBI]
|
6.54979e-06
|
|
|
TCF21
|
[NCBI]
|
6.54979e-06
|
|
|
CBLB
|
[NCBI]
|
6.54979e-06
|
|
|
BCS1L
|
[NCBI]
|
6.54979e-06
|
|
|
ATP10A
|
[NCBI]
|
6.54979e-06
|
|
|
DST
|
[NCBI]
|
6.53184e-06
|
|
|
PRODH
|
[NCBI]
|
6.53184e-06
|
|
|
CST3
|
[NCBI]
|
6.53184e-06
|
|
|
transcobalamin ii deficiency
|
[NCBI]
|
6.43808e-06
|
|
|
C4B
|
[NCBI]
|
6.43808e-06
|
|
|
ASPS
|
[NCBI]
|
6.28572e-06
|
|
|
pyruvate carboxylase deficiency
|
[NCBI]
|
6.28572e-06
|
|
|
pitt syndrome
|
[NCBI]
|
6.28572e-06
|
|
|
seckel syndrome 1
|
[NCBI]
|
6.28572e-06
|
|
|
FGF23
|
[NCBI]
|
6.28189e-06
|
|
|
testicular tumors
|
[NCBI]
|
6.24844e-06
|
|
|
JPS
|
[NCBI]
|
6.18216e-06
|
|
|
SMA3
|
[NCBI]
|
6.1576e-06
|
|
|
CLTC
|
[NCBI]
|
6.13283e-06
|
|
|
MRE11A
|
[NCBI]
|
6.13283e-06
|
|
|
ATR
|
[NCBI]
|
6.13283e-06
|
|
|
EEF2
|
[NCBI]
|
6.13283e-06
|
|
|
CDK4
|
[NCBI]
|
6.10755e-06
|
|
|
PTPRC
|
[NCBI]
|
6.10704e-06
|
|
|
HDGF
|
[NCBI]
|
6.10704e-06
|
|
|
FY
|
[NCBI]
|
6.10049e-06
|
|
|
PC
|
[NCBI]
|
6.07367e-06
|
|
|
SCA2
|
[NCBI]
|
6.02217e-06
|
|
|
EPAS1
|
[NCBI]
|
5.95359e-06
|
|
|
PLAU
|
[NCBI]
|
5.95359e-06
|
|
|
SDHB
|
[NCBI]
|
5.95359e-06
|
|
|
ATRN
|
[NCBI]
|
5.95359e-06
|
|
|
TNFRSF11A
|
[NCBI]
|
5.95359e-06
|
|
|
TULP1
|
[NCBI]
|
5.95359e-06
|
|
|
PIK3R1
|
[NCBI]
|
5.95359e-06
|
|
|
ME2
|
[NCBI]
|
5.95359e-06
|
|
|
TNFRSF25
|
[NCBI]
|
5.95359e-06
|
|
|
NLK
|
[NCBI]
|
5.95359e-06
|
|
|
GALE
|
[NCBI]
|
5.95359e-06
|
|
|
TAP1
|
[NCBI]
|
5.95359e-06
|
|
|
NP
|
[NCBI]
|
5.89235e-06
|
|
|
CALCRL
|
[NCBI]
|
5.86432e-06
|
|
|
PSCA
|
[NCBI]
|
5.77982e-06
|
|
|
ADRP
|
[NCBI]
|
5.77982e-06
|
|
|
LTA
|
[NCBI]
|
5.77982e-06
|
|
|
FN1
|
[NCBI]
|
5.77982e-06
|
|
|
GH1
|
[NCBI]
|
5.72733e-06
|
|
|
SRF
|
[NCBI]
|
5.70063e-06
|
|
|
severe combined immunodeficiency with sensitivity to ionizing radiation
|
[NCBI]
|
5.66108e-06
|
|
|
infantile sialic acid storage disorder
|
[NCBI]
|
5.66108e-06
|
|
|
hartnup disorder
|
[NCBI]
|
5.66108e-06
|
|
|
PABPC1
|
[NCBI]
|
5.63581e-06
|
|
|
osteoarthritis
|
[NCBI]
|
5.56951e-06
|
|
|
CASP1
|
[NCBI]
|
5.55185e-06
|
|
|
MSX1
|
[NCBI]
|
5.55185e-06
|
|
|
DRPLA
|
[NCBI]
|
5.55185e-06
|
|
|
C3
|
[NCBI]
|
5.54355e-06
|
|
|
HGS
|
[NCBI]
|
5.53546e-06
|
|
|
RAC1
|
[NCBI]
|
5.53546e-06
|
|
|
CTCF
|
[NCBI]
|
5.45662e-06
|
|
|
PAI1
|
[NCBI]
|
5.45662e-06
|
|
|
HDAC3
|
[NCBI]
|
5.45662e-06
|
|
|
PEPB
|
[NCBI]
|
5.43104e-06
|
|
|
TDGF1
|
[NCBI]
|
5.43104e-06
|
|
|
ARHGEF6
|
[NCBI]
|
5.43104e-06
|
|
|
CACNB2
|
[NCBI]
|
5.43104e-06
|
|
|
BSCL2
|
[NCBI]
|
5.43104e-06
|
|
|
RABAC1
|
[NCBI]
|
5.43104e-06
|
|
|
KRT12
|
[NCBI]
|
5.43104e-06
|
|
|
GPR98
|
[NCBI]
|
5.43104e-06
|
|
|
PGAM1
|
[NCBI]
|
5.43104e-06
|
|
|
TICAM2
|
[NCBI]
|
5.43104e-06
|
|
|
FACL2
|
[NCBI]
|
5.43104e-06
|
|
|
LIG1
|
[NCBI]
|
5.43104e-06
|
|
|
BCL10
|
[NCBI]
|
5.43104e-06
|
|
|
BCAT1
|
[NCBI]
|
5.43104e-06
|
|
|
TFAP2C
|
[NCBI]
|
5.43104e-06
|
|
|
GNAI2
|
[NCBI]
|
5.43104e-06
|
|
|
FGF14
|
[NCBI]
|
5.43104e-06
|
|
|
NOTCH2
|
[NCBI]
|
5.43104e-06
|
|
|
NUMBL
|
[NCBI]
|
5.43104e-06
|
|
|
CUL4A
|
[NCBI]
|
5.43104e-06
|
|
|
DSC2
|
[NCBI]
|
5.43104e-06
|
|
|
SIP1
|
[NCBI]
|
5.43104e-06
|
|
|
PXN
|
[NCBI]
|
5.43104e-06
|
|
|
ARSE
|
[NCBI]
|
5.43104e-06
|
|
|
SP1
|
[NCBI]
|
5.43104e-06
|
|
|
PDCD6IP
|
[NCBI]
|
5.43104e-06
|
|
|
SLC30A4
|
[NCBI]
|
5.43104e-06
|
|
|
BTG2
|
[NCBI]
|
5.43104e-06
|
|
|
TRPC3
|
[NCBI]
|
5.43104e-06
|
|
|
PRDX1
|
[NCBI]
|
5.43104e-06
|
|
|
HCF2
|
[NCBI]
|
5.43104e-06
|
|
|
RFNG
|
[NCBI]
|
5.43104e-06
|
|
|
heat-shock protein, 75-kd
|
[NCBI]
|
5.43104e-06
|
|
|
DAXX
|
[NCBI]
|
5.43104e-06
|
|
|
TK2
|
[NCBI]
|
5.43104e-06
|
|
|
ABCG8
|
[NCBI]
|
5.43104e-06
|
|
|
GAB2
|
[NCBI]
|
5.43104e-06
|
|
|
TXK
|
[NCBI]
|
5.43104e-06
|
|
|
OPHN1
|
[NCBI]
|
5.43104e-06
|
|
|
SYNJ2
|
[NCBI]
|
5.43104e-06
|
|
|
CITED2
|
[NCBI]
|
5.43104e-06
|
|
|
MTRR
|
[NCBI]
|
5.43104e-06
|
|
|
UNC119
|
[NCBI]
|
5.43104e-06
|
|
|
1-@aminocyclopropane-1-carboxylate synthase
|
[NCBI]
|
5.43104e-06
|
|
|
ACTN3
|
[NCBI]
|
5.43104e-06
|
|
|
ACVR2
|
[NCBI]
|
5.43104e-06
|
|
|
LBP
|
[NCBI]
|
5.41612e-06
|
|
|
ABL
|
[NCBI]
|
5.27046e-06
|
|
|
DM2
|
[NCBI]
|
5.27046e-06
|
|
|
CLN1
|
[NCBI]
|
5.23947e-06
|
|
|
bartter syndrome, type 3
|
[NCBI]
|
5.23947e-06
|
|
|
TGD
|
[NCBI]
|
5.23947e-06
|
|
|
CDC25C
|
[NCBI]
|
5.23895e-06
|
|
|
SNX1
|
[NCBI]
|
5.23895e-06
|
|
|
PNPLA2
|
[NCBI]
|
5.23895e-06
|
|
|
NCF1
|
[NCBI]
|
5.23895e-06
|
|
|
NFKBIA
|
[NCBI]
|
5.23895e-06
|
|
|
LAMP2
|
[NCBI]
|
5.23895e-06
|
|
|
LEF1
|
[NCBI]
|
5.23895e-06
|
|
|
CDH2
|
[NCBI]
|
5.23895e-06
|
|
|
CYBA
|
[NCBI]
|
5.23895e-06
|
|
|
ATP1A2
|
[NCBI]
|
5.23895e-06
|
|
|
LCAT
|
[NCBI]
|
5.19399e-06
|
|
|
F13A1
|
[NCBI]
|
5.16596e-06
|
|
|
ATS
|
[NCBI]
|
5.16298e-06
|
|
|
nijmegen breakage syndrome
|
[NCBI]
|
5.16298e-06
|
|
|
KDR
|
[NCBI]
|
5.16048e-06
|
|
|
PSIP1
|
[NCBI]
|
5.13765e-06
|
|
|
TNFSF13B
|
[NCBI]
|
5.13765e-06
|
|
|
ICAM1
|
[NCBI]
|
5.13765e-06
|
|
|
GHRL
|
[NCBI]
|
5.13765e-06
|
|
|
velocardiofacial syndrome
|
[NCBI]
|
5.10343e-06
|
|
|
DRD4
|
[NCBI]
|
5.02255e-06
|
|
|
tibial muscular dystrophy, tardive
|
[NCBI]
|
5.018e-06
|
|
|
GAN1
|
[NCBI]
|
5.018e-06
|
|
|
CDG2C
|
[NCBI]
|
5.018e-06
|
|
|
CRS1
|
[NCBI]
|
5.018e-06
|
|
|
SOST
|
[NCBI]
|
5.018e-06
|
|
|
nondisjunction
|
[NCBI]
|
5.018e-06
|
|
|
HIPK2
|
[NCBI]
|
5.01626e-06
|
|
|
carboxypeptidase n deficiency
|
[NCBI]
|
4.91416e-06
|
|
|
FBD
|
[NCBI]
|
4.91416e-06
|
|
|
hereditary motor and sensory neuropathy vi
|
[NCBI]
|
4.91416e-06
|
|
|
retinitis pigmentosa-deafness syndrome
|
[NCBI]
|
4.91416e-06
|
|
|
VAMAS1
|
[NCBI]
|
4.91416e-06
|
|
|
erythrocyte lactate transporter defect
|
[NCBI]
|
4.91416e-06
|
|
|
myxoma, intracardiac
|
[NCBI]
|
4.91416e-06
|
|
|
charcot-marie-tooth disease, axonal, with vocal cord paresis, autosomal recessive
|
[NCBI]
|
4.91416e-06
|
|
|
marshall-smith syndrome
|
[NCBI]
|
4.91416e-06
|
|
|
epidermolysis bullosa simplex, ogna type
|
[NCBI]
|
4.91416e-06
|
|
|
malonyl-coa decarboxylase deficiency
|
[NCBI]
|
4.91416e-06
|
|
|
hypophosphatemic rickets, autosomal recessive
|
[NCBI]
|
4.91416e-06
|
|
|
heterotaxy, visceral, 2, autosomal
|
[NCBI]
|
4.91416e-06
|
|
|
SCA27
|
[NCBI]
|
4.91416e-06
|
|
|
CORDX3
|
[NCBI]
|
4.91416e-06
|
|
|
myasthenia, limb-girdle, familial
|
[NCBI]
|
4.91416e-06
|
|
|
hyperlysinemia
|
[NCBI]
|
4.91416e-06
|
|
|
SPG7
|
[NCBI]
|
4.91416e-06
|
|
|
DPR
|
[NCBI]
|
4.91416e-06
|
|
|
mental retardation, x-linked, syndromic, jarid1c-related
|
[NCBI]
|
4.91416e-06
|
|
|
platelet disorder, familial, with associated myeloid malignancy
|
[NCBI]
|
4.91416e-06
|
|
|
trigonocephaly, nonsyndromic
|
[NCBI]
|
4.91416e-06
|
|
|
corneal dystrophy and perceptive deafness
|
[NCBI]
|
4.91416e-06
|
|
|
cardiac arrhythmia, ankyrin-b-related
|
[NCBI]
|
4.91416e-06
|
|
|
pyruvate dehydrogenase phosphatase deficiency
|
[NCBI]
|
4.91416e-06
|
|
|
isobutyryl-coa dehydrogenase deficiency
|
[NCBI]
|
4.91416e-06
|
|
|
branchial arch syndrome, x-linked
|
[NCBI]
|
4.91416e-06
|
|
|
FSGS2
|
[NCBI]
|
4.91416e-06
|
|
|
clubfoot
|
[NCBI]
|
4.91416e-06
|
|
|
ASAT
|
[NCBI]
|
4.91416e-06
|
|
|
lactase deficiency, congenital
|
[NCBI]
|
4.91416e-06
|
|
|
fibromatosis, juvenile hyaline
|
[NCBI]
|
4.91416e-06
|
|
|
osteogenesis imperfecta, type vii
|
[NCBI]
|
4.91416e-06
|
|
|
PRTS
|
[NCBI]
|
4.91416e-06
|
|
|
CAMT
|
[NCBI]
|
4.91416e-06
|
|
|
donnai-barrow syndrome
|
[NCBI]
|
4.91416e-06
|
|
|
CDG1D
|
[NCBI]
|
4.91416e-06
|
|
|
caudal duplication anomaly
|
[NCBI]
|
4.91416e-06
|
|
|
leigh syndrome, x-linked
|
[NCBI]
|
4.91416e-06
|
|
|
nephrotic syndrome, early-onset, with diffuse mesangial sclerosis
|
[NCBI]
|
4.91416e-06
|
|
|
RP18
|
[NCBI]
|
4.91416e-06
|
|
|
RCM1
|
[NCBI]
|
4.91416e-06
|
|
|
bietti crystalline corneoretinal dystrophy
|
[NCBI]
|
4.91416e-06
|
|
|
CDG1K
|
[NCBI]
|
4.91416e-06
|
|
|
RP19
|
[NCBI]
|
4.91416e-06
|
|
|
yellow nail syndrome
|
[NCBI]
|
4.91416e-06
|
|
|
cataract, autosomal dominant, multiple types 1
|
[NCBI]
|
4.91416e-06
|
|
|
CCL
|
[NCBI]
|
4.91416e-06
|
|
|
corneal fleck dystrophy
|
[NCBI]
|
4.91416e-06
|
|
|
immunodeficiency with hyper-igm, type 3
|
[NCBI]
|
4.91416e-06
|
|
|
laurence-moon syndrome
|
[NCBI]
|
4.91416e-06
|
|
|
OPTA1
|
[NCBI]
|
4.91416e-06
|
|
|
ACG1B
|
[NCBI]
|
4.91416e-06
|
|
|
buruli ulcer, susceptibility to
|
[NCBI]
|
4.91416e-06
|
|
|
CSNBAD1
|
[NCBI]
|
4.91416e-06
|
|
|
OPTB2
|
[NCBI]
|
4.91416e-06
|
|
|
tietz syndrome
|
[NCBI]
|
4.91416e-06
|
|
|
SPD2
|
[NCBI]
|
4.91416e-06
|
|
|
FHCA
|
[NCBI]
|
4.91416e-06
|
|
|
syndactyly, type iii
|
[NCBI]
|
4.91416e-06
|
|
|
HHF3
|
[NCBI]
|
4.91416e-06
|
|
|
EBN2
|
[NCBI]
|
4.91416e-06
|
|
|
hyperoxaluria, primary, type ii
|
[NCBI]
|
4.91416e-06
|
|
|
familial mediterranean fever, autosomal dominant
|
[NCBI]
|
4.91416e-06
|
|
|
complement component 4, partial deficiency of
|
[NCBI]
|
4.91416e-06
|
|
|
oncocytoma
|
[NCBI]
|
4.91416e-06
|
|
|
acyl-coa dehydrogenase, long-chain, deficiency of
|
[NCBI]
|
4.91416e-06
|
|
|
precocious puberty, male-limited
|
[NCBI]
|
4.91416e-06
|
|
|
LI3
|
[NCBI]
|
4.91416e-06
|
|
|
CMT1C
|
[NCBI]
|
4.91416e-06
|
|
|
mevalonic aciduria
|
[NCBI]
|
4.91416e-06
|
|
|
CDB1
|
[NCBI]
|
4.9122e-06
|
|
|
lymphedema, hereditary, i
|
[NCBI]
|
4.9122e-06
|
|
|
renal tubular acidosis, distal, autosomal dominant
|
[NCBI]
|
4.9122e-06
|
|
|
JWS
|
[NCBI]
|
4.9122e-06
|
|
|
kindler syndrome
|
[NCBI]
|
4.9122e-06
|
|
|
hypouricemia, renal
|
[NCBI]
|
4.9122e-06
|
|
|
SMMCI
|
[NCBI]
|
4.9122e-06
|
|
|
keratitis-ichthyosis-deafness syndrome, autosomal dominant
|
[NCBI]
|
4.9122e-06
|
|
|
hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
|
[NCBI]
|
4.9122e-06
|
|
|
PCS
|
[NCBI]
|
4.9122e-06
|
|
|
epstein syndrome
|
[NCBI]
|
4.9122e-06
|
|
|
spinocerebellar ataxia, 16q22-linked
|
[NCBI]
|
4.9122e-06
|
|
|
stuve-wiedemann syndrome
|
[NCBI]
|
4.9122e-06
|
|
|
SPG17
|
[NCBI]
|
4.9122e-06
|
|
|
CREM
|
[NCBI]
|
4.82315e-06
|
|
|
FABP3
|
[NCBI]
|
4.82315e-06
|
|
|
CDK6
|
[NCBI]
|
4.82315e-06
|
|
|
SYNGAP1
|
[NCBI]
|
4.8167e-06
|
|
|
GTF2A2
|
[NCBI]
|
4.8167e-06
|
|
|
MSI1
|
[NCBI]
|
4.8167e-06
|
|
|
INOC1
|
[NCBI]
|
4.8167e-06
|
|
|
ERBB2IP
|
[NCBI]
|
4.8167e-06
|
|
|
PTPRT
|
[NCBI]
|
4.8167e-06
|
|
|
UNC93B1
|
[NCBI]
|
4.8167e-06
|
|
|
POLD3
|
[NCBI]
|
4.8167e-06
|
|
|
REC8L1
|
[NCBI]
|
4.8167e-06
|
|
|
PACS2
|
[NCBI]
|
4.8167e-06
|
|
|
NLGN4Y
|
[NCBI]
|
4.8167e-06
|
|
|
HRASLS
|
[NCBI]
|
4.8167e-06
|
|
|
SAPS3
|
[NCBI]
|
4.8167e-06
|
|
|
CAMK1
|
[NCBI]
|
4.8167e-06
|
|
|
EGLN3
|
[NCBI]
|
4.8167e-06
|
|
|
leucine-rich repeat-containing g protein-coupled receptor 7
|
[NCBI]
|
4.8167e-06
|
|
|
homeobox a11, antisense
|
[NCBI]
|
4.8167e-06
|
|
|
WNT9B
|
[NCBI]
|
4.8167e-06
|
|
|
CD96
|
[NCBI]
|
4.8167e-06
|
|
|
CHST5
|
[NCBI]
|
4.8167e-06
|
|
|
SLC7A6
|
[NCBI]
|
4.8167e-06
|
|
|
t-cell antigen receptor, gamma subunit, alternate reading frame protein
|
[NCBI]
|
4.8167e-06
|
|
|
POP1
|
[NCBI]
|
4.8167e-06
|
|
|
nebulette
|
[NCBI]
|
4.8167e-06
|
|
|
ORC5L
|
[NCBI]
|
4.8167e-06
|
|
|
HOXD1
|
[NCBI]
|
4.8167e-06
|
|
|
GPSM2
|
[NCBI]
|
4.8167e-06
|
|
|
SLC22A18AS
|
[NCBI]
|
4.8167e-06
|
|
|
HCST
|
[NCBI]
|
4.8167e-06
|
|
|
traf-interacting protein with a forkhead-associated domain
|
[NCBI]
|
4.8167e-06
|
|
|
CTH
|
[NCBI]
|
4.8167e-06
|
|
|
SUMO3
|
[NCBI]
|
4.8167e-06
|
|
|
d-2-@hydroxyglutarate dehydrogenase
|
[NCBI]
|
4.8167e-06
|
|
|
TARBP1
|
[NCBI]
|
4.8167e-06
|
|
|
HACE1
|
[NCBI]
|
4.8167e-06
|
|
|
COL4A3BP
|
[NCBI]
|
4.8167e-06
|
|
|
RPS6KA2
|
[NCBI]
|
4.8167e-06
|
|
|
CETN2
|
[NCBI]
|
4.8167e-06
|
|
|
SMURF2
|
[NCBI]
|
4.8167e-06
|
|
|
PPP3CB
|
[NCBI]
|
4.8167e-06
|
|
|
GTF2A1
|
[NCBI]
|
4.8167e-06
|
|
|
sds3, yeast, homolog of
|
[NCBI]
|
4.8167e-06
|
|
|
RBM17
|
[NCBI]
|
4.8167e-06
|
|
|
PSMA7
|
[NCBI]
|
4.8167e-06
|
|
|
HERC5
|
[NCBI]
|
4.8167e-06
|
|
|
NDUFA7
|
[NCBI]
|
4.8167e-06
|
|
|
UPF3A
|
[NCBI]
|
4.8167e-06
|
|
|
EIF2B1
|
[NCBI]
|
4.8167e-06
|
|
|
AP1M1
|
[NCBI]
|
4.8167e-06
|
|
|
SMARCAL1
|
[NCBI]
|
4.8167e-06
|
|
|
DMBX1
|
[NCBI]
|
4.8167e-06
|
|
|
CNTN1
|
[NCBI]
|
4.8167e-06
|
|
|
PPP1R3B
|
[NCBI]
|
4.8167e-06
|
|
|
GDF3
|
[NCBI]
|
4.8167e-06
|
|
|
CHL1
|
[NCBI]
|
4.8167e-06
|
|
|
ARID3A
|
[NCBI]
|
4.8167e-06
|
|
|
NXT1
|
[NCBI]
|
4.8167e-06
|
|
|
DMRT2
|
[NCBI]
|
4.8167e-06
|
|
|
PFAS
|
[NCBI]
|
4.8167e-06
|
|
|
GBA2
|
[NCBI]
|
4.8167e-06
|
|
|
fuse-binding protein-interacting repressor
|
[NCBI]
|
4.8167e-06
|
|
|
INPP4A
|
[NCBI]
|
4.8167e-06
|
|
|
TNRC6B
|
[NCBI]
|
4.8167e-06
|
|
|
NGLY1
|
[NCBI]
|
4.8167e-06
|
|
|
ELF1
|
[NCBI]
|
4.8167e-06
|
|
|
IPO11
|
[NCBI]
|
4.8167e-06
|
|
|
RAP1GA1
|
[NCBI]
|
4.8167e-06
|
|
|
PCBP4
|
[NCBI]
|
4.8167e-06
|
|
|
RECQL
|
[NCBI]
|
4.8167e-06
|
|
|
RAB34
|
[NCBI]
|
4.8167e-06
|
|
|
TUFM
|
[NCBI]
|
4.8167e-06
|
|
|
LARS
|
[NCBI]
|
4.8167e-06
|
|
|
PAFAH1B3
|
[NCBI]
|
4.8167e-06
|
|
|
SHROOM4
|
[NCBI]
|
4.8167e-06
|
|
|
ZNF41
|
[NCBI]
|
4.8167e-06
|
|
|
ABHD5
|
[NCBI]
|
4.8167e-06
|
|
|
DDX15
|
[NCBI]
|
4.8167e-06
|
|
|
SLC24A5
|
[NCBI]
|
4.8167e-06
|
|
|
parathyroid hormone-responsive b1 gene
|
[NCBI]
|
4.8167e-06
|
|
|
ETFDH
|
[NCBI]
|
4.8167e-06
|
|
|
SPRY4
|
[NCBI]
|
4.8167e-06
|
|
|
EIF3I
|
[NCBI]
|
4.8167e-06
|
|
|
CLCF1
|
[NCBI]
|
4.8167e-06
|
|
|
UNC5B
|
[NCBI]
|
4.8167e-06
|
|
|
C6ORF55
|
[NCBI]
|
4.8167e-06
|
|
|
CDC16
|
[NCBI]
|
4.8167e-06
|
|
|
MKS1
|
[NCBI]
|
4.8167e-06
|
|
|
CHMP2A
|
[NCBI]
|
4.8167e-06
|
|
|
MKRN3
|
[NCBI]
|
4.8167e-06
|
|
|
PI12
|
[NCBI]
|
4.8167e-06
|
|
|
CHK
|
[NCBI]
|
4.8167e-06
|
|
|
LSM6
|
[NCBI]
|
4.8167e-06
|
|
|
KNTC1
|
[NCBI]
|
4.8167e-06
|
|
|
SMAP1
|
[NCBI]
|
4.8167e-06
|
|
|
DAPK3
|
[NCBI]
|
4.8167e-06
|
|
|
LCA5
|
[NCBI]
|
4.8167e-06
|
|
|
MTHFD1L
|
[NCBI]
|
4.8167e-06
|
|
|
UBR2
|
[NCBI]
|
4.8167e-06
|
|
|
EGLN2
|
[NCBI]
|
4.8167e-06
|
|
|
POLD2
|
[NCBI]
|
4.8167e-06
|
|
|
PKDREJ
|
[NCBI]
|
4.8167e-06
|
|
|
TPK1
|
[NCBI]
|
4.8167e-06
|
|
|
RNASE1
|
[NCBI]
|
4.8167e-06
|
|
|
TXNL4A
|
[NCBI]
|
4.8167e-06
|
|
|
PPM2C
|
[NCBI]
|
4.8167e-06
|
|
|
MAPRE1
|
[NCBI]
|
4.8167e-06
|
|
|
NAP1L1
|
[NCBI]
|
4.8167e-06
|
|
|
RUVBL2
|
[NCBI]
|
4.8167e-06
|
|
|
DCP1A
|
[NCBI]
|
4.8167e-06
|
|
|
HLA-DO
|
[NCBI]
|
4.8167e-06
|
|
|
TP53RK
|
[NCBI]
|
4.8167e-06
|
|
|
NDUFA6
|
[NCBI]
|
4.8167e-06
|
|
|
BAG3
|
[NCBI]
|
4.8167e-06
|
|
|
RAD51C
|
[NCBI]
|
4.8167e-06
|
|
|
CNO
|
[NCBI]
|
4.8167e-06
|
|
|
HIBCH
|
[NCBI]
|
4.8167e-06
|
|
|
CAMTA2
|
[NCBI]
|
4.8167e-06
|
|
|
PIGQ
|
[NCBI]
|
4.8167e-06
|
|
|
C1ORF36
|
[NCBI]
|
4.8167e-06
|
|
|
TIMM8B
|
[NCBI]
|
4.8167e-06
|
|
|
ESCO1
|
[NCBI]
|
4.8167e-06
|
|
|
TSFM
|
[NCBI]
|
4.8167e-06
|
|
|
CART1
|
[NCBI]
|
4.8167e-06
|
|
|
HIST1H4A
|
[NCBI]
|
4.8167e-06
|
|
|
PIWIL4
|
[NCBI]
|
4.8167e-06
|
|
|
ELOVL3
|
[NCBI]
|
4.8167e-06
|
|
|
UGP2
|
[NCBI]
|
4.8167e-06
|
|
|
MTRNR2
|
[NCBI]
|
4.8167e-06
|
|
|
DLGAP3
|
[NCBI]
|
4.8167e-06
|
|
|
RPL39
|
[NCBI]
|
4.8167e-06
|
|
|
CYP2G1
|
[NCBI]
|
4.8167e-06
|
|
|
ATP13A2
|
[NCBI]
|
4.8167e-06
|
|
|
NDUFB8
|
[NCBI]
|
4.8167e-06
|
|
|
WNT2B
|
[NCBI]
|
4.8167e-06
|
|
|
PPP6C
|
[NCBI]
|
4.8167e-06
|
|
|
CYP7B1
|
[NCBI]
|
4.8167e-06
|
|
|
CALML5
|
[NCBI]
|
4.8167e-06
|
|
|
HS1BP3
|
[NCBI]
|
4.8167e-06
|
|
|
PHGDH
|
[NCBI]
|
4.8167e-06
|
|
|
TMOD3
|
[NCBI]
|
4.8167e-06
|
|
|
PTPRH
|
[NCBI]
|
4.8167e-06
|
|
|
EPHB6
|
[NCBI]
|
4.8167e-06
|
|
|
MMP28
|
[NCBI]
|
4.8167e-06
|
|
|
XRN2
|
[NCBI]
|
4.8167e-06
|
|
|
ERDA1
|
[NCBI]
|
4.8167e-06
|
|
|
PAK7
|
[NCBI]
|
4.8167e-06
|
|
|
CCNF
|
[NCBI]
|
4.8167e-06
|
|
|
APOBEC3B
|
[NCBI]
|
4.8167e-06
|
|
|
GARNL1
|
[NCBI]
|
4.8167e-06
|
|
|
CSNK1A1
|
[NCBI]
|
4.8167e-06
|
|
|
MDFI
|
[NCBI]
|
4.8167e-06
|
|
|
SYT11
|
[NCBI]
|
4.8167e-06
|
|
|
HOXA11
|
[NCBI]
|
4.8167e-06
|
|
|
ACP6
|
[NCBI]
|
4.8167e-06
|
|
|
CLASP1
|
[NCBI]
|
4.8167e-06
|
|
|
NEUROD4
|
[NCBI]
|
4.8167e-06
|
|
|
SESN2
|
[NCBI]
|
4.8167e-06
|
|
|
AMTN
|
[NCBI]
|
4.8167e-06
|
|
|
FCRL3
|
[NCBI]
|
4.8167e-06
|
|
|
HPS5
|
[NCBI]
|
4.8167e-06
|
|
|
SLC2A4RG
|
[NCBI]
|
4.8167e-06
|
|
|
AS3MT
|
[NCBI]
|
4.8167e-06
|
|
|
selective lim-binding factor, rat, homolog of
|
[NCBI]
|
4.8167e-06
|
|
|
NCAPG
|
[NCBI]
|
4.8167e-06
|
|
|
COPG2
|
[NCBI]
|
4.8167e-06
|
|
|
AGTPBP1
|
[NCBI]
|
4.8167e-06
|
|
|
ACTA2
|
[NCBI]
|
4.8167e-06
|
|
|
caytaxin
|
[NCBI]
|
4.8167e-06
|
|
|
MYO1C
|
[NCBI]
|
4.8167e-06
|
|
|
WSB1
|
[NCBI]
|
4.8167e-06
|
|
|
PAK4
|
[NCBI]
|
4.8167e-06
|
|
|
MAN2A2
|
[NCBI]
|
4.8167e-06
|
|
|
SPBC25
|
[NCBI]
|
4.8167e-06
|
|
|
PCGF1
|
[NCBI]
|
4.8167e-06
|
|
|
oncogene ovc
|
[NCBI]
|
4.8167e-06
|
|
|
NEIL2
|
[NCBI]
|
4.8167e-06
|
|
|
CTDSP2
|
[NCBI]
|
4.8167e-06
|
|
|
UBL5
|
[NCBI]
|
4.8167e-06
|
|
|
PYGB
|
[NCBI]
|
4.8167e-06
|
|
|
ras-gtpase-activating protein sh3 domain-binding protein
|
[NCBI]
|
4.8167e-06
|
|
|
deleted in endometrial carcinoma
|
[NCBI]
|
4.8167e-06
|
|
|
MESDC2
|
[NCBI]
|
4.8167e-06
|
|
|
EVER2
|
[NCBI]
|
4.8167e-06
|
|
|
MARK1
|
[NCBI]
|
4.8167e-06
|
|
|
ADPRHL2
|
[NCBI]
|
4.8167e-06
|
|
|
CTDSP1
|
[NCBI]
|
4.8167e-06
|
|
|
CPSF1
|
[NCBI]
|
4.8167e-06
|
|
|
MTTR
|
[NCBI]
|
4.8167e-06
|
|
|
KIAA0196
|
[NCBI]
|
4.8167e-06
|
|
|
USP14
|
[NCBI]
|
4.8167e-06
|
|
|
CRBN
|
[NCBI]
|
4.8167e-06
|
|
|
AKR7A2
|
[NCBI]
|
4.8167e-06
|
|
|
IQCB1
|
[NCBI]
|
4.8167e-06
|
|
|
EI24
|
[NCBI]
|
4.8167e-06
|
|
|
HEY1
|
[NCBI]
|
4.8167e-06
|
|
|
ATP5J
|
[NCBI]
|
4.8167e-06
|
|
|
SMARCA1
|
[NCBI]
|
4.8167e-06
|
|
|
PELO
|
[NCBI]
|
4.8167e-06
|
|
|
SLC35A2
|
[NCBI]
|
4.8167e-06
|
|
|
EHMT1
|
[NCBI]
|
4.8167e-06
|
|
|
DPH1
|
[NCBI]
|
4.8167e-06
|
|
|
SEMA6A
|
[NCBI]
|
4.8167e-06
|
|
|
UBE2D2
|
[NCBI]
|
4.8167e-06
|
|
|
PRRX2
|
[NCBI]
|
4.8167e-06
|
|
|
ANKRD3
|
[NCBI]
|
4.8167e-06
|
|
|
NDUFS6
|
[NCBI]
|
4.8167e-06
|
|
|
REXO2
|
[NCBI]
|
4.8167e-06
|
|
|
SETD1A
|
[NCBI]
|
4.8167e-06
|
|
|
ACAD8
|
[NCBI]
|
4.8167e-06
|
|
|
GPR109A
|
[NCBI]
|
4.8167e-06
|
|
|
actin-binding protein, 34-kd
|
[NCBI]
|
4.8167e-06
|
|
|
kinesin family member 27, kif27
|
[NCBI]
|
4.8167e-06
|
|
|
MRPS22
|
[NCBI]
|
4.8167e-06
|
|
|
TULP3
|
[NCBI]
|
4.8167e-06
|
|
|
STK36
|
[NCBI]
|
4.8167e-06
|
|
|
kiaa1199
|
[NCBI]
|
4.8167e-06
|
|
|
PAPOLB
|
[NCBI]
|
4.8167e-06
|
|
|
SCEL
|
[NCBI]
|
4.8167e-06
|
|
|
STXBP3
|
[NCBI]
|
4.8167e-06
|
|
|
SPAG6
|
[NCBI]
|
4.8167e-06
|
|
|
ATP6V0A2
|
[NCBI]
|
4.8167e-06
|
|
|
CERKL
|
[NCBI]
|
4.8167e-06
|
|
|
APOBEC3A
|
[NCBI]
|
4.8167e-06
|
|
|
BRF2
|
[NCBI]
|
4.8167e-06
|
|
|
NOBOX
|
[NCBI]
|
4.8167e-06
|
|
|
GRWD1
|
[NCBI]
|
4.8167e-06
|
|
|
USP26
|
[NCBI]
|
4.8167e-06
|
|
|
TNIK
|
[NCBI]
|
4.8167e-06
|
|
|
NDUFS5
|
[NCBI]
|
4.8167e-06
|
|
|
GPR1
|
[NCBI]
|
4.8167e-06
|
|
|
NDRG2
|
[NCBI]
|
4.8167e-06
|
|
|
ATP11A
|
[NCBI]
|
4.8167e-06
|
|
|
RPPH1
|
[NCBI]
|
4.8167e-06
|
|
|
SAMD9
|
[NCBI]
|
4.8167e-06
|
|
|
FGF17
|
[NCBI]
|
4.8167e-06
|
|
|
POLD4
|
[NCBI]
|
4.8167e-06
|
|
|
RGS7
|
[NCBI]
|
4.8167e-06
|
|
|
kiaa0442
|
[NCBI]
|
4.8167e-06
|
|
|
BRWD3
|
[NCBI]
|
4.8167e-06
|
|
|
CATSPER1
|
[NCBI]
|
4.8167e-06
|
|
|
MIRN27B
|
[NCBI]
|
4.8167e-06
|
|
|
RNF8
|
[NCBI]
|
4.8167e-06
|
|
|
PHLDB2
|
[NCBI]
|
4.8167e-06
|
|
|
WNT8B
|
[NCBI]
|
4.8167e-06
|
|
|
LBX2
|
[NCBI]
|
4.8167e-06
|
|
|
COL25A1
|
[NCBI]
|
4.8167e-06
|
|
|
PLXNA3
|
[NCBI]
|
4.8167e-06
|
|
|
RCE1
|
[NCBI]
|
4.8167e-06
|
|
|
FBN3
|
[NCBI]
|
4.8167e-06
|
|
|
VGLL1
|
[NCBI]
|
4.8167e-06
|
|
|
MAP7
|
[NCBI]
|
4.8167e-06
|
|
|
CENTG2
|
[NCBI]
|
4.8167e-06
|
|
|
DUSP16
|
[NCBI]
|
4.8167e-06
|
|
|
KCNJ13
|
[NCBI]
|
4.8167e-06
|
|
|
XAB1
|
[NCBI]
|
4.8167e-06
|
|
|
MIRN24-1
|
[NCBI]
|
4.8167e-06
|
|
|
MAEA
|
[NCBI]
|
4.8167e-06
|
|
|
B2M
|
[NCBI]
|
4.74757e-06
|
|
|
drug metabolism, poor, cyp2d6-related
|
[NCBI]
|
4.72089e-06
|
|
|
NBS1
|
[NCBI]
|
4.66001e-06
|
|
|
RNASEL
|
[NCBI]
|
4.59947e-06
|
|
|
PAX1
|
[NCBI]
|
4.59947e-06
|
|
|
GJA4
|
[NCBI]
|
4.59947e-06
|
|
|
GNB3
|
[NCBI]
|
4.59947e-06
|
|
|
orotic aciduria i
|
[NCBI]
|
4.59947e-06
|
|
|
GABRG2
|
[NCBI]
|
4.59947e-06
|
|
|
CYP11A1
|
[NCBI]
|
4.59947e-06
|
|
|
ANG
|
[NCBI]
|
4.5623e-06
|
|
|
LYZ
|
[NCBI]
|
4.5223e-06
|
|
|
CACNA1C
|
[NCBI]
|
4.5223e-06
|
|
|
TPO
|
[NCBI]
|
4.51763e-06
|
|
|
SAA1
|
[NCBI]
|
4.51338e-06
|
|
|
ARF3
|
[NCBI]
|
4.5027e-06
|
|
|
SHANK3
|
[NCBI]
|
4.5027e-06
|
|
|
KRTHB6
|
[NCBI]
|
4.5027e-06
|
|
|
CASP9
|
[NCBI]
|
4.5027e-06
|
|
|
KCNMA1
|
[NCBI]
|
4.5027e-06
|
|
|
AMT
|
[NCBI]
|
4.5027e-06
|
|
|
SNCG
|
[NCBI]
|
4.5027e-06
|
|
|
TNNI2
|
[NCBI]
|
4.5027e-06
|
|
|
MDC1
|
[NCBI]
|
4.5027e-06
|
|
|
KRTHA1
|
[NCBI]
|
4.5027e-06
|
|
|
GRHL3
|
[NCBI]
|
4.5027e-06
|
|
|
SLC22A18
|
[NCBI]
|
4.5027e-06
|
|
|
EXO1
|
[NCBI]
|
4.5027e-06
|
|
|
FGF5
|
[NCBI]
|
4.5027e-06
|
|
|
ACACB
|
[NCBI]
|
4.5027e-06
|
|
|
NCAM1
|
[NCBI]
|
4.5027e-06
|
|
|
SOS1
|
[NCBI]
|
4.5027e-06
|
|
|
SFN
|
[NCBI]
|
4.5027e-06
|
|
|
EMT
|
[NCBI]
|
4.5027e-06
|
|
|
CDH3
|
[NCBI]
|
4.5027e-06
|
|
|
IL2RB
|
[NCBI]
|
4.5027e-06
|
|
|
SYN1
|
[NCBI]
|
4.5027e-06
|
|
|
SCN1B
|
[NCBI]
|
4.5027e-06
|
|
|
ING1
|
[NCBI]
|
4.5027e-06
|
|
|
BBS4
|
[NCBI]
|
4.5027e-06
|
|
|
KLK4
|
[NCBI]
|
4.5027e-06
|
|
|
FXR1
|
[NCBI]
|
4.5027e-06
|
|
|
farber lipogranulomatosis
|
[NCBI]
|
4.5027e-06
|
|
|
CD3E
|
[NCBI]
|
4.5027e-06
|
|
|
UBE2I
|
[NCBI]
|
4.5027e-06
|
|
|
XRCC1
|
[NCBI]
|
4.5027e-06
|
|
|
IRAK4
|
[NCBI]
|
4.5027e-06
|
|
|
RPS4X
|
[NCBI]
|
4.5027e-06
|
|
|
SREBF2
|
[NCBI]
|
4.5027e-06
|
|
|
PSMB9
|
[NCBI]
|
4.5027e-06
|
|
|
RIPK1
|
[NCBI]
|
4.49022e-06
|
|
|
SCD
|
[NCBI]
|
4.47106e-06
|
|
|
MCP
|
[NCBI]
|
4.44378e-06
|
|
|
menkes disease
|
[NCBI]
|
4.42914e-06
|
|
|
REG3A
|
[NCBI]
|
4.33752e-06
|
|
|
mucolipidosis ii
|
[NCBI]
|
4.27325e-06
|
|
|
DAP
|
[NCBI]
|
4.26312e-06
|
|
|
SLAMF1
|
[NCBI]
|
4.26312e-06
|
|
|
STAT5A
|
[NCBI]
|
4.25491e-06
|
|
|
EVR1
|
[NCBI]
|
4.24296e-06
|
|
|
TMAU
|
[NCBI]
|
4.24296e-06
|
|
|
GACI
|
[NCBI]
|
4.24296e-06
|
|
|
EDC
|
[NCBI]
|
4.24296e-06
|
|
|
crigler-najjar syndrome
|
[NCBI]
|
4.24296e-06
|
|
|
alopecia areata 1
|
[NCBI]
|
4.23791e-06
|
|
|
twinning, dizygotic
|
[NCBI]
|
4.23791e-06
|
|
|
PAND1
|
[NCBI]
|
4.23791e-06
|
|
|
IL8
|
[NCBI]
|
4.20861e-06
|
|
|
HLA-B
|
[NCBI]
|
4.20861e-06
|
|
|
CXCL12
|
[NCBI]
|
4.20861e-06
|
|
|
REST
|
[NCBI]
|
4.18525e-06
|
|
|
IL2RA
|
[NCBI]
|
4.18525e-06
|
|
|
RUNX1
|
[NCBI]
|
4.18525e-06
|
|
|
prostate cancer
|
[NCBI]
|
4.17893e-06
|
|
|
SCDO1
|
[NCBI]
|
4.10432e-06
|
|
|
PRKCM
|
[NCBI]
|
4.07594e-06
|
|
|
IL4R
|
[NCBI]
|
4.0667e-06
|
|
|
SLC22A5
|
[NCBI]
|
4.0667e-06
|
|
|
PER1
|
[NCBI]
|
4.0667e-06
|
|
|
JK
|
[NCBI]
|
4.02622e-06
|
|
|
GLUD1
|
[NCBI]
|
4.02622e-06
|
|
|
H2AFX
|
[NCBI]
|
4.02622e-06
|
|
|
TGFBR1
|
[NCBI]
|
4.02622e-06
|
|
|
GDI1
|
[NCBI]
|
4.02622e-06
|
|
|
CD40
|
[NCBI]
|
4.02622e-06
|
|
|
CBL
|
[NCBI]
|
4.02622e-06
|
|
|
VCAM1
|
[NCBI]
|
4.02622e-06
|
|
|
ACTA1
|
[NCBI]
|
4.02622e-06
|
|
|
AK1
|
[NCBI]
|
3.90915e-06
|
|
|
DCN
|
[NCBI]
|
3.90915e-06
|
|
|
SRC
|
[NCBI]
|
3.89987e-06
|
|
|
MDM2
|
[NCBI]
|
3.89138e-06
|
|
|
PARP1
|
[NCBI]
|
3.86001e-06
|
|
|
mucopolysaccharidosis type iiic
|
[NCBI]
|
3.84594e-06
|
|
|
diabetes mellitus, insulin-resistant, with acanthosis nigricans
|
[NCBI]
|
3.84594e-06
|
|
|
complement component 7 deficiency
|
[NCBI]
|
3.84594e-06
|
|
|
JBS
|
[NCBI]
|
3.84594e-06
|
|
|
trichodentoosseous syndrome
|
[NCBI]
|
3.84594e-06
|
|
|
COFS1
|
[NCBI]
|
3.84594e-06
|
|
|
EA1
|
[NCBI]
|
3.84594e-06
|
|
|
pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities
|
[NCBI]
|
3.84594e-06
|
|
|
HMN5
|
[NCBI]
|
3.84594e-06
|
|
|
kaposi sarcoma
|
[NCBI]
|
3.84594e-06
|
|
|
autism
|
[NCBI]
|
3.77688e-06
|
|
|
HCRT
|
[NCBI]
|
3.74428e-06
|
|
|
MLL
|
[NCBI]
|
3.74428e-06
|
|
|
GRIA3
|
[NCBI]
|
3.72405e-06
|
|
|
GP9
|
[NCBI]
|
3.72405e-06
|
|
|
SPRY2
|
[NCBI]
|
3.72405e-06
|
|
|
INHA
|
[NCBI]
|
3.72405e-06
|
|
|
KPNB1
|
[NCBI]
|
3.72405e-06
|
|
|
TNFSF12
|
[NCBI]
|
3.72405e-06
|
|
|
PRM1
|
[NCBI]
|
3.72405e-06
|
|
|
CSPG2
|
[NCBI]
|
3.72405e-06
|
|
|
PKP1
|
[NCBI]
|
3.72405e-06
|
|
|
COL5A2
|
[NCBI]
|
3.72405e-06
|
|
|
TEF
|
[NCBI]
|
3.72405e-06
|
|
|
SMAD7
|
[NCBI]
|
3.72405e-06
|
|
|
KRT16
|
[NCBI]
|
3.72405e-06
|
|
|
POT1
|
[NCBI]
|
3.72405e-06
|
|
|
RORA
|
[NCBI]
|
3.72405e-06
|
|
|
FOXF1
|
[NCBI]
|
3.72405e-06
|
|
|
SLC8A1
|
[NCBI]
|
3.72405e-06
|
|
|
MCM2
|
[NCBI]
|
3.72405e-06
|
|
|
DAP3
|
[NCBI]
|
3.72405e-06
|
|
|
CASP8AP2
|
[NCBI]
|
3.72405e-06
|
|
|
LIM2
|
[NCBI]
|
3.72405e-06
|
|
|
NID
|
[NCBI]
|
3.72405e-06
|
|
|
TGIF
|
[NCBI]
|
3.72405e-06
|
|
|
RGS4
|
[NCBI]
|
3.72405e-06
|
|
|
LAMA3
|
[NCBI]
|
3.72405e-06
|
|
|
BBC3
|
[NCBI]
|
3.72405e-06
|
|
|
EPHA4
|
[NCBI]
|
3.72405e-06
|
|
|
RBBP8
|
[NCBI]
|
3.72405e-06
|
|
|
CRMO
|
[NCBI]
|
3.70368e-06
|
|
|
glycogen storage disease v
|
[NCBI]
|
3.70368e-06
|
|
|
ITGA2B
|
[NCBI]
|
3.64655e-06
|
|
|
FGF8
|
[NCBI]
|
3.62487e-06
|
|
|
NCOA3
|
[NCBI]
|
3.61532e-06
|
|
|
IRS2
|
[NCBI]
|
3.61532e-06
|
|
|
IL1B
|
[NCBI]
|
3.61532e-06
|
|
|
STAT4
|
[NCBI]
|
3.61532e-06
|
|
|
AT
|
[NCBI]
|
3.6002e-06
|
|
|
BSG
|
[NCBI]
|
3.57658e-06
|
|
|
JAK1
|
[NCBI]
|
3.54336e-06
|
|
|
ACTC1
|
[NCBI]
|
3.51178e-06
|
|
|
FGF3
|
[NCBI]
|
3.51178e-06
|
|
|
FLT4
|
[NCBI]
|
3.51178e-06
|
|
|
NR4A2
|
[NCBI]
|
3.51178e-06
|
|
|
TNFRSF13B
|
[NCBI]
|
3.51178e-06
|
|
|
HDAC1
|
[NCBI]
|
3.51064e-06
|
|
|
CD47
|
[NCBI]
|
3.50491e-06
|
|
|
CHS
|
[NCBI]
|
3.38317e-06
|
|
|
CAV1
|
[NCBI]
|
3.3275e-06
|
|
|
NOS2A
|
[NCBI]
|
3.3275e-06
|
|
|
KLRK1
|
[NCBI]
|
3.3275e-06
|
|
|
CGD
|
[NCBI]
|
3.31463e-06
|
|
|
SGBS1
|
[NCBI]
|
3.2875e-06
|
|
|
CDL1
|
[NCBI]
|
3.27856e-06
|
|
|
Ii
|
[NCBI]
|
3.27856e-06
|
|
|
DFNA12
|
[NCBI]
|
3.27856e-06
|
|
|
SPG6
|
[NCBI]
|
3.27856e-06
|
|
|
GVM
|
[NCBI]
|
3.27856e-06
|
|
|
SCA14
|
[NCBI]
|
3.27856e-06
|
|
|
metachromatic leukodystrophy due to saposin b deficiency
|
[NCBI]
|
3.27856e-06
|
|
|
phosphoglycerate kinase 1 deficiency
|
[NCBI]
|
3.27856e-06
|
|
|
gracile syndrome
|
[NCBI]
|
3.27856e-06
|
|
|
brody myopathy
|
[NCBI]
|
3.27856e-06
|
|
|
GINGF
|
[NCBI]
|
3.27856e-06
|
|
|
ichthyosis vulgaris
|
[NCBI]
|
3.27856e-06
|
|
|
PPP5C
|
[NCBI]
|
3.27482e-06
|
|
|
CNTNAP2
|
[NCBI]
|
3.27482e-06
|
|
|
UPB1
|
[NCBI]
|
3.27482e-06
|
|
|
COG1
|
[NCBI]
|
3.27482e-06
|
|
|
MCM5
|
[NCBI]
|
3.27482e-06
|
|
|
CFHR5
|
[NCBI]
|
3.27482e-06
|
|
|
NUF2
|
[NCBI]
|
3.27482e-06
|
|
|
PNPT1
|
[NCBI]
|
3.27482e-06
|
|
|
scribble, drosophila, homolog of
|
[NCBI]
|
3.27482e-06
|
|
|
ALG3
|
[NCBI]
|
3.27482e-06
|
|
|
EFNA2
|
[NCBI]
|
3.27482e-06
|
|
|
glycolipid transfer protein
|
[NCBI]
|
3.27482e-06
|
|
|
PF4V1
|
[NCBI]
|
3.27482e-06
|
|
|
PROKR2
|
[NCBI]
|
3.27482e-06
|
|
|
ATIC
|
[NCBI]
|
3.27482e-06
|
|
|
FDFT1
|
[NCBI]
|
3.27482e-06
|
|
|
ITGA9
|
[NCBI]
|
3.27482e-06
|
|
|
HAT1
|
[NCBI]
|
3.27482e-06
|
|
|
RNGTT
|
[NCBI]
|
3.27482e-06
|
|
|
RPA3
|
[NCBI]
|
3.27482e-06
|
|
|
SLC25A3
|
[NCBI]
|
3.27482e-06
|
|
|
SEC63
|
[NCBI]
|
3.27482e-06
|
|
|
HTATIP2
|
[NCBI]
|
3.27482e-06
|
|
|
MLF1IP
|
[NCBI]
|
3.27482e-06
|
|
|
UGT1A9
|
[NCBI]
|
3.27482e-06
|
|
|
TINF2
|
[NCBI]
|
3.27482e-06
|
|
|
CHMP1B
|
[NCBI]
|
3.27482e-06
|
|
|
OSR2
|
[NCBI]
|
3.27482e-06
|
|
|
CNOT7
|
[NCBI]
|
3.27482e-06
|
|
|
PIGB
|
[NCBI]
|
3.27482e-06
|
|
|
actin filament-associated protein
|
[NCBI]
|
3.27482e-06
|
|
|
MIRN34A
|
[NCBI]
|
3.27482e-06
|
|
|
PPT2
|
[NCBI]
|
3.27482e-06
|
|
|
UBE2V2
|
[NCBI]
|
3.27482e-06
|
|
|
GDI2
|
[NCBI]
|
3.27482e-06
|
|
|
LMX1A
|
[NCBI]
|
3.27482e-06
|
|
|
APPBP1
|
[NCBI]
|
3.27482e-06
|
|
|
CLK2
|
[NCBI]
|
3.27482e-06
|
|
|
TLE4
|
[NCBI]
|
3.27482e-06
|
|
|
RNF6
|
[NCBI]
|
3.27482e-06
|
|
|
SLC28A3
|
[NCBI]
|
3.27482e-06
|
|
|
PTHR2
|
[NCBI]
|
3.27482e-06
|
|
|
M6PRBP1
|
[NCBI]
|
3.27482e-06
|
|
|
mast cell immunoreceptor signal transducer
|
[NCBI]
|
3.27482e-06
|
|
|
GZMH
|
[NCBI]
|
3.27482e-06
|
|
|
PHKG1
|
[NCBI]
|
3.27482e-06
|
|
|
ISL2
|
[NCBI]
|
3.27482e-06
|
|
|
PRPF8
|
[NCBI]
|
3.27482e-06
|
|
|
FTMT
|
[NCBI]
|
3.27482e-06
|
|
|
KIR2DL5
|
[NCBI]
|
3.27482e-06
|
|
|
LAF4
|
[NCBI]
|
3.27482e-06
|
|
|
MINPP1
|
[NCBI]
|
3.27482e-06
|
|
|
ELAVL2
|
[NCBI]
|
3.27482e-06
|
|
|
EXTL1
|
[NCBI]
|
3.27482e-06
|
|
|
ZNF423
|
[NCBI]
|
3.27482e-06
|
|
|
TCEB2
|
[NCBI]
|
3.27482e-06
|
|
|
SSTR4
|
[NCBI]
|
3.27482e-06
|
|
|
FAM123B
|
[NCBI]
|
3.27482e-06
|
|
|
PSME3
|
[NCBI]
|
3.27482e-06
|
|
|
SNTA1
|
[NCBI]
|
3.27482e-06
|
|
|
OXCT1
|
[NCBI]
|
3.27482e-06
|
|
|
TTC11
|
[NCBI]
|
3.27482e-06
|
|
|
ATBF1
|
[NCBI]
|
3.27482e-06
|
|
|
AGPS
|
[NCBI]
|
3.27482e-06
|
|
|
NDE1
|
[NCBI]
|
3.27482e-06
|
|
|
DCLRE1A
|
[NCBI]
|
3.27482e-06
|
|
|
IGBP1
|
[NCBI]
|
3.27482e-06
|
|
|
ARHGAP8
|
[NCBI]
|
3.27482e-06
|
|
|
ANAPC2
|
[NCBI]
|
3.27482e-06
|
|
|
TLR6
|
[NCBI]
|
3.27482e-06
|
|
|
CRELD1
|
[NCBI]
|
3.27482e-06
|
|
|
ADHFE1
|
[NCBI]
|
3.27482e-06
|
|
|
ROR1
|
[NCBI]
|
3.27482e-06
|
|
|
deleted in split-hand/split-foot 1 region
|
[NCBI]
|
3.27482e-06
|
|
|
C1QTNF5
|
[NCBI]
|
3.27482e-06
|
|
|
COPS2
|
[NCBI]
|
3.27482e-06
|
|
|
TIMM10
|
[NCBI]
|
3.27482e-06
|
|
|
RDH10
|
[NCBI]
|
3.27482e-06
|
|
|
FAT
|
[NCBI]
|
3.27482e-06
|
|
|
POLG2
|
[NCBI]
|
3.27482e-06
|
|
|
SHROOM3
|
[NCBI]
|
3.27482e-06
|
|
|
DOCK10
|
[NCBI]
|
3.27482e-06
|
|
|
SUPT4H1
|
[NCBI]
|
3.27482e-06
|
|
|
SLC12A6
|
[NCBI]
|
3.27482e-06
|
|
|
MTTY
|
[NCBI]
|
3.27482e-06
|
|
|
PDE6D
|
[NCBI]
|
3.27482e-06
|
|
|
EPB41L5
|
[NCBI]
|
3.27482e-06
|
|
|
PAXIP1
|
[NCBI]
|
3.27482e-06
|
|
|
ETFB
|
[NCBI]
|
3.27482e-06
|
|
|
SHMT2
|
[NCBI]
|
3.27482e-06
|
|
|
DGCR2
|
[NCBI]
|
3.27482e-06
|
|
|
CENTA1
|
[NCBI]
|
3.27482e-06
|
|
|
COIL
|
[NCBI]
|
3.27482e-06
|
|
|
UBE1C
|
[NCBI]
|
3.27482e-06
|
|
|
PIGT
|
[NCBI]
|
3.27482e-06
|
|
|
AXIN2
|
[NCBI]
|
3.27482e-06
|
|
|
SLC28A1
|
[NCBI]
|
3.27482e-06
|
|
|
B4GALNT1
|
[NCBI]
|
3.27482e-06
|
|
|
PRKACA
|
[NCBI]
|
3.27482e-06
|
|
|
SRR
|
[NCBI]
|
3.27482e-06
|
|
|
CTDSPL
|
[NCBI]
|
3.27482e-06
|
|
|
LRP4
|
[NCBI]
|
3.27482e-06
|
|
|
CLDN7
|
[NCBI]
|
3.27482e-06
|
|
|
ORC3L
|
[NCBI]
|
3.27482e-06
|
|
|
STARD8
|
[NCBI]
|
3.27482e-06
|
|
|
TCF15
|
[NCBI]
|
3.27482e-06
|
|
|
DYRK3
|
[NCBI]
|
3.27482e-06
|
|
|
CDR2
|
[NCBI]
|
3.27482e-06
|
|
|
NKX2-8
|
[NCBI]
|
3.27482e-06
|
|
|
HGSNAT
|
[NCBI]
|
3.27482e-06
|
|
|
pcna-associated factor, 15-kd
|
[NCBI]
|
3.27482e-06
|
|
|
MLLT3
|
[NCBI]
|
3.27482e-06
|
|
|
HSD17B8
|
[NCBI]
|
3.27482e-06
|
|
|
CDC37
|
[NCBI]
|
3.27482e-06
|
|
|
RGS9BP
|
[NCBI]
|
3.27482e-06
|
|
|
LUC7L
|
[NCBI]
|
3.27482e-06
|
|
|
PDSS1
|
[NCBI]
|
3.27482e-06
|
|
|
MAFB
|
[NCBI]
|
3.27482e-06
|
|
|
HES6
|
[NCBI]
|
3.27482e-06
|
|
|
ACAA1
|
[NCBI]
|
3.27482e-06
|
|
|
RHOG
|
[NCBI]
|
3.27482e-06
|
|
|
SHPRH
|
[NCBI]
|
3.27482e-06
|
|
|
double parked, drosophila, homolog of
|
[NCBI]
|
3.27482e-06
|
|
|
NBR1
|
[NCBI]
|
3.27482e-06
|
|
|
EVER1
|
[NCBI]
|
3.27482e-06
|
|
|
TBR1
|
[NCBI]
|
3.27482e-06
|
|
|
ZNF350
|
[NCBI]
|
3.27482e-06
|
|
|
COL8A2
|
[NCBI]
|
3.27482e-06
|
|
|
ATG4B
|
[NCBI]
|
3.27482e-06
|
|
|
SCARB2
|
[NCBI]
|
3.27482e-06
|
|
|
RAB13
|
[NCBI]
|
3.27482e-06
|
|
|
KCNK9
|
[NCBI]
|
3.27482e-06
|
|
|
MIPEP
|
[NCBI]
|
3.27482e-06
|
|
|
SOSTDC1
|
[NCBI]
|
3.27482e-06
|
|
|
CLN5
|
[NCBI]
|
3.27482e-06
|
|
|
VIPR2
|
[NCBI]
|
3.27482e-06
|
|
|
CECR2
|
[NCBI]
|
3.27482e-06
|
|
|
MIB1
|
[NCBI]
|
3.27482e-06
|
|
|
ING3
|
[NCBI]
|
3.27482e-06
|
|
|
SH3KBP1
|
[NCBI]
|
3.27482e-06
|
|
|
CTDP1
|
[NCBI]
|
3.27482e-06
|
|
|
solute carrier family 26 (anion transporter), member 6: slc26a6
|
[NCBI]
|
3.27482e-06
|
|
|
LILRB3
|
[NCBI]
|
3.27482e-06
|
|
|
MND1
|
[NCBI]
|
3.27482e-06
|
|
|
MAP4K4
|
[NCBI]
|
3.27482e-06
|
|
|
SEPT4
|
[NCBI]
|
3.27482e-06
|
|
|
KRT13
|
[NCBI]
|
3.27482e-06
|
|
|
TNPO1
|
[NCBI]
|
3.27482e-06
|
|
|
SLC6A1
|
[NCBI]
|
3.27482e-06
|
|
|
TIAF1
|
[NCBI]
|
3.27482e-06
|
|
|
JRK
|
[NCBI]
|
3.27482e-06
|
|
|
SBF1
|
[NCBI]
|
3.27482e-06
|
|
|
CENPI
|
[NCBI]
|
3.27482e-06
|
|
|
EIF4EBP1
|
[NCBI]
|
3.27482e-06
|
|
|
ITGA7
|
[NCBI]
|
3.27482e-06
|
|
|
SNX3
|
[NCBI]
|
3.27482e-06
|
|
|
MAML1
|
[NCBI]
|
3.27482e-06
|
|
|
NR2F6
|
[NCBI]
|
3.27482e-06
|
|
|
BAAT
|
[NCBI]
|
3.27482e-06
|
|
|
NDUFS3
|
[NCBI]
|
3.27482e-06
|
|
|
SFRS8
|
[NCBI]
|
3.27482e-06
|
|
|
IQSEC1
|
[NCBI]
|
3.27482e-06
|
|
|
RSPO1
|
[NCBI]
|
3.27482e-06
|
|
|
SNAP29
|
[NCBI]
|
3.27482e-06
|
|
|
BEST3
|
[NCBI]
|
3.27482e-06
|
|
|
SLITRK1
|
[NCBI]
|
3.27482e-06
|
|
|
SH2D2A
|
[NCBI]
|
3.27482e-06
|
|
|
RAD51AP1
|
[NCBI]
|
3.27482e-06
|
|
|
hemoglobin--alpha locus 3
|
[NCBI]
|
3.27482e-06
|
|
|
GPR40
|
[NCBI]
|
3.27482e-06
|
|
|
SRP54
|
[NCBI]
|
3.27482e-06
|
|
|
TMED10
|
[NCBI]
|
3.27482e-06
|
|
|
SETDB1
|
[NCBI]
|
3.27482e-06
|
|
|
GEM
|
[NCBI]
|
3.27482e-06
|
|
|
SLC35A1
|
[NCBI]
|
3.27482e-06
|
|
|
transcriptional adaptor 3-like
|
[NCBI]
|
3.27482e-06
|
|
|
ARFGEF2
|
[NCBI]
|
3.27482e-06
|
|
|
HOXA2
|
[NCBI]
|
3.27482e-06
|
|
|
GPD1L
|
[NCBI]
|
3.27482e-06
|
|
|
SF3B1
|
[NCBI]
|
3.27482e-06
|
|
|
CRI1
|
[NCBI]
|
3.27482e-06
|
|
|
PACS1
|
[NCBI]
|
3.27482e-06
|
|
|
MTMR4
|
[NCBI]
|
3.27482e-06
|
|
|
CACNA2D2
|
[NCBI]
|
3.27482e-06
|
|
|
RPL37
|
[NCBI]
|
3.27482e-06
|
|
|
ORC2L
|
[NCBI]
|
3.27482e-06
|
|
|
ARL3
|
[NCBI]
|
3.27482e-06
|
|
|
SETMAR
|
[NCBI]
|
3.27482e-06
|
|
|
JMJD1A
|
[NCBI]
|
3.27482e-06
|
|
|
ATF5
|
[NCBI]
|
3.27482e-06
|
|
|
SRGAP3
|
[NCBI]
|
3.27482e-06
|
|
|
TAF10
|
[NCBI]
|
3.27482e-06
|
|
|
OTOR
|
[NCBI]
|
3.27482e-06
|
|
|
CACNG4
|
[NCBI]
|
3.27482e-06
|
|
|
ZNF81
|
[NCBI]
|
3.27482e-06
|
|
|
CLDN19
|
[NCBI]
|
3.27482e-06
|
|
|
ALG10
|
[NCBI]
|
3.27482e-06
|
|
|
INM7
|
[NCBI]
|
3.27482e-06
|
|
|
SC5DL
|
[NCBI]
|
3.27482e-06
|
|
|
ZNF12
|
[NCBI]
|
3.27482e-06
|
|
|
ATP11B
|
[NCBI]
|
3.27482e-06
|
|
|
CENPM
|
[NCBI]
|
3.27482e-06
|
|
|
FRAP1
|
[NCBI]
|
3.27302e-06
|
|
|
TCF7L2
|
[NCBI]
|
3.27051e-06
|
|
|
TLR5
|
[NCBI]
|
3.26638e-06
|
|
|
ADAM17
|
[NCBI]
|
3.26638e-06
|
|
|
LFNG
|
[NCBI]
|
3.25924e-06
|
|
|
SPTB
|
[NCBI]
|
3.25924e-06
|
|
|
THRA
|
[NCBI]
|
3.25924e-06
|
|
|
SLC25A4
|
[NCBI]
|
3.25924e-06
|
|
|
CVS
|
[NCBI]
|
3.21452e-06
|
|
|
ST3
|
[NCBI]
|
3.15988e-06
|
|
|
MRXHF1
|
[NCBI]
|
3.13634e-06
|
|
|
OFD1
|
[NCBI]
|
3.07796e-06
|
|
|
SHEP2
|
[NCBI]
|
3.07796e-06
|
|
|
MMP2
|
[NCBI]
|
3.0705e-06
|
|
|
GRB2
|
[NCBI]
|
3.0705e-06
|
|
|
ARG1
|
[NCBI]
|
3.06622e-06
|
|
|
RDH5
|
[NCBI]
|
3.06622e-06
|
|
|
ZNF148
|
[NCBI]
|
3.06622e-06
|
|
|
PAX9
|
[NCBI]
|
3.06622e-06
|
|
|
ITPA
|
[NCBI]
|
3.06622e-06
|
|
|
NFATC3
|
[NCBI]
|
3.06622e-06
|
|
|
JARID1C
|
[NCBI]
|
3.06622e-06
|
|
|
NUMB
|
[NCBI]
|
3.06622e-06
|
|
|
LTK
|
[NCBI]
|
3.06622e-06
|
|
|
GNL3
|
[NCBI]
|
3.06622e-06
|
|
|
tritanopia
|
[NCBI]
|
3.06622e-06
|
|
|
BCAR1
|
[NCBI]
|
3.06622e-06
|
|
|
FYB
|
[NCBI]
|
3.06622e-06
|
|
|
CX3CR1
|
[NCBI]
|
3.06622e-06
|
|
|
FUT3
|
[NCBI]
|
3.06622e-06
|
|
|
CCND1
|
[NCBI]
|
3.05996e-06
|
|
|
TMOD
|
[NCBI]
|
3.04992e-06
|
|
|
EEA1
|
[NCBI]
|
3.04992e-06
|
|
|
NCSTN
|
[NCBI]
|
3.04992e-06
|
|
|
SMAD2
|
[NCBI]
|
3.04992e-06
|
|
|
HSD11B1
|
[NCBI]
|
3.04992e-06
|
|
|
TFF1
|
[NCBI]
|
3.04608e-06
|
|
|
HLA-DQA1
|
[NCBI]
|
3.04608e-06
|
|
|
SLC3A2
|
[NCBI]
|
3.04608e-06
|
|
|
HMGA2
|
[NCBI]
|
3.04608e-06
|
|
|
CMT1B
|
[NCBI]
|
3.03638e-06
|
|
|
MBL2
|
[NCBI]
|
2.99845e-06
|
|
|
AKT1
|
[NCBI]
|
2.99352e-06
|
|
|
MSTN
|
[NCBI]
|
2.99352e-06
|
|
|
PRF1
|
[NCBI]
|
2.99352e-06
|
|
|
ATF2
|
[NCBI]
|
2.91348e-06
|
|
|
PROS1
|
[NCBI]
|
2.90246e-06
|
|
|
CHUK
|
[NCBI]
|
2.90246e-06
|
|
|
DISC1
|
[NCBI]
|
2.90246e-06
|
|
|
DDOST
|
[NCBI]
|
2.90246e-06
|
|
|
sudden infant death syndrome
|
[NCBI]
|
2.88165e-06
|
|
|
GSR
|
[NCBI]
|
2.81744e-06
|
|
|
ZNF145
|
[NCBI]
|
2.81744e-06
|
|
|
MTS
|
[NCBI]
|
2.78513e-06
|
|
|
cyclic hematopoiesis
|
[NCBI]
|
2.78431e-06
|
|
|
cutis laxa, autosomal recessive, type i
|
[NCBI]
|
2.78431e-06
|
|
|
OPPG
|
[NCBI]
|
2.78431e-06
|
|
|
AEZ
|
[NCBI]
|
2.78431e-06
|
|
|
d-bifunctional protein deficiency
|
[NCBI]
|
2.78431e-06
|
|
|
chromosome 22q13.3 deletion syndrome
|
[NCBI]
|
2.78431e-06
|
|
|
ACCPN
|
[NCBI]
|
2.78431e-06
|
|
|
BMND1
|
[NCBI]
|
2.78431e-06
|
|
|
parkinson disease, mitochondrial
|
[NCBI]
|
2.78431e-06
|
|
|
CES1
|
[NCBI]
|
2.77151e-06
|
|
|
CD8A
|
[NCBI]
|
2.77151e-06
|
|
|
TNFRSF6B
|
[NCBI]
|
2.77151e-06
|
|
|
KL
|
[NCBI]
|
2.77151e-06
|
|
|
MYCN
|
[NCBI]
|
2.77151e-06
|
|
|
CD
|
[NCBI]
|
2.68281e-06
|
|
|
SI
|
[NCBI]
|
2.66426e-06
|
|
|
GSC
|
[NCBI]
|
2.64357e-06
|
|
|
CHRNA1
|
[NCBI]
|
2.63534e-06
|
|
|
SLC2A1
|
[NCBI]
|
2.63534e-06
|
|
|
XK
|
[NCBI]
|
2.63534e-06
|
|
|
HIP1
|
[NCBI]
|
2.63534e-06
|
|
|
ITGB1
|
[NCBI]
|
2.63534e-06
|
|
|
USF2
|
[NCBI]
|
2.63534e-06
|
|
|
UMOD
|
[NCBI]
|
2.62933e-06
|
|
|
CUTL1
|
[NCBI]
|
2.62933e-06
|
|
|
STAR
|
[NCBI]
|
2.54163e-06
|
|
|
KRT18
|
[NCBI]
|
2.50796e-06
|
|
|
AEBP1
|
[NCBI]
|
2.50796e-06
|
|
|
AQP9
|
[NCBI]
|
2.50796e-06
|
|
|
CNTFR
|
[NCBI]
|
2.50796e-06
|
|
|
OLIG2
|
[NCBI]
|
2.50796e-06
|
|
|
MEF2C
|
[NCBI]
|
2.50796e-06
|
|
|
CHRNB2
|
[NCBI]
|
2.50796e-06
|
|
|
EMX2
|
[NCBI]
|
2.50796e-06
|
|
|
MEG3
|
[NCBI]
|
2.50796e-06
|
|
|
MAD2L1
|
[NCBI]
|
2.50796e-06
|
|
|
DLGAP1
|
[NCBI]
|
2.50796e-06
|
|
|
APOBEC1
|
[NCBI]
|
2.50796e-06
|
|
|
SPI1
|
[NCBI]
|
2.50796e-06
|
|
|
ERBB4
|
[NCBI]
|
2.50796e-06
|
|
|
SEMA3F
|
[NCBI]
|
2.50796e-06
|
|
|
SEPT9
|
[NCBI]
|
2.50796e-06
|
|
|
NCOA6
|
[NCBI]
|
2.50796e-06
|
|
|
CTNNA1
|
[NCBI]
|
2.50796e-06
|
|
|
SIX3
|
[NCBI]
|
2.50796e-06
|
|
|
ZAP70
|
[NCBI]
|
2.50796e-06
|
|
|
BCL2L11
|
[NCBI]
|
2.50796e-06
|
|
|
KRT15
|
[NCBI]
|
2.50796e-06
|
|
|
SILV
|
[NCBI]
|
2.50796e-06
|
|
|
PPARGC1A
|
[NCBI]
|
2.50427e-06
|
|
|
PPID
|
[NCBI]
|
2.50427e-06
|
|
|
ADH2
|
[NCBI]
|
2.50427e-06
|
|
|
RPS6
|
[NCBI]
|
2.50427e-06
|
|
|
GJA5
|
[NCBI]
|
2.50427e-06
|
|
|
NOS1
|
[NCBI]
|
2.50427e-06
|
|
|
CD4
|
[NCBI]
|
2.50427e-06
|
|
|
LRP8
|
[NCBI]
|
2.50427e-06
|
|
|
CD44
|
[NCBI]
|
2.50427e-06
|
|
|
ALDH1A1
|
[NCBI]
|
2.50427e-06
|
|
|
AHSG
|
[NCBI]
|
2.50427e-06
|
|
|
ATXN8OS
|
[NCBI]
|
2.50427e-06
|
|
|
RCD3A
|
[NCBI]
|
2.4559e-06
|
|
|
CCZS
|
[NCBI]
|
2.4559e-06
|
|
|
anderson disease
|
[NCBI]
|
2.4559e-06
|
|
|
lymphedema, hereditary, ii
|
[NCBI]
|
2.4559e-06
|
|
|
PGL3
|
[NCBI]
|
2.4559e-06
|
|
|
growth-mental deficiency syndrome of myhre
|
[NCBI]
|
2.4559e-06
|
|
|
myopathy, centronuclear, autosomal recessive
|
[NCBI]
|
2.4559e-06
|
|
|
enterokinase deficiency
|
[NCBI]
|
2.4559e-06
|
|
|
wildervanck syndrome
|
[NCBI]
|
2.4559e-06
|
|
|
vasculopathy, retinal, with cerebral leukodystrophy
|
[NCBI]
|
2.4559e-06
|
|
|
JAE
|
[NCBI]
|
2.4559e-06
|
|
|
spinal muscular atrophy, type i, with congenital bone fractures
|
[NCBI]
|
2.4559e-06
|
|
|
west nile virus, susceptibility to
|
[NCBI]
|
2.4559e-06
|
|
|
MRX54
|
[NCBI]
|
2.4559e-06
|
|
|
optic nerve hypoplasia, bilateral
|
[NCBI]
|
2.4559e-06
|
|
|
NN
|
[NCBI]
|
2.4559e-06
|
|
|
renal tubular acidosis, proximal, with ocular abnormalities and mental retardation
|
[NCBI]
|
2.4559e-06
|
|
|
APBD
|
[NCBI]
|
2.4559e-06
|
|
|
pulmonary alveolar microlithiasis
|
[NCBI]
|
2.4559e-06
|
|
|
shprintzen-goldberg craniosynostosis syndrome
|
[NCBI]
|
2.4559e-06
|
|
|
3-@methylglutaconic aciduria, type iii
|
[NCBI]
|
2.4559e-06
|
|
|
dentin dysplasia, type ii
|
[NCBI]
|
2.4559e-06
|
|
|
PDB1
|
[NCBI]
|
2.4559e-06
|
|
|
ODG1
|
[NCBI]
|
2.4559e-06
|
|
|
hyperprolinemia, type ii
|
[NCBI]
|
2.4559e-06
|
|
|
peroxisomal acyl-coa oxidase deficiency
|
[NCBI]
|
2.4559e-06
|
|
|
CACP
|
[NCBI]
|
2.4559e-06
|
|
|
robinow-sorauf syndrome
|
[NCBI]
|
2.4559e-06
|
|
|
peters-plus syndrome
|
[NCBI]
|
2.4559e-06
|
|
|
follicle-stimulating hormone deficiency, isolated
|
[NCBI]
|
2.4559e-06
|
|
|
carpenter syndrome
|
[NCBI]
|
2.4559e-06
|
|
|
watson syndrome
|
[NCBI]
|
2.4559e-06
|
|
|
mucopolysaccharidosis type iiid
|
[NCBI]
|
2.4559e-06
|
|
|
VF
|
[NCBI]
|
2.4559e-06
|
|
|
pseudodiastrophic dysplasia
|
[NCBI]
|
2.4559e-06
|
|
|
hypogammaglobulinemia and isolated growth hormone deficiency, x-linked
|
[NCBI]
|
2.4559e-06
|
|
|
WARBM
|
[NCBI]
|
2.4559e-06
|
|
|
seizures, benign familial neonatal-infantile
|
[NCBI]
|
2.4559e-06
|
|
|
cystinosis, late-onset juvenile or adolescent nephropathic type
|
[NCBI]
|
2.4559e-06
|
|
|
hairy ears
|
[NCBI]
|
2.4559e-06
|
|
|
insulin-like growth factor i deficiency
|
[NCBI]
|
2.4559e-06
|
|
|
TTDN1
|
[NCBI]
|
2.4559e-06
|
|
|
macrocephaly, benign familial
|
[NCBI]
|
2.4559e-06
|
|
|
KRS
|
[NCBI]
|
2.4559e-06
|
|
|
keratosis palmoplantaris striata i
|
[NCBI]
|
2.4559e-06
|
|
|
MRX59
|
[NCBI]
|
2.4559e-06
|
|
|
ovarian cancer, epithelial
|
[NCBI]
|
2.4559e-06
|
|
|
ramon syndrome
|
[NCBI]
|
2.4559e-06
|
|
|
epidermolysis bullosa herpetiformis, dowling-meara type
|
[NCBI]
|
2.4559e-06
|
|
|
AVSD2
|
[NCBI]
|
2.4559e-06
|
|
|
thalassemia, beta+, silent allele
|
[NCBI]
|
2.4559e-06
|
|
|
TRPS3
|
[NCBI]
|
2.4559e-06
|
|
|
d-2-@hydroxyglutaric aciduria
|
[NCBI]
|
2.4559e-06
|
|
|
RSTS
|
[NCBI]
|
2.41703e-06
|
|
|
SOCS1
|
[NCBI]
|
2.38691e-06
|
|
|
SLC6A6
|
[NCBI]
|
2.38691e-06
|
|
|
LPA
|
[NCBI]
|
2.38691e-06
|
|
|
AMACR
|
[NCBI]
|
2.38691e-06
|
|
|
GRIA1
|
[NCBI]
|
2.38691e-06
|
|
|
RDT
|
[NCBI]
|
2.37017e-06
|
|
|
CASP3
|
[NCBI]
|
2.26351e-06
|
|
|
PAX5
|
[NCBI]
|
2.26351e-06
|
|
|
JUN
|
[NCBI]
|
2.26351e-06
|
|
|
B4GALT7
|
[NCBI]
|
2.25129e-06
|
|
|
PRDX3
|
[NCBI]
|
2.25129e-06
|
|
|
COL13A1
|
[NCBI]
|
2.25129e-06
|
|
|
AARS
|
[NCBI]
|
2.25129e-06
|
|
|
GLMN
|
[NCBI]
|
2.25129e-06
|
|
|
SPTBN4
|
[NCBI]
|
2.25129e-06
|
|
|
CLCNKA
|
[NCBI]
|
2.25129e-06
|
|
|
RGS8
|
[NCBI]
|
2.25129e-06
|
|
|
AP1B1
|
[NCBI]
|
2.25129e-06
|
|
|
IPO13
|
[NCBI]
|
2.25129e-06
|
|
|
LECT1
|
[NCBI]
|
2.25129e-06
|
|
|
DNMT2
|
[NCBI]
|
2.25129e-06
|
|
|
SNF1LK
|
[NCBI]
|
2.25129e-06
|
|
|
GP2
|
[NCBI]
|
2.25129e-06
|
|
|
ADRM1
|
[NCBI]
|
2.25129e-06
|
|
|
CSMD1
|
[NCBI]
|
2.25129e-06
|
|
|
POLI
|
[NCBI]
|
2.25129e-06
|
|
|
PLOD2
|
[NCBI]
|
2.25129e-06
|
|
|
SNCAIP
|
[NCBI]
|
2.25129e-06
|
|
|
TCEB3
|
[NCBI]
|
2.25129e-06
|
|
|
AP1S2
|
[NCBI]
|
2.25129e-06
|
|
|
RBM3
|
[NCBI]
|
2.25129e-06
|
|
|
SENP2
|
[NCBI]
|
2.25129e-06
|
|
|
LRRFIP1
|
[NCBI]
|
2.25129e-06
|
|
|
rad54, s. cerevisiae, homolog of, b
|
[NCBI]
|
2.25129e-06
|
|
|
ALG12
|
[NCBI]
|
2.25129e-06
|
|
|
jtv1 gene
|
[NCBI]
|
2.25129e-06
|
|
|
SOX14
|
[NCBI]
|
2.25129e-06
|
|
|
U2AF2
|
[NCBI]
|
2.25129e-06
|
|
|
ATP5A1
|
[NCBI]
|
2.25129e-06
|
|
|
KLF15
|
[NCBI]
|
2.25129e-06
|
|
|
EIF4B
|
[NCBI]
|
2.25129e-06
|
|
|
DNAH5
|
[NCBI]
|
2.25129e-06
|
|
|
IPMK
|
[NCBI]
|
2.25129e-06
|
|
|
PTGER1
|
[NCBI]
|
2.25129e-06
|
|
|
FAM20C
|
[NCBI]
|
2.25129e-06
|
|
|
PIP5K3
|
[NCBI]
|
2.25129e-06
|
|
|
YARS
|
[NCBI]
|
2.25129e-06
|
|
|
PPP1R9A
|
[NCBI]
|
2.25129e-06
|
|
|
NUDT3
|
[NCBI]
|
2.25129e-06
|
|
|
GIT1
|
[NCBI]
|
2.25129e-06
|
|
|
SLIT1
|
[NCBI]
|
2.25129e-06
|
|
|
SARDH
|
[NCBI]
|
2.25129e-06
|
|
|
OSTM1
|
[NCBI]
|
2.25129e-06
|
|
|
SLC25A32
|
[NCBI]
|
2.25129e-06
|
|
|
JMJD2A
|
[NCBI]
|
2.25129e-06
|
|
|
piwi-like 2: piwil2
|
[NCBI]
|
2.25129e-06
|
|
|
NMNAT2
|
[NCBI]
|
2.25129e-06
|
|
|
ADH7
|
[NCBI]
|
2.25129e-06
|
|
|
MAP2K6
|
[NCBI]
|
2.25129e-06
|
|
|
VPS33B
|
[NCBI]
|
2.25129e-06
|
|
|
MIB2
|
[NCBI]
|
2.25129e-06
|
|
|
SIM1
|
[NCBI]
|
2.25129e-06
|
|
|
CRYGS
|
[NCBI]
|
2.25129e-06
|
|
|
RAD54L
|
[NCBI]
|
2.25129e-06
|
|
|
neuroblastoma stage 4s gene
|
[NCBI]
|
2.25129e-06
|
|
|
TCERG1
|
[NCBI]
|
2.25129e-06
|
|
|
MTHFD2
|
[NCBI]
|
2.25129e-06
|
|
|
CXXC1
|
[NCBI]
|
2.25129e-06
|
|
|
U2AF1
|
[NCBI]
|
2.25129e-06
|
|
|
MIRN122A
|
[NCBI]
|
2.25129e-06
|
|
|
GIF
|
[NCBI]
|
2.25129e-06
|
|
|
CAMLG
|
[NCBI]
|
2.25129e-06
|
|
|
DMTF1
|
[NCBI]
|
2.25129e-06
|
|
|
INSRR
|
[NCBI]
|
2.25129e-06
|
|
|
BEST2
|
[NCBI]
|
2.25129e-06
|
|
|
KCNB1
|
[NCBI]
|
2.25129e-06
|
|
|
GFRA3
|
[NCBI]
|
2.25129e-06
|
|
|
ADMR
|
[NCBI]
|
2.25129e-06
|
|
|
UBE2A
|
[NCBI]
|
2.25129e-06
|
|
|
PPAT
|
[NCBI]
|
2.25129e-06
|
|
|
VAPB
|
[NCBI]
|
2.25129e-06
|
|
|
RPS24
|
[NCBI]
|
2.25129e-06
|
|
|
DGKA
|
[NCBI]
|
2.25129e-06
|
|
|
SLC26A5
|
[NCBI]
|
2.25129e-06
|
|
|
FBP1
|
[NCBI]
|
2.25129e-06
|
|
|
VPS24
|
[NCBI]
|
2.25129e-06
|
|
|
PHLDA2
|
[NCBI]
|
2.25129e-06
|
|
|
NDUFA2
|
[NCBI]
|
2.25129e-06
|
|
|
CORT
|
[NCBI]
|
2.25129e-06
|
|
|
MAP3K11
|
[NCBI]
|
2.25129e-06
|
|
|
TREH
|
[NCBI]
|
2.25129e-06
|
|
|
DNAJB1
|
[NCBI]
|
2.25129e-06
|
|
|
PRSS7
|
[NCBI]
|
2.25129e-06
|
|
|
PDE6A
|
[NCBI]
|
2.25129e-06
|
|
|
SART1
|
[NCBI]
|
2.25129e-06
|
|
|
TCP10
|
[NCBI]
|
2.25129e-06
|
|
|
SH3GL3
|
[NCBI]
|
2.25129e-06
|
|
|
MAP3K13
|
[NCBI]
|
2.25129e-06
|
|
|
SLC34A2
|
[NCBI]
|
2.25129e-06
|
|
|
FANCF
|
[NCBI]
|
2.25129e-06
|
|
|
CTPS
|
[NCBI]
|
2.25129e-06
|
|
|
PRKCSH
|
[NCBI]
|
2.25129e-06
|
|
|
MALL
|
[NCBI]
|
2.25129e-06
|
|
|
HSPB6
|
[NCBI]
|
2.25129e-06
|
|
|
IKZF3
|
[NCBI]
|
2.25129e-06
|
|
|
UGT2B7
|
[NCBI]
|
2.25129e-06
|
|
|
CDK5RAP2
|
[NCBI]
|
2.25129e-06
|
|
|
FGF13
|
[NCBI]
|
2.25129e-06
|
|
|
PDHB
|
[NCBI]
|
2.25129e-06
|
|
|
GYPE
|
[NCBI]
|
2.25129e-06
|
|
|
PPP2R1B
|
[NCBI]
|
2.25129e-06
|
|
|
TGFA
|
[NCBI]
|
2.25129e-06
|
|
|
TGM5
|
[NCBI]
|
2.25129e-06
|
|
|
PCQAP
|
[NCBI]
|
2.25129e-06
|
|
|
RABGAP1L
|
[NCBI]
|
2.25129e-06
|
|
|
TSTA3
|
[NCBI]
|
2.25129e-06
|
|
|
TCEB1
|
[NCBI]
|
2.25129e-06
|
|
|
BRSK2
|
[NCBI]
|
2.25129e-06
|
|
|
ITGB3BP
|
[NCBI]
|
2.25129e-06
|
|
|
ESX1L
|
[NCBI]
|
2.25129e-06
|
|
|
VAX2
|
[NCBI]
|
2.25129e-06
|
|
|
PHF8
|
[NCBI]
|
2.25129e-06
|
|
|
IHPK1
|
[NCBI]
|
2.25129e-06
|
|
|
CHMP1A
|
[NCBI]
|
2.25129e-06
|
|
|
VSIG4
|
[NCBI]
|
2.25129e-06
|
|
|
CTRC
|
[NCBI]
|
2.25129e-06
|
|
|
KRT3
|
[NCBI]
|
2.25129e-06
|
|
|
ACTR1A
|
[NCBI]
|
2.25129e-06
|
|
|
RHEB2
|
[NCBI]
|
2.25129e-06
|
|
|
EVC
|
[NCBI]
|
2.25129e-06
|
|
|
PRM2
|
[NCBI]
|
2.25129e-06
|
|
|
PEX14
|
[NCBI]
|
2.25129e-06
|
|
|
RAB3GAP1
|
[NCBI]
|
2.25129e-06
|
|
|
CABP1
|
[NCBI]
|
2.25129e-06
|
|
|
ESPL1
|
[NCBI]
|
2.25129e-06
|
|
|
BEST4
|
[NCBI]
|
2.25129e-06
|
|
|
TJP2
|
[NCBI]
|
2.25129e-06
|
|
|
vesicle docking protein, 115-kd
|
[NCBI]
|
2.25129e-06
|
|
|
SSB
|
[NCBI]
|
2.25129e-06
|
|
|
CSPG3
|
[NCBI]
|
2.25129e-06
|
|
|
SSTR3
|
[NCBI]
|
2.25129e-06
|
|
|
GDF9
|
[NCBI]
|
2.25129e-06
|
|
|
MYOG
|
[NCBI]
|
2.25129e-06
|
|
|
CATSPER2
|
[NCBI]
|
2.25129e-06
|
|
|
KRTHB1
|
[NCBI]
|
2.25129e-06
|
|
|
SUPT5H
|
[NCBI]
|
2.25129e-06
|
|
|
CIZ1
|
[NCBI]
|
2.25129e-06
|
|
|
PASK
|
[NCBI]
|
2.25129e-06
|
|
|
AP1S1
|
[NCBI]
|
2.25129e-06
|
|
|
SHANK1
|
[NCBI]
|
2.25129e-06
|
|
|
EPN1
|
[NCBI]
|
2.25129e-06
|
|
|
SP4
|
[NCBI]
|
2.25129e-06
|
|
|
DOCK1
|
[NCBI]
|
2.25129e-06
|
|
|
RGR
|
[NCBI]
|
2.25129e-06
|
|
|
ITM2B
|
[NCBI]
|
2.25129e-06
|
|
|
MSC
|
[NCBI]
|
2.25129e-06
|
|
|
SDCBP
|
[NCBI]
|
2.25129e-06
|
|
|
ELAVL3
|
[NCBI]
|
2.25129e-06
|
|
|
NLGN1
|
[NCBI]
|
2.25129e-06
|
|
|
CLSTN1
|
[NCBI]
|
2.25129e-06
|
|
|
PRSS2
|
[NCBI]
|
2.25129e-06
|
|
|
SP3
|
[NCBI]
|
2.25129e-06
|
|
|
BFSP1
|
[NCBI]
|
2.25129e-06
|
|
|
CDH6
|
[NCBI]
|
2.25129e-06
|
|
|
SLAMF6
|
[NCBI]
|
2.25129e-06
|
|
|
PYCS
|
[NCBI]
|
2.25129e-06
|
|
|
WNT7B
|
[NCBI]
|
2.25129e-06
|
|
|
GPR109B
|
[NCBI]
|
2.25129e-06
|
|
|
GDF6
|
[NCBI]
|
2.25129e-06
|
|
|
SLC5A8
|
[NCBI]
|
2.25129e-06
|
|
|
SLC6A5
|
[NCBI]
|
2.25129e-06
|
|
|
SLC7A8
|
[NCBI]
|
2.25129e-06
|
|
|
SPG20
|
[NCBI]
|
2.25129e-06
|
|
|
YWHAH
|
[NCBI]
|
2.25129e-06
|
|
|
SEC61B
|
[NCBI]
|
2.25129e-06
|
|
|
ABCD3
|
[NCBI]
|
2.25129e-06
|
|
|
PTK7
|
[NCBI]
|
2.25129e-06
|
|
|
KNSL2
|
[NCBI]
|
2.25129e-06
|
|
|
PIP5K1B
|
[NCBI]
|
2.25129e-06
|
|
|
MTTL2
|
[NCBI]
|
2.25129e-06
|
|
|
USP6NL
|
[NCBI]
|
2.25129e-06
|
|
|
ITGA6
|
[NCBI]
|
2.25129e-06
|
|
|
SHOX2
|
[NCBI]
|
2.25129e-06
|
|
|
EPX
|
[NCBI]
|
2.25129e-06
|
|
|
RFX1
|
[NCBI]
|
2.25129e-06
|
|
|
MAF1
|
[NCBI]
|
2.25129e-06
|
|
|
HIPK1
|
[NCBI]
|
2.25129e-06
|
|
|
MCHR2
|
[NCBI]
|
2.25129e-06
|
|
|
AK3L1
|
[NCBI]
|
2.25129e-06
|
|
|
FGF4
|
[NCBI]
|
2.24491e-06
|
|
|
HPX
|
[NCBI]
|
2.24491e-06
|
|
|
ETS1
|
[NCBI]
|
2.24491e-06
|
|
|
PNKP
|
[NCBI]
|
2.24491e-06
|
|
|
HTR2A
|
[NCBI]
|
2.24491e-06
|
|
|
TLR7
|
[NCBI]
|
2.24491e-06
|
|
|
AQP1
|
[NCBI]
|
2.22979e-06
|
|
|
ILK
|
[NCBI]
|
2.2282e-06
|
|
|
CTLA4
|
[NCBI]
|
2.18073e-06
|
|
|
SEMA3A
|
[NCBI]
|
2.18073e-06
|
|
|
DNMT1
|
[NCBI]
|
2.15152e-06
|
|
|
pulmonary fibrosis, idiopathic
|
[NCBI]
|
2.14271e-06
|
|
|
aortic aneurysm, abdominal
|
[NCBI]
|
2.14271e-06
|
|
|
RTD
|
[NCBI]
|
2.14271e-06
|
|
|
PCLD
|
[NCBI]
|
2.13602e-06
|
|
|
HRPT1
|
[NCBI]
|
2.13602e-06
|
|
|
AIED
|
[NCBI]
|
2.13602e-06
|
|
|
TRAF2
|
[NCBI]
|
2.11755e-06
|
|
|
STAT1
|
[NCBI]
|
2.05515e-06
|
|
|
DFNA6
|
[NCBI]
|
2.05178e-06
|
|
|
PMDS
|
[NCBI]
|
2.05178e-06
|
|
|
XPF
|
[NCBI]
|
2.05178e-06
|
|
|
tight skin contracture syndrome, lethal
|
[NCBI]
|
2.05178e-06
|
|
|
ALUNC
|
[NCBI]
|
2.05178e-06
|
|
|
myotonia congenita, autosomal recessive
|
[NCBI]
|
2.05178e-06
|
|
|
acheiropody
|
[NCBI]
|
2.05178e-06
|
|
|
CMT2B
|
[NCBI]
|
2.05178e-06
|
|
|
RLBP1
|
[NCBI]
|
2.05157e-06
|
|
|
TPH2
|
[NCBI]
|
2.03321e-06
|
|
|
CRYGA
|
[NCBI]
|
2.03321e-06
|
|
|
ATP1A1
|
[NCBI]
|
2.03321e-06
|
|
|
ATXN2
|
[NCBI]
|
2.03321e-06
|
|
|
FCGR2A
|
[NCBI]
|
2.03321e-06
|
|
|
MED12
|
[NCBI]
|
2.03321e-06
|
|
|
CA4
|
[NCBI]
|
2.03321e-06
|
|
|
NCF2
|
[NCBI]
|
2.03321e-06
|
|
|
EN2
|
[NCBI]
|
2.03321e-06
|
|
|
PRPS1
|
[NCBI]
|
2.03321e-06
|
|
|
HMGA1
|
[NCBI]
|
2.03321e-06
|
|
|
MPI
|
[NCBI]
|
2.03321e-06
|
|
|
PVRL1
|
[NCBI]
|
2.03321e-06
|
|
|
CDX2
|
[NCBI]
|
2.03321e-06
|
|
|
OLR1
|
[NCBI]
|
2.03321e-06
|
|
|
UBB
|
[NCBI]
|
2.03321e-06
|
|
|
tyrosine transaminase deficiency
|
[NCBI]
|
2.03321e-06
|
|
|
PML
|
[NCBI]
|
1.99552e-06
|
|
|
IL12B
|
[NCBI]
|
1.99552e-06
|
|
|
HK1
|
[NCBI]
|
1.99403e-06
|
|
|
MMP1
|
[NCBI]
|
1.99403e-06
|
|
|
PIAS1
|
[NCBI]
|
1.99403e-06
|
|
|
ALCAM
|
[NCBI]
|
1.99403e-06
|
|
|
MTCO3
|
[NCBI]
|
1.99403e-06
|
|
|
DFFA
|
[NCBI]
|
1.99403e-06
|
|
|
CDA
|
[NCBI]
|
1.981e-06
|
|
|
EGR1
|
[NCBI]
|
1.981e-06
|
|
|
LIFR
|
[NCBI]
|
1.981e-06
|
|
|
HIF1A
|
[NCBI]
|
1.981e-06
|
|
|
KLF4
|
[NCBI]
|
1.96371e-06
|
|
|
RBS
|
[NCBI]
|
1.95164e-06
|
|
|
NRP1
|
[NCBI]
|
1.93053e-06
|
|
|
FOS
|
[NCBI]
|
1.93053e-06
|
|
|
CASP8
|
[NCBI]
|
1.93053e-06
|
|
|
AACT
|
[NCBI]
|
1.93053e-06
|
|
|
H3F3A
|
[NCBI]
|
1.93053e-06
|
|
|
CARM1
|
[NCBI]
|
1.93053e-06
|
|
|
HHT
|
[NCBI]
|
1.92665e-06
|
|
|
GRA
|
[NCBI]
|
1.89956e-06
|
|
|
AMH
|
[NCBI]
|
1.89655e-06
|
|
|
carbamoyl phosphate synthetase i deficiency, hyperammonemia due to
|
[NCBI]
|
1.85156e-06
|
|
|
von willebrand disease, recessive form
|
[NCBI]
|
1.85156e-06
|
|
|
CYLD
|
[NCBI]
|
1.85156e-06
|
|
|
HPE2
|
[NCBI]
|
1.85156e-06
|
|
|
plasminogen deficiency, type i
|
[NCBI]
|
1.85156e-06
|
|
|
HHS
|
[NCBI]
|
1.85156e-06
|
|
|
PPD2
|
[NCBI]
|
1.85156e-06
|
|
|
SNDI
|
[NCBI]
|
1.85156e-06
|
|
|
abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism
|
[NCBI]
|
1.85156e-06
|
|
|
hyperlipoproteinemia, type ii
|
[NCBI]
|
1.85156e-06
|
|
|
EIF4E
|
[NCBI]
|
1.84973e-06
|
|
|
BCHE
|
[NCBI]
|
1.79222e-06
|
|
|
ACOX1
|
[NCBI]
|
1.75231e-06
|
|
|
CDSN
|
[NCBI]
|
1.75231e-06
|
|
|
TRAF6
|
[NCBI]
|
1.75231e-06
|
|
|
CFI
|
[NCBI]
|
1.742e-06
|
|
|
PRLR
|
[NCBI]
|
1.72156e-06
|
|
|
LEP
|
[NCBI]
|
1.68824e-06
|
|
|
SOCS3
|
[NCBI]
|
1.67803e-06
|
|
|
TFRC
|
[NCBI]
|
1.6623e-06
|
|
|
INSL3
|
[NCBI]
|
1.6623e-06
|
|
|
OPTB1
|
[NCBI]
|
1.6463e-06
|
|
|
COL4A1
|
[NCBI]
|
1.633e-06
|
|
|
BIRC5
|
[NCBI]
|
1.633e-06
|
|
|
SF1
|
[NCBI]
|
1.6295e-06
|
|
|
3-@hydroxy-3-methylglutaryl-coa lyase deficiency
|
[NCBI]
|
1.6295e-06
|
|
|
SLC25A1
|
[NCBI]
|
1.6295e-06
|
|
|
DSCR1
|
[NCBI]
|
1.6295e-06
|
|
|
FOLR1
|
[NCBI]
|
1.6295e-06
|
|
|
P2RX7
|
[NCBI]
|
1.6295e-06
|
|
|
FSHB
|
[NCBI]
|
1.6295e-06
|
|
|
SPAM1
|
[NCBI]
|
1.6295e-06
|
|
|
PRPH
|
[NCBI]
|
1.6295e-06
|
|
|
ADAR
|
[NCBI]
|
1.6295e-06
|
|
|
SCN2A
|
[NCBI]
|
1.6295e-06
|
|
|
MT1A
|
[NCBI]
|
1.6295e-06
|
|
|
DVL1
|
[NCBI]
|
1.6295e-06
|
|
|
KRT10
|
[NCBI]
|
1.6295e-06
|
|
|
CLDN1
|
[NCBI]
|
1.6295e-06
|
|
|
SLC1A2
|
[NCBI]
|
1.60213e-06
|
|
|
HNMT
|
[NCBI]
|
1.60213e-06
|
|
|
PDYN
|
[NCBI]
|
1.60213e-06
|
|
|
CDK8
|
[NCBI]
|
1.53306e-06
|
|
|
DYNLL1
|
[NCBI]
|
1.53306e-06
|
|
|
TLE1
|
[NCBI]
|
1.53306e-06
|
|
|
ABCB7
|
[NCBI]
|
1.53306e-06
|
|
|
HMGCS1
|
[NCBI]
|
1.53306e-06
|
|
|
DHCR24
|
[NCBI]
|
1.53306e-06
|
|
|
STK3
|
[NCBI]
|
1.53306e-06
|
|
|
DIA3
|
[NCBI]
|
1.53306e-06
|
|
|
ARMET
|
[NCBI]
|
1.53306e-06
|
|
|
SPAG9
|
[NCBI]
|
1.53306e-06
|
|
|
ASF1A
|
[NCBI]
|
1.53306e-06
|
|
|
PLXNB1
|
[NCBI]
|
1.53306e-06
|
|
|
IGFBP4
|
[NCBI]
|
1.53306e-06
|
|
|
NDST1
|
[NCBI]
|
1.53306e-06
|
|
|
PDHX
|
[NCBI]
|
1.53306e-06
|
|
|
precursor mrna-processing factor 3, s. cerevisiae, homolog of
|
[NCBI]
|
1.53306e-06
|
|
|
LSS
|
[NCBI]
|
1.53306e-06
|
|
|
SRG1
|
[NCBI]
|
1.53306e-06
|
|
|
FOXF2
|
[NCBI]
|
1.53306e-06
|
|
|
TAS1R1
|
[NCBI]
|
1.53306e-06
|
|
|
CCT3
|
[NCBI]
|
1.53306e-06
|
|
|
SLC9A3
|
[NCBI]
|
1.53306e-06
|
|
|
DLX3
|
[NCBI]
|
1.53306e-06
|
|
|
MYO9B
|
[NCBI]
|
1.53306e-06
|
|
|
ATOX1
|
[NCBI]
|
1.53306e-06
|
|
|
SPTBN1
|
[NCBI]
|
1.53306e-06
|
|
|
MGP
|
[NCBI]
|
1.53306e-06
|
|
|
NAB1
|
[NCBI]
|
1.53306e-06
|
|
|
HOXD11
|
[NCBI]
|
1.53306e-06
|
|
|
NIPA1
|
[NCBI]
|
1.53306e-06
|
|
|
BAD
|
[NCBI]
|
1.53306e-06
|
|
|
SMG6
|
[NCBI]
|
1.53306e-06
|
|
|
IFITM1
|
[NCBI]
|
1.53306e-06
|
|
|
CAMTA1
|
[NCBI]
|
1.53306e-06
|
|
|
PXF
|
[NCBI]
|
1.53306e-06
|
|
|
ANK2
|
[NCBI]
|
1.53306e-06
|
|
|
NEK2
|
[NCBI]
|
1.53306e-06
|
|
|
COL19A1
|
[NCBI]
|
1.53306e-06
|
|
|
KLK8
|
[NCBI]
|
1.53306e-06
|
|
|
TEAD1
|
[NCBI]
|
1.53306e-06
|
|
|
KIF5A
|
[NCBI]
|
1.53306e-06
|
|
|
MAML2
|
[NCBI]
|
1.53306e-06
|
|
|
RPS16
|
[NCBI]
|
1.53306e-06
|
|
|
switch-associated protein 70
|
[NCBI]
|
1.53306e-06
|
|
|
SMG5
|
[NCBI]
|
1.53306e-06
|
|
|
RUVBL1
|
[NCBI]
|
1.53306e-06
|
|
|
BSN
|
[NCBI]
|
1.53306e-06
|
|
|
CACNB3
|
[NCBI]
|
1.53306e-06
|
|
|
RPA2
|
[NCBI]
|
1.53306e-06
|
|
|
GCN5L2
|
[NCBI]
|
1.53306e-06
|
|
|
ARRB1
|
[NCBI]
|
1.53306e-06
|
|
|
PVRL2
|
[NCBI]
|
1.53306e-06
|
|
|
CSDE1
|
[NCBI]
|
1.53306e-06
|
|
|
KPNA1
|
[NCBI]
|
1.53306e-06
|
|
|
BCOR
|
[NCBI]
|
1.53306e-06
|
|
|
SLC35C1
|
[NCBI]
|
1.53306e-06
|
|
|
PARD3
|
[NCBI]
|
1.53306e-06
|
|
|
RASD1
|
[NCBI]
|
1.53306e-06
|
|
|
KDELR1
|
[NCBI]
|
1.53306e-06
|
|
|
S100A6
|
[NCBI]
|
1.53306e-06
|
|
|
PFTK1
|
[NCBI]
|
1.53306e-06
|
|
|
GLI2
|
[NCBI]
|
1.53306e-06
|
|
|
AQP8
|
[NCBI]
|
1.53306e-06
|
|
|
GDF1
|
[NCBI]
|
1.53306e-06
|
|
|
TP53BP1
|
[NCBI]
|
1.53306e-06
|
|
|
VBP1
|
[NCBI]
|
1.53306e-06
|
|
|
ZFPM1
|
[NCBI]
|
1.53306e-06
|
|
|
NFE2
|
[NCBI]
|
1.53306e-06
|
|
|
SLC2A10
|
[NCBI]
|
1.53306e-06
|
|
|
GFRA2
|
[NCBI]
|
1.53306e-06
|
|
|
RTN3
|
[NCBI]
|
1.53306e-06
|
|
|
PLOD3
|
[NCBI]
|
1.53306e-06
|
|
|
MAD1L1
|
[NCBI]
|
1.53306e-06
|
|
|
HOXD12
|
[NCBI]
|
1.53306e-06
|
|
|
golgi-localized syntaphilin-related protein
|
[NCBI]
|
1.53306e-06
|
|
|
TNFRSF12A
|
[NCBI]
|
1.53306e-06
|
|
|
MIRN124A1
|
[NCBI]
|
1.53306e-06
|
|
|
PARP2
|
[NCBI]
|
1.53306e-06
|
|
|
SOAT2
|
[NCBI]
|
1.53306e-06
|
|
|
humanin
|
[NCBI]
|
1.53306e-06
|
|
|
PI9
|
[NCBI]
|
1.53306e-06
|
|
|
ZBP1
|
[NCBI]
|
1.53306e-06
|
|
|
PLEKHC1
|
[NCBI]
|
1.53306e-06
|
|
|
GABRA2
|
[NCBI]
|
1.53306e-06
|
|
|
HMOX2
|
[NCBI]
|
1.53306e-06
|
|
|
STUB1
|
[NCBI]
|
1.53306e-06
|
|
|
PCSK7
|
[NCBI]
|
1.53306e-06
|
|
|
NDEL1
|
[NCBI]
|
1.53306e-06
|
|
|
RAB8A
|
[NCBI]
|
1.53306e-06
|
|
|
GNA13
|
[NCBI]
|
1.53306e-06
|
|
|
IGLL1
|
[NCBI]
|
1.53306e-06
|
|
|
SMS
|
[NCBI]
|
1.53306e-06
|
|
|
ARF4
|
[NCBI]
|
1.53306e-06
|
|
|
TIRAP
|
[NCBI]
|
1.53306e-06
|
|
|
PDLIM7
|
[NCBI]
|
1.53306e-06
|
|
|
DEFB103A
|
[NCBI]
|
1.53306e-06
|
|
|
FXR2
|
[NCBI]
|
1.53306e-06
|
|
|
TYRO3
|
[NCBI]
|
1.53306e-06
|
|
|
ARID4A
|
[NCBI]
|
1.53306e-06
|
|
|
HNRNPK
|
[NCBI]
|
1.53306e-06
|
|
|
DLG3
|
[NCBI]
|
1.53306e-06
|
|
|
ATG7
|
[NCBI]
|
1.53306e-06
|
|
|
CSK
|
[NCBI]
|
1.53306e-06
|
|
|
OPCML
|
[NCBI]
|
1.53306e-06
|
|
|
ovary-, testis-, and epididymis-expressed gene
|
[NCBI]
|
1.53306e-06
|
|
|
CARD8
|
[NCBI]
|
1.53306e-06
|
|
|
AIM1
|
[NCBI]
|
1.53306e-06
|
|
|
BLK
|
[NCBI]
|
1.53306e-06
|
|
|
EHD1
|
[NCBI]
|
1.53306e-06
|
|
|
ADAMTS1
|
[NCBI]
|
1.53306e-06
|
|
|
ING4
|
[NCBI]
|
1.53306e-06
|
|
|
TNRC6A
|
[NCBI]
|
1.53306e-06
|
|
|
DEAF1
|
[NCBI]
|
1.53306e-06
|
|
|
SAI1
|
[NCBI]
|
1.53306e-06
|
|
|
lipase, congenital absence of pancreatic
|
[NCBI]
|
1.53306e-06
|
|
|
HMCN1
|
[NCBI]
|
1.53306e-06
|
|
|
TOPORS
|
[NCBI]
|
1.53306e-06
|
|
|
NDST2
|
[NCBI]
|
1.53306e-06
|
|
|
FUCA2
|
[NCBI]
|
1.53306e-06
|
|
|
RANGAP1
|
[NCBI]
|
1.53306e-06
|
|
|
DACH1
|
[NCBI]
|
1.53306e-06
|
|
|
KLF7
|
[NCBI]
|
1.53306e-06
|
|
|
H2AFZ
|
[NCBI]
|
1.53306e-06
|
|
|
SUPT16H
|
[NCBI]
|
1.53306e-06
|
|
|
FZD8
|
[NCBI]
|
1.53306e-06
|
|
|
PHLPP
|
[NCBI]
|
1.53306e-06
|
|
|
CRYBB3
|
[NCBI]
|
1.53306e-06
|
|
|
HOXB2
|
[NCBI]
|
1.53306e-06
|
|
|
snf2-related cbp activator protein
|
[NCBI]
|
1.53306e-06
|
|
|
NOD1
|
[NCBI]
|
1.53306e-06
|
|
|
CFL1
|
[NCBI]
|
1.53306e-06
|
|
|
LAIR1
|
[NCBI]
|
1.53306e-06
|
|
|
HINT1
|
[NCBI]
|
1.53306e-06
|
|
|
DUOX1
|
[NCBI]
|
1.53306e-06
|
|
|
NEIL1
|
[NCBI]
|
1.53306e-06
|
|
|
DCP2
|
[NCBI]
|
1.53306e-06
|
|
|
bkm dna
|
[NCBI]
|
1.53306e-06
|
|
|
KIF11
|
[NCBI]
|
1.53306e-06
|
|
|
MSH5
|
[NCBI]
|
1.53306e-06
|
|
|
KMO
|
[NCBI]
|
1.53306e-06
|
|
|
LSM1
|
[NCBI]
|
1.53306e-06
|
|
|
CBX2
|
[NCBI]
|
1.53306e-06
|
|
|
EEF1A2
|
[NCBI]
|
1.53306e-06
|
|
|
RFWD2
|
[NCBI]
|
1.53306e-06
|
|
|
CAPN10
|
[NCBI]
|
1.52051e-06
|
|
|
LTC4S
|
[NCBI]
|
1.52051e-06
|
|
|
HSPA1A
|
[NCBI]
|
1.52051e-06
|
|
|
RHD
|
[NCBI]
|
1.52051e-06
|
|
|
TRIM27
|
[NCBI]
|
1.52051e-06
|
|
|
GCCR
|
[NCBI]
|
1.51638e-06
|
|
|
AS
|
[NCBI]
|
1.49934e-06
|
|
|
RIEG1
|
[NCBI]
|
1.49498e-06
|
|
|
CDPX1
|
[NCBI]
|
1.49498e-06
|
|
|
CCAL2
|
[NCBI]
|
1.49498e-06
|
|
|
EBR1
|
[NCBI]
|
1.49498e-06
|
|
|
NFKB1
|
[NCBI]
|
1.48633e-06
|
|
|
PARG
|
[NCBI]
|
1.48633e-06
|
|
|
PROCR
|
[NCBI]
|
1.48101e-06
|
|
|
GRIA2
|
[NCBI]
|
1.42368e-06
|
|
|
ABO
|
[NCBI]
|
1.42368e-06
|
|
|
ADRB2
|
[NCBI]
|
1.42368e-06
|
|
|
NRCLP1
|
[NCBI]
|
1.42194e-06
|
|
|
MCOPS7
|
[NCBI]
|
1.42194e-06
|
|
|
RP3
|
[NCBI]
|
1.42194e-06
|
|
|
SLC11A2
|
[NCBI]
|
1.41641e-06
|
|
|
DA2A
|
[NCBI]
|
1.39215e-06
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive
|
[NCBI]
|
1.39215e-06
|
|
|
SCA10
|
[NCBI]
|
1.39215e-06
|
|
|
PMC
|
[NCBI]
|
1.39215e-06
|
|
|
walker-warburg syndrome
|
[NCBI]
|
1.3759e-06
|
|
|
FPGS
|
[NCBI]
|
1.36984e-06
|
|
|
MIP
|
[NCBI]
|
1.36795e-06
|
|
|
GSK3B
|
[NCBI]
|
1.36795e-06
|
|
|
AGT
|
[NCBI]
|
1.33186e-06
|
|
|
STAT3
|
[NCBI]
|
1.33042e-06
|
|
|
MAPK1
|
[NCBI]
|
1.31224e-06
|
|
|
KSS
|
[NCBI]
|
1.30717e-06
|
|
|
DBH
|
[NCBI]
|
1.29951e-06
|
|
|
PLSCR1
|
[NCBI]
|
1.29951e-06
|
|
|
CPM
|
[NCBI]
|
1.29951e-06
|
|
|
HLA-DQB1
|
[NCBI]
|
1.29951e-06
|
|
|
OR1D2
|
[NCBI]
|
1.29951e-06
|
|
|
IL1RN
|
[NCBI]
|
1.29951e-06
|
|
|
IFNAR1
|
[NCBI]
|
1.29951e-06
|
|
|
CYP2A6
|
[NCBI]
|
1.29951e-06
|
|
|
NSF
|
[NCBI]
|
1.29356e-06
|
|
|
IRF7
|
[NCBI]
|
1.28697e-06
|
|
|
GGCX
|
[NCBI]
|
1.28697e-06
|
|
|
ANP32A
|
[NCBI]
|
1.28697e-06
|
|
|
MTND4L
|
[NCBI]
|
1.28697e-06
|
|
|
CCKAR
|
[NCBI]
|
1.28697e-06
|
|
|
EFNB2
|
[NCBI]
|
1.28697e-06
|
|
|
TP73
|
[NCBI]
|
1.28697e-06
|
|
|
SOCS2
|
[NCBI]
|
1.28697e-06
|
|
|
APOA2
|
[NCBI]
|
1.28697e-06
|
|
|
JARID1D
|
[NCBI]
|
1.28697e-06
|
|
|
SIX5
|
[NCBI]
|
1.28697e-06
|
|
|
PRDM1
|
[NCBI]
|
1.28697e-06
|
|
|
ACTB
|
[NCBI]
|
1.28697e-06
|
|
|
DSPP
|
[NCBI]
|
1.222e-06
|
|
|
erythrocytosis, familial, 1
|
[NCBI]
|
1.16037e-06
|
|
|
indifference to pain, congenital, autosomal recessive
|
[NCBI]
|
1.16037e-06
|
|
|
monilethrix
|
[NCBI]
|
1.16037e-06
|
|
|
galactose epimerase deficiency
|
[NCBI]
|
1.16037e-06
|
|
|
cutis laxa, autosomal recessive, type ii
|
[NCBI]
|
1.16037e-06
|
|
|
pearson marrow-pancreas syndrome
|
[NCBI]
|
1.16037e-06
|
|
|
pituitary dwarfism due to isolated growth hormone deficiency, autosomal dominant
|
[NCBI]
|
1.16037e-06
|
|
|
amelogenesis imperfecta, hypoplastic/hypomaturation, x-linked 1
|
[NCBI]
|
1.16037e-06
|
|
|
NCIE1
|
[NCBI]
|
1.16037e-06
|
|
|
sacral defect with anterior meningocele
|
[NCBI]
|
1.16037e-06
|
|
|
LDHB
|
[NCBI]
|
1.13277e-06
|
|
|
KCNA1
|
[NCBI]
|
1.13277e-06
|
|
|
MAPK7
|
[NCBI]
|
1.13277e-06
|
|
|
MTND2
|
[NCBI]
|
1.13277e-06
|
|
|
PDGFB
|
[NCBI]
|
1.10811e-06
|
|
|
TRPV1
|
[NCBI]
|
1.1045e-06
|
|
|
NTRK2
|
[NCBI]
|
1.0907e-06
|
|
|
ACP1
|
[NCBI]
|
1.0907e-06
|
|
|
INHBA
|
[NCBI]
|
1.0907e-06
|
|
|
NGB
|
[NCBI]
|
1.0907e-06
|
|
|
TNXB
|
[NCBI]
|
1.09028e-06
|
|
|
EIF4G1
|
[NCBI]
|
1.09028e-06
|
|
|
ORM1
|
[NCBI]
|
1.09028e-06
|
|
|
FLT1
|
[NCBI]
|
1.09028e-06
|
|
|
HLA-G
|
[NCBI]
|
1.09028e-06
|
|
|
PTGS1
|
[NCBI]
|
1.09028e-06
|
|
|
ABCC3
|
[NCBI]
|
1.09028e-06
|
|
|
DRD3
|
[NCBI]
|
1.09028e-06
|
|
|
BIRC4
|
[NCBI]
|
1.09028e-06
|
|
|
SCA7
|
[NCBI]
|
1.08992e-06
|
|
|
ATS
|
[NCBI]
|
1.0712e-06
|
|
|
corpus callosum, agenesis of
|
[NCBI]
|
1.0712e-06
|
|
|
IRID2
|
[NCBI]
|
1.0712e-06
|
|
|
SLSN1
|
[NCBI]
|
1.0712e-06
|
|
|
IRID1
|
[NCBI]
|
1.0712e-06
|
|
|
feingold syndrome
|
[NCBI]
|
1.0712e-06
|
|
|
IFD
|
[NCBI]
|
1.0712e-06
|
|
|
HSS
|
[NCBI]
|
1.0712e-06
|
|
|
LGMD1A
|
[NCBI]
|
1.0712e-06
|
|
|
uridine 5-prime monophosphate hydrolase deficiency, hemolytic anemia due to
|
[NCBI]
|
1.0712e-06
|
|
|
myeloperoxidase deficiency
|
[NCBI]
|
1.0712e-06
|
|
|
PFHB1A
|
[NCBI]
|
1.0712e-06
|
|
|
kniest dysplasia
|
[NCBI]
|
1.0712e-06
|
|
|
SCZD2
|
[NCBI]
|
1.0712e-06
|
|
|
OCD1
|
[NCBI]
|
1.0712e-06
|
|
|
LIPC
|
[NCBI]
|
1.06696e-06
|
|
|
CD36
|
[NCBI]
|
1.06696e-06
|
|
|
PVR
|
[NCBI]
|
1.05253e-06
|
|
|
ADCC
|
[NCBI]
|
1.0258e-06
|
|
|
LIS2
|
[NCBI]
|
1.0258e-06
|
|
|
whim syndrome
|
[NCBI]
|
1.0258e-06
|
|
|
pyruvate dehydrogenase e3-binding protein deficiency
|
[NCBI]
|
1.0258e-06
|
|
|
CRS2
|
[NCBI]
|
1.0258e-06
|
|
|
BDE
|
[NCBI]
|
1.0258e-06
|
|
|
UL
|
[NCBI]
|
1.0258e-06
|
|
|
optic atrophy 1 and deafness
|
[NCBI]
|
1.0258e-06
|
|
|
basal ganglia disease, adult-onset
|
[NCBI]
|
1.0258e-06
|
|
|
DFNA20
|
[NCBI]
|
1.0258e-06
|
|
|
mitochondrial complex iii deficiency
|
[NCBI]
|
1.0258e-06
|
|
|
boomerang dysplasia
|
[NCBI]
|
1.0258e-06
|
|
|
hemoglobin--variants for which the chain carrying the mutation is unknown or uncertain
|
[NCBI]
|
1.0258e-06
|
|
|
GRTH
|
[NCBI]
|
1.0258e-06
|
|
|
thrombophilia
|
[NCBI]
|
1.0258e-06
|
|
|
keratoderma, palmoplantar, with deafness
|
[NCBI]
|
1.0258e-06
|
|
|
alternating hemiplegia of childhood
|
[NCBI]
|
1.0258e-06
|
|
|
RCDP2
|
[NCBI]
|
1.0258e-06
|
|
|
tyrosinemia, type iii
|
[NCBI]
|
1.0258e-06
|
|
|
STHAG1
|
[NCBI]
|
1.0258e-06
|
|
|
bartter syndrome, infantile, with sensorineural deafness
|
[NCBI]
|
1.0258e-06
|
|
|
sarcosinemia
|
[NCBI]
|
1.0258e-06
|
|
|
MRXSL
|
[NCBI]
|
1.0258e-06
|
|
|
leiomyomatosis, esophageal and vulval, with nephropathy
|
[NCBI]
|
1.0258e-06
|
|
|
hyperalphalipoproteinemia
|
[NCBI]
|
1.0258e-06
|
|
|
MONA
|
[NCBI]
|
1.0258e-06
|
|
|
RP13
|
[NCBI]
|
1.0258e-06
|
|
|
adenosine deaminase, elevated, hemolytic anemia due to
|
[NCBI]
|
1.0258e-06
|
|
|
enchondromatosis, multiple
|
[NCBI]
|
1.0258e-06
|
|
|
arthrogryposis, renal dysfunction, and cholestasis
|
[NCBI]
|
1.0258e-06
|
|
|
HDL2
|
[NCBI]
|
1.0258e-06
|
|
|
MRT1
|
[NCBI]
|
1.0258e-06
|
|
|
HOMG2
|
[NCBI]
|
1.0258e-06
|
|
|
HPE4
|
[NCBI]
|
1.0258e-06
|
|
|
gaucher disease, atypical, due to saposin c deficiency
|
[NCBI]
|
1.0258e-06
|
|
|
PPNAD1
|
[NCBI]
|
1.0258e-06
|
|
|
cherubism
|
[NCBI]
|
1.0258e-06
|
|
|
charcot-marie-tooth disease and deafness
|
[NCBI]
|
1.0258e-06
|
|
|
glaucoma, normal tension, susceptibility to
|
[NCBI]
|
1.0258e-06
|
|
|
peters anomaly
|
[NCBI]
|
1.0258e-06
|
|
|
RP14
|
[NCBI]
|
1.0258e-06
|
|
|
HCA2
|
[NCBI]
|
1.0258e-06
|
|
|
cataract, lamellar
|
[NCBI]
|
1.0258e-06
|
|
|
azoospermia due to perturbations of meiosis
|
[NCBI]
|
1.0258e-06
|
|
|
CTNS
|
[NCBI]
|
1.02464e-06
|
|
|
CLCN3
|
[NCBI]
|
1.01657e-06
|
|
|
WNT11
|
[NCBI]
|
1.01657e-06
|
|
|
VAMP1
|
[NCBI]
|
1.01657e-06
|
|
|
PTBP1
|
[NCBI]
|
1.01657e-06
|
|
|
FBXW4
|
[NCBI]
|
1.01657e-06
|
|
|
VDAC2
|
[NCBI]
|
1.01657e-06
|
|
|
TUBA1A
|
[NCBI]
|
1.01657e-06
|
|
|
CHRNB1
|
[NCBI]
|
1.01657e-06
|
|
|
CRYBA4
|
[NCBI]
|
1.01657e-06
|
|
|
NEGF2
|
[NCBI]
|
1.01657e-06
|
|
|
KLF11
|
[NCBI]
|
1.01657e-06
|
|
|
AKAP13
|
[NCBI]
|
1.01657e-06
|
|
|
DEK
|
[NCBI]
|
1.01657e-06
|
|
|
NFIA
|
[NCBI]
|
1.01657e-06
|
|
|
DPYSL2
|
[NCBI]
|
1.01657e-06
|
|
|
SUFU
|
[NCBI]
|
1.01657e-06
|
|
|
GNAT1
|
[NCBI]
|
1.01657e-06
|
|
|
CACNA1H
|
[NCBI]
|
1.01657e-06
|
|
|
SPO11
|
[NCBI]
|
1.01657e-06
|
|
|
MLYCD
|
[NCBI]
|
1.01657e-06
|
|
|
HSPB8
|
[NCBI]
|
1.01657e-06
|
|
|
CTBP2
|
[NCBI]
|
1.01657e-06
|
|
|
PTPN13
|
[NCBI]
|
1.01657e-06
|
|
|
CRYM
|
[NCBI]
|
1.01657e-06
|
|
|
BTF3
|
[NCBI]
|
1.01657e-06
|
|
|
DIAPH2
|
[NCBI]
|
1.01657e-06
|
|
|
PRKCB1
|
[NCBI]
|
1.01657e-06
|
|
|
CENTG1
|
[NCBI]
|
1.01657e-06
|
|
|
XCE
|
[NCBI]
|
1.01657e-06
|
|
|
ALDH4A1
|
[NCBI]
|
1.01657e-06
|
|
|
TRPV5
|
[NCBI]
|
1.01657e-06
|
|
|
CPN1
|
[NCBI]
|
1.01657e-06
|
|
|
NPAT
|
[NCBI]
|
1.01657e-06
|
|
|
MDH2
|
[NCBI]
|
1.01657e-06
|
|
|
GPR68
|
[NCBI]
|
1.01657e-06
|
|
|
RNF2
|
[NCBI]
|
1.01657e-06
|
|
|
MPP1
|
[NCBI]
|
1.01657e-06
|
|
|
QKI
|
[NCBI]
|
1.01657e-06
|
|
|
PPARGC1B
|
[NCBI]
|
1.01657e-06
|
|
|
MGEA5
|
[NCBI]
|
1.01657e-06
|
|
|
ESCO2
|
[NCBI]
|
1.01657e-06
|
|
|
APOL1
|
[NCBI]
|
1.01657e-06
|
|
|
LYN
|
[NCBI]
|
1.01657e-06
|
|
|
FNTA
|
[NCBI]
|
1.01657e-06
|
|
|
PNOC
|
[NCBI]
|
1.01657e-06
|
|
|
DLAT
|
[NCBI]
|
1.01657e-06
|
|
|
SIL
|
[NCBI]
|
1.01657e-06
|
|
|
RBMY1A1
|
[NCBI]
|
1.01657e-06
|
|
|
GLP1R
|
[NCBI]
|
1.01657e-06
|
|
|
ADH4
|
[NCBI]
|
1.01657e-06
|
|
|
ST14
|
[NCBI]
|
1.01657e-06
|
|
|
SORT1
|
[NCBI]
|
1.01657e-06
|
|
|
locus control region, beta
|
[NCBI]
|
1.01657e-06
|
|
|
MEF2B
|
[NCBI]
|
1.01657e-06
|
|
|
negative elongation factor polypeptide b
|
[NCBI]
|
1.01657e-06
|
|
|
ACVR1B
|
[NCBI]
|
1.01657e-06
|
|
|
HOXD10
|
[NCBI]
|
1.01657e-06
|
|
|
CNGA2
|
[NCBI]
|
1.01657e-06
|
|
|
CAPN1
|
[NCBI]
|
1.01657e-06
|
|
|
PIWIL1
|
[NCBI]
|
1.01657e-06
|
|
|
SMC3
|
[NCBI]
|
1.01657e-06
|
|
|
OMG
|
[NCBI]
|
1.01657e-06
|
|
|
DEFA5
|
[NCBI]
|
1.01657e-06
|
|
|
LAMA1
|
[NCBI]
|
1.01657e-06
|
|
|
MIRN15A
|
[NCBI]
|
1.01657e-06
|
|
|
SNAI1
|
[NCBI]
|
1.01657e-06
|
|
|
MFN1
|
[NCBI]
|
1.01657e-06
|
|
|
RYK
|
[NCBI]
|
1.01657e-06
|
|
|
PMX1
|
[NCBI]
|
1.01657e-06
|
|
|
CDC5L
|
[NCBI]
|
1.01657e-06
|
|
|
TAS2R10
|
[NCBI]
|
1.01657e-06
|
|
|
PTPRZ1
|
[NCBI]
|
1.01657e-06
|
|
|
JAG2
|
[NCBI]
|
1.01657e-06
|
|
|
HYOU1
|
[NCBI]
|
1.01657e-06
|
|
|
ELK1
|
[NCBI]
|
1.01657e-06
|
|
|
PLB1
|
[NCBI]
|
1.01657e-06
|
|
|
M6PR
|
[NCBI]
|
1.01657e-06
|
|
|
PCK1
|
[NCBI]
|
1.01657e-06
|
|
|
C1QG
|
[NCBI]
|
1.01657e-06
|
|
|
P2RY12
|
[NCBI]
|
1.01657e-06
|
|
|
PDLIM3
|
[NCBI]
|
1.01657e-06
|
|
|
LMNB2
|
[NCBI]
|
1.01657e-06
|
|
|
SATB2
|
[NCBI]
|
1.01657e-06
|
|
|
CYP2B6
|
[NCBI]
|
1.01657e-06
|
|
|
C1QB
|
[NCBI]
|
1.01657e-06
|
|
|
IL13RA1
|
[NCBI]
|
1.01657e-06
|
|
|
FOSB
|
[NCBI]
|
1.01657e-06
|
|
|
TICAM1
|
[NCBI]
|
1.01657e-06
|
|
|
CASP2
|
[NCBI]
|
1.01657e-06
|
|
|
LCP2
|
[NCBI]
|
1.01657e-06
|
|
|
NHLH1
|
[NCBI]
|
1.01657e-06
|
|
|
CRAT
|
[NCBI]
|
1.01657e-06
|
|
|
GTF2B
|
[NCBI]
|
1.01657e-06
|
|
|
FUBP1
|
[NCBI]
|
1.01657e-06
|
|
|
FABP4
|
[NCBI]
|
1.01657e-06
|
|
|
NCOA4
|
[NCBI]
|
1.01657e-06
|
|
|
MYH2
|
[NCBI]
|
1.01657e-06
|
|
|
ABCC4
|
[NCBI]
|
1.01657e-06
|
|
|
NR2E1
|
[NCBI]
|
1.01657e-06
|
|
|
TNNT1
|
[NCBI]
|
1.01657e-06
|
|
|
YEATS4
|
[NCBI]
|
1.01657e-06
|
|
|
HIST1H1B
|
[NCBI]
|
1.01657e-06
|
|
|
GAB1
|
[NCBI]
|
1.01657e-06
|
|
|
PALLD
|
[NCBI]
|
1.01657e-06
|
|
|
XPNPEP2
|
[NCBI]
|
1.01657e-06
|
|
|
EPHB3
|
[NCBI]
|
1.01657e-06
|
|
|
DNMT3L
|
[NCBI]
|
1.01657e-06
|
|
|
PPL
|
[NCBI]
|
1.01657e-06
|
|
|
FOXJ1
|
[NCBI]
|
1.01657e-06
|
|
|
KCNA2
|
[NCBI]
|
1.01657e-06
|
|
|
HLA-DPA1
|
[NCBI]
|
9.97681e-07
|
|
|
GABRB3
|
[NCBI]
|
9.97681e-07
|
|
|
THBD
|
[NCBI]
|
9.97681e-07
|
|
|
PPARBP
|
[NCBI]
|
9.97681e-07
|
|
|
GRIN2A
|
[NCBI]
|
9.97681e-07
|
|
|
KEAP1
|
[NCBI]
|
9.97681e-07
|
|
|
NR4A1
|
[NCBI]
|
9.97681e-07
|
|
|
COL18A1
|
[NCBI]
|
9.97681e-07
|
|
|
IKZF1
|
[NCBI]
|
9.97681e-07
|
|
|
polycythemia vera
|
[NCBI]
|
9.47837e-07
|
|
|
KTCN1
|
[NCBI]
|
9.47837e-07
|
|
|
masa syndrome
|
[NCBI]
|
9.47837e-07
|
|
|
EL1
|
[NCBI]
|
9.47837e-07
|
|
|
CLN3
|
[NCBI]
|
9.38147e-07
|
|
|
EPHX1
|
[NCBI]
|
9.37045e-07
|
|
|
HDAC4
|
[NCBI]
|
9.25161e-07
|
|
|
PTPN1
|
[NCBI]
|
9.25161e-07
|
|
|
PGK1
|
[NCBI]
|
8.96755e-07
|
|
|
CYGB
|
[NCBI]
|
8.93942e-07
|
|
|
HAP1
|
[NCBI]
|
8.93942e-07
|
|
|
BMP1
|
[NCBI]
|
8.93942e-07
|
|
|
DLL4
|
[NCBI]
|
8.93942e-07
|
|
|
PPARD
|
[NCBI]
|
8.93942e-07
|
|
|
NNMT
|
[NCBI]
|
8.93942e-07
|
|
|
MME
|
[NCBI]
|
8.93942e-07
|
|
|
NFATC1
|
[NCBI]
|
8.93942e-07
|
|
|
LCP1
|
[NCBI]
|
8.93942e-07
|
|
|
RELA
|
[NCBI]
|
8.93942e-07
|
|
|
H6PD
|
[NCBI]
|
8.48558e-07
|
|
|
IRS1
|
[NCBI]
|
8.39956e-07
|
|
|
PLG
|
[NCBI]
|
8.36948e-07
|
|
|
CDK2
|
[NCBI]
|
8.32622e-07
|
|
|
hyperoxaluria, primary, type i
|
[NCBI]
|
8.25371e-07
|
|
|
TRPS1
|
[NCBI]
|
8.25371e-07
|
|
|
MYC
|
[NCBI]
|
8.17935e-07
|
|
|
AANAT
|
[NCBI]
|
8.00169e-07
|
|
|
ACCN2
|
[NCBI]
|
7.9258e-07
|
|
|
CBD
|
[NCBI]
|
7.9258e-07
|
|
|
H4FN
|
[NCBI]
|
7.55148e-07
|
|
|
KEL
|
[NCBI]
|
7.55148e-07
|
|
|
MIF
|
[NCBI]
|
7.55148e-07
|
|
|
CAST
|
[NCBI]
|
7.55148e-07
|
|
|
WNT1
|
[NCBI]
|
7.55148e-07
|
|
|
C7
|
[NCBI]
|
7.55148e-07
|
|
|
MYOD1
|
[NCBI]
|
7.55148e-07
|
|
|
PTTG1
|
[NCBI]
|
7.55148e-07
|
|
|
ITGAV
|
[NCBI]
|
7.55148e-07
|
|
|
KCNQ1OT1
|
[NCBI]
|
7.55148e-07
|
|
|
POLR2A
|
[NCBI]
|
7.43069e-07
|
|
|
PRG4
|
[NCBI]
|
7.43069e-07
|
|
|
ATF4
|
[NCBI]
|
7.43069e-07
|
|
|
INPP5D
|
[NCBI]
|
7.43069e-07
|
|
|
PTK2B
|
[NCBI]
|
7.20261e-07
|
|
|
RETN
|
[NCBI]
|
7.11789e-07
|
|
|
ID2
|
[NCBI]
|
7.11789e-07
|
|
|
PGM3
|
[NCBI]
|
7.11789e-07
|
|
|
ADRB3
|
[NCBI]
|
7.11789e-07
|
|
|
ENO1
|
[NCBI]
|
7.11789e-07
|
|
|
LRP2
|
[NCBI]
|
7.11789e-07
|
|
|
HMOX1
|
[NCBI]
|
7.11789e-07
|
|
|
HDAC6
|
[NCBI]
|
7.11789e-07
|
|
|
BMP4
|
[NCBI]
|
6.81016e-07
|
|
|
RP1
|
[NCBI]
|
6.74295e-07
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i
|
[NCBI]
|
6.74295e-07
|
|
|
UGCG
|
[NCBI]
|
6.57841e-07
|
|
|
GRPR
|
[NCBI]
|
6.57841e-07
|
|
|
IL5
|
[NCBI]
|
6.57841e-07
|
|
|
PAFAH1B1
|
[NCBI]
|
6.57841e-07
|
|
|
PDE10A
|
[NCBI]
|
6.4346e-07
|
|
|
KSR1
|
[NCBI]
|
6.4346e-07
|
|
|
TP53BP2
|
[NCBI]
|
6.4346e-07
|
|
|
SMAD1
|
[NCBI]
|
6.4346e-07
|
|
|
FKBP1B
|
[NCBI]
|
6.4346e-07
|
|
|
CAMK2G
|
[NCBI]
|
6.4346e-07
|
|
|
PROZ
|
[NCBI]
|
6.4346e-07
|
|
|
FSCN1
|
[NCBI]
|
6.4346e-07
|
|
|
GOPC
|
[NCBI]
|
6.4346e-07
|
|
|
DEFA3
|
[NCBI]
|
6.4346e-07
|
|
|
HAND2
|
[NCBI]
|
6.4346e-07
|
|
|
DSC3
|
[NCBI]
|
6.4346e-07
|
|
|
UXT
|
[NCBI]
|
6.4346e-07
|
|
|
HSD17B1
|
[NCBI]
|
6.4346e-07
|
|
|
PIP5K1C
|
[NCBI]
|
6.4346e-07
|
|
|
F2RL2
|
[NCBI]
|
6.4346e-07
|
|
|
DNASE2
|
[NCBI]
|
6.4346e-07
|
|
|
ADCY8
|
[NCBI]
|
6.4346e-07
|
|
|
MBNL1
|
[NCBI]
|
6.4346e-07
|
|
|
TM4SF2
|
[NCBI]
|
6.4346e-07
|
|
|
NDUFA13
|
[NCBI]
|
6.4346e-07
|
|
|
cocaine- and amphetamine-regulated transcript
|
[NCBI]
|
6.4346e-07
|
|
|
APBB1
|
[NCBI]
|
6.4346e-07
|
|
|
ACP2
|
[NCBI]
|
6.4346e-07
|
|
|
GFRA1
|
[NCBI]
|
6.4346e-07
|
|
|
NR2F2
|
[NCBI]
|
6.4346e-07
|
|
|
AURKC
|
[NCBI]
|
6.4346e-07
|
|
|
POU3F1
|
[NCBI]
|
6.4346e-07
|
|
|
IRGM
|
[NCBI]
|
6.4346e-07
|
|
|
SLC9A1
|
[NCBI]
|
6.4346e-07
|
|
|
ADARB1
|
[NCBI]
|
6.4346e-07
|
|
|
PPP2CA
|
[NCBI]
|
6.4346e-07
|
|
|
FOXG1
|
[NCBI]
|
6.4346e-07
|
|
|
ZBTB32
|
[NCBI]
|
6.4346e-07
|
|
|
BRD4
|
[NCBI]
|
6.4346e-07
|
|
|
TTK
|
[NCBI]
|
6.4346e-07
|
|
|
GCGR
|
[NCBI]
|
6.4346e-07
|
|
|
ING2
|
[NCBI]
|
6.4346e-07
|
|
|
GPR4
|
[NCBI]
|
6.4346e-07
|
|
|
GATA6
|
[NCBI]
|
6.4346e-07
|
|
|
IFNGR2
|
[NCBI]
|
6.4346e-07
|
|
|
BMP5
|
[NCBI]
|
6.4346e-07
|
|
|
CLCN2
|
[NCBI]
|
6.4346e-07
|
|
|
PTPRG
|
[NCBI]
|
6.4346e-07
|
|
|
AGRP
|
[NCBI]
|
6.4346e-07
|
|
|
NOVA1
|
[NCBI]
|
6.4346e-07
|
|
|
methemoglobinemia due to deficiency of cytochrome b5
|
[NCBI]
|
6.4346e-07
|
|
|
TAPBP
|
[NCBI]
|
6.4346e-07
|
|
|
IBSP
|
[NCBI]
|
6.4346e-07
|
|
|
CRYBB1
|
[NCBI]
|
6.4346e-07
|
|
|
NEUROG1
|
[NCBI]
|
6.4346e-07
|
|
|
EED
|
[NCBI]
|
6.4346e-07
|
|
|
RAB5A
|
[NCBI]
|
6.4346e-07
|
|
|
SLC10A2
|
[NCBI]
|
6.4346e-07
|
|
|
ACVR2B
|
[NCBI]
|
6.4346e-07
|
|
|
CLDN4
|
[NCBI]
|
6.4346e-07
|
|
|
RPL4
|
[NCBI]
|
6.4346e-07
|
|
|
NDUFS4
|
[NCBI]
|
6.4346e-07
|
|
|
EGR3
|
[NCBI]
|
6.4346e-07
|
|
|
DVL2
|
[NCBI]
|
6.4346e-07
|
|
|
PBX1
|
[NCBI]
|
6.4346e-07
|
|
|
TBL1X
|
[NCBI]
|
6.4346e-07
|
|
|
NR1H2
|
[NCBI]
|
6.4346e-07
|
|
|
KPNA2
|
[NCBI]
|
6.4346e-07
|
|
|
LAMP1
|
[NCBI]
|
6.4346e-07
|
|
|
TBX4
|
[NCBI]
|
6.4346e-07
|
|
|
WASL
|
[NCBI]
|
6.4346e-07
|
|
|
S100A7
|
[NCBI]
|
6.4346e-07
|
|
|
YAP1
|
[NCBI]
|
6.4346e-07
|
|
|
PROX1
|
[NCBI]
|
6.4346e-07
|
|
|
SYT4
|
[NCBI]
|
6.4346e-07
|
|
|
UNC13B
|
[NCBI]
|
6.4346e-07
|
|
|
NASP
|
[NCBI]
|
6.4346e-07
|
|
|
SNX9
|
[NCBI]
|
6.4346e-07
|
|
|
SLC12A2
|
[NCBI]
|
6.4346e-07
|
|
|
CENPJ
|
[NCBI]
|
6.4346e-07
|
|
|
COL4A6
|
[NCBI]
|
6.4346e-07
|
|
|
IFNAR2
|
[NCBI]
|
6.4346e-07
|
|
|
TRIP10
|
[NCBI]
|
6.4346e-07
|
|
|
ERRFI1
|
[NCBI]
|
6.4346e-07
|
|
|
SAT1
|
[NCBI]
|
6.4346e-07
|
|
|
DTNA
|
[NCBI]
|
6.4346e-07
|
|
|
DNM1
|
[NCBI]
|
6.4346e-07
|
|
|
SNCB
|
[NCBI]
|
6.4346e-07
|
|
|
RPL10
|
[NCBI]
|
6.4346e-07
|
|
|
BLR1
|
[NCBI]
|
6.4346e-07
|
|
|
EMP1
|
[NCBI]
|
6.4346e-07
|
|
|
RLN1
|
[NCBI]
|
6.4346e-07
|
|
|
TST
|
[NCBI]
|
6.4346e-07
|
|
|
EDG3
|
[NCBI]
|
6.4346e-07
|
|
|
FUT6
|
[NCBI]
|
6.4346e-07
|
|
|
EDG5
|
[NCBI]
|
6.4346e-07
|
|
|
CASP7
|
[NCBI]
|
6.4346e-07
|
|
|
MEOX2
|
[NCBI]
|
6.4346e-07
|
|
|
POFUT1
|
[NCBI]
|
6.4346e-07
|
|
|
CSNK2B
|
[NCBI]
|
6.4346e-07
|
|
|
MIRN1-1
|
[NCBI]
|
6.4346e-07
|
|
|
WNT3
|
[NCBI]
|
6.4346e-07
|
|
|
SLC27A4
|
[NCBI]
|
6.4346e-07
|
|
|
CHRNG
|
[NCBI]
|
6.4346e-07
|
|
|
HES1
|
[NCBI]
|
6.4346e-07
|
|
|
CPA1
|
[NCBI]
|
6.4346e-07
|
|
|
KIF1B
|
[NCBI]
|
6.4346e-07
|
|
|
PSPH
|
[NCBI]
|
6.4346e-07
|
|
|
KRT4
|
[NCBI]
|
6.4346e-07
|
|
|
MYST3
|
[NCBI]
|
6.4346e-07
|
|
|
HYAL2
|
[NCBI]
|
6.4346e-07
|
|
|
ZFP36
|
[NCBI]
|
6.29514e-07
|
|
|
LEPR
|
[NCBI]
|
6.2388e-07
|
|
|
chiari malformation type i
|
[NCBI]
|
6.06803e-07
|
|
|
PCD
|
[NCBI]
|
5.91807e-07
|
|
|
neuraminidase deficiency
|
[NCBI]
|
5.90236e-07
|
|
|
COH1
|
[NCBI]
|
5.90236e-07
|
|
|
PLK1
|
[NCBI]
|
5.82555e-07
|
|
|
TPT1
|
[NCBI]
|
5.77006e-07
|
|
|
GPI
|
[NCBI]
|
5.58901e-07
|
|
|
TSIX
|
[NCBI]
|
5.54006e-07
|
|
|
C5
|
[NCBI]
|
5.54006e-07
|
|
|
ACY1
|
[NCBI]
|
5.54006e-07
|
|
|
Ge
|
[NCBI]
|
5.54006e-07
|
|
|
TCF3
|
[NCBI]
|
5.54006e-07
|
|
|
HLF
|
[NCBI]
|
5.54006e-07
|
|
|
BHMT
|
[NCBI]
|
5.54006e-07
|
|
|
CDK7
|
[NCBI]
|
5.54006e-07
|
|
|
HSD17B4
|
[NCBI]
|
5.54006e-07
|
|
|
CORDX1
|
[NCBI]
|
5.50191e-07
|
|
|
HFTC
|
[NCBI]
|
5.50191e-07
|
|
|
asplenia with cardiovascular anomalies
|
[NCBI]
|
5.50191e-07
|
|
|
LPG
|
[NCBI]
|
5.50191e-07
|
|
|
ISS
|
[NCBI]
|
5.50191e-07
|
|
|
SGD
|
[NCBI]
|
5.50191e-07
|
|
|
JME
|
[NCBI]
|
5.50191e-07
|
|
|
AGS1
|
[NCBI]
|
5.50191e-07
|
|
|
PPS
|
[NCBI]
|
5.50191e-07
|
|
|
OPD2
|
[NCBI]
|
5.50191e-07
|
|
|
DEFA1
|
[NCBI]
|
5.45314e-07
|
|
|
G6PC2
|
[NCBI]
|
5.45314e-07
|
|
|
CGB
|
[NCBI]
|
5.45314e-07
|
|
|
IL6ST
|
[NCBI]
|
5.45314e-07
|
|
|
CBP
|
[NCBI]
|
5.45314e-07
|
|
|
TRHR
|
[NCBI]
|
5.45314e-07
|
|
|
MAPK8IP1
|
[NCBI]
|
5.45314e-07
|
|
|
NCOA1
|
[NCBI]
|
5.45314e-07
|
|
|
SPHK1
|
[NCBI]
|
5.45314e-07
|
|
|
SREBF1
|
[NCBI]
|
5.45314e-07
|
|
|
TCRD
|
[NCBI]
|
5.45314e-07
|
|
|
ALDOA
|
[NCBI]
|
5.45314e-07
|
|
|
TAL1
|
[NCBI]
|
5.45314e-07
|
|
|
RAF1
|
[NCBI]
|
5.45314e-07
|
|
|
hypertelorism with esophageal abnormality and hypospadias
|
[NCBI]
|
5.39778e-07
|
|
|
FASN
|
[NCBI]
|
5.33411e-07
|
|
|
EDN1
|
[NCBI]
|
5.17281e-07
|
|
|
HNA
|
[NCBI]
|
5.12192e-07
|
|
|
ED1
|
[NCBI]
|
5.03561e-07
|
|
|
EBS2
|
[NCBI]
|
4.73856e-07
|
|
|
hydrocephalus
|
[NCBI]
|
4.73856e-07
|
|
|
situs inversus viscerum
|
[NCBI]
|
4.73856e-07
|
|
|
monosomy 7 of bone marrow
|
[NCBI]
|
4.73856e-07
|
|
|
NYS1
|
[NCBI]
|
4.73856e-07
|
|
|
schwannomatosis
|
[NCBI]
|
4.73856e-07
|
|
|
17-@beta hydroxysteroid dehydrogenase iii deficiency
|
[NCBI]
|
4.73856e-07
|
|
|
CDG2A
|
[NCBI]
|
4.73856e-07
|
|
|
WZS
|
[NCBI]
|
4.73856e-07
|
|
|
DA1
|
[NCBI]
|
4.73856e-07
|
|
|
hepatitis b virus, susceptibility to
|
[NCBI]
|
4.73856e-07
|
|
|
ATF3
|
[NCBI]
|
4.57323e-07
|
|
|
ADK
|
[NCBI]
|
4.48316e-07
|
|
|
HDAC2
|
[NCBI]
|
4.48316e-07
|
|
|
PBP
|
[NCBI]
|
4.48316e-07
|
|
|
APOB
|
[NCBI]
|
4.30817e-07
|
|
|
FTL
|
[NCBI]
|
4.19925e-07
|
|
|
IRF3
|
[NCBI]
|
4.19925e-07
|
|
|
CDKN1B
|
[NCBI]
|
4.19925e-07
|
|
|
CMH
|
[NCBI]
|
4.18479e-07
|
|
|
hepatitis c virus, susceptibility to
|
[NCBI]
|
4.17843e-07
|
|
|
MDC1A
|
[NCBI]
|
4.17843e-07
|
|
|
fraser syndrome
|
[NCBI]
|
4.17843e-07
|
|
|
LAT
|
[NCBI]
|
3.97225e-07
|
|
|
SMAD3
|
[NCBI]
|
3.96263e-07
|
|
|
DLG4
|
[NCBI]
|
3.96263e-07
|
|
|
CALM1
|
[NCBI]
|
3.96263e-07
|
|
|
CCR2
|
[NCBI]
|
3.96263e-07
|
|
|
CBFA2T1
|
[NCBI]
|
3.96263e-07
|
|
|
ANKRD1
|
[NCBI]
|
3.96263e-07
|
|
|
IL7R
|
[NCBI]
|
3.96263e-07
|
|
|
JMJD6
|
[NCBI]
|
3.96263e-07
|
|
|
DNMT3A
|
[NCBI]
|
3.96263e-07
|
|
|
PEG3
|
[NCBI]
|
3.96263e-07
|
|
|
CSH1
|
[NCBI]
|
3.96263e-07
|
|
|
ADAM10
|
[NCBI]
|
3.96263e-07
|
|
|
IL17A
|
[NCBI]
|
3.96263e-07
|
|
|
KLF5
|
[NCBI]
|
3.96263e-07
|
|
|
PTPN22
|
[NCBI]
|
3.89761e-07
|
|
|
FGF9
|
[NCBI]
|
3.89761e-07
|
|
|
IRDN
|
[NCBI]
|
3.89761e-07
|
|
|
TSC22D3
|
[NCBI]
|
3.89761e-07
|
|
|
ECM1
|
[NCBI]
|
3.89761e-07
|
|
|
CSF1R
|
[NCBI]
|
3.89761e-07
|
|
|
ACACA
|
[NCBI]
|
3.89761e-07
|
|
|
TERF2
|
[NCBI]
|
3.89761e-07
|
|
|
ELN
|
[NCBI]
|
3.89221e-07
|
|
|
DAZ
|
[NCBI]
|
3.85553e-07
|
|
|
TCRA
|
[NCBI]
|
3.85553e-07
|
|
|
NR0B2
|
[NCBI]
|
3.81154e-07
|
|
|
PLD1
|
[NCBI]
|
3.77558e-07
|
|
|
FGF19
|
[NCBI]
|
3.77558e-07
|
|
|
CYP3A7
|
[NCBI]
|
3.77558e-07
|
|
|
BDKRB2
|
[NCBI]
|
3.77558e-07
|
|
|
EDNRA
|
[NCBI]
|
3.77558e-07
|
|
|
RPS6KB1
|
[NCBI]
|
3.77558e-07
|
|
|
SSTR1
|
[NCBI]
|
3.77558e-07
|
|
|
CASP10
|
[NCBI]
|
3.77558e-07
|
|
|
SYT7
|
[NCBI]
|
3.77558e-07
|
|
|
SIPA1
|
[NCBI]
|
3.77558e-07
|
|
|
ABCA2
|
[NCBI]
|
3.77558e-07
|
|
|
CTAG1B
|
[NCBI]
|
3.77558e-07
|
|
|
ERCC4
|
[NCBI]
|
3.77558e-07
|
|
|
CHRND
|
[NCBI]
|
3.77558e-07
|
|
|
SDC3
|
[NCBI]
|
3.77558e-07
|
|
|
FADD
|
[NCBI]
|
3.77558e-07
|
|
|
SIRT3
|
[NCBI]
|
3.77558e-07
|
|
|
DAB1
|
[NCBI]
|
3.77558e-07
|
|
|
FRZB
|
[NCBI]
|
3.77558e-07
|
|
|
CCKBR
|
[NCBI]
|
3.77558e-07
|
|
|
FGF20
|
[NCBI]
|
3.77558e-07
|
|
|
TBX2
|
[NCBI]
|
3.77558e-07
|
|
|
TOP3A
|
[NCBI]
|
3.77558e-07
|
|
|
PVALB
|
[NCBI]
|
3.77558e-07
|
|
|
TLN1
|
[NCBI]
|
3.77558e-07
|
|
|
RAD21
|
[NCBI]
|
3.77558e-07
|
|
|
PAX4
|
[NCBI]
|
3.77558e-07
|
|
|
HTR2C
|
[NCBI]
|
3.77558e-07
|
|
|
DR1
|
[NCBI]
|
3.77558e-07
|
|
|
SUV39H1
|
[NCBI]
|
3.77558e-07
|
|
|
HOXC8
|
[NCBI]
|
3.77558e-07
|
|
|
TEK
|
[NCBI]
|
3.77558e-07
|
|
|
F2RL3
|
[NCBI]
|
3.77558e-07
|
|
|
DNASE1
|
[NCBI]
|
3.77558e-07
|
|
|
ITGAL
|
[NCBI]
|
3.77558e-07
|
|
|
GCKR
|
[NCBI]
|
3.77558e-07
|
|
|
NEUROG3
|
[NCBI]
|
3.77558e-07
|
|
|
SNAI2
|
[NCBI]
|
3.77558e-07
|
|
|
DUSP1
|
[NCBI]
|
3.77558e-07
|
|
|
PITPN
|
[NCBI]
|
3.77558e-07
|
|
|
DYNC1H1
|
[NCBI]
|
3.77558e-07
|
|
|
MIRN16-1
|
[NCBI]
|
3.77558e-07
|
|
|
P2RX3
|
[NCBI]
|
3.77558e-07
|
|
|
SOD3
|
[NCBI]
|
3.77558e-07
|
|
|
ST8SIA2
|
[NCBI]
|
3.77558e-07
|
|
|
HOMER1
|
[NCBI]
|
3.77558e-07
|
|
|
SFRS10
|
[NCBI]
|
3.77558e-07
|
|
|
HBQ1
|
[NCBI]
|
3.77558e-07
|
|
|
PTF1A
|
[NCBI]
|
3.77558e-07
|
|
|
ACVR1C
|
[NCBI]
|
3.77558e-07
|
|
|
MECT1
|
[NCBI]
|
3.77558e-07
|
|
|
IRF2
|
[NCBI]
|
3.77558e-07
|
|
|
PEG10
|
[NCBI]
|
3.77558e-07
|
|
|
TFAM
|
[NCBI]
|
3.77558e-07
|
|
|
GP1BB
|
[NCBI]
|
3.77558e-07
|
|
|
GPD2
|
[NCBI]
|
3.77558e-07
|
|
|
SEMA5A
|
[NCBI]
|
3.77558e-07
|
|
|
MAPK10
|
[NCBI]
|
3.77558e-07
|
|
|
PPP2R2B
|
[NCBI]
|
3.77558e-07
|
|
|
HOXD3
|
[NCBI]
|
3.77558e-07
|
|
|
MPG
|
[NCBI]
|
3.77558e-07
|
|
|
CASQ2
|
[NCBI]
|
3.77558e-07
|
|
|
hypophosphatasia, infantile
|
[NCBI]
|
3.58634e-07
|
|
|
krabbe disease
|
[NCBI]
|
3.35763e-07
|
|
|
HLA-A
|
[NCBI]
|
3.32602e-07
|
|
|
complement component 6 deficiency
|
[NCBI]
|
3.32541e-07
|
|
|
E2F1
|
[NCBI]
|
3.32541e-07
|
|
|
VASP
|
[NCBI]
|
3.23512e-07
|
|
|
HGFAC
|
[NCBI]
|
3.18078e-07
|
|
|
AQP3
|
[NCBI]
|
3.18078e-07
|
|
|
RTN4R
|
[NCBI]
|
3.18078e-07
|
|
|
CDK9
|
[NCBI]
|
3.18078e-07
|
|
|
APOH
|
[NCBI]
|
3.18078e-07
|
|
|
IFNB1
|
[NCBI]
|
3.18078e-07
|
|
|
NR1H4
|
[NCBI]
|
3.18078e-07
|
|
|
TGFB1
|
[NCBI]
|
3.15089e-07
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
3.13748e-07
|
|
|
thyroid carcinoma, papillary
|
[NCBI]
|
3.08735e-07
|
|
|
CEL
|
[NCBI]
|
3.04905e-07
|
|
|
SVAS
|
[NCBI]
|
2.91769e-07
|
|
|
pancreatic cancer, susceptibility to, 1
|
[NCBI]
|
2.75068e-07
|
|
|
FMO2
|
[NCBI]
|
2.75068e-07
|
|
|
TD2
|
[NCBI]
|
2.75068e-07
|
|
|
SCA5
|
[NCBI]
|
2.75068e-07
|
|
|
F5F8D
|
[NCBI]
|
2.75068e-07
|
|
|
palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal
|
[NCBI]
|
2.75068e-07
|
|
|
MPD1
|
[NCBI]
|
2.75068e-07
|
|
|
NEM2
|
[NCBI]
|
2.75068e-07
|
|
|
legg-calve-perthes disease
|
[NCBI]
|
2.75068e-07
|
|
|
winchester syndrome
|
[NCBI]
|
2.75068e-07
|
|
|
AEXS
|
[NCBI]
|
2.75068e-07
|
|
|
twinning, monozygotic
|
[NCBI]
|
2.75068e-07
|
|
|
myasthenic syndrome, congenital, fast-channel
|
[NCBI]
|
2.75068e-07
|
|
|
LGMD2J
|
[NCBI]
|
2.75068e-07
|
|
|
succinyl-coa:3-oxoacid coa transferase deficiency
|
[NCBI]
|
2.75068e-07
|
|
|
pancreas, annular
|
[NCBI]
|
2.75068e-07
|
|
|
AOII
|
[NCBI]
|
2.75068e-07
|
|
|
amme complex
|
[NCBI]
|
2.75068e-07
|
|
|
endometrial cancer
|
[NCBI]
|
2.75068e-07
|
|
|
vacterl association with hydrocephalus
|
[NCBI]
|
2.75068e-07
|
|
|
hand-foot-uterus syndrome
|
[NCBI]
|
2.75068e-07
|
|
|
complement component 5 deficiency
|
[NCBI]
|
2.75068e-07
|
|
|
sulfocysteinuria
|
[NCBI]
|
2.75068e-07
|
|
|
frontonasal dysplasia
|
[NCBI]
|
2.75068e-07
|
|
|
EJM1
|
[NCBI]
|
2.75068e-07
|
|
|
ALS4
|
[NCBI]
|
2.75068e-07
|
|
|
DSAP1
|
[NCBI]
|
2.75068e-07
|
|
|
pierson syndrome
|
[NCBI]
|
2.75068e-07
|
|
|
congenital disorder of glycosylation, type i/iix
|
[NCBI]
|
2.75068e-07
|
|
|
FSGS1
|
[NCBI]
|
2.75068e-07
|
|
|
thyrotoxic periodic paralysis
|
[NCBI]
|
2.75068e-07
|
|
|
weill-marchesani syndrome, autosomal recessive
|
[NCBI]
|
2.75068e-07
|
|
|
foveal hypoplasia and presenile cataract syndrome
|
[NCBI]
|
2.75068e-07
|
|
|
polymicrogyria, bilateral frontoparietal
|
[NCBI]
|
2.75068e-07
|
|
|
SPMM
|
[NCBI]
|
2.75068e-07
|
|
|
GBS
|
[NCBI]
|
2.75068e-07
|
|
|
drug metabolism, poor, cyp2c19-related
|
[NCBI]
|
2.75068e-07
|
|
|
TNFRSF1A
|
[NCBI]
|
2.74141e-07
|
|
|
EIF2C2
|
[NCBI]
|
2.66688e-07
|
|
|
FST
|
[NCBI]
|
2.66688e-07
|
|
|
VIL2
|
[NCBI]
|
2.66688e-07
|
|
|
PRKCA
|
[NCBI]
|
2.66688e-07
|
|
|
SELE
|
[NCBI]
|
2.66688e-07
|
|
|
GJD2
|
[NCBI]
|
2.66688e-07
|
|
|
TERF1
|
[NCBI]
|
2.66688e-07
|
|
|
BAK1
|
[NCBI]
|
2.66688e-07
|
|
|
CNR1
|
[NCBI]
|
2.66688e-07
|
|
|
CD99
|
[NCBI]
|
2.66688e-07
|
|
|
POLD1
|
[NCBI]
|
2.66688e-07
|
|
|
FCGR3A
|
[NCBI]
|
2.66688e-07
|
|
|
SYT1
|
[NCBI]
|
2.58617e-07
|
|
|
CSF1
|
[NCBI]
|
2.58617e-07
|
|
|
NR4A3
|
[NCBI]
|
2.58617e-07
|
|
|
IGHV
|
[NCBI]
|
2.58617e-07
|
|
|
TLR3
|
[NCBI]
|
2.54129e-07
|
|
|
UBTF
|
[NCBI]
|
2.54129e-07
|
|
|
CDC2
|
[NCBI]
|
2.49427e-07
|
|
|
DFFB
|
[NCBI]
|
2.39206e-07
|
|
|
MET
|
[NCBI]
|
2.36011e-07
|
|
|
SKP2
|
[NCBI]
|
2.36011e-07
|
|
|
DSTN
|
[NCBI]
|
2.34031e-07
|
|
|
ETV6
|
[NCBI]
|
2.28634e-07
|
|
|
DHH
|
[NCBI]
|
2.28634e-07
|
|
|
HSPB1
|
[NCBI]
|
2.28634e-07
|
|
|
PLD2
|
[NCBI]
|
2.28634e-07
|
|
|
MNS
|
[NCBI]
|
2.00833e-07
|
|
|
weaver syndrome
|
[NCBI]
|
2.00833e-07
|
|
|
BGS
|
[NCBI]
|
2.00833e-07
|
|
|
bladder cancer
|
[NCBI]
|
2.00833e-07
|
|
|
SCN1
|
[NCBI]
|
2.00833e-07
|
|
|
CEBPE
|
[NCBI]
|
1.94872e-07
|
|
|
TRPC6
|
[NCBI]
|
1.94872e-07
|
|
|
DDB1
|
[NCBI]
|
1.94872e-07
|
|
|
NRP2
|
[NCBI]
|
1.94872e-07
|
|
|
CBX1
|
[NCBI]
|
1.94872e-07
|
|
|
PAPSS1
|
[NCBI]
|
1.94872e-07
|
|
|
WNT4
|
[NCBI]
|
1.94872e-07
|
|
|
RSN
|
[NCBI]
|
1.94872e-07
|
|
|
HIRA
|
[NCBI]
|
1.94872e-07
|
|
|
MAPK6
|
[NCBI]
|
1.94872e-07
|
|
|
PBK
|
[NCBI]
|
1.94872e-07
|
|
|
ERBB3
|
[NCBI]
|
1.94872e-07
|
|
|
TNFSF13
|
[NCBI]
|
1.94872e-07
|
|
|
HAL
|
[NCBI]
|
1.94872e-07
|
|
|
RB1CC1
|
[NCBI]
|
1.94872e-07
|
|
|
MBD4
|
[NCBI]
|
1.94872e-07
|
|
|
FKHL16
|
[NCBI]
|
1.94872e-07
|
|
|
PICK1
|
[NCBI]
|
1.94872e-07
|
|
|
KIF5B
|
[NCBI]
|
1.94872e-07
|
|
|
ADRBK1
|
[NCBI]
|
1.94872e-07
|
|
|
GH2
|
[NCBI]
|
1.94872e-07
|
|
|
CHEK1
|
[NCBI]
|
1.94872e-07
|
|
|
NANOG
|
[NCBI]
|
1.94872e-07
|
|
|
PPP1CA
|
[NCBI]
|
1.94872e-07
|
|
|
TYK2
|
[NCBI]
|
1.94872e-07
|
|
|
NCOR1
|
[NCBI]
|
1.94872e-07
|
|
|
PTPRF
|
[NCBI]
|
1.94872e-07
|
|
|
PCSK2
|
[NCBI]
|
1.94872e-07
|
|
|
ACCN1
|
[NCBI]
|
1.94872e-07
|
|
|
EPHX2
|
[NCBI]
|
1.94872e-07
|
|
|
KIF3A
|
[NCBI]
|
1.94872e-07
|
|
|
SLC4A4
|
[NCBI]
|
1.94872e-07
|
|
|
DCD
|
[NCBI]
|
1.94872e-07
|
|
|
DSCAM
|
[NCBI]
|
1.94872e-07
|
|
|
EYA2
|
[NCBI]
|
1.94872e-07
|
|
|
MGAT1
|
[NCBI]
|
1.94872e-07
|
|
|
ITGA4
|
[NCBI]
|
1.94872e-07
|
|
|
MYCBP2
|
[NCBI]
|
1.94872e-07
|
|
|
VCL
|
[NCBI]
|
1.94872e-07
|
|
|
RAC2
|
[NCBI]
|
1.94872e-07
|
|
|
SATB1
|
[NCBI]
|
1.94872e-07
|
|
|
SYT2
|
[NCBI]
|
1.94872e-07
|
|
|
SMARCA3
|
[NCBI]
|
1.94872e-07
|
|
|
AMPH
|
[NCBI]
|
1.94872e-07
|
|
|
APBA1
|
[NCBI]
|
1.94872e-07
|
|
|
WHSC1
|
[NCBI]
|
1.94872e-07
|
|
|
CD28
|
[NCBI]
|
1.94872e-07
|
|
|
ADSS
|
[NCBI]
|
1.94872e-07
|
|
|
CD151
|
[NCBI]
|
1.94872e-07
|
|
|
ELAVL4
|
[NCBI]
|
1.94872e-07
|
|
|
TMSB4X
|
[NCBI]
|
1.94872e-07
|
|
|
OXTR
|
[NCBI]
|
1.94872e-07
|
|
|
SLC5A6
|
[NCBI]
|
1.94872e-07
|
|
|
EFNA5
|
[NCBI]
|
1.94872e-07
|
|
|
FCER1A
|
[NCBI]
|
1.94872e-07
|
|
|
CTSG
|
[NCBI]
|
1.94872e-07
|
|
|
TOP1
|
[NCBI]
|
1.94872e-07
|
|
|
GRID2
|
[NCBI]
|
1.94872e-07
|
|
|
HIGM1
|
[NCBI]
|
1.92807e-07
|
|
|
CLL
|
[NCBI]
|
1.92807e-07
|
|
|
XLP1
|
[NCBI]
|
1.92807e-07
|
|
|
SJS1
|
[NCBI]
|
1.92807e-07
|
|
|
meningioma, familial
|
[NCBI]
|
1.92807e-07
|
|
|
A2M
|
[NCBI]
|
1.80843e-07
|
|
|
myasthenic syndrome, congenital, associated with episodic apnea
|
[NCBI]
|
1.79279e-07
|
|
|
alpha-thalassemia/mental retardation syndrome, deletion-type
|
[NCBI]
|
1.79279e-07
|
|
|
heterotopia, periventricular, x-linked dominant
|
[NCBI]
|
1.79279e-07
|
|
|
vitamin d-dependent rickets, type i
|
[NCBI]
|
1.79279e-07
|
|
|
lipoid congenital adrenal hyperplasia
|
[NCBI]
|
1.79279e-07
|
|
|
HPE3
|
[NCBI]
|
1.79279e-07
|
|
|
CTHM
|
[NCBI]
|
1.79279e-07
|
|
|
PGM1
|
[NCBI]
|
1.78315e-07
|
|
|
IGFBP3
|
[NCBI]
|
1.59029e-07
|
|
|
MTA1
|
[NCBI]
|
1.59029e-07
|
|
|
DTNBP1
|
[NCBI]
|
1.59029e-07
|
|
|
SEMA4D
|
[NCBI]
|
1.59029e-07
|
|
|
ECE1
|
[NCBI]
|
1.59029e-07
|
|
|
SDC1
|
[NCBI]
|
1.59029e-07
|
|
|
RHOA
|
[NCBI]
|
1.59029e-07
|
|
|
MMP13
|
[NCBI]
|
1.59029e-07
|
|
|
APOA4
|
[NCBI]
|
1.59029e-07
|
|
|
ID1
|
[NCBI]
|
1.59029e-07
|
|
|
TBX21
|
[NCBI]
|
1.59029e-07
|
|
|
TMPO
|
[NCBI]
|
1.59029e-07
|
|
|
PDCD1
|
[NCBI]
|
1.59029e-07
|
|
|
PDC
|
[NCBI]
|
1.59029e-07
|
|
|
SSTR5
|
[NCBI]
|
1.59029e-07
|
|
|
NFATC2
|
[NCBI]
|
1.59029e-07
|
|
|
CNP
|
[NCBI]
|
1.59029e-07
|
|
|
CAMP
|
[NCBI]
|
1.59029e-07
|
|
|
NTF3
|
[NCBI]
|
1.59029e-07
|
|
|
HSF1
|
[NCBI]
|
1.59029e-07
|
|
|
MGMT
|
[NCBI]
|
1.59029e-07
|
|
|
adipocyte-derived leucine aminopeptidase
|
[NCBI]
|
1.59029e-07
|
|
|
ARNT
|
[NCBI]
|
1.58759e-07
|
|
|
ENPP1
|
[NCBI]
|
1.57522e-07
|
|
|
TNFRSF14
|
[NCBI]
|
1.57522e-07
|
|
|
MAP4K2
|
[NCBI]
|
1.57333e-07
|
|
|
CTSD
|
[NCBI]
|
1.57333e-07
|
|
|
TDG
|
[NCBI]
|
1.57333e-07
|
|
|
NME1
|
[NCBI]
|
1.57333e-07
|
|
|
MYH6
|
[NCBI]
|
1.57333e-07
|
|
|
SSTR2
|
[NCBI]
|
1.57333e-07
|
|
|
PSNP1
|
[NCBI]
|
1.54317e-07
|
|
|
DLG1
|
[NCBI]
|
1.52434e-07
|
|
|
IKBKB
|
[NCBI]
|
1.52434e-07
|
|
|
TCRB
|
[NCBI]
|
1.52434e-07
|
|
|
TNFRSF10A
|
[NCBI]
|
1.52434e-07
|
|
|
amyloidosis vi
|
[NCBI]
|
1.48617e-07
|
|
|
neuroblastoma
|
[NCBI]
|
1.4479e-07
|
|
|
CSA
|
[NCBI]
|
1.4479e-07
|
|
|
DRD2
|
[NCBI]
|
1.26471e-07
|
|
|
MST1
|
[NCBI]
|
1.09599e-07
|
|
|
FXYD1
|
[NCBI]
|
1.09599e-07
|
|
|
SLC16A1
|
[NCBI]
|
1.09599e-07
|
|
|
hepatocellular carcinoma
|
[NCBI]
|
1.04508e-07
|
|
|
ALMS
|
[NCBI]
|
1.04508e-07
|
|
|
MAPK3
|
[NCBI]
|
1.00765e-07
|
|
|
CLPED1
|
[NCBI]
|
1.00404e-07
|
|
|
OPTA2
|
[NCBI]
|
1.00404e-07
|
|
|
renal cell carcinoma, papillary
|
[NCBI]
|
1.00404e-07
|
|
|
FTC
|
[NCBI]
|
1.00404e-07
|
|
|
RNS
|
[NCBI]
|
1.00404e-07
|
|
|
LRS1
|
[NCBI]
|
1.00404e-07
|
|
|
RHN
|
[NCBI]
|
1.00404e-07
|
|
|
AML
|
[NCBI]
|
1.00404e-07
|
|
|
xx male syndrome
|
[NCBI]
|
1.00404e-07
|
|
|
c syndrome
|
[NCBI]
|
1.00404e-07
|
|
|
NIDDM1
|
[NCBI]
|
1.00404e-07
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 2
|
[NCBI]
|
1.00404e-07
|
|
|
HPP
|
[NCBI]
|
1.00404e-07
|
|
|
hexokinase deficiency hemolytic anemia
|
[NCBI]
|
1.00404e-07
|
|
|
polydactyly, postaxial, type a1
|
[NCBI]
|
1.00404e-07
|
|
|
NPHP3
|
[NCBI]
|
1.00404e-07
|
|
|
ACG2
|
[NCBI]
|
1.00404e-07
|
|
|
sc phocomelia syndrome
|
[NCBI]
|
1.00404e-07
|
|
|
SCA12
|
[NCBI]
|
1.00404e-07
|
|
|
CDKN1A
|
[NCBI]
|
9.59757e-08
|
|
|
adenylyl cyclase, soluble
|
[NCBI]
|
9.04111e-08
|
|
|
GPX1
|
[NCBI]
|
9.04111e-08
|
|
|
PPIB
|
[NCBI]
|
9.04111e-08
|
|
|
ABL1
|
[NCBI]
|
8.72017e-08
|
|
|
ATHS
|
[NCBI]
|
8.40376e-08
|
|
|
DHS
|
[NCBI]
|
8.40376e-08
|
|
|
IGF2
|
[NCBI]
|
8.39666e-08
|
|
|
MAP3K7
|
[NCBI]
|
8.31261e-08
|
|
|
MYB
|
[NCBI]
|
8.31261e-08
|
|
|
CYCS
|
[NCBI]
|
8.31261e-08
|
|
|
EBF
|
[NCBI]
|
8.31261e-08
|
|
|
AMPD1
|
[NCBI]
|
8.31261e-08
|
|
|
LRE1
|
[NCBI]
|
8.31261e-08
|
|
|
MPL
|
[NCBI]
|
8.31261e-08
|
|
|
SLC1A5
|
[NCBI]
|
7.8663e-08
|
|
|
FHL2
|
[NCBI]
|
7.8663e-08
|
|
|
ITCH
|
[NCBI]
|
7.8663e-08
|
|
|
FACL4
|
[NCBI]
|
7.8663e-08
|
|
|
TBPL1
|
[NCBI]
|
7.8663e-08
|
|
|
DUT
|
[NCBI]
|
7.8663e-08
|
|
|
PDCD1LG1
|
[NCBI]
|
7.8663e-08
|
|
|
PLEC1
|
[NCBI]
|
7.8663e-08
|
|
|
IGHM
|
[NCBI]
|
7.8663e-08
|
|
|
HTR1A
|
[NCBI]
|
7.8663e-08
|
|
|
BAG4
|
[NCBI]
|
7.8663e-08
|
|
|
RIPK2
|
[NCBI]
|
7.8663e-08
|
|
|
TAS1R3
|
[NCBI]
|
7.8663e-08
|
|
|
LRP6
|
[NCBI]
|
7.8663e-08
|
|
|
PRND
|
[NCBI]
|
7.8663e-08
|
|
|
CCNB1
|
[NCBI]
|
7.8663e-08
|
|
|
SLC22A2
|
[NCBI]
|
7.8663e-08
|
|
|
INSIG1
|
[NCBI]
|
7.8663e-08
|
|
|
IQGAP1
|
[NCBI]
|
7.8663e-08
|
|
|
RGS9
|
[NCBI]
|
7.8663e-08
|
|
|
C1QA
|
[NCBI]
|
7.8663e-08
|
|
|
NPTX2
|
[NCBI]
|
7.8663e-08
|
|
|
CBFB
|
[NCBI]
|
7.8663e-08
|
|
|
IFIH1
|
[NCBI]
|
7.8663e-08
|
|
|
NXF1
|
[NCBI]
|
7.8663e-08
|
|
|
CD3G
|
[NCBI]
|
7.8663e-08
|
|
|
PYCARD
|
[NCBI]
|
7.8663e-08
|
|
|
INSIG2
|
[NCBI]
|
7.8663e-08
|
|
|
HMGCR
|
[NCBI]
|
7.8663e-08
|
|
|
TLX1
|
[NCBI]
|
7.8663e-08
|
|
|
FGF18
|
[NCBI]
|
7.8663e-08
|
|
|
ALPI
|
[NCBI]
|
7.8663e-08
|
|
|
ST8SIA4
|
[NCBI]
|
7.8663e-08
|
|
|
SECISBP2
|
[NCBI]
|
7.8663e-08
|
|
|
TOP2A
|
[NCBI]
|
7.8663e-08
|
|
|
MUC2
|
[NCBI]
|
7.8663e-08
|
|
|
CTSE
|
[NCBI]
|
7.8663e-08
|
|
|
ACO2
|
[NCBI]
|
7.8663e-08
|
|
|
ATP2B2
|
[NCBI]
|
7.8663e-08
|
|
|
PDPK1
|
[NCBI]
|
7.8663e-08
|
|
|
BIN1
|
[NCBI]
|
7.8663e-08
|
|
|
GRIP1
|
[NCBI]
|
7.8663e-08
|
|
|
DAB2
|
[NCBI]
|
7.8663e-08
|
|
|
FMOD
|
[NCBI]
|
7.8663e-08
|
|
|
GATA2
|
[NCBI]
|
7.8663e-08
|
|
|
ATSV
|
[NCBI]
|
7.8663e-08
|
|
|
CD80
|
[NCBI]
|
7.8663e-08
|
|
|
LAMB1
|
[NCBI]
|
7.8663e-08
|
|
|
PFKL
|
[NCBI]
|
7.62127e-08
|
|
|
GGH
|
[NCBI]
|
7.62127e-08
|
|
|
AHCY
|
[NCBI]
|
7.62127e-08
|
|
|
SLC27A1
|
[NCBI]
|
7.62127e-08
|
|
|
BID
|
[NCBI]
|
7.62127e-08
|
|
|
NDN
|
[NCBI]
|
7.62127e-08
|
|
|
OGG1
|
[NCBI]
|
7.62127e-08
|
|
|
SCCA1
|
[NCBI]
|
7.62127e-08
|
|
|
NEFH
|
[NCBI]
|
7.62127e-08
|
|
|
FOXE1
|
[NCBI]
|
7.62127e-08
|
|
|
AURKA
|
[NCBI]
|
7.62127e-08
|
|
|
RGMA
|
[NCBI]
|
7.62127e-08
|
|
|
HIC1
|
[NCBI]
|
7.62127e-08
|
|
|
LMO2
|
[NCBI]
|
7.62127e-08
|
|
|
CSF3R
|
[NCBI]
|
7.62127e-08
|
|
|
TNFRSF10C
|
[NCBI]
|
7.62127e-08
|
|
|
SORBS1
|
[NCBI]
|
7.62127e-08
|
|
|
ASNS
|
[NCBI]
|
7.62127e-08
|
|
|
MAPK14
|
[NCBI]
|
6.71699e-08
|
|
|
VLDLR
|
[NCBI]
|
6.71699e-08
|
|
|
MYH11
|
[NCBI]
|
6.53976e-08
|
|
|
GNMT
|
[NCBI]
|
6.53976e-08
|
|
|
TNFRSF1B
|
[NCBI]
|
6.53976e-08
|
|
|
aneurysm, intracranial berry, 1
|
[NCBI]
|
6.45866e-08
|
|
|
RARA
|
[NCBI]
|
5.03749e-08
|
|
|
MLP
|
[NCBI]
|
4.3596e-08
|
|
|
SFRP1
|
[NCBI]
|
4.3596e-08
|
|
|
CREB1
|
[NCBI]
|
4.3596e-08
|
|
|
POAG
|
[NCBI]
|
3.6064e-08
|
|
|
LPL
|
[NCBI]
|
3.50191e-08
|
|
|
ERBB2
|
[NCBI]
|
3.47832e-08
|
|
|
RPS6KA5
|
[NCBI]
|
3.35815e-08
|
|
|
NRTN
|
[NCBI]
|
3.35815e-08
|
|
|
CPD
|
[NCBI]
|
3.35815e-08
|
|
|
CA1
|
[NCBI]
|
3.35815e-08
|
|
|
CTSB
|
[NCBI]
|
3.35815e-08
|
|
|
ANXA5
|
[NCBI]
|
3.35815e-08
|
|
|
HBEGF
|
[NCBI]
|
3.35815e-08
|
|
|
VAMP2
|
[NCBI]
|
3.35815e-08
|
|
|
DSG1
|
[NCBI]
|
3.20976e-08
|
|
|
AGTR1
|
[NCBI]
|
3.20976e-08
|
|
|
DHRD
|
[NCBI]
|
2.88851e-08
|
|
|
diarrhea 1, secretory chloride, congenital
|
[NCBI]
|
2.88851e-08
|
|
|
ICP
|
[NCBI]
|
2.88851e-08
|
|
|
HPC1
|
[NCBI]
|
2.88851e-08
|
|
|
IGHG1
|
[NCBI]
|
2.62802e-08
|
|
|
SLC11A1
|
[NCBI]
|
2.5705e-08
|
|
|
IGF1
|
[NCBI]
|
2.5705e-08
|
|
|
RAMP1
|
[NCBI]
|
2.17968e-08
|
|
|
ACTG1
|
[NCBI]
|
2.17968e-08
|
|
|
PIM1
|
[NCBI]
|
2.17968e-08
|
|
|
CSF2RB
|
[NCBI]
|
2.17968e-08
|
|
|
RASSF1
|
[NCBI]
|
2.17968e-08
|
|
|
CDK5R1
|
[NCBI]
|
2.17968e-08
|
|
|
LIMK1
|
[NCBI]
|
2.17968e-08
|
|
|
GRIN2B
|
[NCBI]
|
2.17968e-08
|
|
|
ONECUT1
|
[NCBI]
|
2.17968e-08
|
|
|
PEPA
|
[NCBI]
|
2.17968e-08
|
|
|
AQP7
|
[NCBI]
|
2.17968e-08
|
|
|
NCL
|
[NCBI]
|
2.17968e-08
|
|
|
NQO1
|
[NCBI]
|
2.17968e-08
|
|
|
CBP2
|
[NCBI]
|
2.17968e-08
|
|
|
PDE4D
|
[NCBI]
|
2.17968e-08
|
|
|
CD82
|
[NCBI]
|
2.17968e-08
|
|
|
CSPG5
|
[NCBI]
|
2.17968e-08
|
|
|
MEST
|
[NCBI]
|
2.17968e-08
|
|
|
LAMR1
|
[NCBI]
|
2.17968e-08
|
|
|
SKI
|
[NCBI]
|
2.17968e-08
|
|
|
RANBP2
|
[NCBI]
|
2.17968e-08
|
|
|
FYN
|
[NCBI]
|
2.17968e-08
|
|
|
GABBR1
|
[NCBI]
|
2.17968e-08
|
|
|
CYP3A5
|
[NCBI]
|
2.17968e-08
|
|
|
MBD2
|
[NCBI]
|
2.17968e-08
|
|
|
ICOSLG
|
[NCBI]
|
2.17968e-08
|
|
|
glycogen storage disease ib
|
[NCBI]
|
2.16336e-08
|
|
|
BMP2
|
[NCBI]
|
2.05219e-08
|
|
|
CXCR4
|
[NCBI]
|
1.98062e-08
|
|
|
GDF5
|
[NCBI]
|
1.98062e-08
|
|
|
IL13
|
[NCBI]
|
1.98062e-08
|
|
|
LOX
|
[NCBI]
|
1.97925e-08
|
|
|
GNPAT
|
[NCBI]
|
1.67899e-08
|
|
|
BMI1
|
[NCBI]
|
1.67899e-08
|
|
|
GLUL
|
[NCBI]
|
1.67899e-08
|
|
|
IVL
|
[NCBI]
|
1.67899e-08
|
|
|
CX3CL1
|
[NCBI]
|
1.67899e-08
|
|
|
MAP3K8
|
[NCBI]
|
1.67899e-08
|
|
|
DKK1
|
[NCBI]
|
1.67899e-08
|
|
|
PFN1
|
[NCBI]
|
1.67899e-08
|
|
|
SSRP1
|
[NCBI]
|
1.67899e-08
|
|
|
NNAT
|
[NCBI]
|
1.67899e-08
|
|
|
ADH3
|
[NCBI]
|
1.67899e-08
|
|
|
TGFB3
|
[NCBI]
|
1.67899e-08
|
|
|
CD55
|
[NCBI]
|
1.67899e-08
|
|
|
UBQLN1
|
[NCBI]
|
1.67899e-08
|
|
|
TFAP2A
|
[NCBI]
|
1.67899e-08
|
|
|
MMP14
|
[NCBI]
|
1.67899e-08
|
|
|
PAG1
|
[NCBI]
|
1.67899e-08
|
|
|
MEIS1
|
[NCBI]
|
1.67899e-08
|
|
|
GABBR2
|
[NCBI]
|
1.67899e-08
|
|
|
NEDD9
|
[NCBI]
|
1.67899e-08
|
|
|
ITPR1
|
[NCBI]
|
1.67899e-08
|
|
|
AURKB
|
[NCBI]
|
1.67899e-08
|
|
|
SEPT5
|
[NCBI]
|
1.67899e-08
|
|
|
BAI1
|
[NCBI]
|
1.67899e-08
|
|
|
PLK3
|
[NCBI]
|
1.67899e-08
|
|
|
WNT3A
|
[NCBI]
|
1.67899e-08
|
|
|
ERAF
|
[NCBI]
|
1.67899e-08
|
|
|
MYF5
|
[NCBI]
|
1.67899e-08
|
|
|
PEA15
|
[NCBI]
|
1.67899e-08
|
|
|
TRIM24
|
[NCBI]
|
1.67899e-08
|
|
|
PCBP2
|
[NCBI]
|
1.67899e-08
|
|
|
phosphoglycerate mutase, muscle, deficiency of
|
[NCBI]
|
1.67899e-08
|
|
|
robinow syndrome, autosomal recessive
|
[NCBI]
|
1.44208e-08
|
|
|
coumarin resistance
|
[NCBI]
|
1.44208e-08
|
|
|
TTP
|
[NCBI]
|
1.44208e-08
|
|
|
GCE
|
[NCBI]
|
1.44208e-08
|
|
|
SLN
|
[NCBI]
|
1.31387e-08
|
|
|
KLF1
|
[NCBI]
|
9.35064e-09
|
|
|
NOS3
|
[NCBI]
|
9.35064e-09
|
|
|
isoniazid inactivation
|
[NCBI]
|
8.88087e-09
|
|
|
OCRL
|
[NCBI]
|
8.36164e-09
|
|
|
NEM3
|
[NCBI]
|
8.36164e-09
|
|
|
deafness, aminoglycoside-induced
|
[NCBI]
|
7.20957e-09
|
|
|
AITD3
|
[NCBI]
|
7.20957e-09
|
|
|
cystathioninuria
|
[NCBI]
|
7.20957e-09
|
|
|
vacterl association with hydrocephalus, x-linked
|
[NCBI]
|
7.20957e-09
|
|
|
AMDM
|
[NCBI]
|
7.20957e-09
|
|
|
MRX9
|
[NCBI]
|
7.20957e-09
|
|
|
lipomatosis, familial benign cervical
|
[NCBI]
|
7.20957e-09
|
|
|
NPHP2
|
[NCBI]
|
7.20957e-09
|
|
|
KCS
|
[NCBI]
|
7.20957e-09
|
|
|
de sanctis-cacchione syndrome
|
[NCBI]
|
7.20957e-09
|
|
|
psoriatic arthritis, susceptibility to
|
[NCBI]
|
7.20957e-09
|
|
|
kuru, susceptibility to
|
[NCBI]
|
7.20957e-09
|
|
|
IDD
|
[NCBI]
|
7.20957e-09
|
|
|
hermaphroditism, true
|
[NCBI]
|
7.20957e-09
|
|
|
AIH2
|
[NCBI]
|
7.20957e-09
|
|
|
carnitine palmitoyltransferase i deficiency
|
[NCBI]
|
7.20957e-09
|
|
|
globozoospermia
|
[NCBI]
|
7.20957e-09
|
|
|
RP10
|
[NCBI]
|
7.20957e-09
|
|
|
omphalocele
|
[NCBI]
|
7.20957e-09
|
|
|
BPP
|
[NCBI]
|
7.20957e-09
|
|
|
deafness, autosomal recessive
|
[NCBI]
|
7.20957e-09
|
|
|
IDE
|
[NCBI]
|
7.19411e-09
|
|
|
MAP2K1
|
[NCBI]
|
6.59612e-09
|
|
|
LDHA
|
[NCBI]
|
6.59612e-09
|
|
|
CRYAA
|
[NCBI]
|
6.59612e-09
|
|
|
MTND3
|
[NCBI]
|
6.59612e-09
|
|
|
NUP98
|
[NCBI]
|
6.59612e-09
|
|
|
CTSL
|
[NCBI]
|
1.95512e-09
|
|
|
XIST
|
[NCBI]
|
9.73393e-10
|
|
|
MTAP
|
[NCBI]
|
6.48859e-10
|
|
|
ESR2
|
[NCBI]
|
4.86618e-10
|
|
|
ALDH2
|
[NCBI]
|
4.86618e-10
|
|
|
BGN
|
[NCBI]
|
4.86618e-10
|
|
|
GZMB
|
[NCBI]
|
3.24395e-10
|
|
|
FGFR4
|
[NCBI]
|
3.24395e-10
|
|
|
ENAH
|
[NCBI]
|
1.62189e-10
|
|
|
RECK
|
[NCBI]
|
1.62189e-10
|
|
|
F13B
|
[NCBI]
|
1.62189e-10
|
|
|
PIN1
|
[NCBI]
|
1.62189e-10
|
|
|
GDF11
|
[NCBI]
|
1.62189e-10
|
|
|
MSN
|
[NCBI]
|
1.62189e-10
|
|
|
MIRNLET7A1
|
[NCBI]
|
1.62189e-10
|
|
|
CDC25A
|
[NCBI]
|
1.62189e-10
|
|
|
SKP1A
|
[NCBI]
|
1.62189e-10
|
|
|
PITX1
|
[NCBI]
|
1.62189e-10
|
|
|
KLK1
|
[NCBI]
|
1.62189e-10
|
|
|
NR1D1
|
[NCBI]
|
1.62189e-10
|
|
|
SFRP4
|
[NCBI]
|
1.62189e-10
|
|
|
EIF2S1
|
[NCBI]
|
1.62189e-10
|
|
|
G22P1
|
[NCBI]
|
1.62189e-10
|
|
|
CTBP1
|
[NCBI]
|
1.62189e-10
|
|
|
OGN
|
[NCBI]
|
1.62189e-10
|
|
|
diphosphoglycerate mutase deficiency of erythrocyte
|
[NCBI]
|
1.62189e-10
|
|
|
ATP5O
|
[NCBI]
|
1.62189e-10
|
|
|
ICOS
|
[NCBI]
|
1.62189e-10
|
|
|
PRDX5
|
[NCBI]
|
1.62189e-10
|
|
|
ART4
|
[NCBI]
|
1.62189e-10
|
|
|
ASCL1
|
[NCBI]
|
1.62189e-10
|
|
|
SIX1
|
[NCBI]
|
1.62189e-10
|
|
|
GRM1
|
[NCBI]
|
1.62189e-10
|
|
|
EZH2
|
[NCBI]
|
1.62189e-10
|
|
|
LTA4H
|
[NCBI]
|
1.62189e-10
|
|
|
ADD1
|
[NCBI]
|
1.62189e-10
|
|
|
GADD45A
|
[NCBI]
|
1.62189e-10
|
|
|
HDAC5
|
[NCBI]
|
1.62189e-10
|
|
|
ID3
|
[NCBI]
|
1.62189e-10
|
|
|
DYRK1A
|
[NCBI]
|
1.62189e-10
|
|
|
STAT2
|
[NCBI]
|
1.62189e-10
|
|
|
HHEX
|
[NCBI]
|
1.62189e-10
|
|
|
ICAM5
|
[NCBI]
|
1.62189e-10
|
|